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Breast Conserving Surgery (BCS) in the treatment of breast cancer aims to 
provide optimal oncological results, with minimal tissue excision to optimise 
cosmetic outcome. Positive margins due to an inadequate resection occurs in 
17% of UK patients undergoing BCS and prompts recommendation for further 
tissue re-excision to reduce recurrence risk. A second operation causes patient 
anxiety and significant healthcare costs. This issue could be resolved with 
accurate intra-operative margin analysis (IMA) to enable excision of all cancerous 
tissue at the index procedure. High wavenumber Raman Spectroscopy (HWN 
RS) is a vibrational spectroscopy highly sensitive to changes in protein/lipid 
environment and water content –biochemical differences found between tumour 
and normal breast tissue. We proposed that HWN RS could be used to 
differentiate between tumour and non-tumour breast tissue with a view to future 
IMA. 
 
This thesis presents the development of a Raman system to measure the HWN 
region capable of accurately detecting changes in protein, lipid and water content, 
in the presence of highly fluorescent surgical pigments such as blue dye that are 
present in surgically excised specimens. We investigate the relationship between 
changes in the HWN spectra with changes in water content in constructed breast 
phantoms to mimic protein and lipid rich environments and biological tissue. 
Human breast tissue of paired tumour and non-tumour samples were then 
measured and analysed. We found that breast tumour tissue is a protein rich, 
high water, low fat environment and that non-tumour is a low protein, fat rich 
environment with a low water content, and this can be used to identify breast 
cancer using HWN RS with excellent accuracy of over 90%. 
 
This thesis demonstrates a HWN RS Raman system capable of differentiating 
between tumour and non-tumour tissue in human breast tissue, and this has the 
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CHAPTER 1: Background 
 
1.1 Breast cancer  
1.1.1 Incidence 
Breast cancer is the most common cancer to affect women in the world and the 
second most common cancer overall, accounting for 6.6% of all cancer deaths 1. 
There is an incidence of 55,000 cases per year in the UK with a 1 in 8 lifetime 
risk for women, accounting for 15% of all cancer diagnoses in the UK and over 
11,000 deaths per year 2. This represents a significant burden to the NHS and a 
major public health issue for the UK. Cancer survival in the UK lags behind many 
other European countries, and an emphasis on earlier diagnosis and 5 other 
priority areas was highlighted in the Cancer Strategy Implementation Plan 2015-
2020 to improve cancer survival, and demonstrates that cancer care remains a 
priority for NHS England 3. 
 
The incidence rate of breast cancer is rising and there is a much higher incidence 
in high-income countries such as western Europe and the USA 4. This is 
postulated to be due to the primary risk factors being difficult to modify, and 
lifestyle risk factors becoming increasingly prevalent in Western lifestyle, such as 
obesity, late age of first child and reduced fertility rate. The known protective 
factors of breast cancer are breastfeeding – the relative risk decreases by 4.3% 
for every 12 months of breastfeeding - and a moderate degree of physical activity 
5. 
 
The risk factors associated with breast cancer are 1: 
Age – increasing age, however the rate doubles every 10 years until menopause 
then the rate slows 6. Therefore, the largest proportion of breast cancer is in 
women aged 45-69. 
Geographical location – Higher incidence in western Europe and USA 4. Migrants 
from a low risk area to a high risk area show the same incidence within one or 
two generations demonstrating the significance of environmental factors 6, with a 




Timing of onset/cessation of menses – early age at menarche and later age at 
menopause is associated with an increased risk of breast cancer 
Reproduction – nulliparity, late age at first birth and having fewer children 
increases the risk of breast cancer 
Exogenous hormone intake – oral contraception use (particularly the combined 
pill containing oestrogens) 8  and hormone replacement therapy 
Nutrition – increased alcohol intake increases the risk of breast cancer 
Cigarette Smoking – possible direct link to increased incidence, though it is not a 
significant risk factor 9 
Anthropometry – increased weight, weight gain during adulthood and body fat 
distribution 
Breast density- dense breasts increase the risk of breast cancer. Although breast 
density is affected by age and certain hormonal agents (such as tamoxifen and 
HRT), the relative risk of breast cancer is increased four to fivefold in women with 
high density breasts compared to those with low density breasts 5. 
Genetics –Being a carrier of the identified gene mutation BRCA 1 or 2 increases 
risk of breast cancer 10, with a lifetime risk of 60-85% for BRCA1 carriers, and 50-
85% for BRCA 2 carriers 6. 4-5% of breast cancer is due to inheritance of a high-
penetrance, autosomal dominant, cancer pre-disposing gene 11. Therefore, 
certain family histories, even without identified gene mutations, may result in a 




Figure 1-1 Summary of NICE guidelines for those at greater risk of breast cancer based on Family 
History.  
Patients with a family history that fits these criteria should be referred to a secondary care family history 




Although incidence is increasing, mortality rates have improved substantially over 
the last 40 years. Survival at 1, 5 and 10 years has improved. At 10 years, survival 
has risen from 40% in 1971-72 to 78 % for those patients diagnosed in 2010-11 
(Figure 1-2).  One reason for this is improved early diagnosis and the 
establishment of the UK breast screening programme in 1987; even adjusting for 
the lead time bias introduced by early detection, screen-detected cancers had a 
substantial survival advantage compared to those that were symptom detected 
13. Another reason is the substantial improvements in essentially all treatments 
particularly radiotherapy, hormonal therapy, molecular profiling of cancers with 
targeted treatments, and the advent of individualised treatments based on 
genetic profiling. This rate of improved long term survival has not plateaued, 





The cost of treating breast cancer in the USA in 2008 is estimated to be USD $20 
– 100, 000 for a lifetime per patient cost of breast cancer 16. The cost to the whole 
US healthcare economy is estimated to be USD 15-20 billion for the year 2001. 
USD 16.5 billion is spent each year on breast cancer diagnosis and treatment, 
and as it occurs in a young age group, there are economic factors such as lost 
work productivity which increases the cost. The cost continues to rise as the 
Figure 1-2. Graph showing  Age-Standardised Ten-Year Net Survival, Women (Aged 15-99), England 
and Wales, 1971-2011 . 
There is an increase in net 10 year survival in those diagnosed with Breast Cancer. Credit – Cancer 




incidence increases, and treatment (particularly new, targeted drug treatment) 
gets more sophisticated leading to increased survivorship.  
 
It can be seen that Breast cancer is an increasingly important public health issue, 
with a large number of women being diagnosed with the disease and this is a 
financially expensive disease for society. Improving efficiency of diagnosis and 
reducing treatment costs whilst continuing to see a continuation in survivorship is 
a priority for the NHS.  
 
1.1.2 Anatomy of the breast 
The mammary glands are modified sweat glands in the superficial fascia anterior 
to the pectoral muscles and the anterior thoracic wall. The breast lies on the 
underlying muscle separated by a layer of deep connective tissue that forms the 




Although there is a degree of variation in size, the breast is positioned on the 
anterior thoracic wall between ribs II and VI, overlying the pectoralis major 
muscle. The breast extends superolaterally around the lower margin of pectoralis 
major and enters the axilla. 
 
Arterial supply and venous drainage 17 
The breast gains its blood supply from the vessels of the axillary artery (superior 
thoracic, thoraco-acromial, lateral thoracic and subscapular arteries, medially 
from branches of the internal thoracic artery and perforator vessels from the 
thoracic wall from the second third and fourth intercostal arteries). 
Venous drainage is via veins that mirror the arterial system, and drain to the 
axillary, internal thoracic and intercostal veins. Innervation is from the anterior 
and lateral cutaneous branches of the second to sixth intercostal nerves, the 
nipple being innervated by the fourth intercostal nerve. 
 
Lymphatic drainage 
The lymphatic system is an extensive network of channels that drain the fluid 




and deliver it back to the venous system 17. The lymph system is a major route of 
spread of cancer from one body organ or space to another, and particularly in 
breast cancer, the lymph system is often the first route of invasion, therefore the 
anatomy of the lymph drainage is important in understanding breast cancer. 
 
Lymphatic drainage of a breast is: 
- 75% via lymphatic vessels draining laterally and superiorly into axillary 
nodes 
- The majority of the rest drain medially to parasternal nodes associated 
with the internal mammary artery 





Figure 1-3 Diagram showing the underlying structures of the breast, its anatomical relationships, the 
arterial supply and venous and lymphatic drainage.  
Lymphatic drainage is denoted by green arrows -note that Level I axillary lymph nodes are those defined 
below Pectoralis Minor, Level II underneath pectoralis minor, and Level III any lymph nodes above pectoralis 
minor. Reprinted from Gray’s Anatomy for Students, 4th Ed, Drake, Vigl and Mitchell, Thorax, Page No 133., 





The anatomy of the human breast was originally described by Cooper in 1840 
based on an extensive number of dissections and the majority of the concepts 
remain unchanged 18. The breast is composed of fat, and a series of ducts and 
associated secretory lobules that consist of clusters of alveoli containing 
lactocytes that during lactation undergo widespread hypertrophy and hyperplasia 
and synthesise breastmilk 19. These lobules then converge to form ducts, the 
number of which was originally thought to be around 22, but is now thought to be 
a more modest 5-9 based on  more recent ultrasound studies 18, 20. These 
lactiferous ducts then open independently onto the nipple 17 (Figure 1-4). Adipose 
tissue is between lobes rather than within lobules and a connective tissue stroma 
surrounds the ducts and lobules, which condense in some regions to form the 
Astley Cooper ligaments, which support the breast. There is significant variation 
in the number and size of ducts and amount of glandular / fat tissue between 
women, but is consistent between breasts within women 20.  
 
The development of the female breast is under hormonal control of progesterone 
and prolactin during pubertal mammogenesis, and continues to respond to the 
fluctuations of oestrogen and progesterone associated with the menstrual cycle 
and ageing 21. Glandular tissue is abundant in lactation with a corresponding 
increase and engorgement in breast size, whereas glandular tissue reduces with 













1.1.3 Pathology of breast cancer 
Although there are other cancers of the breast, this thesis mainly deals with the 
most common types of ductal carcinoma (both in situ and invasive) and lobular 
carcinoma. The most common location of tumours within the breast are upper 
outer quadrant (50%), and central portion (20%) with 4% of women having 
bilateral primary tumours.  
 
1.1.3.1 Carcinogenesis 
The development of cancer is a result of the dysregulation of the body’s normal 
mechanisms for controlling cellular growth. Kumar et al. highlight three main 
features that underpin carcinogenesis, and succinctly describe the fundamental 
shared characteristics of cancers 23:   
 
Figure 1-4 Diagram showing Cross – section of the female breast demonstrating the relationship of 
fat, lobules and ducts.  
The mammary glands that produce milk drain to lactiferous sinuses that discharge to the nipple during 
lactation. Reprinted from Gray’s Anatomy for Students, 4th Ed, Drake, Vigl and Mitchell, Thorax, Page No 




1. All cancers are to some degree due to DNA mutations, either induced 
spontaneously or through environmental insult.  
- An example in breast cancer is the HER2/NEU protooncogene, that is 
associated with a poor prognosis 
2. These genetic alterations are therefore heritable, and so family history is 
an important risk factor of cancer 
- An example in breast cancer are the previously discussed BRCA 
mutations 
3. Accumulation of mutations result in the hallmarks of cancer; 
-  Self- sufficiency in growth signals and autonomous growth which is 
unregulated 
- lack of response to inhibitory mechanisms of cell proliferation 
- evasion of cell death 
- limitless replicative potential 
- development of angiogenesis to sustain tumour growth 
- ability to invade local tissues and systemic spread (distant metastases) 
- reprogramming of metabolic pathways 
- ability to evade the immune system 
 
In breast cancer this dysregulated growth arises from cells in the terminal lobular 
unit.  
 
Breast cancer is classified according to whether it is in situ and therefore has not 
breached the basement membrane (which does not have the capacity to 
metastasise) or it has breached the basement membrane (and has the capacity 








Non invasive (in situ) Breast cancer 
This can be either Ductal or Lobular in origin (DCIS or LCIS). DCIS is the 
commonest form of non invasive cancer, it can be mass forming (though rare) 
but is associated with mammographically detectable calcifications. It therefore 
accounts for 3 – 4% of symptomatic cancers, and 17-25% of screen detected 
cancers 6, 24. Histologically DCIS has a wide variation and is associated with 
pleomorphic cells with areas of calcified necrotic debris or calcified secretary 
material 25. 
 
DCIS is generally treated once it is detected, and the treatment is similar for 
invasive breast cancer with surgical excision. The reason for treating DCIS is that 
it is associated with a higher risk of developing invasive cancer with a cumulative 
incidence of invasive breast cancer of 38% after 10 years 26, and there is a small 
risk of metastasis, likely due to undiagnosed small foci of invasive cancer within 
DCIS 25. The natural history of pure DCIS is unknown as it has traditionally been 
treated; however one study looking at incompletely excised DCIS with no other 
treatment demonstrated that low-grade DCIS may follow an indolent course 27. 
The incidence (number of new cases per year) of such lesions has increased 
considerably (particularly in older patients) with screening 28. Therefore, there are 
concerns that breast abnormalities that may not be life limiting are being 
overtreated , and the LORIS trial has been established to compare outcomes of 
primary excision versus 10 year active surveillance in screen detected or 
incidental low risk pure DCIS lesions 24. 
Figure 1-5 Diagram showing the difference between normal breast duct, DCIS and invasive breast 
cancer.  
The purple cells represent abnormal ‘cancerous’ cells, the orange cells the basement membrane. It is only 
then the cancerous cells breach the basement membrane do the cells become a true cancer, with an ability 




In comparison, LCIS is neither mass forming nor associated with calcifications 
and is nearly always an incidental finding in biopsies. LCIS has a uniform 
appearance with round nuclei in clusters within the lobules 25. A diagnosis of LCIS 
is associated with an increased risk of breast cancer, and is managed only with 
regular follow up 6. 
 
Invasive Carcinoma 
The majority of invasive cancers have no special type – and are referred to as 
Invasive Ductal Carcinoma (IDC) and account for 85% of invasive breast cancer. 
Histologically this is a heterogenous group of tumours ranging from well- 
developed tubule formation and low grade nuclei to anaplastic cells 23. They are 
commonly hard mass forming cancers, which replace normal fat tissue. There 
are a number of special subtypes such as lobular (which account for 10% of 
invasive breast cancer) and tubular, cribiform, papillary, mucinous and medullary 
(accounting for the rest) 6.  
Breast cancers are histologically graded Grade I (best prognosis) to Grade III 
(poorest prognosis), based on the type of tumour, mitotic rate and degree of 
cellular differentiation. 
 
Despite the wide range of histopathological characteristics which do have a 
prognostic significance, these histological subtypes of invasive breast cancers 
are diagnosed and treated in a similar may and will be considered as a single 
group in the rest of this thesis.  
 
1.1.3.2 Molecular Subtypes 
Even before modern medicine, it was recognised that breast cancer was a 
heterogenous disease as patients could present in very similar fashions, but 
some progressed rapidly, whereas some patients stayed alive for many years (up 
to 20 years) without treatment 26, 29. An increasingly clinically relevant pathological 
distinction between breast cancers is receptor expression. If a cancer expresses 
a particular receptor to a higher degree than its surrounding normal tissue, this 








The (o)Estrogen receptor (ER) is present in 75% of breast cancers and can be 
targeted in treatment. The majority of ER positive tumours also present 
progesterone receptors (PR), this cannot be targeted therapeutically, but has 
prognostic significance. A tumour that is ER and PR positive, has a better 
prognosis than a tumour that is ER positive, but PR negative.  
 
Growth Factor Receptors 
Growth factor receptors show increased expression and activation in breast 
cancer.  Tyrosine kinase receptors such as the Human Epidermal Growth Factor 
(HER) receptors have been therapeutically targeted; HER2 being the most 
relevant. A tumour that is HER2 positive is a biologically poor prognostic indicator, 
but with modern treatments (Tranztuzamab) that target this receptor, this is no 
longer necessarily the case 30. 
 
Genomic Profiling 
Recent advances in genomic profiling of the molecular subtypes of breast cancer 
are revealing that these biochemical differences in tumours also signify 
underlying differences in cancer biology and can be subtyped to identify the 
prognostic significance between groups and an ability to predict response to 
therapies. 
 
Gene expression profiling based on receptor expression has developed to show 
four different prognostic groups 31 , Figure 1-6 shows the difference in survival 
between the groups, which are: 
 
Luminal A – High level of ER and a low proliferation rate. HER2 -ve. 
Luminal B – Lower level of ER and a high proliferation rate. HER2 -ve. 
HER2 +ve (or ERBB2+) – HER2+ve and either ER + or - 
Basal like – ER -, PR -, HER2 -ve – so called ‘triple negative’ tumours and tend 







1.1.3.3 Other Prognostic factors 
Alongside these molecular classifications of breast cancer, there are more 
traditional prognostic factors which have been known about for decades: 
Tumour size – the larger the tumour, the greater the risk of metastasis and a 
worse prognosis 33.  
Lymph node spread – The number of axillary lymph nodes involved with tumour. 
The more lymph nodes, the worse the prognosis, with > 4 lymph nodes having a 
particularly poor prognosis 34. This is a prognostic marker, rather than the simple 
idea that all metastatic activity occurs through the ipsilateral lymph nodes, 
exemplified by the fact that patients with node negative disease can still develop 
metastatic disease 35. 
Histological grade- those with a Grade I tumour have a significantly better survival 
than those with Grade II or III tumours 36. 
 
These factors can then be used to inform prognostic classification systems which 
are used to guide treatment decisions. The commonest used methods are the 
T(umour) N(ode) M(etastasis) staging, and the Nottingham Prognostic index 
(NPI).  
Figure 1-6. Kaplan Meier survival graph of overall survival for 72 patients with locally advanced 
breast disease in a Norway cohort according to molecular subtype. 







The TNM classification is an evolving method of stratifying tumours. There is a 
‘clinical’ stage which is based on pre- operative staging, and this can be modified 
with the subsequent pathological diagnosis from the excised tumour, denoted by 
a pre-script ‘p’. The TNM classification ascribes a number to each category, the 
combination of which then stratifies the disease into a Stage grouping.  A 
modified, and simplified description of clinical TNM staging is described in Figure 
1-7. A criticism of using this staging classification system is that it relies on clinical 





T(umour) Primary Tumour 
Tis Carcinoma in situ e.g. DCIS 
T1 Tumour <2 cm in greatest dimension 
T2 Tumour 2-5 cm in greatest dimension 
T3 Tumour >5cm in greatest dimension 
T4 Tumour of any size with direct extension to chest wall or skin 
N(odes),Regional Lymph nodes 
N0 No regional lymph node metastasis 
N1 Metastases to movable ipsilateral level I,II axillary lymph nodes 
N2 Metastases to ipsilateral axillary lymph nodes that are fixed or to 
ipsilateral internal mammary nodes 
N3 Metastasis to ipsilateral level III axillary lymph nodes, internal 
mammary nodes AND axillary lymph nodes, any supraclavicular 
lymph nodes 
M(etastasis) 
M1 No distant metastasis 
M2 Distant metastasis  
 
Stage T N M 
0 Tis N0 M0 
I T1 N0 M0 
IIA T1 N1 M0 
T2 N0 M0 
IIB T2 N1 M0 
T3 N0 M0 
IIIA T0-2 N2 M0 
T3 N1 or 2 M0 
IIIB T4 N0,1,2 M0 
IIIC Any T N3 M0 
IV Any T Any N M1 
 
Figure 1-7 TNM staging classification and stage grouping. 




The Nottingham Prognostic Index (NPI) uses similar information, but from the 
pathological diagnosis only, in Equation 1-1 38: 
 
NPI = [0.2 X S] + N + G 
 
The resultant score can give an estimated 5 year survival 39. Both of the TNM 
and NPI tools are used regularly to guide management and inform prognosis. 
Increasingly online tools such as Adjuvant! Online and Predict! are used to 
determine prognosis and how different treatments would be expected to change 
survival rate. The clinician inputs a wide range of the patient and tumour 
characteristics, and the algorithm predicts the patient individualised prognostic 
outcome 40. 
 
1.1.4 Diagnosis  
Patients are diagnosed with Breast cancer in a secondary care setting having 
received a tissue diagnosis. There are two routes through which the vast majority 
of Breast cancer is diagnosed, and they represent different patient groups, and 




Despite screening, the majority of patients diagnosed with breast cancer are 
diagnosed through another route, primarily after referral to a breast unit with 
symptoms. Patients who present with breast symptoms and demographics that 
are associated with a risk of breast cancer are referred to secondary care through 
a fast track service for assessment (Figure 1-8) 41. Speed of assessment is 
critical, as a delay in presentation and treatment of breast cancer is associated 
with a worse survival outcome 42. Symptoms of Breast cancer include breast lump 
(the commonest), breast asymmetry, nipple retraction and nipple discharge 6. 
Patient symptoms are taken in context of their other risk factors, for example the 
positive predictive value (PPV) of a breast lump in women aged 40 -49 being 
breast cancer is 4.8%, compared to a PPV of 48% in women aged >70 years 43. 
Patients undergo ‘triple assessment’ during this clinic, which is discussed later. 
Equation 1-1 The Nottingham Prognostic Index 
S = size of index lesion (cm), N = Nodal status (0 nodes = 1; 1-3 nodes = 2, >3 nodes = 3), and G = Grade 


















Around one quarter of the 55,000 cancers diagnosed per year in the UK are 
diagnosed after screening 41. Screening invitations in the UK are currently offered 
to all women aged 50-70, with a phased rolling out to women aged 47-73. Breast 
cancer screening involves a single mammogram once every three years 44. 1 in 
23 women are called back after attending their screening mammogram for further 
tests, such as repeat mammogram, MRI or biopsy of a suspicious lesion 45. 
Breast cancer screening reduces mortality, as cancers are diagnosed at an 
earlier, and more treatable stage 46. Treating breast cancer at an earlier stage of 
the disease also reduces the overall cost of disease treatment, as it is less likely 
to require expensive adjuvant treatments 47 . Screening prevents 1 breast cancer 
death for every 200 women who are screened regularly 45 and in a meta-analysis 
of 11 studies they found that there was a reduction of 20% in the relative risk of 
mortality from breast cancer in screening patients compared to those not 
screened 48. 
 
Despite this, screening is controversial as there are concerns over a number of 
issues. Over-diagnosis, where a non-life threatening breast cancer is diagnosed 
and treated, is a concern as this causes the morbidity of breast cancer treatment 
with no survival benefit. It was estimated in a Danish trial that there was 2.1 cases 
Figure 1-8 Summary box outlining the ‘fast track’ referral criteria from primary care to secondary 
care for urgent evaluation by a Breast specialist41 
Refer people using a suspected cancer pathway referral (for an 
appointment within 2 weeks) for breast cancer if they are: 
• Aged 30 and over have an unexplained breast lump with or 
without pain or 
• Aged 50 and over with any of the following symptoms in one 
nipple only: 
o Discharge or 
o Retraction or 
o Other changes of concern 
Consider a suspected cancer pathway referral (for an appointment 
within 2 weeks) for breast cancer in people: 
• With skin changes that suggest breast cancer or 




of overdiagnosis per 1000 patients screened 49 and in an analysis of all nations 
offering screening, there was on overall rate of 1 in 3 breast cancers being over 
diagnosed 50. False positive mammograms leading to unnecessary further 
investigation can cause distress and reduces the chance of the patient attending 
subsequent screening invitations 51. Other risks include false reassurance 
leading to subsequent delayed presentation 52, pain and discomfort of 
mammograms 53, and the small radiation risk from mammograms (there are an 
estimated 0.07 radiation induced breast cancers per 1000 women screened)  45.  
 
For these reasons, current uptake of Breast screening is around 70% nationally, 
with many regions falling below the minimum standard for uptake 54. Some 
nations are re-thinking breast cancer screening, with Switzerland recently 
abolishing its breast screening programme citing over-diagnosis concerns as a 
primary reason 55. 
 
1.1.4.3 Triple assessment  
After being referred to a symptomatic clinic or re-called after screening, patients 
are clinically assessed through a history and examination by a specialist Breast 
surgeon/physician, have imaging which is either a mammogram or ultrasound or 
both, depending on their age 56, and if there is a discreet lesion – a core biopsy 
is taken for histopathological diagnosis.  
 
Imaging 
Mammogram is the primary mode of diagnostic imaging for breast cancer 
detection both in screening and symptomatic patients. With the patient standing, 
the breast is compressed between paddles and two X-ray images (cranio-caudal 
and mediolateral oblique) per breast are obtained 6. In one study of 2020 patients 
with a subsequent pathological diagnosis of breast cancer, mammogram alone 
had a sensitivity of 82.9% and specificity of 91.9% for breast cancer detection, 
compared to a combination of mammogram, ultrasound and clinical examination 
(which is usual clinical practice) 57. Factors particularly affecting diagnostic 
accuracy are - increased breast density, heterogenous breast density and young 






Ultrasound is used in addition to mammograms for breast cancer diagnosis, or 
for those under 35 years old as the primary modality. Patients are positioned lying 
on a couch, and the breast is not restricted, and so it is used for guiding biopsies, 
or localised tumours prior to surgery. Ultrasound alone has a sensitivity of 87.6% 
and a specificity of 95.5% when compared to the usual practice of US, 
mammogram and clinical examination of the breast 57, and is particularly useful 
in differentiating between solid and cystic lesions 6. The use of both mammogram 
and ultrasound for detection of breast cancer in a screening population results in 
an improved sensitivity and specificity compared to the techniques used alone 59. 
 
Pathology 
Biopsy samples are now recommended to be taken by core biopsy or vacuum 
assisted core biopsy as this preserves cellular architecture and increases 
diagnostic yield compared to traditional fine needle aspiration (FNA) 44, 60, 61. 
Biopsies are taken from areas of suspicion either by clinical palpation for a 
palpable mass undetected on imaging, or under image guidance if detected by 
imaging such as for non- palpable masses and areas of suspicious heterogeneity 
(such as distortion or asymmetric density areas of calcification on the 
mammogram) 44, 62.  
 
Once taken, biopsy tissue must be fixed in formalin as soon as possible, as a 
delay in formalin fixation by just an hour can reduce the sensitivity of techniques 
in elucidating biomarkers such as progesterone and HER2 receptor status 63. 
After fixation, samples are cut and embedded in paraffin and haematoxylin and 
eosin stained. A histopathologist will then analyse the slide and perform any 
necessary immunohistochemistry to be able to provide the tumour classification, 
grade of tumour, receptor status 64   
 
Although histopathology is the current gold standard for the tissue diagnosis of 
breast cancer, there are issues with the technique. It is slow, the standard time 
for turn-around of a biopsy sample is two weeks. Due to the number of processes 
involved in the analysis of a specimen there are a number of points of potential 
human error 65, 66. There is also a degree of inter-observer variability in aspects 
of histopathological analysis, in a study of 115 pathologists independently reading 




diagnosis with the expert consensus derived diagnosis 67. A particular issue in 
breast cancer is the reporting of the grade which is highly variable – in one study 
with six pathologists, the statistical agreement on grade diagnosis varied from 
moderate to substantial 68, and in a study involving five pathologists, absolute 
agreement was only agreed on in 83% of cases 69.  
 
Multi Disciplinary Team Meeting (MDT) 
The MDT is an important concept in cancer care in the UK, and is designed to 
reduce the unwarranted variation in patient care in the NHS 70. It is a weekly 
meeting with a representative from all clinical members involved with breast 
cancer care attendance, particularly breast surgeons, radiologists, pathologists 
and breast cancer nurses. All patients with a core needle biopsy result should be 
discussed at an MDT 44. During this meeting, all information regarding the 
patients’ diagnosis is presented to agree on a diagnosis and suggest a 
management plan. Treatment is based on patient characteristics, such as co-
morbidities and patient wishes, and tumour characteristics such as TNM stage, 
NPI and grade of tumour.  
 
There is a paucity of evidence demonstrating the efficacy of the MDT 71. And a 
variety of evidence to suggest that not all patients suitable for MDT are discussed 
in the meeting 72, there is a large variation in their use between countries 73 and 
an inability to reach consensus decision in 27-52% of cases in one systematic 
review 74. Despite these criticisms, an effective MDT improves patient outcomes. 
A systematic review of 12 studies demonstrated an improved patient survival 
after the introduction of a cancer MDT 75, and the mortality rate was found to be 
11% lower in an area of Scotland that introduced an MDT compared to an area 
with similar survival statistics prior to the intervention that did not introduce an 
MDT over the same time period 76.  
 
1.1.5 Management of early breast cancer 
Surgery remains the first line treatment in the majority of early and locally 
advanced breast cancer. Recent advancements in adjuvant and neo – adjuvant 





1.1.5.1 Adjuvant therapy 
The recent decrease in mortality from Breast cancer 14, despite a rising incidence, 
is likely due to the widespread adoption of adjuvant systemic therapies. The aim 
of adjuvant therapy is to improve disease free survival and reduce local 
recurrence rate, whilst taking into account the (sometime significant) side effects. 
Breast cancer is a heterogenous disease, and the precise management decisions 
are tailored to the patient and the biology of the tumour, which is decided at MDT. 
A comprehensive review of all possible adjuvant therapies and ongoing clinical 
trials is beyond the scope of this thesis, what follows is a highlighting of the 
common treatment types. 
 
Endocrine therapy 
Around 75% of breast cancers are ER+ve 77 and modulation of ER activation in 
these cancers is essential. This includes stopping any oestrogen containing 
contraception or Hormone replacement therapy, and consideration of ovarian 
suppression with GnRH agonist in high risk pre-menopausal women 78. 
Tamoxifen – is a competitive oestrogen receptor antagonist, blocking estradiol 
from binding and activating the estrogen receptor. It reduces the risk of death by 
around one-third during 5 years of treatment, with some benefit up to 10 years 79. 
NICE recommends offering tamoxifen in ER positive invasive breast cancer for 
men, premenopausal women and postmenopausal women with low risk of 
disease recurrence 56. 
Aromatase Inhibitors (AI)– the mechanism of action is by inhibition of the 
enzyme aromatase that converts androgens into oestrogens. In the ATAC trial, 
looking at an AI and tamoxifen alone or in combination demonstrated that AI 
alone was superior in terms of disease free survival 80, and another trial 
demonstrated a possible survival advantage for those taking AI alone 81. AI is 
contraindicated in premenopausal women and have significant side effects of 
sexual dysfunction, and NICE recommends AI in postmenopausal women with 
ER positive disease at medium or high risk of recurrence 56. 
 
Chemotherapy 
The recommended chemotherapy regime in the treatment of breast cancer is a 
combination containing a taxane (e.g. docetaxel)  and anthracycline (e.g. 




the annual risk of recurrence by almost 25% and reduce breast cancer mortality 
by a third 82. The decision to initiate chemotherapy is based on the benefits of 
survival versus the significant side effects, and is generally offered in higher risk 
patients. The gain from chemotherapy is higher for younger women than in older 
women. A number of factors is taken into account by the MDT in deciding whether 
to offer chemotherapy, this includes age, axillary nodal status, ER status, and 
DNA micro analysis in the form of Oncotype DX 6.  
 
Biological Therapy 
Trastuzamab is a recombinant humanised monoclocal antibody that binds to the 
HER2 receptor and antagonises its activation. It is recommended in HER2 
positive tumours in the adjuvant setting 56, and when given concurrently with 
chemotherapy leads to a decrease in recurrence and death 83 in these tumours 
that classically had a poor prognosis. 
 
Radiotherapy  
Radiotherapy is a local treatment (compared to the systemic treatments of other 
adjuvant therapies) and is a part of breast conserving therapy and is always given 
to the remaining breast tissue after breast conserving surgery 84. Depending on 
the disease characteristics and staging, radiotherapy is given for locally 
advanced tumours and can be given to the tumour bed, axilla, supraclavicular 
fossa and inframammary chain 56. Radiotherapy significantly reduces 
locoregional recurrence and improves survival in locally advanced disease 85. 
 
1.1.5.2 Surgery 
The aim of an oncological resection is to remove the minimal amount of tissue 
necessary to reduce trauma and collateral structure damage, whilst excising the 
entirety of the diseased tissue 86. 
 
Mastectomy 
A mastectomy is the removal of all breast tissue of a single breast, and is the 
traditional operation for the treatment of breast cancer. Originally a Halstead 
mastectomy included removal of the underlying pectoral muscle and all axillary 
lymph nodes as well, but with a recognition that this did not always improve 




modified ‘simple’ mastectomy.  It accounts for 30 – 40 % of breast cancer 
operations. Local recurrence can occur in any residual breast cells which may 
remain, or associated with the scar. 
 
Breast Conserving Therapy 
With the increasing realisation that breast cancer was a systemic disease, the 
improvement of adjuvant therapies, and the detection of smaller cancers through 
mammography and screening, less invasive surgical treatments were developed. 
Breast conserving therapy consists of Breast Conserving Surgery (wide local 
excision of the tumour) – the aim being to remove all cancerous tissue with a 
margin of normal surrounding tissue, followed by whole breast radiotherapy. The 
surgeon makes an incision either over the cancer, or in a more cosmetically 
sensitive place on the breast and excises the breast cancer in a lump, with a rim 
of healthy tissue (roughly aiming for 1 cm of normal feeling tissue around the 







The original randomised trial demonstrating the safety of breast conserving 
therapy was by Fisher et al. where 1843 women were assigned to one of three 
Figure 1-9 Diagram demonstrating options for incisions for Breast conserving surgery.  
Yellow area denotes location of tumour, grey shaded area is the area of tissue resected by surgeon (to 





groups – total mastectomy, segmental mastectomy, and segmental mastectomy 
with breast irradiation 84, this study at the 5 year follow up actually found improved 
disease free survival and overall survival with segmental mastectomy and 
irradiation compared to total mastectomy. There are differences between the 
study conditions and current practice which could limit these conclusions, such 
as greater breast tissue volume excision than current lumpectomy, higher 
radiation doses, and that all patients received systemic chemotherapy. However, 
the findings have been repeatedly confirmed with more current practices, and a 
meta-analysis of nine trials comparing mastectomy with breast conserving 
therapy demonstrated no significant difference in 10 year mortality 87, and review 
of six randomised controlled trials showed no difference in rates of local control 
88, and so mastectomy and breast conserving therapy are viewed as equivalent 
in providing oncological control of disease. 
 
Indications for breast conserving therapy are T1, T2 (tumour < 4 cm), NO, N1, 
M0 tumours, T2 tumour > 4 cm in large breast, unifocal lesions. Contraindications 
are T4, N2 or M1 lesions, multifocal disease, large tumours in small breasts and 
women with a strong family history or proven BRCA genetic mutations 6. The 
advantages of breast conserving therapy compared to mastectomy are related to 
lower psychological morbidity with less anxiety, depression, and an improved 
body image, sexuality and self-esteem 89, 90.  
 
A significant issue with BCS is that incomplete excision and subsequent positive 
pathological margins lead to a second operation for re-excision of margins in 
around 17% of patients in the UK 91  to achieve clear resection margins, which is 
necessary to reduce recurrence rate 92. The current gold standard for margin 
analysis and the rationale for need for intraoperative margin analysis is explored 
in greater detail in section 1.3 of this thesis.  
 
Axillary Surgery 
The management of the axilla in breast cancer continues to be controversial. 
Although having metastatic carcinoma in the ipsilateral axillary lymph nodes has 
undoubted prognostic significance 34, the removal or treatment of these lymph 
nodes with radiotherapy may not carry a survival benefit 93, 94. Therefore, axillary 




Sentinel lymph node biopsy – this is performed in all patients with invasive 
breast cancer with a pre-operative diagnosis of a node negative axilla 95. 
Radioactive and blue dye is injected into the breast to identify the first node(s) 
that the breast drains, and these lymph nodes are excised for staging purposes 
96. If the excised lymph nodes do not contain cancer, no further axillary treatment 
is required. If the excised lymph node(s) do(es) contain cancer the patient may 
be offered axillary lymph node clearance or axillary radiotherapy 94 (this is an area 
of active clinical trials 97). 
Axillary Lymph Node Clearance – in patients who are pre-operatively identified 
as having a node positive axilla with US imaging and pathological confirmation 





Breast cancer is a potentially life-limiting disease, and due to the high, and 
increasing, incidence the disease and its treatment is a significant burden to 
populations and healthcare systems globally. Although there have been 
advancements in treatments and survival has improved, there remains a clinical 
need for improvements in delivering cancer care. Breast Conserving surgery is 
the commonest operation performed for breast cancer, and the issue of positive 
resection margins requiring re-operation is a significant source of anxiety to 
patients, and an expensive burden for healthcare systems. If the resection 
margins of a lumpectomy specimen could be analysed at the time of the index 
operation -intraoperative margin analysis (IMA)- this could reduce the need for 
repeat operations, and improve patient cancer care. The Association of Breast 
Surgeons gap analysis working group recently produced a report highlighting that 
research into technologies that could provide IMA were a priority for surgical 
research 98. Raman Spectroscopy is a method of vibrational spectroscopy that 
can assess the disease specific molecular compositional changes in the cells and 





1.2 Background of Raman Spectroscopy 
1.2.1 The theory of Raman scattering 
Raman scattering is the inelastic scattering of light. When light is directed on a 
molecule, light may either pass through it without any interaction or may interact 
with the molecule – where two processes can occur. The molecule can either 
absorb energy from the incident photon and it is transferred to a higher energy 
state (which is measured in absorption spectroscopy) or it can scatter the incident 
photon, which is measured in Raman spectroscopy.  
 
Light as a form of radiation may be considered both in terms of a wave (with a 
wavelength) and as a particle (a photon) with a discreet amount of energy. The 
amount of energy the light has is related to the wave properties. The energy of a 
photon (E) is related to wave frequency (v) by Equation 1-2: 
𝐸 =  ℎ𝑣 
 Where ℎ = Plancks constant (6.62607004X 10 -34m2kg/s) 
 
The wave frequency (v) is inversely related to the wavelength (𝜆) by Equation 
1-3: 
𝜆 = 𝑐 𝜈⁄  
 Where c = the velocity of light (299,792,458 m/s2) 
 
Therefore, wave frequency is linearly related with energy (Equation 1-4): 
𝜈 =  Δ𝐸 ℎ⁄  
 
and wavelength is inversely related to energy, thus the shortest wavelength 
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Figure 1-10 The Electromagnetic spectrum on the wavelength scale in metres with associated 




The Raman effect was first described experimentally by Raman in 1928 by 
focusing sunlight through a telescope onto samples of purified liquid or dust-free 
vapour, and observing scattered radiation with a different frequency to the 
incident light 99. Nowadays a single wavelength of light is used to provide a 
coherent wavelength as an incident beam to irradiate the sample, and the energy 
changes that can be detected are more subtle, but the principles remain the 
same.  
 
At room temperature the majority of molecules will be in a low energy, ground 
state. When an incident light source interacts with a molecule and the incident 
photon interacts with the molecule it forms a short-lived state of excitement due 
to its polarization of electrons and is promoted to a ‘virtual state’, which is 
unstable, and a photon is re-radiated. Elastic scattering accounts for the majority 
of scattering and occurs when there is only electron cloud distortion involved in 
the scattering process. It is common, and due to the light weight of electrons, 
results in very small frequency change to scattering photons and the molecule 
returns to its ground state and so the scattered photon is of equal energy to that 
of the incident photon. This is called Rayleigh scattering in molecules. Inelastic 
Raman scattering occurs when the energy transfer is significant enough to cause 
nuclear motion. There is energy exchange between incident photon and 
molecule, or molecule to scattered photon. Once the molecule has temporarily 
been promoted to a higher energy excited vibrational state it returns back to an 
energy state that is different to its original state. In this process there is a 
difference of one vibrational unit between incident photon and scattered photon, 
and this is Raman scattering. In Raman scattering there is Stokes and anti-Stokes 
scattering. During Stokes scattering the molecule absorbs energy and is 
promoted to a higher energy excited vibrational state. Some molecules may 
already be in an excited energy state due to thermal energy, and when these 
molecules return to ground state this will result in a scattered photon – this is anti-
Stokes scattering. These energy exchanges are depicted in Figure 1-11. For 
most molecules, at room temperature, the number of molecules at the elevated 
excited energy state would be very small, thus Stokes scattering will be 
prevalent.100. Although highly specific, Raman scattering is considered weak, with 









In order for a molecule to scatter light it requires polarizability, which is the ability 
of an electric field to induce a dipole moment in a molecule. The induced dipole 
moment () is equal to the molecule polarizability () and the incident electric 
field (E) ; Equation 1-5 101:  
 =  E 
 
A change in molecule polarizability is therefore required to change the amplitude 
modulation of the dipole moment that is necessary for Stokes and anti-Stokes 
emission. The change in molecular polarizability occurs through molecular 
vibration and is a result of the alteration in the electron cloud about the molecule. 
The molecular vibration is described by translation of the molecule in space, and 
rotational movement. The degree of symmetry defines how Raman active a 
molecule will be, with symmetrical and nonpolar groups being the most active 101. 
Therefore the molecule, and the molecule number (N), the polarizability of the 
molecule (), the incident laser intensity (Io), frequency of the laser (v), and the 
vibrational amplitude (Q) all determine the intensity of the Raman scattered 
radiation (IR), the relationship is shown in Equation 1-6: 
Figure 1-11. A Jablonski energy diagram of quantum energy transitions for Rayleigh and Raman 
scattering.  
In Rayleigh scattering the energy level returns to its original state and there is no change in energy. In Raman 
scattering the energy level returns to a different state- either gaining (anti-Stokes scattering) or losing (Stokes 
scattering) energy and so the scattered light has a different wavelength to that of the incident light, which 













From this it can be concluded that by increasing the frequency of the laser, or 
using a shorter wavelength can increase the Raman intensity. It is also 
demonstrated that a change of molecular polarizability is essential for a molecule 
to be Raman active.  101 
 
The degree or type of scattering, and the gain or loss of energy, is dependent on 
the degree of movement a molecule has which is a product of its atoms and 
bonds, resulting in each molecule producing a unique Raman spectrum, or 
‘fingerprint’100 . In a steady electrical state, the energy of a molecule is divided 
into different ‘degrees of freedom’. Three degrees of freedom describe the 
translation of the molecule in space, and three describe rotational movement. 
Molecules thus undergo a number of bond vibrations, symmetrical (when it is 
symmetric about the centre) vibrations causing the greatest electron cloud 
distortion and a greater Raman scattering. Bond vibrations include symmetric 





Figure 1-12 Schematic diagram demonstrating the different modes of bond vibrations that may occur 
within a molecule.  





The molecular bond can be mathematically considered to be a spring between 
two masses, and so relationship between the weight of the atom, and the strength 










Where c – the velocity of light, K is the force constant of the bond between atoms 
A and B (which is measure of bond strength), and  is the reduced mass of atoms 
A and B of masses MA and MB which are related by Equation 1-8; 




And it can be seen that the lighter the atom, and the stronger the bond, the higher 
the frequency. The product of these features, along with the different types of 
vibration, will therefore give different energies/wavelengths and different 
intensities for each molecule. 
 
The unique vibration of an atom or bond therefore gives a peak of increased 
intensity of scattered light at a particular wavelength on the spectrum. As the 
wavelength of a particular peak will differ according to the wavelength of the 
incident light, the Raman shift (the energy difference between incident light and 
the scattered (detected) light) is usually used to describe peaks to allow 
comparison of data between different incident lights. As molecules are a result of 
a collection of bonds formed between atoms which interact and influence their 
vibrations, more commonly there are ‘group vibrations’ and spectral peaks are 
assigned to groups – such as the ‘aromatic C-H’ or ‘O-H’ regions. As molecules 
are a consequence of the unique make up of a combination of these vibrational 
groups each molecule will have a unique Raman spectrum. The resulting peaks 
of differing energies and intensity can be assigned to known vibrational groups, 
and the molecular composition of a molecule can be deduced. Reference libraries 
now exist of known energies and frequencies assigned to groups to allow 
spectroscopists to interpret their spectra 103. From a biological perspective, the 
majority of molecular information is gained within the ‘fingerprint’ region, which is 







assignment of nucleic acids, proteins and lipids – which form the bulk of the 
information that can be gained from Raman spectroscopy. There is an ability to 
identify other biomolecules such as hydroxyapatite, porphyrins and 
carbohydrates 104. 
 
The High wavenumber (HWN) region corresponds to Raman shift 2700-3800 cm-
1, which is highly sensitive to lipids, proteins and water 105 but is often seen as 
less specific than the fingerprint region. However, it has a good ability to 
differentiate between a number of different cellular components 106 as 
demonstrated in Figure 1-13. And the diagnostic ability of the HWN region has 
been shown to be equal to the fingerprint region in clinical samples 107. Between 
the Fingerprint and HWN regions there is little useful spectral information. 
 
 
1.2.2 Experimental measurement of Raman scattering  
There are a number of systems used to measure Raman scattering, and there 
are a number of techniques that are discussed later in this thesis, each of which 
can be used to provide different information about the molecule and biological 
tissue probed. However, all systems have the same basic simple components, 
which are demonstrated in Figure 1-14.  
 
 















Figure 1-13 Representative Raman spectra demonstrating the cellular molecular components that 
can be measured using high wavenumber Raman Spectroscopy.  








The excitation light source in Raman spectroscopy is usually a laser – as this 
provides a single narrow band monochromatic light source to probe the molecule. 
Lasers are the most suitable light source because a large amount of light is 
needed to elicit Raman scattering due to its weak effect, and the unique specificity 
of a Raman spectra is dependent on a single wavelength and a broader light 
source would give a broader, overlapping, spectra that would be difficult to 
interpret 104. The commonest type of laser used in Raman spectroscopy of 
biological material are diode lasers that converts electric energy into light energy. 
From Equation 1-6 it could be seen that by decreasing the laser wavelength 
would increase Raman intensity, however there is a balance when dealing with 
biological samples, as shorter wavelengths can heat specimens and cause 
molecular change or damage. It is also at these wavelengths that the more readily 
detected effect of auto-fluorescence can become an issue.  
 
The Near-Infrared spectrum is commonly utilised in Raman spectroscopy, 
particularly of biological tissue samples, as it achieves the optimum balance 
between intensity, tissue penetration and confounding auto-fluorescence 108. It 
also appears to be the safest wavelength to use. One study looking at 
immortalised cell lines demonstrated rapid cell death after short exposure times 
(within 5 minutes) to wavelengths 488 and 514nm, but only very mild 
morphological changes and no cell death after exposure to 785nm wavelength 
for 40 minutes 109. Another study used real-time analysis of cardiomyocytes under 
Figure 1-14 Diagram demonstrating a typical set up for a system to perform Raman spectroscopy.  




a 785nm laser to demonstrate there was no effect on the beating frequency 
suggesting minimal effect on the cells function 110. 
 
Optical filters 
A variety of optical filters are necessary to ensure a homogenous light is 
transmitted and the collection device receives only scattered light. Band-pass 
filters effectively clean up the laser light and are used to allow only the 
transmission of the excitation light to the sample, ensuring monochromatic light 
and optimal spectral resolution. The Dichroic mirror reflects the excitation 
wavelength and longer wavelengths towards the objective lens – which focuses 
the incident light on the sample to be interrogated. The scattered light then comes 
back through the objective lens, the dichroic mirror allows all scattered and red-
shifted light through to the collection device, while reflecting light at the incident 
wavelength and longer away. The notch filter provides a further filter to block light 
at the incident light wavelength through to the spectrometer. 
 
Detection 
Gratings can be used to aid in disperse the light into its individual wavelengths. 
Dispersion gratings separate the collected scattered Raman light at different 
wavelength onto the detector. The more grating lines per mm, the higher the 
dispersion and therefore the spectral resolution. The scattered light is then 
detected by pixels on a camera chip. Each pixel (or group of pixels) in the chip 
corresponds to a separate wavelength, and the amount of charge the pixel 
acquires during an acquisition is directly proportional to the number of photons 
detected. At the end of the acquisition the resultant charge collected by the pixel 
is converted to voltage and this is transferred to a computer to produce a signal 
for that wavelength, and the chip as a whole provides a read out for the entire 
spectral range. The commonest camera used are  thermoelectrically cooled 
Charge – Coupled Devices (CCD). The CCD is a silicon chip made up of a 2D 
array of detectors. The sensitivity of a camera is dependent on the photon 
wavelength and the silicon absorption coefficient. This is described as the 
quantum efficiency of a camera and is defined as the number of photoelectrons 
generated per Raman photon 111. The sensitivity of the CCD is dependent on 





If a silicon CCD is not appropriate for the spectral range being investigated there 
are alternatives. Indium gallium arsenide (InGaAs) cameras are typically back 
illuminated with a two dimensional photodiode array that, due to its lower 
bandgap properties, have an improved quantum efficiency over 900nm, and are 
generally used for investigating in the wavelength around 900 – 1700nm112. 
Alternatives to silicon CCDs also include complementary metal oxide 
semiconductor (CMOS) cameras, which are generally cheaper than CCD 
cameras, and can provide a higher frame rate. 
 
1.2.3 Summary 
The basic principles of Raman spectroscopy have been discussed. It is a versatile 
technique that has a wide range of applications in biomedical science. There are 
a variety of methods of Raman spectroscopy, which can be tailored to the specific 
problem posed; these are discussed in the following section. A potential 
application of Raman Spectroscopy is to the intraoperative assessment of 
pathological margins in surgically excised specimens – the next part of this thesis 





1.3 Raman Spectroscopy for rapid intra-operative margin analysis 
of surgically excised tumour specimens 
(edited version from article published in Analyst) 
Breast Conserving Therapy with wide local excision of breast tumour is the 
commonest form of operation performed in the treatment of primary breast 
cancer, as detailed in section 1.1.5 of this Background chapter. The high rate of 
‘positive’ pathological margins requiring a further operation for re-excision of 
margins in around 17% of patients represents a significant burden to the patient 
and to the healthcare system. Raman spectroscopy may be the ideal 
intraoperative tool to provide intraoperative margin analysis. This section of the 
background evaluates the ability of Raman spectroscopy to provide IMA, setting 
out the clinical need for IMA in breast cancer, and a number of other solid tumour 
pathologies, a current critical review of previous work done, and an evaluation of 
the ability of RS to provide IMA. The literature review is a modified version of the 
article that was published in the journal Analyst (Reproduced from Reference 113 
with permission from the Royal Society of Chemistry). The introduction and 
section on Raman Spectroscopy background have been altered to avoid 




Surgical excision of the primary tumour remains the primary treatment for many 
solid organ tumours 86. The aim of cancer surgery is to remove the smallest 
amount of tissue necessary to minimise tissue trauma and collateral structural 
damage, whilst excising the entirety of the diseased tissue 86. This requires the 
affected tissue to be excised with a rim of normal tissue with an adequate  
‘margin’. The amount of margin, or distance from the cancerous tissue to the 
edge of the specimen, required to be termed ‘clear’ is different for each pathology. 
If there is cancerous tissue within the defined distance from the resected surface, 
it is a  ‘positive’ margin and an inadequate resection, which increases the risk of 










A positive margin not only affects prognosis, but also future management, 
meaning the need for further operations or adjuvant therapies with significant side 
effects. The cost of a positive surgical margin to the patient, in terms of increased 
treatment burden, further anxiety and additional side effects is difficult to quantify 
but the effect on the financial resources of the healthcare provider is undoubtedly 
significant 117, 118. A method to assess the margins of the excised specimen intra-
operatively to allow further tissue to be taken at the time of the initial procedure, 
if possible or necessary would be efficient, could reduce the risk of residual 
cancer at the end of the operation and improve patient care. 
 
1.3.2 Current methods of margin analysis 
The ‘gold standard’ method for analysis of resection margins of surgically excised 
specimens is currently histopathology. Histopathology analysis of prepared, ex 
vivo, tissue is conducted with light microscopy by trained physicians and is able 
to provide a detailed analysis of the excised specimen and the biochemical 
characteristics of the tumour, which contributes to clinical management 
decisions. However, the ‘gold standard’ of histopathology is prone to errors 
although it is likely underreported; one study found an error rate of up to 11% in 
cancer diagnosis 119, there is variability between pathologists in the reporting of 
the tumour grade 68, 69, and even variability in the final diagnosis 67. This is even 
Figure 1-15 A graphic to illustrate the concept of tumour margins. 
 A. A surgically excised specimen with an adequate margin along the resected surface; the cancerous tissue 
is in the centre of the surgically excised specimen, with a rim of normal tissue surrounding it. The distance 
of what defines an ‘adequate’ margin varies between pathologies. B. A surgically excised specimen with an 
inadequate or ‘positive’ margin; the cancerous tissue is at the edge of the specimen. This could mean there 




more apparent when diagnosing early or pre-cancers, where histopathology can 
have of the order of nearly 50% inter-observer agreement 67, 120.  
 
Histopathology analysis of surgical margins may also be subject to errors. Even 
small specimens of around 2 cm across would require an impractical  number of 
histological sections if the entire resected surface was to be examined for 
adequate margins, and so margin assessment should be seen as a 
representative sampling procedure 121. The process also requires a number of 
steps which introduce sampling error - orientation by the surgeon, fixation to 
preserve the specimen, labelling the specimen, transportation to the pathology 
department, re-orientation by the pathologist, slicing the specimen, dehydration, 
embedding, sectioning, staining, representative sampling and then subjective 
assessment by histopathologists 65, 66, 122. In addition to this, the lack of real-time 
reporting delays treatment decision making meaning histopathology is an 
imperfect technique for the reporting of margins. This precludes any removal of 
further, possibly cancerous, tissue without the need for a second, often more 
difficult, operation. In many pathologies, the risk of a second operation outweighs 
the benefits of the risk of recurrence, and so in cases of a positive resection 
margin, potentially cancerous tissue remains 123, 124. It is possible that the concept 
of requiring a defined margin for surgically excised specimens is a result of the 
current inability to check the entire surface margin, and that if a technique could 
accurately assess a specimen, smaller, or no, margin distances would be 
required. 
 
1.3.3 Methods of Intra-operative Margin Analysis (IMA) 
Recognising these limitations of the traditional model, there is a large body of 
research investigating methods of IMA. Current and prospective methods of IMA 
are generally based on ex vivo analysis of the excised specimen, as it is the most 
practical way of avoiding surgical artefacts such as blood contamination and the 
space constraints of in vivo analysis.The number of methods being investigated 
is vast, what follows is an overview of more established techniques that have had 
routine clinical application, though not necessarily widespread adoption.  
 
A commonly used method in cancer surgery is frozen section analysis. The 




interest taken for analysis by a pathologist. It is a technically difficult procedure, 
requiring a histopathologist to be available on demand, a turnaround time that 
can impede surgical workflow, the processing can damage specimens which 
require further histopathological examination and it is expensive 125. Frozen 
section is most successfully used in Moh’s micrographic surgery in the treatment 
of Basal Cell Carcinoma (BCC) of the skin, where the entire resected surface is 
examined in horizontal sections intra-operatively and the surgeon continues to 
excise tissue until the margin is clear. Recurrence rates are as low as 1-3% even 
in recurrent and complex disease 126. However due to cost and time issues it is 
reserved for cosmetically sensitive areas and recurrent BCC.  Frozen section is 
used widely in head and neck cancers 127 however there is a significant number 
of false negatives 127 and it is unreliable for eradicating positive final margins 128. 
The technique has also been used for IMA in breast cancer excision (where there 
is reported sensitivity 70-90% and specificity 80-90%129, 130)  and radical 
prostatectomy (with a poor sensitivity of 42% 131), but has not been widely 
adopted due to clinical and cost-effectiveness concerns 132, 133.  
 
Intraoperative imprint cytology has shown promise in Breast surgery. A slide is 
pressed onto the lumpectomy resected surface and analysed by a pathologist for 
malignant cells, which can be reported within the time frame of an operation. 
Issues identified with the technique are that slide preparation can affect the 
outcome, it is less accurate in lobular carcinoma 134 and in tissue that has been 
subject to previous radiotherapy 135, and it reports only on the resected surface, 
not the entire margin depth.  A meta-analysis of eleven studies revealed a pooled 
sensitivity of 91% and specificity 95% 136, however, in clinical trials the need for 
delayed re-excision remained disappointingly high 134 suggesting this may not 
translate into improved clinical practice.  
 
Intra-operative imaging to assess margins has been used in various pathologies.  
In breast surgery the most common adjunct in the UK to analyse margins is an 
intraoperative specimen X – ray to determine how close radio-opaque lesions are 
to the edge of the sample. It is used by 96% of UK units 91, as it is readily available 
and requires no additional equipment. However, in a recent meta-analysis of nine 




Intraoperative ultrasound has also been used to guide lumpectomy in breast 
conserving surgery, but margin assessment was associated with a high false 
positive and false negative rate 137 and poor sensitivity 138. In brain lesions, 
intraoperative US has been seen as useful to guide excision, however there is a 
high degree of user variability and has been associated with a high rate of false 
positives possibly due to blood artefact which is also hyperechoic 139. 
 
Magnetic Resonance Imaging (MRI) is used extensively in the planning of brain 
cancer surgery and intra-operatively to guide excision. In a randomised controlled 
trial, with a small population of 58 patients, the intra-operative use of MRI was 
associated with complete tumour resection 140. However, an issue is ‘brain-shift’ 
where loss of cerebrospinal fluid and oedema changes the anatomy and so 
reduces the accuracy of neuronavigation 141 and a Cochrane review concluded 
that further studies into efficacy were needed 142.  
 
The sheer number of techniques proposed for IMA demonstrates that no single 
method has proved to be effective enough to be accepted into routine clinical 
practice. To address this gap in surgical care, novel optical techniques show 
promise as they can provide sensitive and specific biochemical information at a 
molecular level in a rapid and non- destructive manner. A number of microscopy 
techniques, such as Microscopy with UV surface excitation (MUSE), and light 
sheet microscopy, show the ability to differentiate between cancerous and non-
cancerous tissue but studies so far have been limited in sample size and to 
physically small samples due to speed of analysis, which limits the conclusions 
as to clinical relevance 143 144. Other optical techniques have struggled to 
succesfully translate promising laboratory work into the clinical environment, such 
as optical coherence tomography (OCT) which was found to have reduced 
effectiveness when it encountered cauterised tissue and blood 145, and a clinical 
trial in breast specimens demonstrated it only identified 63% of those with a 
positive margin 146. Diffuse optical spectroscopy has the potential to provide 
excellent sensitivity and specificity in cancer diagnosis147, but so far this has not 
been realised in the analysis of margins148. Raman Spectroscopy (RS) is a 
technique of vibrational spectroscopy that has gained particular momentum as it 
can provide detailed biochemical information with excellent accuracy, within 




environment in human tissue in a range of pathologies. RS has the potential to 
change the paradigm of oncological surgery and provide IMA; an idealised 
surgical workflow of this is suggested in (see Figure 1-16). 
 
 
1.3.4 Raman spectroscopy  
A detailed review of the basic principles of RS are outlined in the previous section 
1.2 of the thesis. The molecular specificity of the Raman spectrum is holding great 
promise in medical diagnostics 149, and a variety of RS techniques have been 
developed in response to different needs. The following is a review of the different 




This technique combines Raman spectroscopes with optical microscopes, 
allowing for analysis of sub millimetre specimens, such as histological slides 150. 
The tissue is scanned using raster scanning (point by point) which is time 
consuming and so processing a sample can potentially take hours. Line scanning 
(changing the size of the incident beam to a line across the sample), and multi-
focal Raman microspectroscopy (dividing the incident laser into several beams 
to measure multiple Raman spectra simultaneously) can reduce the analysis time 
Figure 1-16 A graphical representation of the ideal paradigm for the surgical workflow of 
intraoperative margin analysis (IMA) by Raman Spectroscopy.  





to more clinically relevant times 151-153. Wide-field global imaging techniques, 
where the whole sample is illuminated and all spectra associated with a particular 
wavelength are collected can also decrease analysis times, but flat field 
illumination can be difficult and this reduces the laser power per pixel, unless a 
very high power laser is utilised 154.  
 
A further method to increase the speed of analysis is to reduce the number of 
Raman spectra taken for measurement by highlighting targeted areas for 
intensive raster scanning, in selective scanning Raman microscopy 155. This can 
be performed by predictive algorithm, where spectra are taken at two random 
points on the sample, and the difference between the spectra informs an 
algorithm to predict where to take the next measurement 155. Another method is 
to use another, less specific, but highly sensitive optical technique such as auto-
fluorescence to rapidly assess the sample and determine where to take Raman 
spectra 156. This allows a substantial reduction in the number of Raman spectra 
taken, with a similar diagnostic yield, and in a shorter time period.  
 
Surface Enhanced Raman Spectroscopy (SERS) 
SERS is a method to enhance the inherently weak Raman scattering by using 
receptor targeted metallic nanoparticles combined with bright Raman reporter 
molecules as biomarkers. Nanoparticles bind to the tissues of interest in a specific 
configuration and ratio that gives a unique spectrum. These nanoparticles give 
an intense signal due to their brightness and specificity, and so a large area can 
be rapidly scanned to give a reliably sensitive and specific Raman Spectrum 157. 
However, the obvious disadvantage lies in the time needed for pre-processing of 
samples with nanoparticles, and the potential risk of toxicity of metallic 
nanoparticles that may limit its in vivo use 158. The inherent heterogeneity of 
tumour biochemistry and receptor expression both within and between patients 
can affect the accuracy of these techniques 159. 
 
Spatially Offset Raman Spectroscopy (SORS) 
SORS can provide biochemical information at depth below the surface. SORS 
illuminates at a central point then collects scattered data at a distance from this 
central point, the light having travelled through varying depths of tissue. In using 




collection is accounted for, and a depth profile of the tissue with tissue information 
can be gained 160. An essential component of this technique is that it ameliorates 
interference by the often- stronger Raman scattering and fluorescence from the 
tissue surface to be able to analyse the tissue below. The configuration of the 
laser illumination centrally with an annular arrangement of collection fibres 2 – 3 
mm has allowed for analysis 1 – 4 mm below skin 161. Transmission Raman 
Spectroscopy (TRS) is an extreme version of SORS, where incident beam and 
collecting camera are opposite one another, to allow analysis through the sample 
to gain clinically relevant information at depths of up to 40 mm 162. 
 
High Wave Number (HWVN) Raman Spectroscopy 
The majority of biomedical RS uses Near Infra-Red (NIR) light to acquire spectra 
within the ‘Finger Print’ (FP) region of 400-1800 cm-1 which has been shown to 
provide extensive detail of the tissue biochemistry. However, when this laser light 
illuminates the fused-silica fibre required for fibre optic probes it generates an 
intense background signal 163. Using the HWVN region of 2400-3800 cm-1 can 
allow Raman spectra to be collected without this background interference 163. 
This opens the way to numerous clinical applications and can be used within 
commercially available devices such as a hypodermic needle 164 core needle 
biopsy system 165 and endoscopes 166(see Figure 1-17). This advantage must be 
weighed against the disadvantage of using HWVN region spectra, which is less 
specific and may have limited diagnostic capabilities compared to data from the 
























Coherent anti – Stokes Raman scattering (CARS) and stimulated Raman 
spectroscopy (SRS) 
CARS and SRS are non- linear processes, where the observed effect is not linear 
to the incident laser power, as it is a result of multiple overlapping photons. It can 
therefore generate a signal intensity greater than coherent Raman. By probing 
specific, narrow spectra with high intensity, specific molecular information can be 
Figure 1-17 Examples of fibre optic probes capable of Raman Spectroscopy measurement in a 
clinical setting for cancer diagnosis, or application to in vivo surgical guidance to provide IMA, 
images Authors own.  
A. A fibre optic probe is incorporated into a standard 5ml syringe with a 15cm long, 20 gauge needle and so 
is capable of subcutaneous measurements (in this example in a Turkey leg) as detailed in reference 168. B. 
A miniature confocal Raman packaged probe with a GRIN lens objective for endoscopic use. A detailed 




gained rapidly 170. The advantages of CARS relate to its sensitivity to CH 
molecules making it particularly effective at studying lipid and fat distributions, 
which can been performed at video rate of 100 ns per pixel 171. However it is a 
near surface technique and interpretation is made difficult by the presence of a 
non-resonant background, causing spectral distortion and artefact 170, 172.  
 
A SRS signal is generated when the molecular vibration is equal to the difference 
in frequency between the pump and Stokes photon. The change in intensity of 
these beams as a result is measured. Its use was previously limited by slow 
acquisition times and its reliance on back-scattering meant it was inherently 
weak. However, new techniques have overcome these issues and allowed rapid 
acquisition of spectra to give detailed biochemical information 172. Further, SRS 
is non-resonant background free, can be performed with ambient light present 
and its ability to provide high-speed imaging has been used in clinical tissue 
diagnosis 173. 
 
Spectroscopic Data Analysis 
Regardless of the method of Raman spectroscopy utilised to gain spectra, the 
raw spectra require careful analysis to elucidate clinically relevant information. 
Differences between tissue spectra, although highly specific and holding detailed 
chemical information, can be subtle. In the setting of IMA, data analysis is focused 
on providing a binary outcome of whether the margin is adequate or not. In 
general, there will be a ‘training set’, which are spectra assigned to known tissue 
correlations i.e. a spectrum taken from tissue which has a histopathological 
diagnosis (as demonstrated in Figure 1-18). These are used to create a model, 
which is then tested on a ‘validation set’, where the diagnostic accuracy can be 
assessed. This training – validation can be run multiple times with a Leave One 
Out Cross Validation (LOOCV) protocol to provide a measure of independence 
in the performance measures 107. 
 
The types of mathematical models used to create spectral classifications are 
numerous, and expanding. A simple technique is Direct Peak Analysis – where 
individual spectral features are analysed e.g. the areas under an individual 
Raman band  can be compared 174. Principal Component Analysis (PCA) and 




spectral peaks, but identify where in the spectrum the greatest variance between 
data lies and classifies data according to these groups. Linear Discriminant 
Analysis (LDA) is a supervised technique that is commonly used to distinguish 
differences in the classes identified by PCA to increase accuracy. Increasingly 
complex models have been developed such as Support Vector Machines (SVM) 
and Random Forest Classifiers 175 and can improve diagnostic accuracy176, 
however they can be more difficult to apply and interpret. The machine learning 
classifier used to analyse spectral data is an important part of system 
development. The balance between simplicity and speed of simpler techniques 
versus the complexity and improved accuracy of more recent models needs to 
be considered when developing a Raman system suitable for performing 
intraoperative margin analysis in the clinical environment. 
 
1.3.5 The use of RS to determine the surgical margin 
1.3.5.1 Breast Cancer 
Breast cancer holds great potential for intra-operative use of RS, with a number 
of groups reporting a variety of advanced techniques to assess the margins of 
lumpectomy specimens.  
 
Background 
For the majority of patients with early primary breast cancer, Breast Conserving 
Surgery (BCS) (with adjuvant radiotherapy) offers an alternative treatment to 
traditional Mastectomy, with equivocal survival rates and improved patient 
satisfaction (Fisher, 1985). In Breast conserving surgery, the cancer is removed 
from the breast, termed a lumpectomy. The method of assessing margins are 
currently mainly by surgeon palpation, if it is a palpable lump, or radiographically 
with an intraoperative X - ray. Neither are a reliable way of assessing the 
specimen for involved or close margins 177, and as a result, the rate of close or 
involved margins is high 91.  
 
The definition of a positive margin is most commonly described as ‘ink on the 
tumour’ 56, 178, the definition of a ‘close’ margin is much more debated, however 
in the UK it is defined as < 2mm, however, the resultant practice as to whether a 
re-excision of margins is recommended, or indeed undertaken, is much more 




recurrence, despite adjuvant therapies 92. Therefore, a positive margin, and more 
variably, a close margin usually necessitates a re-excision of margins. This is a 
further operation where the operation site is re-opened and the tumour bed 
examined, the surgeon then takes a further 1 cm rim of breast tissue at the site 
that was reported as involved. The number of cases requiring re-excision is high, 
with a UK average of 17% and some units reporting up to 38-41% 91, 134. The 
steps involved in this re-excision are numerous and complex and the sheer 
volume is a significant financial burden.  
 
RS ability to differentiate normal from abnormal breast tissue 
There is a large body of evidence confirming the ability of RS to differentiate 
between normal, benign and malignant changes. A meta-analysis included 9 
studies and concluded that using RS in vitro in breast tissue to diagnose breast 
cancer gave a pooled sensitivity of 0.92 and specificity of 0.97 179. However, there 
was a marked heterogeneity between study techniques, and so studies need to 
be considered individually.  
 
In 2005, Haka examined lumpectomy and mastectomy tissue from 58 patients 
that had been snap frozen then thawed. They used Raman micro-imaging to gain 
a sampled volume of 1mm3, and determined a total of 130 spectra, which they 
used in a leave-one-out cross-validation analysis. With this model they got a 94% 
sensitivity, 96% specificity and an overall accuracy of 86% for detecting infiltrating 
carcinoma. Fibroadenomas appeared to count for this diagnostic uncertainty; in 
2 instances the Raman diagnosis was fibroadenoma, and the histopathological 
diagnosis was infiltrating carcinoma. The reason may have been the sole 
differentiation between the two pathologies in the diagnostic algorithm was fat 
content 180.  
 
In a paper to compare the spectroscopic techniques of fluorescence, diffuse 
reflectance, combined fluorescence and diffuse reflectance and RS, in the 
diagnosis of Breast cancer, Majumder et al. found RS to be the most effective 181. 
They used 74 frozen – thawed specimens to measure 293 spectra with point RS. 
They found distinct peaks associated with connective tissue proteins and fatty 
acids discriminated well between normal tissue, fibroadenoma, invasive ductal 




done in laboratory conditions, and the area sampled was not reported, but can 
be presumed to be small. 
 
Barman et al. developed a single step Support Vector Model algorithm using point 
RS to diagnose breast lesions from 33 patients undergoing Vacuum assisted 
biopsy, specifically in those with microcalcifications 182. They achieved an overall 
accuracy of 82% of diagnosis with excellent Positive Predictive Value (PPV) (the 
probability of a positive result being a true positive) of 100% and Negative 
Predictive Value (NPV) (the probability of a negative result being a true negative) 
of 95% for breast cancer. However, this was performed in physically small biopsy 
samples, with a selective population of tissue all with calcifications present, which 
are known to produce relatively intense Raman spectra 183, and thus may be 
unrepresentative of all breast cancers. 
 
Han et al. used a confocal Raman system to look at freezing microtome sections 
of breast tissue 184. They defined the peak assignments of Raman spectra 
associated with breast tissue and found that the relative intensity of the C = O 
peaks increased with increasing grade of malignancy. They took 475 spectra 
from 39 patients and identified that there was little inter-subject variation in the 
spectra. They used a Support Vector Model for their classification model and 
achieved an overall accuracy of 74%. 
 
An issue with these techniques is that they are surface techniques, so if there 
was cancerous tissue more than a few hundred microns from the surface this 
would not be detected, so ‘close’ margins (which usually require excision) of up 
to 2 mm would go undetected. Spatially offset Raman spectroscopy (SORS) can 
resolve this and Keller et al. developed a SORS probe that obtained spectra at a 
depth of 2 mm 185. In 35 samples of frozen- thawed tissue they attained sensitivity 
and specificity of >94%. They assessed the margins compared to histopathology 
as simply ‘positive’ or ‘negative’ rather than gaining specific tissue diagnosis. The 
sampling size of the probe, nor the method of location of tissue sampling is 
described, but the authors recognize that assessing the entire specimen in a 





These studies were all done on micro or point spectroscopy, sampling very small 
areas of breast tissue to obtain Raman spectra. For application to IMA, it is 
necessary for a large area to be analysed, rapidly and so complimentary 
techniques have been applied to enable this. Kong et al. used auto-fluorescence 
imaging to inform selective -sampling Raman microscopy to provide an accurate 
diagnosis within a clinically relevant time frame 156. Tissue samples cut from 
blocks that were frozen-thawed were used and sensitivity and specificity of >90% 
were achieved. An example of these microspectroscopy mapping results and 
assignation of spectra to tissue is shown in Figure 1-18. This study only 
differentiated between ductal carcinoma and normal tissue, and in other studies, 
it is DCIS and fibroadenomas that negatively affect the overall accuracy of the 
analysis. Once again, the breast tissue samples were small (5 X 5 mm2), and so 
the conclusion of analysis within a clinically relevant time frame was extrapolated. 
How the technique would be applied to a whole specimen without cutting the 
sample is also unexplored. 
 
Figure 1-18 Example of assigning Raman spectra to tissue structures and ductal carcinoma of breast 
tissue to inform the diagnostic algorithm.  
(a) + (b) invasive ductal carcinoma (IDC), (c) normal breast tissue. Red arrows show focus of IDC, green 
arrow tumour surrounding inflammatory stroma, blue arrows  lobules and ducts, black arrows, stroma and 
orange, fat (Reproduced from reference 156 K. Kong, F. Zaabar, E. Rakha, I. Ellis, A. Koloydenko and I. 
Towards intra-operative diagnosis of tumours during breast conserving surgery by selective-sampling 
Raman micro-spectroscopy. https://doi.org/10.1088/0031-9155/59/20/6141, under a Creative Commons 





Intra-operative use of Raman spectroscopy 
Based on these promising initial results, the same groups went on to use RS in 
the clinical setting with the potential to give an intra-operative diagnosis. 
Haka et al. used their previously validated technique in freshly excised tissue 
from 28 patients measuring 220 spectra 186. Tissue with Ductal carcinoma in situ 
was excluded, as the validating set had not encountered this pathology which is 
an important exclusion for intra-operative use, as DCIS is associated with a 
higher rate of re-excision of margins 187. It also excluded patients having 
undergone neo-adjuvant chemotherapy, which is increasingly common, and 
those patients with calcifications. Once again, fibroadenoma proved a diagnostic 
challenge, and the positive predictive value of 36% can be considered poor, with 
an overall accuracy of 86%. Although the authors felt that the high NPV of 99% 
was the main clinically relevant outcome, with such a low PPV in clinical use this 
would lead to a high volume of breast tissue unnecessarily being excised. The 
tissue area sampled is not mentioned, meaning the relevance of the technique to 
assessing an entire sample for margin adequacy is difficult to assess. 
Despite these limitations, this was performed adjacent to the operating room, in 
a light box, and analysis was performed in 30 minutes, recreating conditions 
necessary for intra-operative use of the technique. 
 
Wang et al. used SERS with nanoparticles to assess 57 freshly excised 
lumpectomy specimens and processed samples within 15 minutes 188. Each 
specimen was topically stained with Raman active nanoparticles that were 
functionalised with antibodies to target HER2, mER, EGFR and CD44 and then 
raster-scanned to acquire spectra for the entire resected surface on the exposed 
glandular tissue. It was possible to differentiate between normal, benign changes 
and invasive carcinoma tissue, and the overall sensitivity for breast carcinoma 
detection was 89% with 92% specificity, with the accuracy for the specific 
biomarkers slightly less than this. This technique is not affected by haemoglobin, 
surgical dyes or diathermy increasing the clinical relevance, however, it is limited 
by the sensitivity and specificity of not only the functionalised nanoparticles ability 
to bind to the molecules of interest, but also the accuracy of the Raman signal of 
the nanoparticles.  Another limitation is that, as a surface technique, ‘close’ 





Using a method of selective scanning, Shipp et al. performed analysis on freshly 
excised lumpectomy samples from 51 patients, and analysed one resected 
surface of each specimen which was identified as being most likely to be positive 
by a member of the team 189. They used multimodal spectral histopathology 
(MSH), obtaining autofluorescence images, which was highly sensitive but non-
specific, to inform targeted Raman measurement points in identified ‘segments’ 
to reach a final diagnosis. The diagnostic algorithm was validated using a training 
set based on mastectomy samples which included tissue containing 
fibroadenoma, fibrocystic change, DCIS and invasive carcinoma. MSH in the 
lumpectomy samples was highly sensitive, identifying all the margins that 
contained residual cancer even as small as 1 X 1 mm2, and so was 100% 
sensitive, with around 80% specificity. They analysed a single resected surface 
of up to 4 X 6.5 cm2 in 12-24 minutes, which was achievable as MSH reduced 
the number of Raman spectra required by 100 – 200 fold. Although this study 
shows significant improvement in the speed of analysis and the diagnostic 
accuracy, there are some limitations in the way the lumpectomy specimens were 
subsequently examined, and that only one resected surface could be examined 
in a clinically relevant time.  
 
1.3.5.2 Skin Cancer 
Background 
Skin cancer is the most common cancer diagnosed and its diagnosis and 
treatment represents a huge burden on the health economy 190. Basal Cell 
Carcinoma has the highest incidence and is predicted to rise. It is a slow growing 
tumour, that rarely metastasises, but local invasion leads to local tissue 
destruction and deformity. Surgery remains a treatment of BCC, the tumour can 
be excised by standard surgical excision where the lesion is excised with the aim 
of obtaining margins of 3 – 5 mm. A positive, or close margin has been reported 
in up to 7% of cases and is associated with a high recurrence rate of up to 27% 
191 and requires further treatment or re-excision 192. Mohs’ micrographic surgery 
is a current technique used for IMA but it is time consuming, expensive and only 
recommended in high risk cases 192, 193. Melanoma is less prevalent than non-
melanotic cancer but incidence is rapidly rising, it has metastatic potential and 




of melanoma is based on surgical excision, with margins of 0.5 – 2 cm required 
based on the stage of disease, and re-excision performed if there are involved 
margins195. A margin narrower than this is an inadequate resection which 
increases the risk of recurrence associated with a poor prognosis, and may 
possibly be associated with worse survival 196. For both melanoma and 
nonmelanoma skin cancer, there is a need for IMA to improve patient outcome. 
 
RS ability to differentiate normal from abnormal skin tissue 
Confocal RS was first used to differentiate BCC from normal skin in 2002, where 
Raman maps from a small sample of 15 specimens were taken and compared to 
surrounding normal tissue which yielded sensitivity and specificity of over 90% in 
a logistic regression model 197. Acknowledging the practical limitation of using 
confocal RS, the group used a handheld fibre optic probe and gained spectra 
using HWVN RS in the region of 2500 – 3800 cm -1 to avoid background signal 
from silica 198. A number of readings from each of 19 biopsies taken from the 
centre of confirmed BCC’s were analysed, which demonstrated large and 
consistent differences between the spectra from BCC and normal tissue, 
particularly that collagen contains discriminative information at this wavelength, 
with a 100% diagnosis of BCC. However, gaining spectra at this wavenumber 
region took longer due to suboptimal signal-to-noise ratio, which may limit its 
clinical use, and there was a small study size.  
 
These studies looked solely at BCC, whereas non-melanotic skin cancer also 
includes squamous cell carcinoma. Lieber et al. analysed 21 suspected non 
melanotic skin cancers and took measurements with confocal RS from within the 
tumour and compared to normal skin adjacent (1 cm distant) from the tumour 
edge at a depth of 20 µm 199. They achieved good sensitivity of 100% for 
determining the cancerous lesion and specificity of 91%, with squamous cell 
carcinoma lesions accounting for the diagnostic uncertainty. The sample 
population of 19 patients was small and although marked differences in Raman 
spectra were observed for each pathology this was after subtracting the matched 
normal reading. There is marked inter-subject variability in the Raman spectra of 
normal skin, and without a matched normal reading the diagnostic accuracy is 
likely to have been affected. The same group went on to perform measurements 




pathology, BCC, SCC or melanoma and achieved 100% diagnostic accuracy at 
the surface which decreased towards depths of 100 µm 200. 
 
 
Schleusener et al. recruited 104 patients scheduled for excision of a suspicious 
lesion and used a fibre coupled probe in vivo with direct skin contact to sample 3 
measurements on each lesion and the mean used to inform the spectra 201. The 
heterogeneity of the lesions led to poor accuracy in determining non-melanotic 
skin cancer from normal skin cancer. The major differences in skin variability 
between body site also contributed to the results that achieved an accuracy of 
78% in discriminating BCC and SCC from normal skin. For melanotic lesions the 
lesion inhomogeneity was insignificant, and they achieved a balanced accuracy 
of 91% of differentiating melanoma from normal pigmented nevi. 
 
In a large study, Lui et al. investigated all suspicious skin lesions in vivo, both 
potential non-melanoma and melanomas, in 848 patients and acquired 1022 
spectra 202. Spectra from the in vivo lesion were taken, and compared with 
spectra from normal appearing skin 5 cm from the tumour edge. The aim was to 
detect which lesions required invasive biopsy to histologically confirm malignancy 
which was achieved with 90% sensitivity and 64% specificity. The strength of this 
study was its clinical relevance – measurements were gained within 1 second, 
with a handheld probe, and was concerned with the relevant task of differentiating 
cancerous lesions from benign lesions, rather than from normal skin like other 
studies. However, the results were ultimately disappointing, with poor specificity. 
This may have been due to the heterogenous group of benign lesions to compare 
against (which didn’t necessarily have a confirmed histopathological diagnosis), 
and a relatively small number of malignant melanomas (n=44) which may have 
underpowered the diagnostic algorithm.     
 
The same group used a similar approach with a probe measuring a diameter of 
3.5mm at a depth of 1mm to validate the previous diagnostic algorithm on a new 
cohort of 127 cases, where they achieved similar sensitivity and specificity in 
cancer versus non cancer diagnosis to the previous study203. It is noted that, 
setting the sensitivity level to 95%, only 8 of 9 melanoma cases were correctly 




depending on the sensitivity level. The results are perhaps unsurprising as the 
diagnostic algorithm had previously had poor accuracy at melanoma diagnosis. 
 
In a meta -analysis to investigate the accuracy of RS for differentiating cancer 
from normal tissue, 12 studies using different methods of RS were included, then 
analysed according to ex vivo and in vivo studies and types of skin cancer. 10 of 
the studies investigated discrimination of BCC, and in vivo, the pooled sensitivity  
for discriminating BCC from normal tissue samples was 69% and specificity 85%, 
compared to ex vivo sensitivity of 99% and specificity 96% 204. This suggests the 
use of RS to examine ex vivo, resected cancer samples, for margin assessment 
may be a highly accurate technique. 
 
There are a number of studies investigating mixed methods of combining RS with 
other techniques to improve performance. Combining autofluorescence with RS, 
with six spectroscopic criteria, 79 ex vivo patient samples were analysed and 
cancerous tissue was classified with 97% accuracy 205. Another group used 
CARS, second harmonic generation and two- photon excited fluorescence 
imaging to analyse 140 ex vivo skin samples in a multimodal approach that 
allowed large -area scans and the identification of dermal layering, which may 
assist in diagnosis of cancerous lesions 206. 
 
Intra -operative use of Raman spectroscopy 
Kong et al. used a method of measuring tissue autofluorescence to determine 
the sampling points for RS 207, a technique alluded to in the previous section 208. 
This MSH technique was used to analyse samples from 20 patients treated with 
Mohs’ microscopic surgery for BCC, half were BCC positive. Analysing tissue 
samples of up to 1 X 1 cm2 the sensitivity and specificity was 95% and 94% 
respectively for the detection of BCC within a time of under 60 minutes. The same 
group has now reported a fully-automated prototype instrument based on this 
technique that allows assessment of skin surgical resections of up to a 2 X 2 cm2 
area which detects residual tumour at the surface of the resected sample 209. This 







1.3.5.3 Brain cancer 
Background 
Gliomas are tumours of the neuroglia graded by histopathological features that 
account for the majority of malignant brain tumours in adults. They have varying 
prognoses, but the commonest, glioblastoma multiforme accounts for 55% of all 
gliomas and has a 5 year prognosis of 5% with almost inevitable recurrence after 
treatment 210. Surgical resection is generally recommended as part of initial 
management for both histological diagnosis and to remove as much of the tumour 
as possible, if it is safe to do so 211. A major challenge of resectional surgery is 
achieving adequate margins, particularly as excessive tissue excision can lead 
to major neurological morbidity for the patient. With current imaging techniques 
of neurosurgical microscopes or intraoperative MRI, even in cases of an 
apparently complete resection with ‘clear’ surgical margins, the vast majority of 
recurrences occur at the site of resection , suggesting current techniques of 
assessing intraoperative resection are inadequate 212.  
Improving the intra-operative assessment of surgical resection margins could 
improve adequacy of tumour resection, and thus recurrence rates for 
glioblastoma. 
 
RS ability to differentiate normal from abnormal brain tissue 
The majority of initial diagnostic work has been performed in mouse models of 
brain tumours. RS has been used to analyse tissue from mouse models of 
glioblastoma ex vivo and is able differentiate between normal tissue (white and 
grey matter) and malignant tissue with 100% accuracy 213 and has been used to 
examine the tumour margins in mice in vivo, where RS identified tumour 
undetected by bright field microscopy 214. Uckerman et al. used CARS to probe 
the C-H molecular vibration, thus imaging the lipid content of samples 215. A 
mouse model of glioblastoma was analysed ex vivo then the same technique 
used in human glioblastoma tissue to confirm the findings. They found malignant 
tissue was identified by a reduction in lower CARS signal intensity which was 
related to a lower content of total lipids in tumour tissue than normal tissue. This 
was at a cellular level and so tumour borders could be discerned precisely, the 






Two studies using induced glioma formation in mice models have reported the 
use of systemically injected gold nanoparticles preferentially up- taken by tumour 
to inform SERS guided tumour resection 216, 217. The nanoparticles are 
hypothesised to cross the Blood Brain Barrier via low-density lipoprotein-receptor 
-related protein 1, an active transport endothelial receptor that carries exogenous 
substrates across the BBB 218. The activation of the nanoparticles is then reliant 
on the acidic tumour environment, which results in a specific signal at the tumour 
site 216. A handheld Raman probe was used in both cases to demonstrate the 
delineated tumour margin and guide tumour excision. Although they show 
promise in mice models at assisting in obtaining clear excision margins, the 
translation of using a systemic agent in humans for diagnostic purposes only is 
likely to be complex and remains un-investigated. 
 
In human tissue, Raman microspectroscopy has been used to differentiate 
normal brain tissue, necrosis and brain metastasis and achieved accuracy of 
>95% 219.  Kalkanis et al. used ex vivo human tissue from 17 donors to create 
histological slides from frozen samples. Within homogenous areas of normal, 
necrotic and glioblastoma areas a diagnostic accuracy of over 97% was achieved 
in the validation group. However non-diagnostic areas, heterogenous areas and 
those with freeze artefact were excluded which limited sample size, and limits 
validity of application in vivo where heterogenous areas are likely 220. 
 
Another clinically relevant study by Ji et al. used Stimulated Raman Scattering 
(SRS) to examine tissue from 19 patients with CNS malignancy 173. They 
produced two- colour images based on the Raman intensity ratios which 
displayed whether the structure was lipid or protein-rich. Using biopsy samples, 
they asked pathologists to compare these SRS images with standard H+E 
pathology images and achieved excellent diagnostic concordance. This was 
carried out in standard lighting conditions. However, they acknowledge the areas 
sampled were much smaller than a true tumour bed, and SRS can only sample 
at a depth of 100 µm. Furthermore, this approach is only likely to work when 
normal tissues are mostly lipid rich and the cancer or disease leads to a change 
in protein rich tissues. Another group using SRS to analyse histology slides 
achieved similar results in differentiating between normal brain tissue and tissue 




was able to predict an automated diagnosis of tumour subtype with 90% accuracy 
221. 
 
Intra -operative use of Raman spectroscopy 
A recent study by Bury et al. analysed 29 fresh brain tissue samples that had 
been excised during surgery within a clinically relevant time222. Using SERS, the 
samples were processed with gold nanoparticles and Raman spectra obtained, 
the tissue then underwent routine histopathological analysis. There were a 
number of diagnoses within the small sample size meaning it is likely to be 
statistically underpowered. Despite this they gained sensitivity and specificity 
above 75% in diagnosis of normal, glial and metastatic brain tumours, with 
meningiomas proving a diagnostic challenge with poorer accuracy. Results were 
comparable to currently used methods of IMA and superior diagnostic accuracy 
is needed for clinical adoption. However, this could be overcome by increasing 
sample size and measurements were taken in real time in a laboratory linked to 
the operating theatre via air-tube, which is an innovative solution to the often 
encountered problem of space, and demonstrates successful clinical application.  
 
In 2015 Jermyn et al. reported the use of a handheld spectroscopy device that 
used a Raman fibre optic to perform sub-millimetre single point measurements of 
0.2 mm2 in vivo in humans 223. 161 MRI guided intra-operative measurements 
were taken from 17 patients with gliomas, and a biopsy taken at the 
corresponding site for correlation of Raman spectra with H+E pathological 
diagnosis. They found specimens with cancer cells had a difference in the lipid 
bands, a higher nucleic acid content, and an increase in the band associated with 
the breathing mode of phenylalanine in proteins. Tissue with cancer cells present 
were distinguished from normal brain tissue with an accuracy of 92%, which was 
significantly better than the operating surgeons’ visual analysis with a bright field 
microscope. This was performed intra-operatively with a small, hand held probe 
and measurements took less than 1 second. The limitations related to the 
restricted field of view offered by the small area sampled by the probe, and the 
false negatives in the Raman analysis were due to the system needing > 15% 
cancer cell burden to be accurate. The same group then went on to integrate 
intrinsic fluorescence spectroscopy, diffuse reflectance spectroscopy and RS into 




type in a similar study design 224. Using this multimodal approach they achieved 
sensitivity of 100% and specificity of 93% in differentiating between normal brain 
tissue and tissue with cancer cells. 
 
This group have recently developed a probe incorporated within a commercially 
available biopsy system to allow Raman measurements to be taken without 
disrupting surgical workflow 165. It used HWVN RS to collect data mainly from 
lipids and proteins. It was successful at detecting normal brain tissue and dense 
cancer tissue but could not differentiate between normal brain tissue and tissue 
infiltrated with cancer- which is likely to represent the specimens with inadequate 
tumour resection margins. 
 
1.3.5.4 Head and Neck Cancer 
Background 
Head and neck squamous cell carcinoma (HNSCC) represent the main 
oncological burden of head and neck oncology. Resection remains the mainstay 
of treatment for the majority of HNSCC locations 225.  Complete resection of the 
tumour is the goal of surgical treatment, as a positive margin doubles the risk of 
local recurrence compared to those with a negative margin 226. Despite this goal, 
a significant proportion (30-65%) of HNSCC resections have positive resection 
margins 227. A pathologically involved or close margin affects further management 
which is often the use of adjuvant therapy such as chemotherapy and/or 
radiotherapy. Re-resection can be considered, but only if anatomical location 
allows and after associated morbidity is considered 124, 228. A common definition 
of a close margin is <5mm for HNSCC 124, 229. The Intra-operative technique for 
margin analysis has been frozen section which has been specimen or tumour – 
bed based, with variability in the way it is utilised, with no standard method 
adopted 230. However, there has been no convincing evidence that this reduces 
the positive margin rate or improves outcome 128, 231.  
 
RS ability to differentiate normal from abnormal head and neck tissue 
The first report of RS to differentiate between normal and malignant larynx tissue 
was from Stone et al. 232. Raman microspectroscopy was used on biopsies from 
19 patients to differentiate homogenous samples of normal tissue from dysplastic 




rather than absolute spectral peaks to inform a diagnostic prediction model that 
demonstrated sensitivity and specificity of >90% for the diagnosis of squamous 
cell carcinoma. 
 
Using frozen – thawed biopsy samples of vocal cord lesions, Lau et al. analysed 
areas of 3.5 mm within 5 seconds. There was heterogeneity of tissue type within 
measured samples which may have accounted for the reduced diagnostic 
sensitivity of 69% of detecting carcinoma 233.  
 
Lin et al. developed a miniaturized RS fibre optic probe that was inserted down a 
working channel of nasendoscopy instrument to take measurements of 
suspicious laryngeal lesions in 39 patients 234. The probe was put in contact with 
the lesion for < 1 sec prior to taking biopsies for histopathological analysis. They 
used the HWVN range (2800–3020 cm−1) to obtain 94 spectra and identified 
spectral peaks that successfully differentiated normal and malignant tissue. In a 
similar experimental design in 60 patients, the same group used a combination 
of FP and HWVN RS to acquire over 2000 spectra and compared this to 
histopathological biopsy. They gained spectra rapidly in < 1 second, and the 
combined spectra yielded an overall diagnostic accuracy of 91.1% 235. The same 
group then acquired spectra from 90 patients with nasopharyngeal cancer and 
used PCA and LDA with a leave-one-out cross validation method to achieve a 
diagnostic accuracy of 93.1% 236. 
 
In the detection of oral carcinoma, Cals et al.  took histological sections from 11 
samples of oral SCC with surrounding normal tissue, and histopathological 
evaluation then selected the regions for RS measurements 237. Raman mapping 
with an automated confocal Raman microscope took point measurements at 5 
µm steps to determine spectral differences between oral SCC and squamous 
epithelium, connective tissue, gland, muscle, adipose tissue and nerve. They 
achieved excellent distinction between SCC and healthy tissues with >97% 
accuracy. They went on to develop a two-step classification model using a similar 
experimental method for validation in 19 samples and achieved diagnostic 





In vivo detection of oral lesions was performed by Guze et al. with a handheld 
probe in real time 239. The probe, which had disposable plastic sleeves, was used 
to diagnose lesions within 5 minutes and the procedure was tolerated well by the 
18 patients who had a previously known histological diagnosis of the oral lesion. 
They were able to differentiate between pre-malignant and malignant tissue 
versus normal or benign lesions with 100% sensitivity and 77% specificity.  
 
The difference in water content between normal tissue and SCC has been used 
by one group as a marker to identify cancerous tissues in the head and neck. 
Using a confocal Raman microscope with HWVN RS at 2500 - 4000 cm−1 they 
used freshly excised oral SCC samples from 14 patients to take up to 30 spectra 
from each sample within 30 minutes and subsequently compared them to 
histopathological evaluation. They found the intensity of the OH-stretching 
vibration increased in SCC more than normal tissue, along with the water 
concentration being significantly higher in the SCC containing tissue. They 
concluded that water concentration could be determined with HWVN RS and was 
a useful diagnostic marker of SCC tumour 174. The group then used freshly 
resected oral SCC specimen sections containing both tumour and normal tissue 
to analyse how water concentration changes with distance from the tumour. 
Using a confocal Raman microscope at the same wavelength they then obtained 
over 3000 Raman spectra to determine that mean water concentration within the 
tumour was 76% and decreased further away from the tumour down to 54% when 
> 4mm from the tumour in healthy tissue228. A similar design was used in 26 
mandibulectomy specimens and it was also found that water concentration is high 
within tumour (mean of 77%) and decreases with distance from tumour to a mean 
of 44% in healthy tissue. These spectra were then used to develop a classification 
model for diagnosing SCC in bone in a training set and in the validation set 
achieved a sensitivity of 95% and specificity of 87% in tumour detection 240. They 
showed good diagnostic accuracy within clinically relevant times of less than 30 
minutes. However, there are limitations to clinical applicability; the specimens had 
to be handled in a particular way to avoid desiccation, and these studies used cut 
specimens which may have different water properties to an uncut specimen. A 
flat surface was also necessary to achieve adequate contact with the Raman 




The data demonstrates a large inter-subject variation in water content in healthy 
tissue of 17% in bone and 24% in mucosal tissue which suggests pathological 
tissue measurements would always need to be compared with concurrent 
‘normal’ tissue readings 240. The calculation of water content for these 
measurements were based on a protein model and ignored the contribution of 
lipids to the measured spectral band. Although this is acknowledged and in oral 
mucosal tissue any high lipid signals were always associated with healthy tissue, 
this may not be the case with other tissues and so the ability to apply this 
methodology to other pathologies may be limited 240. 
 
1.3.5.5 Other pathologies 
There has been investigation into RS in the diagnosis of other solid tumours such 
as ovary 241, lung 242, 243 and thyroid 244, but with little further exploration to the 
application of this technology to improving the adequacy of surgical excision 
margins. In some solid tumour pathologies, the use of RS in vivo for the detection 
of cancer for identification of residual tumour and ensuring adequacy of resection 
is another method of improving surgical oncological outcomes.  
 
In prostate disease, histological studies have differentiated between benign 
prostatic hyperplasia, prostate cancer and normal prostate tissue with a 
sensitivity of 94% and sepecificity of 100% 245, which was seen to be due to 
increases in DNA and collagen changes in malignancy 246. In freshly excised 
tissue both the Fingerprint and HWVN region has been used with a hand held 
probe to get diagnostic accuracy of over 85%107, 247. The same group have 
succesfully integrated a RS probe into the arm of a robotic operating system and 
demonstrated the possibility of in vivo surgical guidance to ensure there is no 
residual disease 248. 
 
There has also been substantial research into the detection of early malignant 
change in the cervix, aided by the well- defined nature of the disease and ability 
to gain measurements without excision of tissue. Multiple studies have 
demonstrated the ability of RS to differentiate between colposcopically normal 
and abnormal areas of cervical tissue to a clinically relevant degree of accuracy 
249-251. This may be useful in improving early, accurate diagnosis to guide targeted 





The ability of RS probes to be incorporated into fibre optics  has significant benefit 
to the potential for use as a surgical adjunct. In bladder cancer fibre optic RS 
probes have been shown to be able to differentiate normal bladder and bladder 
cancer with an accuracy of 84% in pathological samples 252. Another group 
developed a fibre optic probe used in vivo to gain measurements at sites within 
the bladder of 32 patients with suspected bladder cancer that were subsequently 
biopsied and then matched with the definitive histopathological diagnosis. These 
measurements took place alongside fluorescence cystoscopy, a technique 
already in use to improve bladder cancer detection compared to simple white light 
cystoscopy. This clinically relevant technique obtained a sensitivity of 85% and 
specificity of 79% 253. 
 
The introduction of RS enabled fibre optic probes down working ports in 
endoscopic instruments holds promise for early diagnosis of oesophageal, gastric 
and colorectal pathology, with ex vivo and in vivo studies demonstrating 
consistently good diagnostic accuracy and clinical relevance 254-257. The utility of 
this in achieving adequate surgical margins has not been investigated but given 
the increased risk of recurrence associated with involved circumferential 
resection margins in GI cancers 258-260, further work should be considered. 
 
1.3.6 Translating Raman to the clinical environment for IMA 
The ideal method for providing IMA would be highly sensitive, not alter the 
specimen (to allow subsequent histopathological analysis), recordable to allow 
accountability, give a definitive answer which is easily understood without the 
need for specialist training, and processes the sample without delaying surgery. 
The tool to deliver the analysis should be portable to allow use in multiple 
locations, robust to withstand everyday use, easily sterilised and not interfere with 
the theatre environment / procedure 261.  
 
In many ways RS meets these criteria. The ability of RS to differentiate between 
cancer and normal tissue in a non destructive manner has been established and 
appears reliable in a range of pathologies. The practical advantages of Raman 
as a tool for IMA are the relatively cheap equipment (£10-30K) is also small and 




have been developed that have taken measurements within the confines and 
limitations of the clinical environment, overcoming the obstacles of theatre 
lighting, handling the specimen and the need for a disposable/re-sterilisable 
component 224, 262, 263, demonstrating its ability to perform in the operating theatre. 
 
Despite these promising advances, RS is still not used in routine clinical practice, 
suggesting limitations to the technique for providing IMA. For effective translation 
and widespread adoption, Raman systems must be cost-effective. The advances 
in detector technology and lower cost lasers resulting in cheaper Raman systems 
is addressing some of the historical short falls in the technique, though it is now 
the detectors and cameras that account for the greatest expense 264, systems 
able to make use of high-quality but mass produced CMOS cameras used in 
mobile phones may be expected to reduce costs significantly.  
 
The time taken to analyse samples remains an issue, however innovative 
techniques such as selective scanning microscopy and SERS has reduced this 
time and studies presented in this review analysed samples in a clinically relevant 
time frame of 15 – 60 minutes, which is within acceptable and clinically relevant 
limits 185, 188, 189, 208, 265. The fact that sample analysis can take place within the 
operating theatre obviously saves significant time compared to techniques that 
require the specimen leaving theatres, such as frozen section analysis.  
 
Thus far, studies have required large data sets with complex and potentially 
lengthy chemometrics to provide accurate diagnostic information. Generally 
academic teams have been gaining spectra for a training set to construct a 
diagnostic algorithm. This process requires a significant amount of data 
processing and handling with large volumes of data and computing power to 
‘train’ the diagnostic algorithm, which would be well beyond the capabilities of 
routine clinical staff. However, these are preliminary studies, where the diagnostic 
algorithm is being constructed and tested, but once the diagnostic algorithm has 
been refined, robustly tested and validated, the data produced from a single 
specimen for analysis would not be overwhelming. The speed of running new 






When planning for the translation of a technology to the clinical environment, the 
focus must be on the end -user, which for IMA will be surgeons, as they will 
ultimately determine whether the technique is adopted. When using new 
technologies there can be difficulties with inter-user variability- in one study 
assessing IMA in breast specimens using a bio-impedance spectroscopy probe, 
the results were negatively impacted by the surgeons incorrectly following the 
probe protocol or incorrectly interpretating the results 266. Inter-user variability 
may prove particularly problematic for hand held probe systems, where data can 
be rejected or inaccurate due to incorrect probe positioning 185, 201. However, 
there are a range of other systems such as an automated tissue processing 
machine that uses cassettes209, or automated 3D scanner 265 that may reduce 
this potential for user error. 
 
Not only must the measurements be taken by surgeons, but a clear and definitive 
interpretation of data is required in order to translate to clinical use. It cannot be 
expected that surgeons should be required to understand and interpret raw 
Raman spectra to inform the procedure. Examples of systems that provide an 
indicator of the Raman IMA result to the surgeon is the system capable of emitting 
a sound to indicate abnormal tissues 267 and the automated 3D scanner 
‘Marginbot’ which has the potential to analyse a specimen and provide a colour 
coded interpretation of the Raman spectra for the surgeon mapped onto the 3D 
image of the specimen (see Figure 1-19 B) 265.  
 
So it can be seen that despite the inevitable challenges in translating from bench 
to bedside (or theatre-side), there are solutions that enable clinical Raman 
systems to provide easily interpretable IMA of surgically excised tissue to aid 
intra-operative decision making. Figure 1-19 provides examples of existing 
Raman probes that have the potential to provide IMA, demonstrating the 
beginnings of successful translation into the clinical environment. Indeed, there 
are a number of companies developing commercially suitable Raman systems 
showing a move away from the laboratory and towards larger scale use by 












Figure 1-19 Examples of Raman probe systems that could be used for IMA using Raman 
spectroscopy.  
A. Ex vivo RS analysis of a specimen, where the specimen is placed on top of a probe to enable a surface 
to be analysed. This example uses an axillary lymph node (reproduced from reference 269, with permission 
from the Royal Society of Chemistry, and the authors) B. Design of an automated 3D margin scanner 
prototype (Marginbot), where the specimen is placed on a stage and automated movement of the specimen 
and the Raman probe (depicted by arrows) is required to assess the specimen margins (reproduced from 
reference 265 G. Thomas, T. Q. Nguyen, I. J. Pence, B. Caldwell, M. E. O'Connor, J. Giltnane, M. E. Sanders, 
A. Grau, I. Meszoely, M. Hooks, M. C. Kelley and A. Mahadevan-Jansen, Evaluating feasibility of an 
automated 3-dimensional scanner using Raman spectroscopy for intraoperative breast margin assessment, 
https://doi.org/10.1038/s41598-017-13237-y, under a creative commons attribution 4.0 International 
License) C. Handheld probe (Emvision, LLC) for use in vivo, in this example to interrogate brain tissue during 
surgery with the potential to assist in gaining clear margins in the excised specimen. The schematic diagram 
illustrates the excitation of different molecular species that produces a Raman spectra. From M. Jermyn, K. 
Mok, J. Mercier, J. Desroches, J. Pichette, K. Saint-Arnaud, L. Bernstein, M.-C. Guiot, K. Petrecca and F. 






This review has outlined the importance of the optimal management of surgical 
margins for oncological excised specimens, current methods of IMA and a review 
of the existing literature relevant to the use of RS in IMA in a number of solid 
organ tumour pathologies. It must be noted that the majority of RS studies remain 
in the realms of laboratory work, or ‘processing labs’ adjacent to theatres with the 
work performed by members of academic units. Protocols have not evolved to 
the point of being able to be used by non-experts, which is crucial to its expansion 
into the clinical arena. Other disadvantages of RS is the time taken for spectral 
acquisition, though this is being addressed by multimodal techniques 189, using 
the HWVN spectra 240 or automation of specimen processing 265. Ultimately, 
larger scale clinical studies are required to demonstrate the diagnostic accuracy 
of the technique, and subsequent improvement in patient outcomes. As part of 
this, probes suitable for regular clinical use will have to be developed and go 
through the relevant regulatory processes, and inevitable cost-effectiveness 
evaluation. The focus on translation of RS to the clinical environment must 
persist. In an increasingly competitive market of emerging disruptive 
technologies, future studies must focus not only on improvement of outcomes 
compared to established techniques of IMA, but also show relevance amongst 
novel technologies and techniques. 
 
Despite these hurdles, RS has the ability to provide detailed biochemical 
information of surgical margins with excellent diagnostic accuracy in a range of 
solid tumour pathologies. Further studies are necessary for the translation of this 
technology to a clinically relevant environment and demonstrate improved patient 
outcomes. RS techniques have the potential to provide intra-operative margin 






1.4 The role of water content in breast cancer diagnosis  
1.4.1 Introduction 
The previous section highlighted the work performed by groups in using RS to 
assess the intraoperative margins of breast cancer specimens. Although the 
diagnostic ability of RS to differentiate between normal and cancerous breast 
tissue is good, a major limitation is the time it takes to analyse the large area that 
would be necessary for IMA. Other groups have investigated using nanoparticles 
and SERS 270 and multi-modal spectral histopathology combining tissue auto-
fluorescence with FP RS 189 as techniques that may reduce this time.   
 
High Wave Number Raman Spectroscopy (HWN RS) is an increasing area of 
interest in the analysis of biological tissue. The spectral features in this region are 
from CH-stretching vibrations from protein and lipid at 2800-3040 cm-1. OH 
stretching at 3100-3500 cm-1 which is primarily due to water with some 
contribution from the NH stretching vibrations between 3100 and 3500 cm-1 103. 
The time taken to analyse specimens is reduced using the HWN region due to 
the reduced volume of data, more intense signals 271, and subsequent simplified 
data analysis. In addition to this clinical advantage of reduced time for analysis, 
there is evidence that the diagnostic yield gained from this part of the spectrum 
is similar to that of the FP region 272, 273. HWN RS has been used to differentiate 
between normal and cancerous cervical tissue 272, oral tissue 174, bone 240 and 
brain tissue 165. In these tissues, a difference in water content has been a 
consistent discriminatory feature in the diagnostic analysis, with cancerous tissue 
having a higher water content than normal tissue.  
 
1.4.2 Theories to explain differences in water content in cancerous tissue 
Water content was first noted to be higher in cancerous tissue compared to the 
surrounding normal tissue in 1971, in rat tissue with sarcoma 274. Despite this 
being noted decades ago the biological mechanism as to why water content is 
higher in cancerous tissue compared to the surrounding normal tissue has not 
been fully elucidated. One suggestion is that with the increase in cellularity in 
tumours, there is a reduction of the apparent diffusion coefficient as measured by 
MRI 275. With this reduction in apparent diffusion coefficient in cancerous tissue 




the water diffusion may be related to the increased expression of Aquaporins in 
cancerous tissue, which allows water influx 277. 
 
In measuring the broadband diffuse optical spectroscopy (DOS) of breast tissue, 
Chung et al. 278 calculated that the bound water index decreased in tumours, 
suggesting an increase in free water in tumours, which could be due to increased 
levels of hyaluronic acid and necrosis within tumours. However neither hyaluronic 
acid nor tissue necrosis were actually measured in this study, but it has been 
shown that an increased rate of cell necrosis is correlated with an increase in 
water content 279. 
 
Specifically in breast tissue, a likely reason for the difference in water content is 
because normal breast tissue is predominantly fatty and hydrophobic, and 
cancerous tissue is predominantly stromal with a large amount of protein, which 
is associated with a higher water content 280. 
 
1.4.3 Water content in normal breast tissue 
The water content in normal breast tissue has been estimated using Diffuse 
Optical Spectroscopy (DOS), which is a non-invasive optical technique that 
measures near infrared absorption and scattering. Tromberg et al. performed 
DOS in line scans in vivo on 12 patients who were young (aged 30 – 39), and it 
was demonstrated that the mean water % was 27 (+/- 12 SEM). There were 
limitations with the sampling volume of the line scanner used and the sampling 
depth was only 10mm from the skin surface, and therefore these figures for water 
content may not be representative of the deeper breast tissue water content. 
Using Near Infra Red spectroscopy in the healthy breasts of 24 females it was 
found that the water percentage in breast tissue to be mainly between 40 – 60%, 
however the raw data suggests a wider range was measured from 20-80%, with 
an acknowledged error range of almost 10% suggests that with such a wide 
range, and small number of subjects, a firm conclusion cannot be drawn  281. A 
study that examined differences in the breast density as measured by MRI 
measurement of water content found a significant difference between the median 
water content of mothers (27%) and daughters (44.8%), but again examining the 
raw data it suggests the range was wide and overlapping, as there were women 




This suggests there is significant physiological variation in the water content in 
normal breast tissue. A number of factors may affect the water content of breast 
tissue: 
• Age 
o Independent of menopausal status, as women get older, the breast 
gets more fatty, there is less variation in lipid measurements, and a 
corresponding decrease in water content 282, 283 
• Menopausal status 
o Premenopausal breasts have a higher water and low fat content 
compared to post menopausal breasts 282-284. 
• Relationship to menstrual cycle 
o It was demonstrated with repeated MRI measurements at different 
times in the menstrual cycle there were cyclical differences in the 
water content of the breast, however the clinical significance was 
unclear 285 
o Using NIR imaging in 7 premenopausal patients there was variation 
in water content in radiographic density category, with absolute 
differences of up to 30% of water fraction in normal tissue 
throughout the menstrual cycle 286. 
• Use of oral contraception  
o Those patients taking oral contraception had breasts with higher 
water content and lower lipid content than those not on oral 
contraception 283 
• Location in breast 
o There are differences in water content not only between the two 
breasts of the same patient, but also within the breast and where 
the measurements were taken, with areolar water concentration 
being higher 282.  
• Body Mass Index 
o As BMI increases, the water content decreases and lipid increases, 
as the breast is composed more of fatty tissue compared to 






1.4.4 Differentiating normal from cancerous tissue using water in breast cancer 
There are a number of techniques that have assessed the differences in water 
content in breast cancer. 
 
Terahertz pulsed imaging is a non- invasive optical imaging technique that is 
particularly sensitive to water and lipids (the main areas of spectral interest in 
HWN RS). In a study using 22 samples of human breast tissue, Terahertz 
imaging could differentiate between normal and cancerous tissue with good 
diagnostic accuracy, the increased water content in cancerous tissue 
hypothesised to be a major discriminatory factor in this 287. Subsequently a more 
clinically relevant handheld probe has been developed that had reasonable 
overall diagnostic accuracy of 75%, with a sensitivity of 86%, but a poor specificity 
of 66% 288. This study was limited by the method of measurement, as the probe 
measured both tumour and normal tissue at the same time, and relied on 
matching the pixels of measurements with specimen photographs, which could 
easily be mis-matched after the tissue has been through the specimen 
processing pathway. Another limitation of this technique was that exact water 
content changes were not able to be calculated. 
 
A handheld DOS probe has been used in a series of studies, where spectra were 
taken over a number of points on the skin over tumour containing breast, and the 
contralateral normal breast. When using average readings over the affected 
breast vs the contralateral normal breast, they found a significant increase in 
water concentration of over 50% on the affected side, and decrease in bulk lipids 
of 20% 276. As the readings were averaged over the breast which contained 
normal breast tissue as well it could be assumed that if the specific cancerous 
were isolated and measured the difference may have been greater. It was also 
noted that there was significant physiological variation in the readings of healthy 
tissue between patients. The same group used peak tumour readings compared 
to average readings from the normal breast, and came to similar conclusions with 
regard to the changes in water concentration and lipid concentration 289. 
However, the sample size was small with 11 patients and the tumour 
concentration range was considerable and overlapped with the normal tumour 





Water concentration in breast tissue displays large physiological variations 
between patients, therefore using this as a sole measure of malignancy is likely 
to be inaccurate. It has been seen that areas of tumour not only have an 
increased water concentration, but also a decreased lipid concentration 
compared to normal tissue. 
 
The inverse relationship between water and lipid content is seen in studies using 
MRI for tumour diagnosis. Using Magnetic Resonance Spectroscopy in 15 
patients with cancer, and 14 controls with an average age of 47 years, 
Jaganaathan et al. showed that the water to fat ratio increased in cancerous 
tissue 290. Spectra from tumour showed significantly higher water to fat ratio (6.0 
+/- 6.9) than normal tissue (0.35 +/- 0.26)(+/-SEM). They also demonstrated a 
degree of variability in tumours. The main aim of the study was to illustrate that 
water to fat ratio decreased with response to neoadjuvant chemotherapy, and did 
not investigate the diagnostic ability of the water to fat ratio for cancer diagnosis. 
In a study using MRS on 68 cancers with healthy controls, the fat fraction was 
calculated and this measure was used to demonstrate that malignant tissue had 
significantly lower fat fraction (median 0.12) than normal tissue (median 0.39), 
concluding that this was primarily due to increased water concentration in cancer. 
However, the sensitivity of using the fat fraction to diagnose breast cancer was 
only 75%, probably due to the large ranges of absolute fat and water 
measurements 291. 
 
DOS has also been used to investigate the fat to water ratio as a discriminatory 
factor in differentiating normal from cancerous tissue. It is consistent with the MR 
data, that cancerous tissue has higher water content, and decreased lipid 
content, compared to normal tissue, both in vivo 283 and ex vivo 292, 293 .  
 
1.4.5 Differentiating normal from cancerous tissue using water with HWN RS in 
other cancers  
These studies demonstrate that water content or a measure of water fraction is a 
useful biological feature in differentiating breast cancer from normal breast tissue. 
HWN RS has been used to quantify the difference in water content between 
normal and cancerous tissues, mainly in protein rich biological tissue. The 




stretching band of water at 3390cm-1, and the ratio between these peaks, or the 
ratio between the area under the curve of these peaks has been used to calculate 
water content in porcine brain tissue 294, the stratum corneum in skin 295 and eye 
lenses 296. 
 
This technique was used in the assessment of Oral Squamous cell carcinoma 
with HWN RS to calculate water content 174. Using freshly excised tongue 
resection samples, a number of measurements were taken with a HWN RS probe 
from tumour and normal tissue, before the specimens were fixed and processed 
for a histopathological diagnosis. They found that water content was 20% higher 
in cancerous than normal tissue, and that setting the discriminatory value for 
cancer of water content >69% gave them a sensitivity of 99% and specificity of 
92% for differentiating normal and cancerous tissue. The same group used a 
similar methodology in mandibular bone resection specimens and found a 
significantly higher water concentration in cancerous tissue, and with a 
discriminatory water concentration cut off value of 60% had a 99% sensitivity and 
83% specificity for detection of cancerous tissue 240. The water concentration for 
these studies were calculated based on a calibration using protein/water mixes, 
whereas the biological tissues that were measured had contribution of lipid 
signals, so the absolute numbers calculated may not be accurate. The samples 
were also washed with saline prior to measurement, meaning that fatty 
(hydrophobic) areas would be unaffected, but possibly more metabolically active, 
and hydrophilic areas (tumour containing cells) may have taken up water, thus 
altering and exaggerating the differences in water concentration results seen. 
Despite these limitations, it still holds true that the changes in the protein to water 
ratios can be used to differentiate between normal and cancerous tissues. A 
further limitation of these studies is that Raman microscopy with a 4m sample 
area was used to gain spectra, meaning that with the equipment employed in 
these studies it would be impossible to analyse the entire resection margin of a 
specimen within a clinically relevant time. 
 
Mo et al. obtained measurements from normal and dysplastic cervical tissue with 
HWN RS 272. They observed that Raman intensities at the OH band region of 
3100-3700 cm-1 was significantly higher in dysplastic tissue, indicating that water 




and this was used in the diagnostic algorithm along with changes in the 
protein/lipid region of 2800-3050 cm-1 to differentiate between normal and 
dysplastic tissue. However, signal intensity alone may not provide quantification 
of water changes as they can be affected by other changes in optical properties 
such as scattering or absorption and water concentration changes alone were 
not calculated, so the contribution of changes in water concentration to the 
diagnostic algorithm cannot be assessed.  
 
1.4.6 Differentiating normal from cancerous tissue using water with HWN RS in 
breast cancer 
HWN RS has been used to differentiate between normal and cancerous breast 
tissue in mammary rat tissue 271. In this study, measurements were taken in vivo 
transcutaneous, in vivo skin removed and ex vivo biopsy from 20 rats. The in vivo 
skin removed and ex vivo biopsies demonstrated that the intensity band 
associated with lipid structures (at 2854 cm-1 , 2895 and 3010 cm-1) was higher 
with normal tissue than with cancerous tissue, and the protein band at 2937 cm-
1  was higher in the cancerous tissue. It was also noted that the water signal at 
3100-3500 cm-1 was higher in cancer tissue than in normal and benign tissue 
(Figure 1-20), consistent with there being less lipid and more water in cancerous 
tissue compared to normal breast tissue. However, the analysis used the intensity 
band associated with the proteins and lipids and did not include the signal 
contribution from the water peaks, so the changes in water peak were not 
statistically analysed.  Spectra were analysed by Principle Component Analysis 
and LDA analyses with cross-validation which demonstrated a sensitivity and 
specificity of 100% of distinguishing normal from cancerous tissue in the ex vivo 
biopsy tissue. However, the diagnostic role of the differences in water content 
between the normal and cancerous environments cannot be determined. Another 
limitation is that HWN RS changes in induced tumours in rats may not be relevant 








Abramczyk et al. aimed to investigate the vibrational features of the OH water 
stretching bands using Raman Spectroscopy and HWN RS in human breast 
tissue. Bulk samples of fresh breast tissue were analysed in a controlled 
humidified environment in a reservoir of aqueous salts. Initial experiments 
confirmed that in human breast tissue, water was a major discriminatory factor in 
differentiating normal from cancerous tissue with HWN RS, and that cancerous 
breast tissue had a higher water content and less lipid than normal breast tissue 
297 (Figure 1-21). Subsequently they interpret the vibrational features of water in 
breast tissue to represent interfacial water, and note that the lack of water in 
normal breast tissue is likely due to the hydrophobic adipose tissue, which is not 
present in cancerous tissue 298. There were limitations to this work as the 
specimens were selectively sampled, highly pre-processed and measured under 
controlled laboratory conditions. There was no summary presentation of the 
results from all measured samples, and no statistical analysis of the diagnostic 
ability of the HWN RS data to differentiate between normal/abnormal breast 
tissue, therefore variations between patients or an assessment of the technique 
for clinical use cannot be done. Therefore, whether these HWN RS findings are 
found in the in vivo or clinical setting with ex vivo tissue is yet to be evaluated. 
 
Figure 1-20 Figure of Raman spectra showing the mean spectra of normal and cancer tissue in a 
selected HWN region for Ex vivo biopsy for normal (EVNT) and cancerous (EVCT) breast tissue from 
rats.  
Reprinted by permission from Springer Nature GmbH: Springer Nature, Theoretical Chemistry Accounts, 
High-wavenumber FT – Raman spectroscopy for in vivo and ex vivo measurements of breast cancer, A F 




A recent, more clinical, study by Liao et al. has used HWN RS in fresh frozen 
breast tissue to ‘screen’ specimens of human breast tissue for areas of potential 
tumour prior to using the FP region for definitive diagnosis 299. The technique did 
show promise at highlighting some areas of potential tumour in specimens, 
however, there were a number of limitations. The background fluorescence of 
breast tissue was high with the laser excitation they used for obtaining the HWN 
region (671 nm) which resulted in no spectral information being gained regarding 
protein or water signals. This meant the ‘screening’ tool assessed for the 
presence or absence of lipid only, with no further biochemical information from 
the HWN region. From the current literature, the difference in water content 
between tumour and non-tumour tissue may be essential for diagnosis, and this 
is not assessed in this study. The study was also performed on a, presumably, 
small number of specimens as no sample size is given, with no statistical 
assessment of the technique’s accuracy in terms of sensitivity or specificity, 
meaning the diagnostic ability of HWN RS remains unassessed, and the clinical 







From review of the available literature, cancerous breast tissue has a higher 
water content than normal breast tissue, and this may be used as a discriminatory 
Figure 1-21. HWN Raman spectra of normal (non-cancerous), and cancerous human breast tissue 
(infiltrating ductral carcinoma) compared to the bulk neat water in bulk tissue.  
Note the difference in the signal intensity of the OH stretching vibration of water in cancerous tissue 




feature in differentiating normal from cancerous breast tissue. However, looking 
at water alone shows that water content varies between patients, and even within 
patients depending on hormonally influenced factors. There is an inverse 
relationship between water and lipids which has been demonstrated in cancerous 
tissue, that is, that cancerous tissue has a higher water content and lower lipid 
content compared to normal breast tissue, and this may also be useful for 
discriminatory diagnosis. 
Studies using techniques other than RS utilising the changes in water content or 
a fat to water ratio for diagnosis have predominantly had a small study sample 
size and been in vivo; specimens that require intraoperative margin analysis are 
likely to be freshly excised ex vivo, and are likely to have different hydration 
properties due to their lack of blood supply.  Studies using the HWN region, 
looking at water content for diagnosis, have been limited to rats or highly 
experimental conditions, the protocols being of little relevance to translating this 
knowledge to the clinical environment.  
As a solution to the limitation of fingerprint RS of time taken to analyse a sample, 
it is proposed that the potentially quicker technique of HWN RS and investigating 
the potential of water and/or water to fat ratio changes in discriminating normal 
from cancerous breast tissue may be able to provide intraoperative margin 





CHAPTER 2:  
Developing a Raman system for 
intraoperative margin analysis 
 
2.1 Introduction 
Although a Raman Spectroscopy (RS) system will share the common basic 
components as outlined in previous sections, each system is unique and tailored 
to the aims of the experiment, specimen to be measured, and the environment in 
which it is being used. The initial stage of the project was to develop a RS system 
capable of obtaining measurements from breast tissue to elucidate the 
biochemical features in the High Wavenumber (HWN) spectral region of normal 
and cancerous breast tissue. These spectral features need to be defined and 
diagnostic processes validated before the technique can be used for 
Intraoperative Margin analysis (IMA). 
Therefore, the requirements for our RS system were: 
• Ability to measure the HWN region Raman spectrum  
• Ability to quantify changes in the water concentration and fat/water ratio 
• Suitable for use in ex vivo breast tissue specimens 
• Suitable for use in the clinical environment 
• The footprint of the system needed to fit within the space allocated to it in 
the hospital, where the clinical measurements would be taken 
 
This chapter demonstrates the development of a Raman probe that fulfils these 
needs. Breast tissue phantoms were used to assess the ability of each potential 
Raman system to measure the HWN region and obtain accurate water 
measurements. Potential clinical/logistical problems that may be encountered 
during measurements were then tested, to ensure the Raman system was 






2.2 Materials and Methods  
2.2.1 Measured materials 
Breast Tissue Phantoms 
Tissue phantoms are used extensively in Raman Spectroscopy for the technical 
development of RS systems and to provide a ‘proof of concept’ ability of systems 
to take accurate measurements prior to using that system in a clinical 
environment. The simplicity of a tissue phantom in a controlled laboratory 
environment underestimates the difficulty of achieving similar measurements in 
a complex tissue sample in a clinical environment, however, they are useful to 
validate basic functionality of a system. A variety of phantoms may be used to 
assess different aspects of the intended Raman measurements. Previously used 
tissue phantoms in the field of spectroscopic breast cancer diagnostics include 
porcine tissue 300, chicken breast 301, soybean oil and water 302, a solidifying agent 
TX151 with water, oil and surfactant 303, pure gelatine and water phantoms 304, 
and gelatine, water and intralipid phantoms 278. A single simple phantom cannot 
be constructed that replicates the exact spectroscopic properties of the real tissue 
specimen. The phantoms used in this chapter are Gelatine, Gelatine/intralipid 
constructed phantoms, and pork meat. 
 
The initial challenge is to identify the tissue composition and physiological 
concentrations the tissue phantom is attempting to mimic. Breast tissue is 
primarily composed of epithelial tissue and stroma (protein), adipose tissue (fat) 
and water 284. From an MRI study (with a small sample size of n=8) it was 
predicted the breast was composed of 67% fatty tissue and 33% parenchymal 
tissue 305, however this was with a wide degree of inter-subject variation. A more 
recent MRI study of 306 women suggests the range of fatty tissue is from a mean 
of 53% in women with a mean age of 50.9 to 71% in women with a mean age of 
20.8. The water content of normal breast tissue has been estimated to be around 
27% with Diffuse Optical Spectroscopy 306, 40 – 60% with NIR spectroscopy 281, 
and around 20 – 80% with MRI 280 demonstrating a very wide range in the 
composition of breast tissue. Breast composition varies significantly between 
women in terms of mammographic density (ranging from fatty breast to dense 
and homogenous 307) and water content 284, and within a women’s lifetime due to 
hormonal factors such as pre/post menopause, Body Mass Index (BMI), time of 





Due to these large variations in absolute differences, looking at the change in 
ratios between breast tissue constituents has been used for diagnostic purposes. 
Previous work using MRI and Diffuse Optical Spectroscopy has demonstrated 
that the differing ratios between water and fat relate to the differences observed 
in breast tissue density280, and breast tissue composition changes were observed 
with increasing age, menopausal status and Body Mass Index (BMI) 284. Previous 
work in Raman Spectroscopy using the fingerprint region has demonstrated that 
the differing ratio between collagen (protein) and fat differentiated between 
normal, fibrocystic changes and cancerous breast tissue 180, 262. Ship et al. 
identified major spectral features in normal breast tissue as corresponding to 
collagen and other proteins in stromal tissue and lipids in fatty tissue 189.  
 
This suggests that protein, fat and water are the major constituents in breast 
tissue that can be examined for determining differences in breast tissue 
composition and disease (such as cancer) that can be readily measured with 
Raman Spectroscopy. These constituents are the primary biochemical signals 
that can be detected with HWN RS 105. Therefore, the breast tissue phantoms 
were composed of these constituents, with the ability for the ratio between them 
to be changed. 
 
Justification of type of Breast Tissue Phantoms used 
Gelatine based tissue phantoms are attractive in preliminary work due to their 
simplicity and the ability to set solid in the shape of the mould, which means that 
any physical logistical aspect of measurements could also be assessed. 
Constructing phantoms are preferable for initial experiments compared to meat-
based phantoms because they are homogenous, the phantom constituents are 
known and the percentage water concentration and the phantom constituents is 
a known entity. This is a necessary attribute for the tissue phantom in measuring 
the ability of the RS system to measure in the HWN region and the ability to 
quantify changes in water concentration. A previous study by Masson et al. 
demonstrated the ability of gelatine phantoms to reproduce physiological levels 
of water concentrations, the HWN Raman spectral profile of the phantoms and 







Gelatine based phantoms can also be constructed to be more complex, and set 
with the addition of a lipid (such as Intralipid 278, 308), and scattering agents such 
as india ink308  or nigrosin 278. Prior knowledge of the optical characteristics and 
properties of these phantom constituents such as absorption 309 and scattering 
308  as well as the biochemical properties such as the changes in bound versus 
free water 278 with gelatine concentration makes them a well understood and 
reliable tissue phantom. 
 
There are some limitations of intralipid /gelatine based phantoms. The lipid 
concentration cannot reach the physiological concentrations of the high fat 
concentrations found in breast tissue, as intralipid is only 20% soyabean oil (fat). 
As an oil and predominately unsaturated fat that is liquid at body temperature, it 
may have very different characteristics to that of the complex fat composition of 
human adipose tissue that is solid at body temperature 310. The optical scattering 
properties of intralipid may affect the Raman cross section of phantoms with a 
change in intralipid concentration which could make it difficult to ascertain if it is 
changes in fat content or scattering properties that are being measured 311.  
However, the simplicity in synthesising these phantoms makes them highly 
reproducible and means previous findings are applicable to our own phantoms, 
along with the ability to manufacture a variety of varying lipid/protein/water 
concentrations means they are the optimal phantom to be used for preliminary 




Figure 2-1 HWN Raman spectra from a set of gelatine phantoms of different water concentrations.  
Spectra were normalised to the protein peak at 2940cm-1. Reproduced from reference 304 Reproduced by 




2.2.1.1 Method for Gelatine based Breast Tissue Phantom synthesis 
Pure Gelatine Phantom 
Different concentrations of gelatine phantoms were made by mixing gelatine 
powder from Bovine skin (Sigma Aldrich,Germany) with distilled water to a final 
total weight of 10 grams in a water bath at 55C and stirred with a magnetic 
stirring bar until completely dissolved (20 – 30 minutes) then poured into moulds 
and cooled at 5 – 7 C whilst covered to avoid evaporation for 12 – 24 hours 
before measurement 312. Water concentrations achieved were 85%, 87.5%, 90%, 
92.5% and 95% (Figure 2-2). These water concentrations were chosen as the 
phantoms would not set with water concentrations of > 95%, and when water 
concentrations of <82.5% were attempted the high concentration of gelatine led 
to saturation of solution. Samples were kept in petri dishes with lids between 
measurements to prevent dehydration. 
 
 
95% 92.5% 90% 87.5% 85% 
 
 
Complex intralipid/gelatine Phantoms 
The same method was used for the construction of the complex intralipid/gelatine 
phantoms. With a final weight of 10 grams, a fixed weight of gelatine (1 gram) 
and india ink (2l)(Fischer Scientific,Pittsburgh,USA) were used in varying 
amounts of distilled water and Intralipid 20% (Fresnius,Frankfurt,Germany) with 
final compositions and predicted fat and water % shown in Table 2-1. Figure 2-3 
shows the complex phantoms. Intralipid is composed of 20% soyabean oil, which 
is 100% lipid, and 3.45% other constituents (egg yolk and glycerine) 313, and the 
remainder is water allowing for the calculation of the total fat concentration and 
water concentration. 
 
In order to produce complex phantoms analogous to breast tissue the scattering 
and absorption qualities had to be considered. Intralipid is a scattering fat 
emulsion, the scattering coefficient changing with the intralipid concentration311. 
As the priority with these tissue phantoms was to provide a varying range of fat 




concentrations, a range of intralipid concentrations (including high concentrations 
of 90%) were measured rather than attempting to reproduce physiological levels 
of scattering 314. India ink was used to provide an absorber, concentrations in 
which (0.2l per ml) had been previously used in similar work with intralipid 
phantoms 308. As these were not deep Raman measurements, the importance of 
physiological scattering and absorption coefficients are less, and are unlikely to 
affect the results, however they are considered as deep Raman measurements 






IL 10 Il 30 IL 50 IL 70 IL 90 
 
Bovine Serum Albumin (BSA) 
BSA and water solutions were made to provide a standard against which to test 
the performance of gelatine phantoms. BSA (Sigma Aldrich,Germany) and 
distilled water solutions were made to a total weight of 1 gram to make solutions 
of final water concentrations of 95, 90, 85, 80, 75 and 70% by weight.     
 
2.2.1.2 Recreating the challenges of the surgical environment 
Introduction 
After establishing the ability of the Raman system to accurately measure the 
HWN region, the suitability for use in measuring fresh breast specimens with a 



















IL 10 1 8 1 2 0.345 88 
IL 30 3 6 1 6 1.035 83 
IL 50 5 4 1 10 1.725 78 
IL 70 7 2 1 14 2.415 73 
IL 90 9 0 1 18 3.105 68 
Table 2-1 Table showing the constituent parts of the complex intralipid/gelatine phantoms 




scientific promise have had issues with measuring fresh samples in the clinical 
environment, such as optical coherence tomography that could not gain a signal 
in specimens that had been contaminated with blood or encountered cauterised 
tissue 145, and previous work performed by the Stone group showed that blue dye 
can affect Raman signal 315. As these challenges would be encountered in any 
clinical application of a Raman system for IMA, it was imperative we designed a 
system that could function in the presence of these potential signal altering dyes.  
 
Pork Tissue 
Porcine tissue has been used extensively in previous Raman studies, as it 
contains fat and muscle (protein) and thus grossly replicates the chemical 
composition of human breast tissue 316. The obvious visible distinction between, 
and the existence of areas that are almost exclusively, fat and proteinaceous 
muscle tissue means these areas can be measured to assess spectroscopic 
characteristics in these different tissue types. The benefit of using meat phantoms 
is to assess possible ‘real world’ clinical issues in obtaining measurements from 
breast tissue, such as the effect of surgical dye 315, diathermy 317 and blood / 
haemoglobin contamination292 which is not possible with gelatine phantoms. 
 
Pork chops with distinctive meat and fat portions were selected from local 
supermarkets for measurements. They were measured fresh on day of purchase, 
or frozen on day of purchase at -80 C and thawed for 24 hours in a refrigerator 
at 4 – 8 C prior to measurements. Samples were kept in petri dishes with lids 
between measurements to prevent dehydration. 
 
Patent Blue Dye 
Patent blue dye was used to evaluate the ability to obtain Raman measurements 
in the HWN region in tissue that had been stained with Blue dye. Blue dye is used 
in the dual localisation technique as recommended by NICE for performing 
sentinel lymph node biopsy 56. Blue dye is injected and travels within the 
lymphatic system to identify the first or ‘sentinel’ lymph node that drains the breast 
undergoing surgical excision. The theory is that if the cancer has spread into the 
lymphatics, it will be to these sentinel nodes first – thus if the sentinel nodes are 
negative, it is unlikely any other axillary lymph nodes have metastatic cancer 84. 




the breast cancer excision operation. Blue dye is injected under the nipple 
subdermally, and thus frequently stains the breast tissue that is excised, with the 
potential to affect Raman measurements. Patent Blue V sodium salt (Sigma 
Aldrich, Germany) was dissolved in distilled water to achieve a 1% concentration 
and was applied to pork tissue. Methylene blue and patent blue dye are both used 
in sentinel lymph node operations, at concentrations of 1 – 2.5%318, the 
concentration of staining on the actual breast tissue varies widely according to 
site of tumour, site of injection, length of operation, handling of specimen so the 
amount of staining on the tissue was based on a judgement of whether the 





Blue dye Gelatine phantoms 
To further investigate and quantify the effect of blue dye on the ability of Raman 
systems to obtain Raman spectra, blue dye gelatine phantoms were produced. 
90% water gelatine phantoms were produced as previously described, with blue 
dye pipetted into the gelatine/water mix prior to stirring and cooling at a final 
concentration of 0.01% or 0.1%. 
 
Diathermy 
During breast operations, electrocautery diathermy is used in the excision of 
breast tissue. This can lead to burning / carbonisation of the breast tissue, and 
on histological examination of the tissue can cause significant ‘diathermy 
artefact’. This is where diathermy limits the assessment of the margins of the 
excision due to carbonisation and distortion of cellular architecture319. Therefore, 
this problem is not limited to optical techniques and negatively impacts the ‘gold 
standard’ of histopathology, however, it is important to recognise its effect on 
Raman spectra so it can be accounted for. A soldering iron was used to burn / 
Figure 2-4 Photograph of pork fat (left) and meat (right) that have been stained with 1% patent blue 
dye.  




carbonise edges of pork tissue to replicate this, and assess if there was any effect 
of burnt /carbon on obtaining HWN Raman measurements (Figure 2-5). Pork fat 
simply melted when using a soldering iron – which does occur during breast 





Blood is another pigmented substance that is frequently present on surgically 
excised specimens which may be Raman active and interfere with obtaining 
Raman measurements.  
Haemoglobin is the major pigmented constituent of blood, and is known to have 
be Raman active in the fingerprint region, and to a lesser extent in the HWN 
region 320, however work has mainly been with visible light laser such as 532nm 
excitation. Normal adult haemoglobin concentrations in venous blood are 13-17 
%, however, the concentration on a surgically excised specimen is likely to be 
less as whole blood is mixed with melted fat, blue dye and tissue fluid. To assess 
the potential for blood contamination of surgically excised specimens, 
haemoglobin (Hb from bovine; Sigma Aldrich,Germany) was dissolved in distilled 
water to achieve concentrations of 7.5%, and the porcine tissue soaked in the 




In order to take repeated measurements, and measurements with the same 
probe on a number of different samples, the probe which is interacting with the 
Figure 2-5 Pork meat that has been burnt with some carbonisation evident 




specimen must be able to be cleaned or disposable, to prevent cross-
contamination or tumour seeding leading to inaccurate histopathology results. 
The Raman needle probe used for measurements has the fibre optic needle 
recessed within a hypodermic 22G needle. Theoretically this means the probe is 
capable of having a disposable needle tip, or a needle that can be cleaned while 
not disturbing the optical components. It is also possible to construct a single – 
use needle probe cover which would also ensure cleanliness. However, for 
experiments taking surface measurements from breast specimens, this would 
introduce unnecessary time delays and costs to each measurement. A simple, 
disposable barrier such as Clingfilm between the needle tip and the specimen to 
be measured would ensure no cross-contamination and be more cost-effective. 
Measurements were taken of pork meat and fat with and without a covering of 
clingfilm to investigate if this affected the Raman signal.  
 
2.2.2 Raman Spectroscopy equipment configuration and spectral acquisition 
2.2.2.1 Raman Microspectroscopy 
Preliminary measurements on gelatine phantoms to confirm method of data 
analysis for future Raman systems, and to validate gelatine phantom construction 
reliability were taken on a Renishaw InVia confocal spectrometer system 
(Renishaw, UK). Measurements were taken using a NPlan objective (Leica, 
Germany) with magnification X50. An excitation source of a 785nm laser was 
used with an output of 300 mW to collect spectra in the wavelength range of 2100 
– 2750 cm-1. Calibration of the system was performed daily with silicon, green 
glass, PTFE and Neon Argon lamp. Point measurements were acquired with an 
exposure time of 5 seconds with 12 accumulations. 
 
2.2.2.2 Needle Raman probe 
For all other Raman measurements, a Raman needle probe was used. It has 
been developed, and is similar to, a previously described needle probe 164. The 
purpose of such a probe is that, as it fits within a standard hypodermic needle, it 
can be used to probe within biological tissues, with a view to having in vivo 
diagnostic use and real time subcutaneous pathological diagnosis. This probe 
was used at this stage of the project as it can provide measurements from small 




the histopathology, allowing an accurate diagnosis. With this approach, spectra 
can be gained from normal and cancerous tissue.  
 
The needle probe is not suitable for performing IMA, however it allows this 
preliminary work to be carried out. Once the diagnostic algorithm has been 
validated, a probe that is suitable for analysing the resected surface of a breast 
tissue specimen can be developed. We envisage this would use the same 
experimental set up with a different probe for light delivery and collection more 
suited to assessing a large surface. The basic ability to differentiate between 
normal and cancerous tissue using HWN RS, which is this project’s aim, would 
underpin the ability of this probe to provide IMA. 
 
The needle probe is pictured in Figure 2-7, it is a standard stainless steel 22 
gauge hypodermic needle which provides protection to the fibres, and allows 
cleaning between specimen measurements. Within this probe is a bundle of low-
OH silica optical fibres stripped of coating (0.22NA, Thorlabs), arranged as 6 
collection fibres around 1 excitation fibre. This gives an area of collection of 5.19 
x 104 µm2. 
 
 
Figure 2-7 A picture of the needle component of the Raman needle probe which delivers and collects 
light to the specimen for Raman analysis.  
Covered fibres can be seen entering the unit at the tip, where they are then uncovered and pass down the 





Over the course of the project, some of the collection fibres became dirty or broke, 
giving poor signal, the data from these fibres was omitted from analysis. The 
number of working fibres ranged from 1 – 6.  
 
The exact equipment used is specified in each section for each potential Raman 
system, but all were configured in the same basic way as depicted in Figure 2-8. 
Excitation was delivered at either 680nm or 785nm delivered by an IPS spectrum 
stabilised laser module (Innovative Photonic Solutions,USA) through either a 
680nm or 785nm laser clean up filter (Thorlabs,NJ,USA) and 830nm edge filter 
to the needle tip, providing a maximum power of 100 mW at 680nm  or 250mW 
at 785nm to the sample. The light was then collected through the collection fibres 
through to the entry port on the spectrometer - Kaiser Holospec Imaging 
Spectrograph (Kaiser optical systems inc, Ann Arbour,USA) with a broad grating 
which is coupled to a camera – either a deep-depletion Charge – Coupled Device 
(CCD) camera (PIXIS 400 BRX, Princeton Instruments, NJ, USA) 
thermoelectrically cooled to -80C or an InGaAs camera (iDus InGaAs 1.7m, 






Breast tissue phantoms were placed on a PTFE block (which has no discernible 
spectra in the HWN region) and measured with the tip of the Raman needle probe 
in contact with the specimen. The acquisition times and number of accumulations 
varied according to the Raman system, and are detailed in the corresponding 
sections. All phantoms were measured in three different places to provide a 




representative result for the whole phantom, and to ensure any heterogeneity in 




Calibration in Raman spectroscopy is the process that is used to correlate the 
observed spectral frequencies to their true values. Calibration is essential in 
performing Raman spectroscopy because no two Raman instruments measuring 
the same sample would give identical raw spectrum without calibration.  
 
The need for calibration is due to the large number of sources of variation 
between measurements, such as temperature, and between instruments, such 
as alignment of optical systems, all of which effect the raw spectrum. These 
variations can cause errors leading to miscalibration of the instrument, and 
discordant results. Within the literature, the Raman shift values that are reported 
and taken as standards, can vary significantly; for the example of ethanol in the 
HWN region there was a difference of 2-5 cm-1 between different labs 321, 322, 
which is not uncommon 323. 
 
Common sources of variation are324: 
- Rotation of spectrograph diffraction grating or CCD 
o Spectrographs allow rotation to allow reading of different regions of 
the spectrum, however a misaligned grating by even a small 
amount is a potential source of error in calculating wavelength. 
- Displacement of the camera 
o An inadvertent change to the camera position (i.e. when replacing) 
can cause a shift in camera pixels. 
- Changes in laser excitation wavelength  
o Although stable lasers aim to achieve a single coherent 
wavelength, this can change over time, and can have an 
appreciable effect on wavenumber calculation 
o If using reference spectra that were gained from a laser with a 
different wavelength to the one being used, it can affect the peaks 






o Not only is Raman scattering dependent on temperature, but 
molecular structure is also influenced by temperature.  
o The ambient temperature has a significant influence on the 
camera’s detection of Raman scattering. At room temperature there 
is significant thermally generated background noise which can 
reduce the signal to noise ratio and the ability to detect Raman 
scattering, and so deep cooling of the camera is necessary to 
reduce this ‘Dark noise’.  
 
Therefore, calibration is performed to ensure that there is internal validation – that 
the same instrument will give the same result on different days, and external 
validation – that different instruments in different places will give the same result. 
This is essential if Raman spectra results are to be reproducible, interpretable 
and informative.  
 
Frequency Calibration with Raman shift standards 
There is no universally standardised method of calibration for Raman 
instrumentation, and so there are a number of methods to calibrate an instrument. 
The most common method is to use wavenumber calibration based on known 
frequency standards such as neon-argon lamps, as these standards have a well-
documented and wide range of spectral atomic emission peaks325. Another 
calibration method is to use known frequency Raman shift standards. In this 
method a substrate is used that has well characterised and documented peaks 
that have an assigned Raman shift number, the substrate is measured under the 
same conditions that the experimental samples will be measured under, and the 
‘true’ peak values of the substrate are mathematically fitted (by a polynomial fit) 
to the obtained pixel peak values 323. In this way the instrument’s Raman shift 
axis can be calibrated. The benefits of this method are the laser frequency does 
not need to be known, as long as it is constant, the sample position does not 
influence the result, and it is easy to implement 326. In these experiments, a 
number of different laser wavelengths and lasers were used, and so it was 
practical to use this method for calibration, to avoid repeated measuring of the 





Finding a Standard 
It is suggested that a wide number of at least 10 peaks with a broad range across 
the interested region are used to optimise the accuracy of calibration across the 
spectrum 323. The HWN region has fewer spectral features for shift standards to 
be calibrated against compared to the fingerprint region, and so a number of shift 
standards can be used at the same time in order to increase the range and 
accuracy of calibration 324. The American Society for Testing and Materials 
(ASTM) selected a number of materials that could be used as a common Raman 
shift standard, and examined them in a reproducible manner in a number of 
laboratories to provide the ASTM standard. Commonly used ASTM calibration 
standards that have peaks in the HWN region are 4-Acetamidophenol 
(paracetamol) and acetonitrile 323, 324, 327, and so these were used for our 
calibration. Additionally, it was found that ethanol produced a clearly defined 
spectrum in the HWN region, which remained easily distinguishable in the HWN 
region when using a 785nm excitation wavelength (where the paracetamol 
spectrum peaks became less distinct). To ensure there were enough spectral 
peaks in the HWN region ethanol was also used as a calibration standard 321. 
The Raman system to be used for the measurements therefore was calibrated 
using the frequency calibration method using the Raman shift standards of 
paracetamol, acetylnitrile and ethanol. 
 
Methods of calibration for the Raman Needle probe 
Calibration was performed daily, or with any change of equipment. Using the 
Raman needle probe system, measurements were taken of the calibration 
standards for the relevant wavelength of either 680nm or 785nm. The calibration 
standards were paracetamol (Tesco,UK), acetylnitrile (Sigma Aldrich, Germany), 
and ethanol (Fischer Scientific,Pittsburgh,USA). A single acquisition was taken, 
with an exposure of 0.5 seconds. The pixel number of the characteristic peaks 
for each standard were identified and correlated to the ‘true’ Raman shift number 
from the literature (Table 2-2). These were combined and entered in a table in 
Microsoft Excel, and regression analysis performed to report the adjusted R 
Squared and standard error of regression (as a description of fit) and to report 
the y intercept and 1st, 2nd and 3rd coefficient. These were then used to fit the pixel 






𝑅𝑎𝑚𝑎𝑛 𝑠ℎ𝑖𝑓𝑡𝑝 = 𝐼 + 𝐶1𝑝 + 𝐶2𝑝
2 +  𝐶3𝑝
3 
 
The degree of polynomial to use is a subject that has been debated, as the user 
needs to avoid using too low a polynomial and underfitting, or using a high 
polynomial and overfitting the data. A third order polynomial was used for fitting 
as it is thought to be optimal for shift accuracy when compared to other order 
polynomials for pixel fitting, and is commonly used 329, 330. This produced the 
calibrated Raman shift axis for the experiments produced at that laser excitation 




TRUE RAMAN SHIFT CM-1 LASER WAVELENGTH 
UTILISED 
PARACETAMOL 1278 785nm 
PARACETAMOL 1323 785nm 
PARACETAMOL 1371 785nm 
ACETONITRILE 1374 785nm 
ETHANOL 1463 785nm 
PARACETAMOL 1515 785nm 
PARACETAMOL 1561 785nm 
PARACETAMOL 1648 785nm 
ACETONITRILE 2253 785nm 
ACETONITRILE 2293 785nm 
ETHANOL 2887 785nm + 680nm 
PARACETAMOL 2931 785nm + 680nm 
ETHANOL 2937 785nm + 680nm 
ACETONITRILE 2943 785nm + 680nm 
ETHANOL 2983 785nm + 680nm 
PARACETAMOL 3064 785nm + 680nm 
PARACETAMOL 3102 680nm 
PARACETAMOL 3326 680nm 
 
Equation 2-1 Equation adapted from reference 328 
Where 𝜆𝑝 = 𝑅𝑎𝑚𝑎𝑛 𝑠ℎ𝑖𝑓𝑡 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙 𝑝, I = Raman shift of pixel 0, C1 is the first coefficient (cm
-1/pixel), C2 is 
the second coefficient (cm-1/pixel), C3 is the third coefficient (cm-1/pixel). 
Table 2-2 Table demonstrating the Raman shift references used for calibration of the Raman shift 
axis, and the laser wavelength for which they were utilised.  




2.2.4 Data recording and Analysis 
Raman spectra were recorded using LightField software (Princeton Instruments, 
USA) when using a Princeton Instruments camera, or SOLIS software 
(Andor,UK) when using an Andor camera. Raw data was exported and analysed 
using software Matlab R2019a(The MathWorks Inc, USA). Bar graphs were 
constructed in Microsoft Excel. 
 
Pre-processing 
The calibration protocol for the Raman Needle probe is described in the previous 
section, which allowed the x-axis of Raman shift to be correctly aligned.  
As previously mentioned, the number of working fibres within the Raman needle 
probe varied between 1 and 6 and only spectra from working fibres was included. 
Within each fibre, accumulations were summed together, and then summed to 
the output from the other fibres within that measurement to create a single spectra 
for each measurement. All data were baseline subtracted to remove background 
fluorescence using a 1st order polynomial using the lowest count at the beginning 
of the HWN region, and the end of the HWN region. As we were interested in the 
protein/fat to water ratio, for visualisation purposes, spectra were then normalised 
to the CH2 peak at 2935 cm-1, and the average and standard deviation of the 
triplicate readings calculated. This allowed visual comparison in the water spectra 
to be made between samples of varying water content. 
 
Calculation of water content 
A central idea to this project is the differentiation between normal and cancerous 
tissue using water content. As outlined in Chapter 1, previous studies 
demonstrate that breast cancer tissue has more water than normal breast tissue, 
and that changes in the fat/water ratio can be used to differentiate between 
normal and cancerous breast tissue 290, 291. It would be useful if we could not only 
identify changes in water content using Raman spectroscopy, but quantify what 
those changes are, and provide estimates of water concentration. This would 
allow any results to be compared with results gained from other spectroscopic 
methods such as DOS 289, and compared with other Raman studies investigating 
water concentration changes in other disease states 174. A peak assignation table 
for the protein /fat CH stretch region is displayed in Table 2-3 and for the water 














2817-2849 CH2 symmetric 





2854 CH2 (breast) 297, 271 
 2840 - 2875 CH3 symmetric 





2888-2895 CH3 Lipid (breast) 297, 271 
COLLAGEN 
TYPE I 
2928-2945 CH3 Protein 
(Collagen Tpe 1) 
332, 333 
HUMAN SKIN 2910-2966 CH3 Protein (Human 
Skin) 
295 










3075 DAA Fully hydrogen 
bound 
304 
3200-3250 O-H symmetric 
stretch 
Bound water 334, 297 
3245 DDAA Fully hydrogen 
bound 
304 
3400 - 3450 OH asymmetric 
stretch 
Unbound water 334, 297 
3420 DA Partially hydrogen 
bound 
304 
3550 DDA Partially hydrogen 
bound 
304 
3650 - Free water 304 
3600-3650 O-H non hydrogen 
bonded 
Free Water 334 
 
Table 2-3 Table demonstrating peak assignation for the HWN Raman spectroscopy CH stretch region 
in a variety of human tissues 




The spectral intensity of a Raman peak is often proportional to the change in 
concentration of the molecule assigned to that peak i.e. if a substance has more 
of a molecule then that assigned band will have a higher spectral intensity than a 
substance that has less of that molecule, and this can be used for diagnostic 
purposes 232. We could presume that (using BSA/water mixtures analysed with 
the InVia spectroscope as per the protocol in 2.2.1.1 as an example) the peak 
height of the OH stretch of water at 3390 cm-1 should change proportionally to 
the water concentration (measuring the peak height relative to the baseline, as 
previously described in reference 232). Figure 2-9 demonstrates that this is not the 
case, and the maximum peak intensity for the OH stretch region does not vary 
significantly (one-way ANOVA comparison of means, P>0.05) with a changing 
water concentration. This suggests that another method is needed for quantifying 




The majority of other studies quantifying water content changes with HWN 
Raman spectroscopy have been studying protein rich tissues. Huizinga et al. 
used the ratio between the Raman intensity at the CH stretch of protein at 2935 














Figure 2-9 Bar chart of maximum Raman spectral intensity at 3390 cm-1 at different water 
concentrations calculated by BSA/water mixtures.  




cm-1 and the OH stretch of water at 3390 cm-1 in a range of protein/water solutions 
(including BSA) at similar concentrations of 10-35% water to calibrate and 
quantify the water concentration in rabbit eye lenses 296. A similar method using 
spectral intensity was used by Bauer et al. which used traditional methods of 
drying and lyophilization to confirm the accuracy of this technique to within 3% 
accuracy 335. Both of these techniques are dependent on a single intensity 
reading at the protein peak, which although may be present in fat-laden breast 
tissue, the relationship between this sharp peak, and the broad multiple peaks of 
lipid in breast tissue (which is between 2854 – 2940 cm-1 336) is unlikely to be so 
simple or linear. Caspers et al. used an area under the spectral interval method 
to calculate the water content in skin, and went on to use it in their work on oral 
SCC 228, 295. They calculated the ratio of the area under the curve of OH stretching 
(3350 – 3550 cm-1) and the area under the curve of CH3 stretching (2910 – 
2965cm-1) and used BSA solutions to find the proportionality constant that related 
the ratios before applying the method to skin specimens. Although this area-
under-the-curve method is attractive as it could be broadened to include lipid 
regions, the overlap between the protein (2910-2965 cm-1) and lipid regions 
(2854-2940 cm-1) in the HWN region mean distinction between measuring protein 
or lipids would be arbitrary. It also uses a specific assignment of the OH stretch 
of water, whereas water has a much broader range of Raman activity from 3189 
– 3770 cm-1 336, and so changes in water spectrum might not be truly reflected by 
choosing a narrow part of the spectrum.   
 
A more complex model has been suggested using a training set of brain tissue, 
which has some lipid content. Raman spectra were measured in the training set 
of wet tissue which was then dried and repeat measurements taken, a PLS model 
was then applied and achieved good diagnostic accuracy on the test set 294. 
However, this method requires access to tissue which would not then undergo 
pathological analysis for the training set, as it would undergo severe dehydration 
which may affect diagnosis. This limits its practical use, where this excess tissue 
may be difficult to obtain. 
 
A method based on area under the spectral curve, whilst avoiding using specific 
spectral bands was proposed by Masson et al. 304. In this study they were using 




where they used the ratio of the area under the water curve (3035 – 3680 cm-1) 
to the under the area under the entire HWN region (2850 – 3680 cm-1) to predict 
water concentration and validated it against wet and dry weights. The reason for 
using these areas was because cervix remodelling includes significant changes 
in lipids, and this was captured using this approach, suggesting its suitability for 
fatty breast tissue. This method also uses all the information from the water peak 
in its calculation, thus can take into account the varied contributions to the HWN 
Raman spectra different states of water give. Although this method was validated 
in protein only (with gelatine/water phantoms), it was subsequently used in lipid 
containing biological tissue to observe changes in water content. As this method 
is the only validated method that takes into account the lipid signal, and takes 
into account the entire water spectrum, this method was used in this project for 
calculation of water content. 
 
Method of water calculation  
In the preliminary breast phantom studies, the relationship between the 
water/total area ratio and known water concentration was investigated. The area 
under the curve of the water curve (3035 – 3680 cm-1) and the area under the 
curve of the entire HWN region (2850 – 3680 cm-1) was calculated, and the 
water/total area ratio calculated. This ratio was then plotted against the known 
water concentration (as a ratio) of the breast phantom on the x axis, a 1st order 
polynomial (line of best fit) was then calculated to assess whether the relationship 
was linear. This line was also used to calculate the gradient and the y intercept, 
and the Root Mean Square Error (RMSE) as an indicator of fit. 
 
Statistical analysis 
Data is displayed as mean water/total area ratio with error bars +/- 1 standard 
deviation (SD). Comparison of mean water/total area ratios was performed using 








2.3 Evaluating Breast phantoms and data analysis procedures 
The InVia microspectroscope was used to assess gelatine phantoms to test the 
method of data analysis and to evaluate gelatine phantom reproducibility and 
reliability. The InVia was used for this as it is a fixed, closed, laboratory system 
which has a defined calibration protocol. Therefore, it allows for easier 
comparison between experiments, and is a validated piece of equipment. It 
means any unexpected results or variations can be assumed to be in the 
phantoms measured, whereas in an unvalidated, open system which is more 
dynamic such as the needle probe, unexpected results could be due to system 
set up / calibration rather than the phantoms. 
 
Evaluation of data analysis protocol for measuring water concentration 
As already outlined in the previous section, raw water peak intensity does not 
vary between different concentrations (Figure 2-9  and Figure 2-10 A). However, 
when the data is normalised to the protein peak, it demonstrates that there is a 
relative and linear change in the relative water intensity compared to the 
normalised protein intensity with a change in water concentration i.e. with a 
decrease in phantom water concentration there is a decrease in the relative 
intensity of the water peak (Figure 2-10 B). In order to quantify this change in the 
ratio between the protein and water peaks, the water/total area ratio was 
calculated. A graph was then plotted to show the relationship between the 
water/total area ratio and known water concentration of the BSA/water solutions 
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The suitability of the method of using the water/total area ratio to calculate the 
water concentration was tested. Gelatine phantoms of varying water 
concentrations were constructed, measured in a similar way, and the water/total 
area ratio calculated. The following equation was used to predict the water 






























Figure 2-10 Graph showing Raman spectra in the HWN region of different concentrations of 
BSA/water solutions.  
Data is mean of 3 repeats for each concentration and baselined using 1st order polynomial. A. raw spectrum 
– the peak intensity of the water peak between 3100-3700 cm-1 does not vary according to water 
concentration. B Spectral data normalised to protein peak at 2935 cm-1- the relative intensity of water peak 
decreases corresponds with a decrease in water concentration. Data is the mean (n=3) at each 
concentration after baselining using 1st order polynomial, shading in the same colour either side is +/- 1SD. 
Figure 2-11 Graphs showing calculation of the water/total area ratio in BSA/water solutions with the 
InVia spectrometer. 
 A. Representative baselined Raman spectra of 95% water gelatine phantom showing the areas used for 
calculation of water concentration. Yellow area is the area under water curve of 3035 – 3680 cm-1, orange 
area is the area under the rest of the HWN region 2850 – 3035 cm-1. Area under water =yellow area;  total 
area = yellow + orange area. B. Graph plotting mean water / total area ratio versus known water fraction of 
a number of different concentrations of BSA/ water solutions (n=3), Error bars +/- SD. A line of best fit 




concentration of the gelatine phantoms, using information on the relationship 
between water/total area ratio from the BSA/water solutions. 
From Equation 2-2: 
𝑦 = 𝑚𝑥 + 𝑐 
 
This can be re-arranged to produce Equation 2-3 : 
𝑥 =  (
𝑦 − 𝑐
𝑚
) 𝑋 100 
 
The results of this are in Table 2-5, and demonstrates that this method of 
calculation of water content is highly accurate when using substances of protein 
and water mixtures. It also demonstrates that the method for gelatine phantom 
construction produces phantoms of the desired concentrations. 
  
WATER CONCENTRATION OF 





95 0.79376838 94.8334218 
90 0.71025914 90.5288215 
85 0.61007738 85.3648132 
 
 
Having established that the water/total area ratio having been calibrated to 
BSA/water solution was suitable for predicting water concentration in simple 
protein / water mixtures, the method was used in complex phantoms. Complex 
phantoms were constructed of intralipid, india ink, water and gelatine as 
described in 2.2.1.1. They were analysed and the data processed in a similar way 
to calculate the water/ total ratio. Equation 2-3 was used to predict the water 
concentration of the complex phantoms (Table 2-6), which shows that although 
there was a trend of decreasing predicted water concentration with decrease in 
Equation 2-2 
Equation 2-3 
Where x = predicted water concentration %, y = water/total area ratio of the gelatine phantom, m = gradient 
of the relationship between water/total area (1.9426), c = y intercept (-1.0609) 
Table 2-5 Table showing the validation of using the water/total area ratio to calculate water 
concentration. 
The actual concentration of gelatine phantoms is based on the weight of water and gelatine, the calculated 
water/total area ratio is from the baselined spectra from Raman measurements. The predicted water 
concentration is calculated using the calibration graph from BSA data and Equation 2-3 to predict the water 




actual water concentration, it is inaccurate, and that BSA/water solution cannot 
be used to predict  the water/total water area of complex phantoms. 
 








IL 50 78 0.504 79.9 
IL 70 73 0.1796 63.1 
IL 90 68 0.115 59.8 
 
Reproducibility of breast phantom synthesis 
If there is significant evaporation of water from phantoms during construction or 
measurement, it could lead to large variations between experiments and 
inaccuracies in measurements. If we are to regard the gelatine phantom as being 
a reference point for a particular water concentration, it needs to be reproducible 
and have a stable water content. 
 
Three batches of gelatine phantoms of 95, 90 and 85% water concentration were 
constructed and measured at three different time points. Figure 2-12 shows there 
was no significant variation between experiments in the water/total area ratio 
suggesting the construction of gelatine phantoms is highly reproducible, and 
measurements within the same phantoms show minimal variation suggesting the 
phantoms are homogenous in nature.  
 
Table 2-6 Table showing the actual water concentration of intralipid phantoms, the calculated 





During experiments, the gelatine phantoms can be on the lab bench for a number 
of hours. A gelatine phantom of 95% water concentration was measured at 0 and 
4 hours and was at room temperature between measurements to demonstrate 

























Figure 2-12 Graph showing gelatine phantoms of the same water concentrations in 3 different 
experiments and the water /total ratio.  
Bars show mean water/total area ratio (n=3), error bars +/- SD. There was no significant difference in 
water/total area ratio between experiments (P>0.05;one- Way ANOVA). 
Figure 2-13 Graph showing the same gelatine phantom measured at time zero and 4 hours later.  
Bars show mean water/total area ratio (n=3), error bars +/- SD. Student t-test demonstrated no significant 
difference in water/total area ratio between time points (P>0.05). 

























These experiments demonstrate that the method for producing gelatine 
phantoms produces phantoms of the desired water concentration. It also 
demonstrates the suitability of the water/total area ratio for measuring changes 
in the water concentration as the relationship is linear in both protein/water and 
lipid/water mixtures. However, a protein/water mixture could not be used as a 
reference to predict water concentration in complex phantoms of 
lipid/protein/water. The reproducibility in construction and stability over time of 
gelatine phantoms is also demonstrated. 
 
2.4 Evaluation of Raman systems  
 
2.4.1 NP1- 680 nm laser excitation 
2.4.1.1 Raman system set up 
The general needle probe Raman system set up is described in 2.2.2. The 
following changeable components were used: 
Laser excitation: 680 nm 
Laser clean up filter: 680 nm 
Camera: PIXIS 400 BRX 
Measurement protocol: 1 second acquisition, 10 accumulations 
 
2.4.1.2 Gelatine phantoms 
The raw spectra obtained demonstrate a high background fluorescence at this 
wavelength (Figure 2-14 A). After pre-processing, it can be seen that with a higher 
water concentration there was a higher water peak compared to the protein peak 
(Figure 2-14 B). Figure 2-15 A shows the areas that were used to calculate the 
water/total area ratio. The water/total area ratio was calculated for all 
concentrations of gelatine phantom and plotted against known water 
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2.4.1.3 Intralipid phantoms 
Measuring intralipid phantoms in a similar manner, Figure 2-16 A shows that, in 
normalised spectra, with a decrease in known water content there is a decrease 
in water signal. It can be seen that the water peak has a different morphology to 
that of the water peak observed in the gelatine phantoms. This could be due to 
fluorescence in the intralipid phantoms. Calculation of the water/total area ratio 
to known water concentration demonstrates a linear relationship (Figure 2-16 B).  
 



















































  Figure 2-14 Raman spectra of a range of varying water concentrations of gelatine phantoms 
measured using NP1 Raman system.  
A. Representative Raw Raman spectra at 5 different concentrations. B. Raman spectra after pre-processing. 
Data is the mean (n=3) at each concentration after baselining using 1st order polynomial and normalised to 
the protein peak, shading in the same colour either side is +/- 1SD. 
Figure 2-15 Using NP1 to measuring water/total area ratio in gelatine phantoms 
A. Raman spectra of 85% water gelatine phantom with areas highlighted that are used to calculate water 
(yellow) / total (orange + yellow) ratio. B. Graph of water area/ total area ratio versus known water 
concentration of a number of different concentrations of gelatine phantoms measured using NP1 Raman 
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2.4.1.4 Recreating the challenges of the surgical environment  
Pork meat and fat were analysed and compared to meat and fat that had been 
stained with blue dye or haemoglobin, burnt or wrapped in clingfilm. No Raman 
signal could be recovered from pork stained with blue dye or that had been burnt 
due to fluorescence that obliterated all signal. Haemoglobin staining and clingfilm 
covering did not make a visual difference to the Raman spectra (Figure 2-17), 
and comparison of water/total area ratios between pork meat vs Hb stained meat 
or clingfilm covered meat and between pork fat vs Hb stained fat or clingfilm 
covered fat revealed no significant difference (P>0.05; one- way ANOVA). 
A      B 
    
 





















Figure 2-16 Demonstrating the ability to measure changes in water concentration in complex 
intralipid phantoms measured with NP1.  
A. Raman spectra after pre-processing. Data is the mean (n=3) at each concentration after baselining using 
1st order polynomial and normalised to the protein peak, shading in the same colour either side is +/- 1SD. 
B. Calculated water/ total area ratio versus known water concentration. Average ratio plotted (n=3), Error 
bars +/-SD, with a line of best fit. Gradient 0.7573, RMSE – 0.0050. 
Figure 2-17 Results of measurements of pork phantoms with NP1.  
Raman spectra of A. Pork meat and B. pork fat that had either not been treated, stained with haemoglobin 
or wrapped in clingfilm. Data is the mean (n=3) at each concentration after baselining using 1st order 





These experiments with NP1 with 680 nm excitation demonstrate the ability of 
this system to obtain spectra in the HWN region. Using the water/total area ratio 
for both gelatine and complex phantoms shows a linear relationship, and 
demonstrates that NP1 can identify measurable changes in water concentration. 
Measuring pork tissue with haemoglobin and clingfilm covering did not 
significantly alter Raman spectra. However, blue dye and burnt tissue caused 
fluorescence that obliterated signal.  
 
The large degree of fluorescence caused by burnt / carbonised tissue is a 
potential issue for analysing breast specimens. Diathermy artefact is usually a 
local process that would not prohibit analysis of an entire resected surface, but 
could ultimately reduce the sensitivity of NP1 analysis for IMA. The greater 
problem posed is the fluorescence caused by blue dye, which was significantly 
stronger than the Raman signal and resulted in no Raman scattering being 
detected. The intensity of fluorophores is related to the excitation wavelength, 
and it is generally highest in the UV or visible wavelengths 337; by increasing the 
wavelength away from 680 nm, it is possible to move away from the fluorescence 
produced by blue dye. Using the laser excitation of 785 nm would minimise the 
influence of blue dye on Raman spectra, but would allow for measuring of the 
HWN spectrum within the confines of spectrometer limits (up to 1100 nm 
wavelength). Therefore the needle probe was re-configured for use with a 785 













2.4.2 NP-2 785 nm  set up 
2.4.2.1 Raman system set up 
The general needle probe Raman system set up is described in 2.2.2. The 
following changeable components were used: 
Laser excitation: 785 nm 
Laser clean up filter: 785 nm 
Camera: PIXIS 400 BRX 
Measurement protocol: 1 second acquisition, 10 accumulations 
 
2.4.2.2 Gelatine phantoms 
The raw spectra obtained demonstrates the low intensity of Raman signal 
detected in the HWN region using this wavelength and a CCD camera (Figure 
2-18 A). Despite this, after pre-processing, it was still possible to detect 
differences in water concentration; with a higher water concentration there was a 
higher water peak compared to the protein peak (Figure 2-18 B). A lower signal 
to noise ratio is noted. Figure 2-19 A shows the areas that were used to calculate 
the water/total area ratio. The water/total area ratio was calculated for all 
concentrations of gelatine phantom and plotted against known water 
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2.4.2.3 Intralipid phantoms 
Figure 2-20 A shows that, in normalised spectra, with a decrease in known water 
content there is a decrease in water signal. Calculation of the water/total area 
ratio to known water concentration demonstrates a linear relationship (Figure 
























































Figure 2-18 Raman spectra of a range of gelatine phantoms of varying water concentrations 
measured using NP2 Raman system.  
A. Raw spectra from a 95% water gelatine phantom. B. Raman spectra after pre-processing. Data is the 
mean (n=3) at each concentration after baselining using 1st order polynomial and normalised to the protein 
peak, shading in the same colour either side is +/- 1SD. 
Figure 2-19 Using NP2 to measure water/total area ratio in gelatine phantoms  
 A. Raman spectra of 85% water gelatine phantom with areas highlighted that are used to calculate water 
(yellow) / total (orange + yellow) ratio. B. Graph of water area/ total area ratio versus known water 
concentration of a number of different concentrations of gelatine phantoms measured using NP2 Raman 
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2.4.2.4 Recreating the challenges of the surgical environment 
Pork meat and fat were analysed and compared to meat and fat that had been 
stained with blue dye or haemoglobin, burnt or wrapped in clingfilm. Raman 
signal could not be recovered from pork that had been burnt due to fluorescence. 
After pre-processing the raw signal, blue dye staining, haemoglobin staining and 
clingfilm covering did not make a large visual difference to the Raman spectra 
(Figure 2-21), and comparison of water/total area ratios between pork meat vs 
blue dye stained meat or Hb stained meat or clingfilm covered meat and between 
pork fat vs blue dye stained meat or Hb stained fat or clingfilm covered fat 


































Figure 2-20 Demonstrating the ability to measure changes in water concentration in complex 
intralipid phantoms measured with NP2.  
A. Raman spectra after pre-processing. Data is the mean (n=3) at each concentration after baselining using 
1st order polynomial and normalised to the protein peak, shading in the same colour either side is +/- 1SD. 
B. Calculated water/ total area ratio versus known water concentration. Mean ratio plotted (n=3), Error bars 
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Blue Dye Gelatine phantoms 
To further investigate the effect of blue dye (BD) on obtaining Raman signal, blue 
dye gelatine phantoms containing concentrations of 0.01% and 0.1% blue dye 
were analysed using NP2 system. When comparing the raw spectra of gelatine 
phantoms with increasing concentrations of blue dye, it can be seen that there is 
an increasing background of fluorescence with blue dye. The Raman signal of 
gelatine can be recovered from this, but after pre-processing a 0.01% blue dye 
concentration alters the Raman signal, and led to a significantly different mean 
water/total area ratio (no BD 0.745 (SD 0.17), 0.01% BD 0.776 (SD 0.018), 0.1% 






























Figure 2-21 Results of measurements of pork phantoms with NP2 system.   
Raman spectra of A. Pork meat and B. pork fat that had either not been treated, stained with blue dye, 
stained with haemoglobin or wrapped in clingfilm. Data is the mean (n=3) at each concentration after 
baselining using 1st order polynomial and normalised to the protein peak, shading in the same colour either 









The NP2 system is able to obtain Raman spectra in the HWN region. The system 
can also be used to quantify changes in water concentration in both gelatine and 
complex phantoms using the water/total area ratio as the relationship is linear.  
However when examining the raw spectra there are a number of issues identified 






































Figure 2-22 Results of measurement of blue dye (BD) gelatine phantoms with NP2.  
A. Raw Raman spectrum with 10% gelatine phantom and 10% gelatine phantom with 0.01% and 0.1% blue 
dye. B. Raman spectra with after pre-processing. Data is the mean (n=3) at each concentration after 
baselining using 1st order polynomial and normalised to the protein peak, shading in the same colour either 
side is +/- 1SD. C.  Bar chart comparing the mean water/total area ratio between the three blue dye gelatine 
phantoms,  *- significantly different ratio between 0.01% BD and 0.1% BD (P=0.043), † - significantly different 







which are related to using a CCD camera to obtain HWN spectra using the 785 
nm excitation wavelength. 
 
There is low signal to noise and with a low signal intensity it could significantly 
affect the results as the high background fluctuations may alter the AUC, and 
subtle changes in water content at physiological levels could be immeasurable. 
The NP2 system is only capable of recording to a maximum Raman shift of 
around 3550 cm-1, which is the cut off on all the graphs. And although it appears 
that the Raman spectrum tapers down at this extent – this is actually a result of 
the limitations of the CCD camera ability to read at this wavelength, rather than a 
true reflection of the Raman spectrum. If the NP1 spectra are compared with the 
NP2 spectra when measuring the same gelatine phantoms, it is obvious that in 
the middle of the water peak (at, for example, 3550 cm-1) there is a high signal 
intensity with NP1, but zero intensity with NP2. This demonstrates that the Raman 
signals observed with NP2 are not a true reflection of the entire HWN region – 
particularly in the water peak region of 3035 – 3680 cm-1, and that using the  
water/total area ratio, although a linear relationship is observed, the truncation of 
the water peak means it is not a true measurement of water concentration 
changes. The reason for these observed effects at the end of the CCD camera 
readings is due to the quantum efficiency of the CCD at this wavelength. 
 
CCDs contain sectored pieces of silicon that allows accumulation of scattering 
over the whole exposure time, which allows discrimination between each 
frequency of scattered light and multiwavelength detection 100. This allows for fast 
spectral scanning and rapid spectral acquisition; however silicon has an optimum 
region of sensitivity to photons (QE) and a detection cut off wavelength of 
1100nm. For measuring in the HWN region and to investigate the water spectrum, 
the Raman system used must be able to detect Raman shift at 3035 – 3680 cm-
1. To understand this in relation to the quantum efficiency of the camera it has to 
be converted to the wavelength of light measured using Equation 2-4: 
 







     
Where ex = laser excitation wavelength; 
Raman shift = Raman shift of the molecule being investigated.  





Using Equation 2-4, if using NP2, which is a 785 nm laser excitation to investigate 
a 3400 cm-1 Raman shift (the middle of the water peak): 
 
𝜆 [𝑛𝑚] =  
1




    𝜆 = 1070nm 
 
So the wavelength of 1070 nm is very close to the CCD cut off of 1100 nm. The 
manufacturer provides a quantum efficiency vs wavelength (nm) graph of the 
specific CCD camera used for NP1 and 2 (Figure 2-23). From this it can be seen 
that at a wavelength of 1070 nm, the quantum efficiency of the CCD is less than 
10%, meaning the detection of Raman signal for the water signal is very poor, 






The main reason for performing the experiments with NP2 was to assess if 
Raman spectra could be measured in the presence of blue dye. These 
experiments found that, unlike the NP1 data, Raman spectra could be measured 
in the presence of blue dye with NP2. Measurements from blue dye gelatine 
phantoms demonstrate that the raw Raman spectrum have an increased 
background fluorescence with blue dye, but Raman data is recoverable from this. 
This suggests that 785 nm excitation wavelength is appropriate for measuring the 
Figure 2-23 Quantum efficiency of the Princeton Instruments camera range versus wavelength.  










HWN region in the presence of blue dye, if camera detection quantum efficiency 
can be improved. At a higher concentration of 0.1% blue dye in the gelatine 
phantoms, there was a significantly different water/total area ratio compared to a 
gelatine phantom without blue dye – however it may be that the low intensity 
Raman signal due to the poor camera QE in the HWN means the effect of 
fluorescence is more apparent, and it may be reduced with improved Raman 
scattering detection. 
 
These findings suggest that a camera that uses a 785 nm excitation, but with a 
camera that has greater QE in the desired wavelength range may be the optimal 
system to measure the HWN region in the presence of blue dye. A solution to this 
is using a different type of camera to the silicon chip based CCD. Alternative 
detectors to silicon based CCD’s are Indium gallium arsenide (InGaAs) detectors 
which are semiconductors with a lower bandgap to provide sensitivity in an 
extended near infrared range. The InGaAs camera available for use in this project 
is the Andor InDus InGaAs, the QE data for this camera is seen in Figure 2-24, 
which demonstrates that to investigate a wavelength of 1070 nm (middle of the 
water peak at 785 nm), the QE of this camera would be >85%. This is 
substantially better than the Princeton Instruments CCD camera, and so could 
be suitable for use with a 785 nm excitation wavelength for the investigation of 





Figure 2-24 Quantam efficiency at 20C of the Andor InGaAs camera range versus wavelength which 




of  3400 cm-1 
at 785nm 
excitation– at 
a point of 




2.4.3 NP-3 785 nm InGaAs set up 
2.4.3.1 Raman system set up 
The general needle probe Raman system set up is described in 2.2.2. The 
following changeable components were used: 
Laser excitation: 785 nm 
Laser clean up filter: 785 nm 
Camera: iDus InGaAs 1.7m 
Measurement protocol: 10 second acquisition, 5 accumulations 
 
2.4.3.2 Gelatine phantoms 
The raw spectrum of a 5% gelatine phantom, measured using NP-3 
demonstrated in Figure 2-25 A shows that the signal is of much higher intensity 
than that gained with NP-2 and the CCD camera, and that the morphology of the 
water peak is similar to that of NP-1 and the water peak of the HWN region 
documented in the literature. A higher water peak intensity is seen with increasing 
water concentration when compared to the normalised protein peak (Figure 2-25 
B). Figure 2-26 A shows the areas that were used to calculate the water/total area 
ratio. The water/total area ratio was calculated for all concentrations of gelatine 
phantom and plotted against known water concentration (Figure 2-26 B), which 
shows the relationship is linear, but not directly proportional.  
 
 
A      B 
   
Figure 2-25 Raman spectra of a range of varying water concentrations of gelatine phantoms 
measured using NP1 Raman system.  
A. Raw spectra from a 95% water gelatine phantom. B. Raman spectra after pre-processing. Data is the 
mean (n=3) at each concentration after baselining using 1st order polynomial and normalised to the protein 
peak, shading in the same colour either side is +/- 1SD. 
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2.4.3.3 Intralipid phantoms 
Figure 2-27 A shows that in intralipid phantoms with normalised spectra, with a 
decrease in known water content there is a decrease in water signal. Calculation 
of the water/total area ratio to known water concentration demonstrates a linear 
relationship (Figure 2-27 B).  
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Figure 2-26 Using NP3 to measure water/total area ratio in gelatine phantoms 
A. Raman spectra of 85% water gelatine phantom with areas highlighted that are used to calculate water 
(yellow) / total (orange + yellow) ratio. B. Graph of water area/ total area ratio versus known water 
concentration of a number of different concentrations of gelatine phantoms measured using NP3 Raman 
system. Mean ratio plotted (n=3), Error bars +/-SD. A line of best fit showed a Gradient = 0.46; RMSE = 
0.0012 
Figure 2-27 Demonstrating the ability to measure changes in water concentration in complex 
intralipid phantoms measured with NP3.  
A. Raman spectra after pre-processing. Data is the mean (n=3) at each concentration after baselining using 
1st order polynomial and normalised to the protein peak, shading in the same colour either side is +/- 1SD. 
B. Calculated water/ total area ratio versus known water concentration. Average ratio plotted (n=3), Error 




2.4.3.4 Recreating the challenges of the surgical environment 
Pork meat and fat were analysed and compared to meat and fat that had been 
stained with blue dye or haemoglobin, burnt or wrapped in clingfilm. Similar to 
NP2, the Raman spectra were adversely affected by carbonisation in pork that 
had been burnt due to fluorescence, however the protein peak could be 
recovered, but the spectra from 3250-3700 cm-1 (water region) was altered and 
no Raman signal could be obtained in this region. After pre-processing the raw 
signal, blue dye staining, haemoglobin staining and clingfilm covering did not 
make a large visual difference to the Raman spectra (Figure 2-28), and 
comparison of water/total area ratios between pork meat vs blue dye stained 
meat or Hb stained meat or clingfilm covered meat and between pork fat vs blue 
dye stained meat or Hb stained fat or clingfilm covered fat revealed no significant 
difference (P>0.05; one-way ANOVA). 
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Blue Dye Gelatine phantoms 
NP3 was used to analyse the blue dye gelatine phantoms. Similar to the spectra 
from the NP2 system, there was some increase in the fluorescent background in 
the presence of blue dye when measuring with NP3, however this appeared to 
affect the Raman spectra less than with NP2. There was no significantly different 
water/total area ratio (P>0.05; one-way ANOVA) between gelatine phantoms with 
0%, 0.01% and 0.1% blue dye (Figure 2-29). 
 



















Figure 2-28 Results of measurements of pork phantoms with NP3 system.   
Raman spectra of A. Pork meat and B. pork fat that had either not been treated, stained with blue dye, 
stained with haemoglobin, burnt or wrapped in clingfilm. Data is the mean (n=3) at each concentration after 
baselining using 1st order polynomial and normalised to the protein peak, shading in the same colour either 












Measurements with the NP3 system confirm the ability to take high quality spectra 
in the HWN region, and using this system and the water/total area ratio, the water 
concentration can be measured. The water/total area ratios obtained for the 
different gelatine phantoms are very similar to those obtained with NP1, and the 
water/total area ratio to known concentration graph has a similar gradient 








































Figure 2-29 Results of measurement of blue dye gelatine phantoms with NP3.  
A. Representative raw Raman spectrum with 10% gelatine phantom and 10% gelatine phantom with 0.01% 
and 0.1% blue dye. B. Raman spectra after pre-processing. Data is the mean (n=3) at each concentration 
after baselining using 1st order polynomial and normalised to the protein peak, shading in the same colour 
either side is +/- 1SD.  C. Bar chart comparing the mean water/total area ratio between the three blue dye 





suggesting the information regarding water concentration is equivocal between 
NP1 and NP3.   
 
The water/total area ratios from intralipid phantoms are markedly different 
between NP1 and NP3. The water spectra measured from NP3 from the intralipid 
phantoms has a morphology more consistent with what would be expected from 
the other experiments and from the literature 304, 333, compared to NP1. The 
background fluorescence of the intralipid phantoms was much greater in NP1, 
and it may be that the baseline subtraction was suboptimal, giving rise to the 
unusual morphology, which may have adversely affected the water/total area 
ratio values. Regardless of this discrepancy, the spectra gained from the intralipid 
phantoms from NP3 show a linear relationship between water/total area ratio and 
known water concentration. 
 
The results from pork phantoms suggest that measurements from NP3 system 
are unaffected by blue dye, haemoglobin dye and clingfilm. Carbonisation does 
affect the signal and there is some fluorescence, however, a recognisable signal 
could be recovered which is improved from either the NP1 or NP2 system.  
There was no difference in the water/total area ratio between gelatine phantoms 
with or without blue dye, this demonstrates the ability of NP3 system to measure 
Raman spectra accurately in the HWN region in the presence of blue dye with 
minimal disruption. 
 
Despite these important improvements with NP3 compared to the other systems, 
the reduced signal to noise with the InGaAs camera is a potential issue. InGaAs 
cameras have high dark noise signal due to the low energy photons that are being 
detected340. This effect can be reduced by cooling of the detector (which was 
done to -85C, as recommended by the manufacturer), but is still higher 
compared to silicon CCDs339. Due to this, longer acquisition times for spectral 
acquisition are required. In these experiments, overall measurement time was 5 
times longer (50 seconds vs 10 seconds) with the InGaAs camera. This may have 
an impact in future work when taking spectra in a time-sensitive and clinical 
environment. With regards to margin analysis, it is an issue that will need 
optimisation for it to be effective. However, it is possible that these acquisition 




and spectral analysis of breast tissue is more fully understood, to optimise the 
balance between spectral resolution and time for measurements to be struck for 
meaningful clinical data to be gained when measuring breast tissue. For initial, 
proof of concept experiments investigating HWN region and water concentration 
in breast tissue, NP3 has demonstrated its ability to measure water concentration 
and obtain spectra in the presence of blue dye, meaning it is the most suited 
system for this project. 
 
2.5 Discussion 
In this section of the thesis, the development of a Raman system capable of 
taking high quality HWN spectra, with appropriate analysis of the spectra to 
measure water concentration, whilst overcoming the potential barriers of taking 
measurements in the surgical environment has been explored. Tissue phantoms 
with a range of known water concentrations were constructed and analysed, and 
demonstrated to be reproducible in production and stable in water content over 
time. Using a closed laser, pre-calibrated, laboratory system to acquire Raman 
spectra from a standard of BSA solutions and applying this to the gelatine 
phantoms it was demonstrated that using a first order polynomial for baseline 
subtracting the data and measuring the water/total area ratio was an accurate 
method for determining water concentration.  
 
A number of methods have been suggested for baseline subtraction in Raman 
spectroscopy and particularly in the HWN region. It is often performed using 
baseline subtraction using the visually most appropriate degree of polynomials, 
a number of different polynomials have been used including 1st 174, 271, 295, 2nd 337, 
3rd 304 and 5th 341 order. More complex methods in the form of auto correction 
using multiple regression fitting have also been suggested 337. The aim of 
baseline fluorescence subtraction is to reduce the influence of fluorescence on 
the data, without removing pertinent spectral information. In these experiments 
using phantoms, background fluorescence was not a major issue in the raw 
spectrum and baseline subtraction with a 1st degree polynomial visually appeared 
to be the most appropriate method. When using this method with the NP1 system 
which used a 680nm excitation, there was a higher degree of background 
fluorescence when measuring the intralipid phantoms, and it may be that the 




appearance of the water spectrum seen. However, using other commonly used 
degrees of polynomials such as 2nd and 3rd order did not improve the results or 
visual appearance of the spectra, and it may be that more complex methods 
would be required in this particular case. However, as this system was not to be 
used in the project due to the major fluorescence from blue dye, this was not 
performed as it would not inform the project. It may be that measurements in 
breast tissue cause a higher degree of background fluorescence than the 
phantoms, and that different baseline subtraction methods are needed. 
 
Spectral data from pure protein models (gelatine phantoms) regarding water/total 
area ratio could not predict water concentration in the more complex intralipid 
phantoms. The CH3 stretch is responsible for both the Raman signals of protein 
and lipid, however the lipid band has a tendency towards higher levels of energy 
compared to protein103. The narrow protein peak of CH3 is morphologically 
distinct to the broad lipid peak, and the intralipid phantoms were composed of 
both protein and lipid, and so a phantom that has the same water concentration, 
but a different protein/lipid ratio, will have a different area under the curve in the 
region 2850 – 3035 cm-1 which would affect the water/total area ratio. Although 
Masson et al. used this method in protein only gelatine phantoms, and 
extrapolated it to interpret water concentration in the protein/lipid rich cervix , our 
data suggests this is inappropriate 304. To predict water concentration in fat rich 
breast tissue, water/total area ratio data from intralipid phantoms may be more 
appropriate. 
 
All the systems were capable of measuring Raman scattering in the HWN region. 
NP1 and NP3 gave high quality, high intensity signals in this range, and NP2 
gave lower intensity signals due to the quantum efficiency of the CCD camera. 
All three systems could measure the water concentration of the gelatine and 
intralipid phantoms. NP1 and NP3 gave very similar results in the measurement 
of gelatine phantoms and both produced HWN spectra of gelatine phantoms that 
were similar to the literature and both could detect changes in water 
concentration. NP2 spectral analysis produced quite different results, the water 
peak spectrum was truncated due to the quantum efficiency of the CCD camera 




concentration in the HWN region, meaning that NP2 was not suitable for this 
project.  
 
The Raman systems were also evaluated for their suitability to obtain spectra in 
the presence of blue dye, haemoglobin, carbonisation and clingfilm, as this is 
essential for the future work of the project of taking measurements of surgically 
excised specimens. All three systems detected fluorescence in carbonised pork 
tissue; NP1 and NP2 could not recover any signal, and NP3 could measure the 
CH3 region of protein, but the water signal was adversely affected. This is 
unsurprising as carbonisation intrinsically alters the breast tissue, and confounds 
analysis with the ‘gold standard’ of histopathology319. It may affect analysis in 
breast tissue, but it is likely to with any method of IMA, it is also usually localised 
to small areas rather than prohibiting analysis of an entire surface, and so an 
awareness of its effect on the Raman signal is required, but it does not preclude 
a Raman system from providing IMA. 
 
Blue dye caused significant fluorescence in NP1, and no Raman scattering was 
detected in the presence in even a small amount of blue dye. Blue dye is used 
for sentinel lymph node detection in the majority of BCS, and staining of the 
breast tissue is common; therefore, a system that cannot obtain Raman spectra 
in the presence of blue dye is unsuitable for the preliminary work planned in this 
project, and for any clinically relevant method of IMA. Previous studies 
investigating HWN RS in breast tissue have not considered the effect of blue dye 
on the ability to obtain Raman spectra 299, 336. These studies use laser excitation 
wavelengths (of 671 nm 299 and 532 nm 336) that we predict would result in 
overwhelming fluorescence that obscures Raman signals in the presence of blue 
dye.  Laser excitation with 785nm in NP2 and NP3 could obtain Raman spectra 
in the presence of blue dye. The Raman spectra, and subsequent analysis were 
more affected by blue dye in NP2, this may have been because the signal 
intensity was much weaker than in NP3, and so the slightly higher background 
fluorescence that the blue dye caused overpowered the weak Raman signal, 
whereas in NP3 there was a higher intensity Raman signal so the contribution of 






NP3 which uses an InGaAs camera and 785 nm laser excitation has been shown 
to be the most appropriate system for assessing the HWN region in breast tissue 
for applicability in IMA, where blue dye is used. This is the first Raman system 
that has demonstrated the ability to obtain HWN spectra that are not significantly 
affected by the presence of blue dye, an essential attribute for a system to provide 
IMA.  The NP3 system will be the Raman system used for the human tissue 






CHAPTER 3:  
Investigating the ability of NP3 Raman 
system to quantify changes in water 




In the previous chapter NP3 was demonstrated to be the most appropriate 
Raman system for investigating the provision of intraoperative margin analysis in 
human breast tissue. The analysis for this was performed using phantoms that 
allowed differentiation of performance regarding basic ability to evaluate changes 
in water content, and confounders that may occur in the clinical environment. The 
next stage of this system development is optimisation. This is both optimisation 
of the spectra that are obtained, and optimisation in the understanding of the data 
that can be obtained using the system. This chapter will demonstrate the method 
of optimal signal acquisition set up for NP3, evaluating the ability of NP3 to 
measure changes in water concentration at physiological concentrations and 
then describe a sequence of experiments on a range of phantoms to establish 
what changes are observed in the High Wavenumber (HWN) region spectra with 
a change in water concentration.  
 
The intralipid breast phantoms measured in the experiments in Chapter 2 to 
ascertain the ideal Raman system for measuring HWN spectra in breast tissue 
had the limitation that the fat concentrations were not physiological. The intralipid 
phantoms had a range of fat concentration from 2-18%, with a water 
concentration being 68-88% whereas it has been suggested that the water 
concentration of breast tissue is in the range 30-60%, and correspondingly the 
fat concentration being 40-70% 281. However, these figures are taken as global 
averages for an entire breast, or large areas of the breast. When measuring 
smaller samples of breast tissue, such as a wide local excision specimen for 




and other areas exclusively of protein. Therefore, further investigation is 
performed in soya bean oil phantoms and in pork meat and fat to demonstrate 
the ability of NP3 to measure a change in water concentration at physiological 
ranges, which is necessary in order to be used in human breast tissue. 
 
In section 2.2.4 it was noted that in a set of protein/water mixtures over a range 
of water concentrations, the spectral intensity of the maximum part of the OH 
peak (3390cm-1 in this case, due to the limitations of the CCD coupled with the 
InVia system used) did not change in relation to the change of water 
concentration. This spectral feature has been observed in other studies; using 
lyophilisation to produce cornea phantoms at a range of water concentrations, 
Bauer et al. 335 demonstrated that the OH peak Raman intensity (this time at 3400 
cm-1) did not change proportionally to the change in water concentration, and 
used a ratio of the maximum intensity of the protein peak to water peak to quantify 
the changes in water concentration. The conclusion drawn from this work has 
been cited as an example of how to use protein to water ratios to accurately 
determine water content, and the method has been validated since. However, the 
observation that the OH peak does not change in relation to water content, the 
possible significance of this and why this occurs is not addressed. If the water 
peak intensity doesn’t change with changes in water concentration, and the 
water/total area ratio method is an accurate, validated method for quantifying 
changes in water concentration, it could be presumed that changes in the 
protein/lipid peak are proportionally changing with water concentration, though 
this has not been explicitly demonstrated previously. 
 
In this chapter there is investigation and analysis of how these spectral changes 
may be interpreted to give a better understanding of the HWN region and will 









3.2.1 Establishing the optimal signal acquisition time 
The NP3 system uses an InGaAs camera, the range of Quantum Efficiency 
allows acquisition of spectra from the HWN region using a 785 nm excitation 
laser. An inherent limitation of InGaAs cameras is high dark noise compared to 
silicon CCDs 340 that are more commonly used for Raman Spectroscopy. 
Noise has to be overcome in order to obtain a signal, and accounts for variation 
that can be seen between a number of identical measurements, which is 
expressed as the Signal to Noise Ratio (SNR) which is the average peak height 
above baseline divided by the standard deviation of the peak height 342. 
 
Noise can come from a number of sources such as shot noise, fluorescence 
background noise, dark noise, and readout noise. Shot noise is the random 
variation in observed events, and so as the number of observed events increases 
(e.g. by increasing acquisition time), the shot noise decreases, and so the SNR 
increases. Dark noise is significant in InGaAs cameras. Dark noise is produced 
by spontaneous electron generation from the detector and is best demonstrated 
by obtaining a spectrum in a dark room without laser illumination342. In the 
presence of high dark noise lower acquisition times give a poor SNR, as the dark 
noise is proportionally more, and conversely by prolonging acquisition time more 
signal is obtained, with the same amount of dark noise, meaning the SNR 
improves with a longer acquisition time. Dark noise does not vary with laser 
intensity or variability in samples, and so there is the ability to subtract dark noise 
from spectra. 
 
A method to improve the SNR in NP3 would be subtraction of fixed pattern noise 
as this is due to pixel to pixel variation within the InGaAs detector. Therefore, the 
detector dark noise was obtained by taking a measurement for the same 
acquisition time and number of accumulations as used for the sample 
measurement and a smoothed baseline obtained by Savitzky-Golay filter (7th 





This smoothed baseline was then subtracted from the spectrum obtained from 
the sample, when measured for the same acquisition time and same number of 
accumulations as part of pre – processing. This gave improved spectral 
resolution and was successful at removing a significant source of noise from the 
spectrum, without affecting relevant spectral features (Figure 3-2). 
 
 
Although longer acquisition times may improve the issue caused by shot noise, 
this may lead to sample heating degradation or burning, which for biological 
samples such as breast tissue, is to be avoided. A way to increase acquisition 
times and reduce the risk of burning is by taking shorter acquisition times with 
multiple accumulations, which may reduce sample heating if the laser turns off 
between acquisitions, allowing the sample to cool. However, the number of 




























Figure 3-1 – Spectrum showing the Dark background and Smoothed Dark background at 1 second 
acquisition time with 5 accumulations. 
The Smoothed Dark Background was obtained by Savitzky-Golay filter with a 7th order polynomial fit. 
 
Figure 3-2 Figure showing the effect of Dark noise baseline subtraction on a HWN spectrum.  
Representative spectrum of a Gelatine phantom of 90% water, 10% gelatine composition taken with 1 
second acquisition time, 5 accumulations. Raw spectrum and spectrum after pre-processing with Dark noise 




accumulations taken may be limited by readout noise – that is the noise 
generated in the process of converting electrons detected into a digital signal to 
the computer. This noise increases with the number of accumulations. 
 
A consideration for overall measurement time taken for measurement is that the 
time taken for the measurements needs to remain clinically relevant. If, in order 
to obtain satisfactory spectra, measurements took an hour each to obtain, neither 
the system nor the information gained from it would ever be useful in clinical 
practice. Therefore, we considered a maximum overall measurement time of 30 
seconds per measurement to be one that was clinically relevant. Although this 
time per measurement is likely to be too long for use in practice, it is not so long 
as to be irrelevant. The area of collection of NP3 is 5.19 x 104 µm2. With a view 
to NP3 providing IMA, for a lumpectomy sample of 60 X 60 mm (a normal size of 
sample) it would take approximately 720 individual measurements with NP3 to 
analyse a single resected edge. If each individual measurement took a second it 
would take 12 minutes to analyse a single resected edge, and if the individual 
measurement time took 25 seconds it would take 6 hours to analyse a single 
resected edge. So, although a measurement protocol of 30 seconds would not 
be clinically possible, the purpose of the experiments in this chapter are to explore 
subtle changes in spectra, which require higher spectral resolution. Once the 
HWN region of breast tissue is fully understood, it is likely the measurement time 
could be reduced to more clinically relevant times.  
 
To find the optimal measurement settings of the number of acquisitions and 
accumulations required for NP3, measurements were taken with the NP3 system 
of a 90% water / gelatine phantom and performed pre-processing of baselining 
with a 1st order polynomial and normalisation to the protein peak with dark noise 
baseline subtraction on the obtained spectra. Measurements were taken to 
compare the overall laser exposure time at 2 different times - 5 seconds and 25 
seconds- to compare the signal to noise ratio of measurements. The exposure 
times were chosen to investigate if the spectra that were obtained in a short time 
period (5 seconds), were of sufficient quality to allow detailed analysis, as this 
time period would be closer to a clinically appropriate measurement time, or if a 




Within these overall time periods, measurements were taken with different 
acquisition times and accumulations. 
 
Results and Discussion 
Figure 3-3 demonstrates the spectra obtained with an overall measurement time 
of 5 seconds, but with different acquisition and accumulation times. In both the 5 
second X 1 accumulation and 1 second X 5 accumulations all peaks are clearly 
visible, however, there is more noise with 1 second X 5 accumulations, which 
may be due to an increased readout noise. Although this suggests that we could 
use an overall measurement time of 5 seconds, and this would still give 
reasonable quality spectra, we expect a significantly higher fluorescence 
background in biological tissue (as this has been observed in other studies 
investigating the HWN region in biological tissue 174, 304), so longer acquisition 





Measurements obtained of a 90% water/10% gelatine phantom measured at 5 seconds X 1 accumulation 
(blue line) and at 1 second X 5 accumulations. Data is the sum of all accumulations to allow direct 
comparison and has been baselined, normalised to the protein peak and dark noise baseline subtracted. 
















Figure 3-3 – Figure showing the difference in signal to  noise in Raman spectra obtained with two 







Measurements obtained of a 90% water/10% gelatine phantom measured at 25 seconds X1 accumulation 
(black line), at 1 second X 25 accumulations (green line), and 5 seconds X 5 accumulations (red line). Graph 
on left shows all three spectra combined, graphs on right show each spectrum separately to allow 
comparison. Data is the sum of all accumulations to allow direct comparison and has been baselined, 
normalised to the protein peak and dark noise baseline subtracted. 
 
Figure 3-4 shows the results of spectra obtained at an overall measurement time 
of 25 seconds, with different acquisition times and accumulations. All spectra 
have improved spectral acquisition compared to the spectra obtained with an 
overall measurement time of 5 seconds. There are no obvious spectral 
differences between the three different measurement protocols, however, the 
spectra obtained with 1 second acquisitions with 25 accumulations has slightly 
increased noise which may be a result of a higher readout noise. Spectra 
obtained with a single 25 second acquisition produce spectra comparable to the 
spectra obtained with 5 seconds X 5 accumulations, however, multiple 
accumulations allows the laser light to be off between acquisition and may reduce 
biological sample heating and sample degradation.  
 
Summary  
Based on these results it can be considered that having a single acquisition time 
of 5 seconds rather than 1 second gives improved signal to noise, as would be 
expected. This is important as a smoothed spectrum may allow improved spectral 
analysis. Prolonged acquisition times could lead to sample degradation, so a 
measurement protocol of 5 second acquisition time with 5 accumulations with 
dark noise baseline subtraction is optimal based on the balance of signal to noise 



































Figure 3-4- Figure showing the difference in signal to noise in Raman spectra obtained with three 




and minimising the time taken to analyse a specimen, and so this measurement 
protocol is adopted in the measurements in the rest of this chapter. 
 
3.2.2 Phantom Production and Measurement 
3.2.2.1 Gelatine Phantom production 
Gelatine phantoms were used to observe the changes in water concentration in 
the HWN region within a protein only environment. Gelatine phantoms were 
produced in the previously described method in Chapter 2 at concentrations of 
85%, 87.5%, 90%, 92.5% and 95% water. 
 
3.2.2.2 Soya bean oil/ water phantom production 
Soya bean oil/water phantoms were used to observe the changes in water 
concentration in the HWN region with a lipid only environment and evaluate the 
ability of NP3 to measure the extremes of fat and water concentration that are 
likely to be encountered in clinical specimens. Olive oil would have been the 
preferred choice of oil, as it is composed of monounsaturated fatty acids and is 
predominantly oleic acid, which is the major fat in breast tissue 343, 344. However, 
with 785 nm illumination, it has a broad fluorescent peak within the HWN region 
giving overwhelming fluorescence and no spectra could be obtained. Therefore, 
soya bean oil was chosen to create these phantoms, as it does not have this 
fluorescent band. Soya bean oil is predominantly polyunsaturated fat, composed 
of Linoleic Acid344. 
 
Soya bean oil phantoms were made according to a protocol adapted from a 
method by Merritt et al. 302 to make MRI suitable lipid phantoms. Organic soya 
bean oil (Clearspring,UK) was mixed with 4% of lipid volume of triton X100 
(Sigma-Aldrich,Germany) which is a surfactant, which was added to allow 
emulsification of the lipid. This was warmed at 55C for 5 minutes, before distilled 
water was added, mixed further, before sonification with a Hielscher Ultrasonics 
UP100H Handheld Ultrasonic Processor at 30kHz at 100% amplitude and 100% 
pulse (Hielscher Ultrasonics, Teltow, Germany) for 5 X 10 second pulses to 
create a liquid emulsion, and stored at 5C until measurement at room 






3.2.2.3 Pork serial dehydration 
Serial dehydration with concurrent Raman spectra measurements was performed 
with pork to observe the changes in water concentration in the HWN region within 
a biological system, of both a protein rich (meat) and fat rich (fat) environment.  
Pork was purchased from a local supermarket (Sainsburys,UK), meat and fat was 
separated and cut into small cubes of <5 mm3, and weighed. All specimens 
weighed less than 1 gram. Specimens were then weighed initially, and Raman 
spectra taken, and then left to air dry over the next 24 hours, within which at 7 
different time points the specimens were weighed and Raman spectra taken. 
Raman measurements were taken at random points on the specimen’s surface 
as it was not possible to mark points of previous measurement and take 
measurements from the same points at each measurement cycle. Changes in 
pork specimens were calculated as percentage weight change from the initial 
weight, and all changes in weight were assumed to be water evaporation and so 
provided an estimation of changes in water content of the specimen. There were 
negligible changes in the weight of the specimens after 24 hours (measured 
again at 36 and 48 hours), and so it was presumed that by 24 hours the maximum 
amount of water had evaporated using the air dry technique. The experiment was 
performed 3 times over 3 different days on 3 different pieces of pork, to account 
for possible variation in air drying/meat hydration. All experiments yielded similar 
results, data shown is from a single experiment to reduce the number of 
spectra/data points and allow better visualisation of results.  
 
3.2.2.4 Mixed protein/lipid phantoms production 
To investigate the effect of the protein/lipid environment on the HWN spectrum a 
set of gelatine based phantoms were created that had the same water 
concentrations (70 or 80%), but had varying protein/ lipid ratios. The conversion 
of oil weight to volume was based on the soya bean oil having a weight of 0.92 
grams/ml. Triton X100 is a lipid, with a lipid spectrum in the HWN region the same 
as soya oil (and no protein or water peaks), and therefore the ‘Total oil volume’ 
was composed of the soya oil and Triton volume combined. This allowed the ratio 
of total protein and total lipid substrates that would contribute to the respective 

















1 7 0.5 2.5 2.71 2.60 108 
2 7 1 2 2.17 2.08 87 
3 7 1.5 1.5 1.63 1.56 65 
4 8 0.5 1.5 1.63 1.56 65 
5 8 1 1 1.08 1.037 43 
6 8 1.5 0.5 0.54 0.519 21 
 
 
3.2.2.5 HWN Raman experimental set up 
HWN Raman spectra were acquired using the previously described NP3 set up 
(Chapter 2). Measurements were taken with a 5 second X 5 accumulation. 5 
measurements were taken from different areas in each phantom, and acquired 
with Andor Solis (UK) software. 
 
3.2.2.6 Data processing 
Data was processed using Matlab. The mean was taken of the accumulations 
and then pre-processed by baselining using a 1st order polynomial, and dark 
noise background subtraction as described in section 3.2.1. The mean was taken 
of the 5 different area measurements, the standard deviation (if displayed) is of 
these 5 different area measurements. Normalised spectra were normalised to the 
highest peak in the spectra which related to the CH stretch of either protein or 
lipid (between 2850 -2950 cm-1) 271, 333. 
AUC water peak was calculated by taking the Area under the Curve of the Raman 
spectra between 3035-3680 cm-1. And AUC CH stretch region (combined protein 
and lipid peak) was calculated by taking the Area under the Curve of the Raman 
spectra between 2850 – 3035 cm-1. Water/total area ratio was calculated by 
taking the AUC water divided by AUC water + AUC CH stretch region304. 
Statistical comparison of water/total area ratio means was performed with one-
way ANOVA, statistical significance set to P<0.05.  
 
Table 7 - Table to show the composition of mixed phantoms composed of protein, lipid and water 
In Phantoms 1 – 3 the water concentration was 70 %, and in Phantoms 4 – 6, the water concentration was 




3.2.3 UV Vis experiments 
UV-Vis absorbance of the individual components of the soya bean oil phantoms 
was investigated to assess how the optical absorbance characteristics of these 
components may affect the Raman spectra. If there is unequal absorbance by a 
constituent of the sample through the spectral range, a change in sample 
concentration may affect the Raman spectra due to absorbance as much as the 
effects of the change in sample concentration on the Raman spectra. This would 
affect the ability to quantify changes in the sample concentration, which was an 
area of investigation. UV-Vis absorbance spectra were obtained on a Thermo 
Scientific Evolution Array machine, using manufacturers software. Spectra were 
taken of soya bean oil, Triton X-100 and water with an integration time of 1 
millisecond, average of 20 scans, with a 1 mm pathlength. 
 
3.3 Results 
3.3.1 Gelatine phantoms 
The association between change in water content of gelatine phantoms and 
change in the water/total area ratio is shown in Figure 3-5 and was established 
in Chapter 2 – the relationship is linear and with a decrease in water content, 
there is a decrease in water/total area ratio. Measured with NP3, there is a 



















A      B 
  
 
Figure 3-6 shows that in gelatine phantoms (a protein only environment), the 
water peak spectrum decreases with a decrease in water content, and the protein 
peak increases as the water content decreases. The Area Under the Curve (AUC) 
of the CH stretch region (corresponding to protein in these phantoms) increases 
proportionally with a decrease in water concentration (and increase in protein 
concentration) with low variability, and the Area Under the Curve (AUC) of the 
water peak decreases, however this is with a greater degree of variability and the 
























































Figure 3-5 Figure showing Raman spectra in the HWN region of different water concentrations of 
gelatine phantoms and the relationship with water/total area ratio  
A. Graph showing Raman spectra of gelatine phantoms at 5 different water concentrations, normalised to 
CH stretch region between 2850 -2950 cm-1. Plotted lines are mean (n=5) for each concentration after pre-
processing, shading in the same colour either side is +/- 1 SD. B. Scatter graph of known water fraction 
versus water/total area ratio. Points plotted are mean water/total area ratio (n=5), error bars +/- 1 SD. Red 









3.3.2 Soya bean oil phantoms 
Figure 3-7 shows the normalised mean spectra of the soya bean oil phantoms 
ranging from 0% water to 95% water.  It can be seen that, when normalised to 
the CH stretch region (corresponding to a lipid peak in these phantoms) at 
2940cm-1, the water peak decreases with a decrease in the water concentration 
of the phantom. However, the difference seems greater in the phantoms with high 




































5 Area Under Water Peak
Figure 3-6 Graphs demonstrating the changes in the HWN region with changes in water 
concentration in a protein only environment. 
A. Graph showing the spectral changes in protein peak and water peak signal intensity with changes in water 
concentration. Coloured lines are mean spectrum (n=5) after pre-processing, shading in the same colour 
either side is +/- 1 SD.   B. Scatter plot demonstrating the change in Area Under Curve of CH stretch region 
(protein peak) and Area Under Curve of water peak at different water concentrations. Line of best fit to 
demonstrate linear relationship in change in water concentration and AUC of both CH stretch region (protein 
peak) and water peak. 




relationship between known water concentration of the phantoms and the 
water/total area ratio. If the phantoms are grouped and analysed according to 
those with higher water concentration (70-95% water) and lower water 
concentration (30-65% water), there is a slight difference in the gradients (higher 
water concentration gradient= 1.61 vs lower water concentration gradient = 1.04). 
This suggests that at a lower water concentration (and a higher lipid 
concentration) the difference in water/total area ratio between different water 
concentrations reduces, and so the ability to differentiate between different water 
concentrations may be reduced. 
 
 
A      B 
  
 
Figure 3-8 shows that in soya bean oil phantoms (a lipid and water only 
environment), the water peak spectrum does not appear to decrease with water 
content, and the lipid peak increases as the water content decreases. The scatter 
graph shows that with a decrease in water concentration (and subsequent 
increase in lipid concentration), the AUC of the CH stretch region (lipid peak) 
increases with a linear relationship, with narrow error bars suggesting a small 
degree of variability in measurements. However, the AUC of the water peak 






















Figure 3-7. Figure showing Raman spectra in the HWN region of different water concentrations of 
soya bean oil phantoms and the relationship with water/total area ratio 
A. Graph showing Raman spectra of soya bean oil phantoms at 15 different water concentrations, 
normalised to CH stretch region between 2850 -2950 cm-1. Plotted lines are mean (n=5) for each 
concentration after pre-processing, shading in the same colour either side is +/- 1 SD. 
B. Scatter graph of known water fraction versus water/total area ratio. Points plotted are mean water/total 
area ratio (n=5), error bars +/- 1 SD. Black line is line of best fit of all data points (n=15) (Gradient=1.24, 
RMSE = 0.031), red line is line of best fit of high water concentration phantoms (70-95% water) (Gradient = 
1.61, RMSE = 4X10-16), green line is line of best fit of low water concentration phantoms (30 – 65% 




shows no consistent relationship with a change in water concentration. At higher 
water concentrations (water fraction 0.60-0.95) the AUC of water peak changes 
do not have any pattern with a change in water concentration, whereas at lower 
water concentrations (water fraction 0.55-0.3) with a decrease in water 

























5 Area Under CH stretch region


















5 Area Under Water Peak
Figure 3-8 – Graphs demonstrating changes in the HWN region with changes in water concentration 
in a lipid only environment. 
A. Graph showing the spectral changes in lipid peak and water peak signal intensity with changes in water 
concentration with a range from 30 – 95% water. Coloured lines are mean spectrum (n=5) after pre-
processing, shading in the same colour either side is +/- 1 SD.   B. Scatter plot demonstrating the change in 
Area Under Curve of CH stretch region (lipid peak) and Area Under Curve of water peak at different water 
concentrations. Line of best fit to demonstrate linear relationship in change in water concentration and AUC 
of CH stretch region (lipid peak) only. 




3.3.2.1 UV-Vis results 
To assess the influence of optical properties on the HWN region spectra, 
absorption spectra were taken from the soya bean oil phantoms. These were the 
only phantoms that were suitable for UV-Vis analysis. 
Figure 3-9 shows there is little change in the absorption of soya bean oil and 
Triton X100 through the relevant range of wavelength. However, there is some 
higher absorption of water at the lower wavenumbers, which could 
disproportionally affect the spectrum and the relevant peak ratios, particularly if 
the path length of the Raman scattered photons is increased or decreased by the 






Figure 3-9- Graph demonstrating the UV Vis absorption spectra of water, Triton X100 and soya bean 
oil 
Measurements were taken in a cuvette with 1mm pathlength for 1 millisecond with mean of 20 
accumulations. Shaded area demonstrates the wavelength investigated in the HWN region equivalent to 




3.3.3 Pork phantoms 
3.3.3.1 Meat 
The serial dehydration of pork specimens over 24 hours led to 60% change in the 
meat specimen weight. Figure 3-10 shows the spectral results from the serially 
dehydrated pork meat- as pork meat reduced in weight (which is presumed to be 
predominantly dehydration and decreasing water concentration), there was a 
reduction in the water/total area ratio. The scatter graph shows that this 
relationship is not linear, as the pork changed from 100% weight to 77% weight 
there was very little change in the measured water/total area ratio, and after this 
the water/total area ratio reduced with weight reduction.  
 
A      B 
  
 
Figure 3-11 demonstrates that in a biological system of pork meat (a protein rich 
environment), the water peak spectrum does not appear to decrease with water 
content, and the CH stretch region (relating to protein in this protein rich 
environment) increases as the water content decreases. The scatter graph shows 
that with a decrease in water concentration the AUC of the CH stretch region 
increases with a linear relationship. However, the amount of protein is 
unchanged. It also shows that the AUC of the water peak does not have a 
consistent relationship with a change in water concentration. There is a trend that 
the AUC of the water peak increases with a decrease in water concentration, 

























Figure 3-10 Figure showing Raman spectra in the HWN region of pork meat at different stages of 
dehydration and the relationship with water/total area ratio  
A. Graph showing Raman spectra of pork meat specimens at 7 different stages of dehydration (and different 
water concentrations). Plotted lines are mean (n=5) for each %age change in weight normalised to CH 
stretch region between 2850 -2950 cm-1, after pre-processing, shading in the same colour either side is +/- 
1 SD.  
B. Scatter graph of %age change in weight versus water peak/total area ratio. Points plotted are mean 




though the error bars are wide. This is true until the final measurement, where 



























5 Area Under CH stretch region


















5 Area under Water Peak
Figure 3-11 – Graphs demonstrating changes in the HWN region with changes in water concentration 
in a biological system. 
A. Graph showing the spectral changes in CH stretch region (protein peak) and water peak signal intensity 
with changes in water concentration with a range from 100% weight – 45% weight. Coloured lines are mean 
spectrum (n=5) after pre-processing, shading in the same colour either side is +/- 1 SD.   B. Scatter plot 
demonstrating the change in Area Under Curve of CH stretch region (protein peak) and Area Under Curve 
of water peak at different water concentrations. Line of best fit to demonstrate linear relationship in change 
in water concentration and AUC of CH stretch region only. 




Water in biological systems are sequestered in different environments, broadly 
water is bound or unbound (free). It is known that the water peak in the HWN 
region is composed of peak contributions from water sequestered in different 
environments 336. To analyse the exact contributions of each different water 
environment requires detailed analysis using Voigtian curve fitting 304, however a 
basic assessment of changes in the water environments can be performed by 
looking at the spectral peaks intensities of the different environments 334. Using 
this method, the water peak between 3035 – 3680 cm-1 can be analysed by 
comparing the spectral intensities of contributions from bound water 
(corresponding to the peak at 3300 cm-1) and unbound water (corresponding to 
the peak at 3420 cm-1)304, 334, 345. 
 
To investigate changes in the types of water within the serially dehydrated pork 
meat, the change in ratio between bound water versus unbound water signal 
intensity was calculated. Figure 3-12 shows the spectral features that were used 
to calculate the ratio and demonstrates that with greater dehydration (and a lower 














3.3.3.2 Pork fat 
The serial dehydration of pork fat over 24 hours led to an 18% change in the fat 
specimen weight, compared to the 60% change in the meat specimen weight. 
This suggests that pork fat has a reduced amount of initial water than pork meat. 
The results from the serial dehydration of pork fat are shown in Figure 3-13. This 
shows that there was very little change in the water/total area ratio with weight 
change. The relationship between percentage weight change and water/area 
total ratio demonstrated in graph B is along the y axis of 0, the reason for negative 
values was that baselining in pork fat spectra was difficult as there was an 
inflection at the end of the spectrum due to tissue fluorescence, that was not 
possible to account for leading to the occasional negative reading within the water 
Figure 3-12. Graphs showing the change in Unbound versus Bound water in serially dehydrated 
pork. 
A.Shows HWN Raman spectra of serially dehydrated pork at three different points of dehydration, with a 
range from 100% weight – 45% weight. Plotted lines are mean (n=5) for each %age change in weight 
normalised to CH stretch region between 2850 -2950 cm-1, after pre-processing, shading in the same colour 
either side is +/- 1 SD. Dotted lines show the spectral features of Unbound water at 3420 cm-1 (black), and 
the bound water at 3320 cm-1 (red). B. Shows the Spectral intensity on left axis of Unbound and bound water 
demonstrated with bar graphs, with unbound/bound water ratio on right axis demonstrated with line graph 




spectrum (as the baseline fluctuated around zero), which then gave a small 




Figure 3-13 Figure showing Raman spectra in the HWN region of pork fat at different stages of 
dehydration and the relationship with water/total area ratio  
A. Graph showing Raman spectra of pork fat specimens at 7 different stages of dehydration. Plotted lines 
are mean (n=5) for each %age change in weight normalised to CH stretch region between 2850 -2950 cm-
1, after pre-processing, shading in the same colour either side is +/- 1 SD.  
B. Scatter graph of %age change in weight versus water/total area ratio. Points plotted are mean water/total 
area ratio (n=5) from spectra taken at each stage of dehydration, error bars +/- 1 SD.  
 
 
3.3.4 Mixed protein/lipid phantoms 
Figure 3-14 demonstrates the results from 3 different mixed phantoms that had 
the same water concentration of 70%, but different protein/lipid ratios, and Figure 
3-15 shows the results from 3 different mixed phantoms that had the same water 
concentration of 80%, but different protein/lipid ratios. 
 
In both sets of phantoms it was found that with identical water concentrations, 
with a change in the lipid/protein environment the HWN spectra changes, and, 
significantly there is a change in the water/total area ratio. It can be seen that with 
a decrease in the relative concentration of lipid within the phantom, the AUC CH 
stretch region (relating to both protein and lipid peaks in these phantoms) 
decreases relative to the AUC water peak. It can also be seen that with the 
decrease in relative lipid concentration, there is a decrease in the AUC water 
peak – although the water concentration remains the same for each set of 
phantoms. These changes in the AUC CH stretch region and AUC water peak 
result in changes to the water/total area ratio – the mean water/total area ratio 












































increases significantly as the relative lipid concentration decreases in both the 
70% water phantoms (displayed as mean water/total area ratio (SD); phantom 1- 
0.4759 (SD 0.027) compared to phantom 2 -0.5486 (SD 0.0066); P=4.5X10-5, 
and phantom 1 compared to phantom 3- 0.5796 (SD 0.0076); P=1.2 X10-6 , and 
phantom 2 compared to phantom 3 P= 0.031) and in the 80% water phantoms 
(phantom 4- 0.6401 (SD 0.030) compared to phantom 5- 0.707 (SD 0.009); 
P=2.3X10-4, and compared to phantom 6 - 0.7727 (SD 0.0047); P = 2.1X10-7, and 






Figure 3-14 - Figures demonstrating the effect of a change in lipid/protein environment on the HWN 
spectrum in phantoms with a water concentration of 70% 
Graph – A – baselined and normalised to CH stretch region between 2850 -2950 cm-1for the phantoms 1 – 
3, which all had a 70% water concentration but different protein/lipid ratio. B. Graph showing phantom 
number, Bars demonstrate the area under the curve of the CH stretch region (AUCH - Blue), and area under 
the curve of the water peak (AUW - orange), y axis on the left, with the water/total area ratio a black line with 
y axis on right. All values plotted are mean (n=5), error bars +/- SD. Water/total area ratio was significantly 


























































Figure 3-15 - Figures demonstrating the effect of a change in lipid/protein environment on the HWN 
spectrum in phantoms with a water concentration of 80% 
Graph – A – baselined and normalised to CH stretch region between 2850 -2950 cm-1for the phantoms 4 – 6, 
which all had an 80% water concentration but different protein/lipid ratio. B. Graph showing phantom number, 
Bars demonstrate the area under the curve of the CH stretch region (AUCH - Blue), and area under the curve of 
the water peak (AUW - orange), y axis on the left, with the water/total area ratio a black line with y axis on right. 
All values plotted are mean (n=5), error bars +/- SD. Water/total area ratio was significantly different between all 































































3.4.1 NP3 can measure changes in water concentration at physiological 
concentrations 
The results from the soya bean oil phantoms of varying concentrations 
demonstrate the ability of NP3 to detect changes in water concentration over a 
range from 30% - 95% water in a lipid only environment, with sensitivity to detect 
changes of 5%. The relationship between water/total area ratio and water 
concentration was linear, with an overall gradient of 1.24. However, there was 
some minor difference in the relationship between those phantoms with a higher 
water concentration (70-95%) compared to those with a lower water 
concentration (30-65%). The gradient of the lower water concentration line of best 
fit was 1.05, which suggests that the water/total area ratio is less sensitive to 
changes in the water concentration at lower water concentrations in lipid only 
environments. This could mean that over these broad ranges, that are likely to 
be encountered in human breast tissue, the relationship may not remain constant 
and this could affect the ability to quantify changes in water concentration. 
However, the difference between these two relationships are relatively small. 
It should also be noted that the soya bean oil phantoms had no protein, which 
would be present in human breast tissue. The presence of protein (which has a 
CH peak close to the lipid CH peak) could affect the water/total area ratio and 
may affect these results, and the relationship between water/total area ratio.  
 
The results from the serially dehydrated pork meat (a predominantly protein 
environment) demonstrates that there is a change in water/total area ratio with a 
presumed decrease in water concentration (as calculated by weight change). 
This demonstrates that NP3 is able to measure HWN spectra in biological 
systems, and it is able to detect changes in water concentration. The initial 
absolute water content of the pork could not be ascertained, but there was a loss 
of weight down to 45% of its starting weight over the course of its dehydration 
down to its ‘dry weight’, suggesting that water accounted for 55% of its initial 
weight which is a range encountered in human tissue 294. The relationship 
between water/total area ratio and relative water concentration was not linear, 
the water/total area ratio changed little at higher relative water concentrations of 
100 – 77% weight, but between relative water concentrations of 77-44% with a 




affect the ability of NP3 to quantify changes in water concentration in biological 
tissue, the reasons why this relationship may not be linear are subsequently 
discussed. 
 
The results from the serially dehydrated pork fat demonstrated that the fat 
changes little in weight (by <20%), suggesting it had a very low water 
concentration initially of no greater than 20% which would be expected in 
hydrophobic tissue. It also dried out very quickly, with a number of measurements 
being the same, suggesting that it was truly dehydrated of any free water. There 
may be less bound water in fatty tissue as it is hydrophobic. As there is little bound 
water, it may explain why it dehydrates quickly and completely. There was 
negligible change in the water/total area in Raman spectrum over this range of 
20%, and all values were close to zero (the reason for negative values is the fixed 
noise pattern oscillates around the zero baseline which give negative values for 
water AUC). The lowest soya bean oil phantom concentration was 30% water, 
and this fat dehydrated over a range of 20%, and probably has an initial 
concentration of < 30% water. It may be that in fat based environments in 
biological tissue of low water concentration of < 30% , the fat/total area ratio or 
any measure of HWN spectra, there is little change, and so changes in water 
content at low water concentrations (or high fat concentrations) cannot be 
detected. This suggests that for water concentrations <30% in predominantly lipid 
environments NP3 cannot detect changes in water concentration. These low 
water concentrations are likely to be encountered in some areas of fatty human 
breast tissue, and so this needs to be taken into account when analysing data 
from areas of low water concentration or high fat. 
 
Summary 
NP3 is capable of detecting changes in water concentration in soya bean oil 
phantoms, and these changes have a linear relationship with the water/total area 
ratio. The range that was investigated covers the physiological range likely of fat 
and water in human breast tissue. In biological tissue of serially dehydrated pork 
meat and fat the ability of the HWN region to detect changes in water 
concentration are less definitive. Although there was a trend of decreasing 
water/total area ratio with a decrease in water concentration in the protein rich 




particularly when the pork meat had a higher water concentration.  In pork fat, 
where the initial water concentration was very low, further dehydration did not 
lead to any measurable change in the water/total area ratio, suggesting that in fat 
environments of very low water concentration, HWN RS may not be capable of 
detecting changes in water concentration.   
 
3.4.2 The effect of changes in water concentration on the HWN spectrum in 
three different environments  
This section of the discussion aims to understand more about the spectra in the 
HWN region, the influences on the protein/lipid and water peak, and what needs 
to be taken into account when interpreting spectra and data from the HWN region 
to observe changes in water concentration or quantify changes in water 
concentration. Three systems were used to explore the effect of changes in water 
concentration on the HWN spectrum, protein only (gelatine/water phantoms), lipid 
only (soya bean oil/ water phantoms) and a biological system (serially dehydrated 
pork meat, mostly protein). 
 
3.4.2.1 Protein only environment 
In the protein only environment the spectral intensity of the protein peak 
increases, and the spectral intensity of the water peak decreases with a decrease 
in water concentration. This is expected as the relative protein concentration in 
the sampling volume is increasing with decreasing water. The AUC water peak 
decreases as water concentration decreases, and this relationship is linear. 
Similarly, the AUC protein peak increases as the protein concentration increases 
(and water concentration decreases), so the change in water/total area ratio seen 
with a change in water concentration is a result of these two spectral changes. 
This model is limited as the range of water concentrations is narrow (a 10% 
range), and so this relationship may not be true at lower water concentrations. 
However, it is in similar, simple, protein only systems that using HWN RS to 
quantify changes in water concentration has been validated previously. Masson 
et al. quantified water concentration changes in gelatin phantoms with a range of 
water concentrations from 66.67-90.91% 304 and Caspers et al. used a range of 
protein only solutions such as albumin, pepsin, lysozyme and urease to produce 




on water: protein ratios 295. So, it may be that this relationship remains at a greater 
range of water concentrations than studied in this thesis.  
 
This linear relationship between the protein and water peaks and water 
concentration in these simple protein models has also been used by those 
authors to suggest that this relationship is true in biological tissue, and therefore 
they use these simple systems (such as albumin and pepsin) to ‘calibrate’ their 
interpretation of the HWN spectra obtained in biological tissue (such as surgically 
excised tongue specimens) and provide a quantification of change of water 
concentration 174. However, as has already been noted in the biological system 
of pork meat, this linear relationship is not necessarily true in more complex 
systems, which also involve the effect of sampling location, sampling volume and 
changing optical properties of the material with water concentration. 
 
3.4.2.2 Lipid only environment 
The results from the soya bean oil phantoms demonstrates that although in the 
lipid environment there is a linear relationship between water/total area ratio and 
change in water concentration the baselined, but not normalised, spectra shows 
that the water peak doesn’t change much with different water concentrations, and 
it is the lipid peak that changes the most. This suggests that by using just the 
water/total area ratio, although validated in previous work, it may be an 
insufficient method to explain or understand the changes that occur in the HWN 
region with changes in water concentration.  
 
In a lipid environment the relationship between change in water concentration 
and changes in the AUC are different compared to the protein system. The AUC 
water peak does not have a constant relationship with changes in water 
concentration, particularly at higher water concentrations, however the AUC lipid 
peak has a linear relationship of increasing with a decrease in water 
concentration (and increase in lipid concentration) with a small degree of 
variability throughout the range of water concentrations from 30 – 95%. There is 
a linear relationship between change in water concentration and the water/total 
area ratio in these soya bean phantoms. From the AUC graphs it can be assumed 
that the reason for this relationship is primarily due to changes in the AUC of the 




This suggests that HWN RS in a lipid only environment is more sensitive to 
relative changes in lipid than changes in water concentration. In a phantom, such 
as the soya bean oil phantoms, where there is only lipid or water concentrations 
that are changed, the water/total area ratio remains constant with changes in 
water concentration, as if the lipid increases, the water concentration must also 
change. However, in a complex system which has protein, lipid and water and a 
number of different concentrations, the ability to detect and quantify changes in 
water concentration may be affected. 
 
A reason for this observation is that the optical properties of the measured 
substrates will affect the pathlength of the laser photons and therefore the 
sampling volume, the pathlength also impacts on any differential self- absorption 
of the solution, as shown by the water absorption spectrum in the HWN 
wavenumber region. A limitation of the soya bean oil phantoms is that these 
emulsions are highly scattering. Intralipid, which is a similar emulsion composed 
of soya bean oil, has been used as a scattering agent to mimic the optical 
properties of breast tissue308, 311. So, it could be these changes in scattering 
properties of the soya bean oil phantoms that are causing the changes seen in 
the AUC peaks, as the changes in the highly scattering lipid may affect the 
changes in the water spectrum. However, creating a lipid only phantom over a 
broad range of physiological water concentrations is challenging, and a lipid only 
phantom that was capable of having a known water concentration, over a large 
range, that did not cause significant scattering, could not be found in the literature. 
Even if this is the cause for the changes seen, it is still relevant, as breast tissue 
is heterogenous and likely to contain areas of different scattering properties – 
indeed the reduced scattering coefficient (a measure of light diffusion in a tissue 
and reflection of scattered light from a tissue314) reported in the literature for 
breast tissue ranges from 8.3 to 31.8 cm-1 346, 347 (one of the greatest ranges in 
biological tissues that has been reported 314). Kim et al. found in skin that changes 
in water content of a sample led to changes in the optical properties of the sample 
348. For example, it was found that the reduced scattering coefficient (μs') doubled 
as the water content of the skin increased by 15%. This could be due to an 
increase in backscattered light with an increase in water content, and this was 




ability of HWN RS to quantify changes in water concentration is affected by 
changes in scattering properties, it must be considered when interpreting spectra. 
 
UV-Vis measurements of the constituents of the soya bean oil phantoms were 
performed to investigate if the results were affected by the absorption 
characteristics of the phantoms’ constituents. The results suggest that soya bean 
oil and Triton X100 had some degree of absorption, however it is at the same 
level throughout the relevant wavelength region and so it wouldn’t 
disproportionately affect one part of the spectrum more than the other. 
Broadband absorption like this will change the entire HWN region equally, and so 
ratios between intensities are unchanged. However, the water absorption does 
vary throughout the spectrum, with an increase absorption between 1011-
1050nm, which corresponds to a Raman shift of 2850 cm-1 and 3300 cm-1 at 
785nm excitation. This may mean the water absorption would reduce the CH3 
stretch region of lipid disproportionately with increases in water concentration. 
This could affect the water/total area ratio as changes in water concentration are 
not affecting all of the spectrum to the same degree. 
 
The absorption characteristics in skin were investigated by Kim et al. who found 
that there was a decrease in the absorption coefficient with an increase in water 
content in porcine skin 348. This correlates with our findings that optical absorption 
properties change with changes in water concentration in biological systems, and 
so these observations need to be considered when interpreting spectra in the 
HWN region when using a 785 nm laser excitation. These findings will need to 
be considered in analysing spectra from breast tissue. 
 
So, while broadband absorption will change the entire HWN region equally (when 
using a 785 nm excitation laser), and so the ability of using ratios or peak 
intensities for quantification of water content with HWN region remains 
unchanged, the absorption properties of water may mean that differing water 
concentrations may affect the HWN region spectra, and the relationship between 








These results demonstrate that although the water/total area ratio changes with 
a linear relationship with a change in water concentration in a lipid only 
environment, the change in water peak doesn’t have a consistent relationship 
with a change in water concentration, whereas the change in lipid peak shows a 
robust and consistent relationship with a change in water concentration. This 
suggests that HWN spectra of lipid rich tissue are more affected by changes in 
lipid concentration than changes in water concentration. 
 
It has also been discussed that spectra in the HWN region are affected by the 
optical properties of scattering and absorption of the tissue measured, and that 
the scattering properties of fat, and the absorption properties of water will change 
with their respective concentrations, which may affect interpretation of HWN 
spectra in the assessment of changes in water concentration when using a 785 
nm excitation laser. These findings are highly relevant to measuring in biological 
tissue such as breast tissue, as tissues are heterogenous with different 
concentration of water and lipid, and thus will have different optical properties. It 
is difficult to experimentally separate out the optical properties of our substrates 
measured here (soya bean oil and water) from their concentration, as they are 
inherently linked, i.e. if the concentration of lipid is increased, the scattering 
properties will change, and these cannot be isolated easily. Changes in optical 
properties may affect the HWN spectra to the same degree as changes in water 
or fat concentration.  
 
Therefore, when interpreting spectra from the HWN region using a 785 nm 
excitation laser it must be considered that the HWN region is affected more by 
changes in lipid than in water concentration and by changes in the optical 
properties of the specimen. If there are changes seen between tumour and non-
tumour breast tissue in the HWN region, it must be considered that changes in 
lipid concentration and optical properties affect the HWN spectra, as well as water 
concentration. Therefore, any changes in the water peak of the HWN spectra 
should not be considered to be due to solely a change in water content. These 
findings will aid interpretation of spectra when measuring a variety of 





3.4.2.3 Biological system 
The results from the serially dehydrated pork show that, although there is a 
relationship between water change and water/total area ratio in pork meat, it is 
not linear as it is with the more simple protein model of gelatine phantoms at 
different concentrations. The pork meat is protein rich, however the results from 
the changes in the HWN spectra with water concentration are more similar to the 
lipid only phantom. The AUC CH stretch region peak increases with a decrease 
in water concentration. It is interesting that the protein peak intensity increases 
with a decrease in water content, even as we presume the amount of protein or 
lipid is unchanged as they are the same pieces of meat. A presumption in these 
experiments is that the weight loss of the pork is due to dehydration, and loss 
only of water. The meat only dehydrated for 24 hours in a laboratory, so it is 
unlikely that any decay or consumption of the protein occurred, and so we also 
assume that the amount of protein remained stable throughout the experiments. 
The AUC water peak does not have a consistent relationship with a decrease in 
water concentration, there is however a trend of increasing AUC water with a 
decrease in water concentration, although the meat lost >50% of its mass, which 
is presumed to be water. Biological systems are inherently more complex than 
simple phantoms constructed in the laboratory, and there are a number of 
phenomena occurring that may help to interpret these findings. 
 
As water evaporates from the dehydrating pork it may not occur evenly from the 
specimen. It can be presumed that surface dehydration occurs more rapidly, and 
so the percentage weight change of the whole sample may not reflect the water 
change at the surface, which is where the concurrent Raman measurement is 
taken. The sampling depth of the NP3 system is estimated to be 500 µm (>50% 
of collected Raman photons are obtained from within this distance) 164. Therefore, 
the majority of the collected photons will be collected from the surface, which is 
drying more rapidly from the bulk of the specimen, and thus may be an 
unrepresentative reflection of the specimen’s water content. Another 
consideration is that some Raman scattering contribution will be from beyond 500 
µm, from areas of greater hydration, and so within a single measurement different 
depths and water concentrations are being sampled, and  this may be 




The sampling of the specimen may also differ – certain areas of the specimen 
may have different water concentrations, and at every time point, it was not 
possible to ensure that the same part of the specimen was measured, which 
could lead to varying results. 
 
Dehydrating biological tissue leads to a change in their optical properties. 
Rylander et al. demonstrated in skin that as it dehydrated the scattering particles 
such as collagen and organelles become more densely packed349. The pork 
specimen in these experiments visibly decreased in size, so as water leaves the 
specimen protein molecules come closer together increasing the amount of 
protein (and likely scattering) sampled in a given measurement. The specimens 
were also exposed to light, which may degrade or change biological pigments 
such as haem or carotene which may change the optical properties of the pork 
through its time of dehydration. These considerations may explain the greater 
variation in measurements with larger standard deviations compared to those of 
the gelatine or soya bean oil phantoms. 
 
Another reason for the changes in HWN Raman spectra having a non-linear 
relationship with changes in water concentration in biological tissue is that water 
is sequestered in a number of different environments in biological tissues.  
In the spectra of pork meat at its ‘dry’ weight (the point at which no further 
dehydration occurred) there is still a small spectral peak at 3280 cm-1 – this is 
due to the vibration of the NH group present in protein, which was also observed 
by Yang et al. 345 in dehydrated chicken, rather than signifying any residual water. 
It has been shown that water associated with presence of this NH group is more 
tightly bound 334. Therefore the presence of the NH group in protein not only 
effects the HWN spectra because its vibration contributes a peak within the OH 
region, but also because water may be sequestered differently in the presence of 
the NH peak, which can affect the OH vibration, and subsequently the 
morphology, and behaviour of the HWN OH peak350. 
 
Unal et al. demonstrated that in biological tissue (bone), water is lost at different 
rates according to whether it is bound or unbound 351. In their experiments they 
dehydrated bone of unbound water (by air drying) and bound water (by ethanol 




with these two types of water, and found that unbound water loss followed a 
similar non-linear relationship to the pork meat dehydration, whereas the bound 
water loss followed a linear relationship with the associated Raman peaks. It is 
likely the water loss in the pork meat also represents unbound water. It may also 
be that as the specimen slowly dehydrates, water moves between compartments 
from bound to unbound, which would also affect the relationship of overall water 
concentration of the specimen with Raman spectra.  
 
Figure 3-12 demonstrates that there are changes in the ratio of bound to unbound 
water, as pork meat dehydrates. As the water concentration of the pork 
decreases, the proportion of unbound water decreases and the unbound/bound 
water ratio changes from 1 (100% weight) to 0.43 (at 31% weight), this suggests 
that water losses are disproportionately from unbound water rather than bound 
water. These relative changes between bound and unbound water may 
contribute to our understanding as to why the water/total area ratio is not linearly 
related to a change in water concentration. The relationship between water 
concentration and the Raman peak intensity is dependent on the water type - the 
bound water peak Raman intensity has a linear relationship with changes in water 
concentration and unbound water Raman peak intensity has a non linear 
relationship water. This suggests that for the same number of water molecules, 
the Raman scattering cross section is dependent on the environment of the 
water. This means the AUC water peak is dependent not only on the total water 
concentration, but also what environment the water is in. The different water types 
are contributing differing proportions towards the overall AUC water peak at the 
different water concentrations which may explain why neither the AUC water nor 
the water/total area ratio has a linear relationship with water concentration in 
serially dehydrated pork. 
 
This finding also helps to understand why the relationship between water/total 
area ratio and water concentration is different between the protein only 
environment of gelatine phantoms and the protein rich environment of pork. In 
pork dehydration, there are changes in where water is sequestered over time, 
whereas in gelatine phantoms that are composed of a set concentration this does 
not change (the unbound/water ratio in gelatine phantoms is 1.04 and does not 





The rationale for using the water/total area ratio area rather than specific parts of 
the water peak for calculation in water content is that it will include the changes 
between these types of water, whereas if only a narrow part of the water peak 
(e.g. just detecting unbound water) is used it may not detect changes in the other 
part of the water peak (e.g. changes in unbound water). A benefit of using a 
narrow part of the spectrum may be that the changes in water concentration with 
that part of the spectrum are more fully understood, e.g. if the bound part is used, 
one could assume a linear relationship with changes in water concentration. 
However, this would not give a full representation of what is occurring to the 
specimen in terms of total water concentration. It is not known whether the 
changes in water content between tumour and non- tumour breast tissue occur 
mainly in bound or unbound water, and so the whole water peak area should be 
used to capture any potential differences between tissue types. 
 
Summary 
These results demonstrate that in a protein rich biological tissue there is a 
relationship between water/total area ratio with change in water concentration, 
but it is not a linear relationship. It is also seen that the AUC water peak does not 
change in relation to a decrease in water concentration. The reasons for this 
relationship may be due to sampling technique, changes in sample structure and 
optical properties or changes in bound versus unbound water as the pork meat 
dehydrates. 
 
 Although these may be seen as ‘limitations’ of using serially dehydrated pork as 
a model, they represent challenges that are likely to be faced in biological tissue 
such as breast tissue. These properties that affect the HWN spectra are unique 
to each biological tissue, so what is found in pork tissue may not hold true of 
breast tissue. The shifts in water compartments are likely to be different between 
a tissue that is dehydrated to a certain water concentration, and a tissue that is 
in homeostasis at a certain water concentration. However, a highly relevant 
finding from these results is that there are changes to the HWN spectra according 
to where the water is sequestered, and changes in where the water is 
sequestered affects the water peak in a different manner. When measuring a 




water in a different manner. Measuring the entire water peak therefore may give 
the best indicator of changes, but it may be there is a non- linear relationship, as 
seen in this biological pork tissue. 
 
3.4.3 The water/total area ratio relationship with water concentration is 
dependent on protein/lipid environment 
This section will discuss the influence on the HWN spectrum of changes to the 
protein/lipid environment on the ability to detect changes in water concentration, 
examining the results from the mixed gelatine phantoms.  
 
In 3.4.2, the results suggested that the changes in the HWN region, and more 
specifically the water/total area ratio, is more a product of changes in lipid/protein 
concentration than of water concentration. It could therefore be hypothesised that 
the spectral changes with water concentration and the water/total area ratio will 
be dependent on the protein and lipid environment. 
 
Caspers et al. used a range of different protein substrates (BSA, pepsin, 
lysozyme and urease) at a range of concentrations, to create a calibration tool for 
quantifying changes in water concentration using the HWN region 295. There was 
a 15% difference in the proportionality constant calculated from the four different 
calibration proteins that was used to determine the changes in the water to protein 
ratio. This suggests that even between different simple protein/water mixes there 
is a different relationship between change in water content and the HWN spectra, 
and this may impact on the ability to assess changes in water concentration. 
 
The water/total area ratio relationship between soya bean oil and gelatin 







In both gelatine phantoms (protein only) and soya bean oil phantoms (lipid only) 
there is a straight line fit relationship –the changes in water concentration are 
proportional to the changes in water/total area. However, they have different 
gradients, that is the rate of change in the water/total area ratio is dependent on 
whether the water is in a protein or lipid environment. This suggests that changes 
between protein and lipid environments changes the relationship between 
water/total area ratio. A water/total area ratio from a protein rich environment will 
not equate to the same water/total area ratio in a lipid rich environment of the 
same water concentration. 
 
The results from the mixed phantoms in Figure 3-14 and Figure 3-15 show that 
with a constant water concentration, the AUC of the water peak and the 
water/total area ratio changes with a change in protein/lipid ratio. This 
demonstrates that the water peak and the relationship of the water/total area ratio 
and water concentration changes is dependent on the protein/lipid environment. 
 
These results also show that the lipid signal is dominant in the HWN region. 
Observing the Raman spectra from these phantoms demonstrate that even in 
phantom 5, which had the same concentrations of lipid (1%) and protein (1%), 


























Soya bean oil phantom
Figure 3-16 Graph showing linear relationship between known water fraction and water/total area 
ratio  





the lipid signal dominates. What is also observed is that as the concentration of 
lipid decreases, the total AUC of both CH stretch region and water peaks 
decreases. This may be due to the scattering effect of the soya bean oil emulsion, 
meaning the Raman cross section of the entire phantom is reduced. However, 
also note that as the lipid content decreases, the water/total area ratio increases, 
this is because the AUC water peak decreases at a lesser rate than the AUC CH 
stretch region.  
 
If the relative change in lipid concentration in the phantoms is calculated, it is 
equal to the relative change in the water/total area ratio that would be found in 
the change in lipid concentration in a soya bean oil phantom. For example, in the 
phantoms 4 – 6, the total oil concentration decreases by a total of 10% (from 15% 
lipid to 5% lipid), over this range the water/total area ratio increases by 14 % (from 
0.69 to 0.83). Figure 3-16 B demonstrates the relationship between soya bean oil 
phantoms and water concentration has a gradient of 1.24, so in soya bean oil 
phantoms, if the water concentration increased by 10% (and therefore the lipid 
content decreased by the same amount), a 12.4% increase in water/total area 
ratio would be expected. This shows that with a change in lipid concentration, but 
with the same water concentration, there are changes in both the spectral 
features and water/total area ratio, that are comparable to if there were significant 
changes in water concentration. 
 
Within this range of phantoms there are changes in protein concentration, 
however it is changes in lipid concentration that are predominately observed. This 
suggests that HWN spectrum may not identify more subtle changes in protein 
concentrations in the presence of lipids.  
 
Summary 
These results suggest that in a protein/ lipid environment, the HWN region mainly 
observes changes in lipids, more than changes in protein or water. A change in 
lipid concentration within a constant water concentration will change the 
water/total area ratio to a similar degree as a change in water concentration. 
This suggests that using water/total area ratio within different protein/lipid 




altering the protein/lipid environment affects the water/total area ratio as much as 
a change in water concentration. 
 
3.5 Conclusion 
This chapter has demonstrated the influences on spectral measurements in the 
HWN region, and the ability to detect and quantify changes in water 
concentration. The results demonstrate the ability of NP3 to measure and 
quantify changes in water concentration in a lipid only environment at a range of 
physiological concentrations, and the relationship between changes in water 
concentration and the water/total area ratio in a biological tissue. However, the 
subsequent data analysis of measuring changes in AUC of the spectral peaks, 
and analysis of mixed phantoms with a constant water concentration and different 
protein/lipid environments demonstrate that the relationship between water/total 
area ratio is complex. The signal intensity of the water peak does not always 
increase or decrease with corresponding changes in water concentration, and 
the lipid peak appears to dominate the spectral features in the HWN region. 
 
The rationale for performing these experiments was to understand the influences 
on spectra in the HWN region and the changes that occur with water 
concentrations. The ability to quantify changes in water concentration would be 
useful, as it would allow findings to be put in context with imaging modalities other 
than Raman spectroscopy. The findings from these experiments suggests that 
HWN Raman can quantify changes in water concentration, if the changes occur 
within the same protein/lipid environment. It is also possible to measure these 
changes in a number of different protein and lipid environments. However, the 
relationship between changes in water concentration and changes in the HWN 
region are dependent on the protein/lipid environment and so one cannot equate 
spectra or measurements of water concentration from one environment to 
another. 
 
Previous studies have used the protein/water ratio from a set of protein only 
solutions to calibrate the system and then used these figures to quantify changes 
in water concentration in a different environment of biological tissue. In a protein 
only biological environment, such as skin 295 or corneas 296, this may be valid as 




environments may be acceptable. However, the use of a protein only calibration 
tool for water quantification of spectra obtained in biological tissue including 
protein and lipid spectra as was done by Barosso et al. 174, based on our data, is 
likely to lead to significant inaccuracies in estimation of water content. 
 
As biological tissue is composed of multiple different protein/lipid environments, 
of different optical properties, and water is sequestered in different ways, this 
complexity cannot be replicated to a sufficient degree to allow accurate 
calibration. The only reliable method of accurately quantifying water 
concentration within tissue is to use that tissue itself to provide a calibration tool. 
One method is by calculating water fraction by freeze drying breast tissue, taking 
a wet and a dry weight, and using a PLS model to correlate with the spectra 
obtained from different known water concentrations, as performed in brain tissue 
by Wolthuis et al. 294. A limitation with this method is they were only able to 
produce a narrow range of water concentrations of 75-95%. Another method 
would be with serially dehydrating breast tissue and taking Raman spectra, 
similar to the serially dehydrated pork experiments. Access to appropriate 
samples obviously may limit the possibility of being able to perform these 
calibration experiments. Additionally, when analysing an area of breast tissue, 
measurements would be taken from a range of different lipid, protein and water 
environments, with constant changes within the specimen between these 
different environments. Therefore, calibration to enable quantification water 
content would require separate measurements for each environment likely to be 
encountered. 
 
It may be that quantification of water content is difficult with HWN Raman in 
specific biological tissues due to limitations of accessing the appropriate 
biological tissue for experimentation and calibration. However, the HWN region 
has been shown to be able to detect changes in the HWN region between 
different protein/lipid environments, and can provide indicators of a high water 
concentration environment and a low water concentration environment. It can 
detect changes between lipid and protein environments and give individual 
information on where water is sequestered. Our hypothesis outlined in the 
introduction is that the spectral differences between cancerous and normal breast 




content, and normal breast tissue is predominantly a lipid environment with a low 
water content. The experiments described in this chapter suggest that High 
wavenumber Raman Spectroscopy and the NP3 system is capable of detecting 
these differences, and therefore may be able to differentiate between cancerous 
and normal breast tissue necessary for Intraoperative Margin Analysis. 
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CHAPTER 4:  
High wavenumber Raman spectroscopy for 




In the background section to this thesis, the rationale for using HWN Raman 
spectroscopy for intraoperative margin analysis (IMA), and in particular the use 
of changes in water content to differentiate between tumour and non-tumour 
tissue was outlined. The major advantages of using the HWN region for diagnosis 
is that the acquisition times can be quicker and because of the reduced spectral 
features, analysis can be simplified, allowing a rapid assessment of large surface 
areas suitable for clinical IMA. Chapter 2 described the development of the NP3 
system, which demonstrated the theoretical capability of measuring HWN Raman 
spectra in breast tissue, within the clinical environment, and Chapter 3 outlined 
an understanding of the influences on the HWN spectra, and how spectral data 
can be interpreted in relation to changes in water content which may aid in 
developing diagnostic algorithms for HWN spectra. 
 
The next step in developing the NP3 Raman spectroscopy tool capable of 
performing IMA is to assess the ability of the system to differentiate tumour from 
non-tumour tissue. Raman spectroscopy has been shown to be capable of 
diagnosing breast cancer with clinical breast samples, but not in a clinically 
relevant timeframe for IMA 185, 262. In laboratory conditions there has been 
assessment of the HWN region spectral differences between tumour and non- 
tumour human breast tissue, mainly observing changes in lipid and protein 
abundance 297. There is evidence that there are some stark differences in lipid in 
the HWN spectrum between tumour and non-tumour tissue 271, 297, and there is 
potential for these differences to be used along with spectral information from the 
FP region to identify potential areas of tumour 299. However, the differences in 




as a diagnostic tool in a clinical setting, with human breast tissue, has not been 
investigated. The aim of this chapter is to assess the diagnostic ability of HWN 
Raman to differentiate between tumour and non-tumour tissue in human breast 
specimens. 
 
In the Raman literature there is an obvious focus on the differentiation between 
tumour and non-tumour tissue, as this is likely to be the most clinically relevant 
concerning IMA. However, there are a number of other potential uses for HWN 
Raman in breast cancer, particularly as the NP3 system is a needle probe which 
could be used for subcutaneous diagnosis. This system could be used for initial 
cancer diagnosis in addition, or in place of, core biopsy for rapid diagnosis, or 
information from these studies could be used in the development of a deep 
Raman system for screening of asymptomatic patients. Therefore, assessing the 
ability of NP3 system to provide a pathological diagnosis, or detect differences 
between pathological subtypes is an important part of developing the NP3 system 
for future clinical uses.  
 
Assessment of NP3 thus far have been focused on the HWN region, as 
differences in water content may be key in rapid IMA. However, the NP3 system 
has a much broader spectral window due to the choice of grating that is required 
to capture the HWN region. Therefore, a large portion of the fingerprint region is 
also measured in any spectral acquisition. The fingerprint region is known to be 
able to differentiate between tumour and different types of non-tumour breast 
tissue 186, and it may give complementary and more  specific biochemical 
information than the HWN region. The ability to capture both regions presents the 
opportunity to have a sensitive tool that can rapidly differentiate between tumour 
and non-tumour breast tissue with HWN spectral data and provide specific 
biochemical information from the fingerprint region that could give detailed 
pathological information.  
 
An important part of differentiating between tumour and non-tumour specimens 
is an understanding of what is the ‘normal’ baseline against which the tumour 
tissue is being compared. When using changes in water content to differentiate 
between tumour and non-tumour, it must be considered that there are 




and that these physiological variations may be clinically relevant to disease states 
280. This will inevitably have an effect on the diagnostic ability to differentiate this 
normal tissue from tumour tissue, particularly as it may be that the extremes of 
the ‘normal’ physiological variation overlap with the pathological tumour state 276. 
Therefore, the spectral differences observed between the normal specimens 
must be investigated as part of the pathological assessment. 
 
Taking the aforementioned issues into account, the aim of this chapter is to 
assess the ability of the NP3 system to differentiate tumour from non-tumour 
tissue in human breast tissue samples. There is an emphasis on investigating the 
ability of detecting changes in water content to provide this diagnosis, and 
generally on the HWN spectral features that may provide diagnosis as part of 
IMA, but the spectral data acquired from the fingerprint region are also assessed 
to evaluate whether it can be used in conjunction, or in addition to, the HWN 




4.2.1 Human Tissue samples 
Human tissue samples were acquired between 2011-2015 from the Royal Devon 
and Exeter Hospital. Freshly excised breast tissue removed from patients as part 
of their routine cancer treatments were processed following informed consent 
according to local protocols, having been approved by the Clinical Research 
Facility Tissue Bank steering committee (Ref: CRF320; Tissue bank ethics 
number 16/SC/0162; further information at https://exetercrfnihr.org/about/rde-
tissue-bank). Inclusion criteria were females aged >16 and able to consent for 
the procedure, with a malignant tumour of greater than 2 cm determined by pre-
operative examination or imaging. Routine demographic data were collected from 
clinical notes and linked anonymously with the research samples. The specimen 
was sliced open fresh, and a 3 mm core biopsy was taken from the tumour and 
a separate 3 mm core biopsy taken from surrounding normal tissue, distant from 
the tumour edge (to allow a matched pair of biopsies of tumour and normal breast 
tissue from each patient). This was performed by a histopathologist or pathology 
practitioner. The rest of the specimen then underwent routine histopathological 




immediately frozen in liquid nitrogen and stored at -80 ºC. Subsequently, 5 µm 
sections were taken from all of the frozen biopsies for Haemolysin and Eosin 
(H+E) staining and underwent analysis by a histopathologist from 
Gloucestershire Royal Hospital for a histopathological diagnosis, and sections 
taken to be fixed on barium fluoride slides to enable microscopic Raman imaging. 
The remainder of the biopsy (which varied in volume between roughly 2 mm3 to 
5 mm3) was available for needle probe analysis. 
 
4.2.2 Needle Probe Raman Spectroscopy configuration 
The Raman needle Probe was configured as outlined in Chapter 2 for the NP3 
system. In brief, a 785 nm laser excitation was used, with a Kaiser Spectrometer 
with a broad grating with an InGaAs camera, with fibre optics within a needle 
probe for light delivery/collection. 
Daily calibrations were performed with Neon Argon lamp, Ethanol, water, PTFE 
Paracetamol and aspirin. This was used to calibrate the Raman shift using the 
inbuilt calibration tool in the SOLIS software. A dark signal measurement of 5 
second acquisition and 5 accumulations were taken daily for baseline subtraction 
(method detailed in Chapter 3).  
 
4.2.3 Fresh Frozen sample Breast Tissue measurements 
The fresh frozen biopsy samples were measured individually. The sample was 
removed from the freezer, thawed at room temperature and measured 
immediately to minimise loss of water by evaporation before being disposed of 
appropriately. The whole process took less than 5 minutes for each sample.  
Measurements were performed at an ambient temperature of 21 – 24 ºC in a dark 
room. The specimen was removed from its container once thawed and placed on 
a calcium fluoride slide. The needle probe was then put in contact with the 
specimen for measurement. 5 – 8 different areas of the specimen were measured 
at random, depending on the size of the specimen. Measurements were taken as 
5 second acquisitions and 5 accumulations in each of the 5-8 different areas. 
 
4.2.4 Estimation of water content by dehydration  
To obtain a correlation between the HWN Raman spectra and calculated 
water/total area ratio and water content of breast tissue, a series of dehydration 




specimens were chosen for the experiments – they were the largest specimens 
available (to enable measurable change in weight). 
 
Immediately after the initial Raman measurements for tumour diagnosis 
experiments, samples were weighed using weighing scales accurate to 0.0001 
g. This initial weight was the ‘wet weight’. The samples were then placed in the 
laboratory environment to dehydrate over time and were measured every hour 
until the weight was unchanged for two consecutive readings (approximately 6 
hours), and this was recorded as the ‘dry weight’. Weight loss was presumed to 
be wholly due to water dehydration. Water fraction was calculated as per 
Equation 4-1: 
 
𝑊𝑎𝑡𝑒𝑟 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛−′𝑑𝑟𝑦 𝑤𝑒𝑖𝑔ℎ𝑡′
′𝑤𝑒𝑡 𝑤𝑒𝑖𝑔ℎ𝑡′ 𝑜𝑓 𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛
  
 
Immediately prior to the weighing of the specimen at each time point, 
measurements were taken as per the other Needle probe Raman measurements. 
This resulted in a series of Raman spectra at each stage of dehydration for each 
specimen. 
 
4.2.5 Data Processing 
Spectra were recorded using SOLIS software (Andor,UK) and processed in 
Matlab (Mathworks, USA). For each measurement the mean of the 5 
accumulations was taken. A smoothed dark noise baseline was obtained by a 
Savitzky-Golay filter with a 7th order polynomial of the dark noise reading and this 
was subtracted from the spectra. Spectra that had high levels of background 
fluorescence that resulted in little visible measurable Raman spectral data were 
rejected (n=3). 
 
4.2.5.1 HWN region 
For calculation and analysis of the water/total area ratio the HWN spectra 
underwent 3rd order polynomial baselining with no normalisation (as 
demonstrated in Figure 4-1 A). This is similar to other studies that have 
investigated water / protein / lipid ratios , where the data has undergone minimal 




pre-processing with fluorescent baseline subtraction only prior to calculation of 
the ratio 174, 304. 
 
Pre-processing for the High wavenumber (HWN) data (2600-3800 cm-1) 
underwent fluorescent baseline subtraction with a 3rd order polynomial and 
minimum/maximum normalisation (whereby the lowest reading in the individual 
spectrum =0 and the highest reading = 1). 3rd order polynomial background 
subtraction has been used previously for HWN Raman in biological tissue 240, 304 
and has been shown to be optimal for baselining this region compared to other 
polynomials337. Other methods of pre-processing of spectral data such as 
normalising using the median Area under the Curve, normalising using the mean 
Area under the Curve, and normalisation with minimum/maximum without 
baselining were trialled (shown in Figure 4-1). This sequence of pre-processing 


































4.2.5.2 Fingerprint Region 
The Fingerprint (FP) region data (900-1886 cm-1) had a more complex fluorescent 
background to consider, and needed to be pre-processed differently to the HWN 
region. Using different pre-processing for the different spectral regions of 
fingerprint and HWN is commonly performed when both are being measured 107, 
304. An example of a raw spectrum is displayed in Figure 4-2, with a hand-drawn 
line demonstrates the complex shape of the background that needs subtraction. 
 
Figure 4-1 High wavenumber spectra of human breast tissue using different pre-processing methods 
A Fluorescent Baseline subtraction using 3rd order polynomial. This was used for the calculation of 
water/total area ratio. B. Normalisation of spectra using the Median Area Under the Curve C. Normalisation 
of spectra using the Mean Area Under the Curve D. Normalisation using Minimum/Maximum E. Fluorescent 
Baseline subtraction using 3rd order polynomial followed by normalisation using Minimum/Maximum. This is 






Baseline subtraction is performed to subtract the fluorescence sufficiently to 
enhance spectral features to allow greater clarity for interpretation, however if the 
spectrum is ‘overfitted’ it can remove important spectral features and have the 
opposite effect on interpretation 100. The process is a balance between 
underfitting, which leads to ‘false’ peaks of background being interpreted as 
Raman peaks, and overfitting, with Raman peaks being subtracted out along with 
the baseline.  
 
Another method of processing Raman spectra, particularly  for PCA and LDA 
analysis (which was one of our planned methods of analysis) is to perform the 
analysis on spectra that have been normalised (to provide standardisation in 
intensity between spectra and allow comparison) but without any baseline 
subtraction. This removes the human error of visual interpretation of a baseline 
and avoids under or over fitting the baseline to the spectrum. Compared to the 
HWN region, the spectral features of tumour and non-tumour breast tissue in the 
fingerprint region are very well documented. Therefore, we processed the Raman 
spectra without a baseline and trialled a number of different polynomial baseline 
subtractions (what is displayed is representative of the baselines attempted, 
rather than exhaustive) (Figure 4-3). A tumour spectrum was used, as this was 
the group that was the most difficult to fit and gave the most disparate results – 
non-tumour spectra were affected less by the different methods of baselining. 
Figure 4-2 Demonstrating the complex fluorescent background baseline of breast tissue specimens 
Representative raw Raman spectrum from a tumour (red) and non-tumour specimen (green). Hand drawn 





Raw Spectrum Processed Spectrum 
A                                       No Baseline, Normalised 
  
B                                        2nd order polynomial baseline 
  
C                                         7rd order polynomial baseline 
  
 
In the spectrum that did not undergo baselining and in the spectrum that has been 














































































Figure 4-3 Demonstrating different methods of pre-processing a representative tumour spectrum 
On the left are the raw spectra, with the polynomial baseline that is calculated for subtraction, on the right 
are the resultant spectra after baseline subtraction, and min/max normalisation. A. Spectrum does not 
undergo baselining, just normalisation. B. Spectrum undergoes 2nd order polynomial baselining and 
normalisation. An example of baseline underfitting, as there remains significant fluorescence baseline 
artefact. C. Spectrum undergoes 7th order polynomial baselining and normalisation. An example of baseline 




peaks is difficult because the baseline is significant, there is no amide III region 
(1200-1300 cm-1103 ) which would be expected in protein rich tissue, and from the 
literature352, and there is a large peak at 1700-1900 cm-1. There are no Raman 
active molecules beyond 1800 cm-1, so it is certain that this is an artefact of 
fluorescence. When we performed a PCA analysis of the spectra that had not 
been baselined, or baselined with a second order polynomial, the principle 
components were difficult to interpret due to the remaining baseline, and so made 
it impossible to analyse the biochemical differences that were separating the 
data.  
 
The spectrum that has been processed with a 7th order polynomial shows signs 
of overfitting. The amide III region, which would be expected to be present, is 
absent, and so some of the specific biochemical features for tissue differentiation 
are lost. However, it has successfully subtracted the fluorescence from 1700-
1900 cm-1.  
 
We then used a 6th order polynomial to fluorescence baseline subtract, which 
gave the optimal results (Figure 4-4). The processed spectrum shows clearly the 
amide III region, which was to be expected, and there is no significant peak in the 
1700-1900 cm-1 region. When compared to a previous study’s results, which were 
also obtained in fresh frozen breast tissue using a 785 nm laser excitation, the 
spectrum is similar352. A 6th order polynomial has also been used in a previous 
publication for baseline subtraction in the fingerprint region when measuring 
fluorescent biological tissue 107. This ability to perform specific biochemical 
analysis of the spectrum and the concordance with previous results suggested 
this was the optimal method for processing our fingerprint spectral data, and so 




























































 Figure 4-4 Demonstrating pre-processing tumour spectrum with a 6th order polynomial flourescence 
baseline subtraction prior to min/max normalisation. 
A Representative raw tumour Raman spectrum, with the fitted baseline to be subtracted. B Representative 
tumour spectrum after pre-processing. C. Representative tumour spectrum (smoothed with a savitzky-golay 
span of 5, 1st order polynomial) with peaks highlighted with corresponding Raman shift number. D. Figure 
of Raman spectrum from the literature obtained with a 785 nm laser excitation demonstrating similarity in 
Raman peaks with our spectrum in C. Reproduced from reference Li et al. 352,( copyright the authors 2017,  




4.2.5.3 Concatenated data 
Concatenation was then performed where the pre- processed fingerprint 
spectrum was ‘stitched’ with the high wavenumber data to allow analysis without 



















































Figure 4-5 Representative baselined and normalised Raman spectrum obtained from a single non-
tumour specimen, with demonstration of the different spectral regions measured 
A Fingerprint region B. Highwavenumber (HWN) region C. Concatenated data composed of the HWN and 




4.2.6 Data analysis 
Spectra were analysed both as individual, independent spectra (e.g. each 
different area on a single sample viewed as a discrete spectrum and so each 
specimen had a number of spectral outputs that contributed to analysis), and as 
mean/median specimen spectra (e.g. each sample had a single combined 
spectral output). 
 
The pre-processed HWN spectra were analysed using the water/total area ratio 
calculation using the protocol outlined in Chapter 2. The water/total area ratio was 
calculated for each individual spectrum and then the mean ratio from each 
specimen was used and categorised as coming from either a tumour or not 
tumour specimen. The standard deviation was calculated for mean data.  
 
Binomial Logistic Regression was then used to obtain the optimal water/total area 
ratio threshold that could be used to predict if a spectrum was from a tumour or 
not tumour specimen. Classification tree machine learning was also used with a 
2- way split as an alternative method to obtain the same goal. In data with more 
than two classifiers (e.g. carcinoma type and grade), a multiclass error-correcting 
output codes (ECOC) model using support vector machine binary learners was 
trained for prediction. For each model a Receiver Operating Characteristic (ROC) 
curve was plotted, with the y axis being true positive rate, and x axis 1-specificity 
(or false positive rate). The optimal threshold was calculated as the point at which 
the test gives the optimal accuracy and balance of sensitivity and specificity. The 
accuracy of these models can be assessed by the Area Under the Curve (AUC) 
of the ROC curve- a ROC with an AUC of 1 is a perfect test with 100% sensitivity 
and specificity, and therefore, the closer the AUC is to 1, the more accurate the 
model.  
 
These techniques were then cross validated by a number of methods, using built 
in functions within MatLab. Different cross validation techniques were used to 
assess which were the most suitable to use for future data analysis. No technique 
is perfect, and there is no ‘correct’ one for use in a particular scenario; it is 
important to acknowledge the potential risk of bias due to each method, when 




 ‘Hold out’ cross validation is where 30% of the data is held out, the model uses 
the remaining 70% of data as the ‘training set’, and it then uses this output to 
predict the outcome of the previously held out 30% as the ‘prediction set’. The 
advantage of this technique is that none of the training set data is used for the 
prediction set, meaning the prediction set is truly ‘new’ data to the algorithm. 
However, with a limited data set there is a possibility of bias, as the test set (which 
does not inform the algorithm) may contain important information (e.g. it may 
contain all the data from a sub-population)354.  
 
 ‘K folds’ cross validation is where the data is randomly split into the number of 
‘folds’ stipulated, e.g. in K folds 5, the data is split into 5 groups. One group is left 
out, the remaining groups are used as a ‘training set’ and this output is used to 
predict the outcome of the previously left out group as the ‘prediction set’, this is 
then repeated, but with the next group left out etc. until all groups have been held 
out and used as a ‘prediction set’. The advantage to this technique, particularly 
with a smaller data set, is that all the dataset is used in at least one iteration of 
the training set, reducing the risk that important information or a sub-population 
is not included in algorithm construction354, however this increases the possibility 
of overestimation of the algorithm prediction accuracy 355.Leave-One-Out-Cross-
Validation (LOOCV) is the logical extreme of a K folds cross validation, with the 
number of folds being n-1. LOOCV is the most exhaustive cross validation 
procedure and is commonly used in clinical studies providing a ‘subject-wise’ 
cross validation method (the training set does not include the prediction set data), 
and is considered to be particularly appropriate in the evaluation of diagnostic 
models 353, 355. 
 
For each of the cross validation methods the accuracy of the test was assessed 
by the outcome in the form of a confusion matrix with the sensitivity (true positive 
rate, or true positive / true positive + false negative), specificity (true negative 
rate, or true negative / false positive + true negative) and overall accuracy of the 
analysis (true positive + true negative) / true positive +true negative + false 
positive + false negative) calculated. 
 
The individual specimen data also underwent analysis with a voting threshold 




each spectrum as either ‘tumour’ or ‘non-tumour’. The optimal water/total area 
ratio that had been determined from the binomial logistic regression model 
without cross validation was used as this used all available spectra, whereas in 
the cross validated models a certain proportion was held out, and so reduced the 
size of the training set. Algorithms were constructed in Matlab to classify the 
entire sample based on the proportion of ‘tumour’ or ‘non-tumour’ spectra for that 
sample. The rules of the algorithms for Voting threshold 1 or 2 are detailed in the 
Results section. This gave a single binary output for each specimen, as the entire 
specimen either being classified as tumour or non-tumour.  
 
All spectral data (from individual or mean spectra from all spectral regions) was 
analysed by Principal Component Analysis (PCA). Principal components (PC) 
describe data as sections of spectra and the degree of variance between spectra. 
It therefore describes each spectrum as a score for each PC and P values assess 
the difference between the scores between spectra. It is an unsupervised test 
and the potential differences between groups (e.g. tumour or not tumour) are not 
acknowledged by the analysis. It is a commonly used technique in Raman 
spectroscopy to analyse differences in spectra. 
 
Spectral data were mean centred and underwent PCA, with 12 separate 
component separations. Scores had P values calculated by one-way ANOVA and 
were regarded as significant if P<0.01, and this cut off was used to highlight the 
components that required plotting. The component scores were plotted on graphs 
with the ability to differentiate between different pathologies/demographics (e.g. 
tumour or non- tumour) by colour.  
 
If there was separation on PCA by P score values, a Linear Discriminant Analysis 
(LDA) was performed with the PCA fed scores. LDA is a supervised test, where 
the differences in the samples (e.g. if they came from tumour or not tumour) are 
loaded into the test and used to classify the spectra and so the known 
pathological state is acknowledged in the analysis. In our analysis the 
pathology/demographic label was loaded with the scores, with 100 bins. This was 
then cross validated by a Leave-One-Out Cross Validation (LOOCV) technique, 




to have a ‘training’ set, and this is then used to predict the outcome of the sample 
that was left out. This is then performed n-1 times.  
 
Spectral data was analysed according to patient/tumour subtypes. Tumour 
spectra was classified according pathological subtypes, and non- tumour spectra 
classified according to patient physiological factors of Menopausal status (pre 
and post) and age. Age is a continuous variable, whereas the analysis to be 
performed relied on classification according to a binary or ordinal variable. To 
split age into a number of different age brackets would result in a small number 
of patients being in each group and under- powered calculations. Therefore, age 
was divided into a binary variable, with a cut off of either 60 (i.e. below or above 
60), or cut off of 50 (i.e. below or above 50). This lower age bracket was used as 
there is good evidence that breast composition with regards to water content is 
markedly different in much younger age groups regardless of menopausal 
status280, and if the cut off had been lower (e.g. 40), there would have been too 
few patients in the group to allow analysis. In these analyses, if the subtype had 
not been collected (left blank on the patient information spreadsheet), the spectra 
was excluded from that analysis. 
 
4.2.7 Raman micro spectrometry experiments 
To enable matching between the measured Raman spectra obtained from the 
needle probe and histological features of the breast tissue, a series of 
experiments were conducted on a micro spectroscopy system. The results from 
the fresh frozen specimen were examined to determine which required 
corresponding microscopic analysis. Two specimens were chosen to have 
microscopic analysis as they had some Raman spectra indicating ‘non-tumour’ 
tissue in the tumour specimen, and the prepared slides were all of sufficient 
quality, with an adequate amount of tissue, to allow detailed analysis.  
 
H+E stained slides were digitised using an upright light microscope (Carl Zeiss 
AG,Oberkochen, Germany)   at a X 20 magnification (20X/0.30 objective, Leitz 
Wezlar, Germany), with a CMOS camera (Model - acA1920-155uc, Basler AG, 
Ahrensburg, Germany) and images were captured using Manual MSI, 
Microvisioneer software (Freising, Germany). The digitised images were printed, 




from the Royal Devon and Exeter Hospital for a more detailed microscopic 
diagnosis at X 40 magnification, and pathological features of the slide, which was 
annotated on the digitised image. 
 
The corresponding tissue slices that had been prepared on BaF2 slides were 
thawed at room temperature and immediately measured. The Renishaw InVia 
confocal spectrometer system (Renishaw, UK) was used for Raman 
measurements after calibration of the system with silicon, green glass, PTFE and 
Neon Argon lamp. A slide scan was then performed with white light, at X5 
magnification and this was correlated with the annotated digitised H+E slide. 
Areas of interest had Raman measurements taken using a NPlan objective 
(Leica, Germany) with magnification X50. An excitation source of a 785 nm laser 
was used with an output of 300 mW to collect spectra in the wavelength range of 
2100 – 2750 cm-1, with a single accumulation and 5 second acquisition time. 
Raman spectra was analysed in Matlab, and had pre-processing by fluorescent 
























4.3.1 Patient/ Tumour demographics 
Fresh frozen samples from 96 patients were used for this study. The patient and 
tumour characteristics of the patients are shown in Table 4-1. 
 
DEMOGRAPHIC DETAIL NUMBER (%) / MEAN (± SD) 
PATIENT DEMOGRAPHIC 
 
MEAN AGE 67.3 (±14) 
POST MENOPAUSAL 80 (83%) 
POSITIVE FAMILY HISTORY 24 (25%) 
ROUTE OF REFERRAL - SYMPTOMATIC 85 (89%)   
TYPE OF SURGERY 
 
SITE OF OPERATION - LEFT BREAST 57 (59%) 
WIDE LOCAL EXCISION 50 (52%) 
MASTECTOMY 46 (48%) 
SENTINEL NODE BIOPSY (OF 95 THAT HAD 
AXILLARY PROCEDURE) 
73 (77%) 
AXILLARY NODE CLEARANCE 23 (23%)   
TUMOUR CHARACTERISTICS 
 
DCIS ONLY 3 (3%) 
INVASIVE CARCINOMA 93 (97%) 
MEAN SIZE OF TUMOUR ( MM) 30.2 (± 11.8) 
INVASIVE TUMOUR CHARACTERISTICS (N=93) 
 
POSITIVE LYMPH NODES 37 (39%) 
MEAN NUMBER OF POSITIVE LYMPH NODES 1.3 (± 2.3) 
INVASIVE ASSOCIATED WITH DCIS 72 (77%) 
INVASIVE CARCINOMA GRADE (N=93) 
 
- GRADE 1 2 (2%) 
- GRADE 2 54 (58%) 
- GRADE 3 37 (39%) 
CARCINOMA TYPE (N=93) 
 
- DUCTAL 64 (67%) 
- LOBULAR 21 (23%) 
- MIXED 5 (5%) 
- MUCINOUS 3 (3%) 
RECEPTOR STATUS (N= 96) 
 
ER + 82 (85%) 
HER2 + 17 (18%) 
 
Table 4-1 Table of patient and tumour characteristics for the samples that were measured in this 
study. 
Note that in demographics with a dichotomous outcome (e.g. post- menopausal) only one is included, and 
it can be presumed the other patients were in the other category (e.g. pre-menopausal). ER = Estrogen 





4.3.2 Fresh frozen specimen measurements 
4.3.2.1 Spectra obtained  
In total 192 specimens were measured (96 tumour specimens, 96 non-tumour 
specimens), with a total of 1335 spectra obtained. 









Figure 4-6 Graphs showing spectral data obtained from all measurements (n=1335) after pre-
processing 
A. HWN region B. FP region C. Concatenated data. In all graphs the spectra shown have had fluorescent 




4.3.2.2 Water content analysis to diagnose breast cancer 
After pre-processing, it is evident that there are visual differences in the HWN 
region between spectra obtained from tumour specimens and non-tumour 
specimens. Figure 4-7 shows there is a clear difference in the water peak 
between tumour and non-tumour specimens, with tumour specimens having a 
larger water peak than non-tumour specimens, when spectra have been 
normalised to the CH2 stretch region (2935 cm-1). Non-tumour specimens also 
have a predominately lipid peak at the CH stretch region (2800-3040 cm-1), 





The water/total area ratio was calculated for each spectrum, and the mean and 
median of the ratio calculated for each specimen. Figure 4-8 shows that there is 
a significant difference for both the mean (P=1.6X10-42) and median (P=2.3X10-
30) water/total area ratio between tumour and non-tumour specimens.  
 
Figure 4-7 Mean HWN spectra of all specimens (n=1335) according to diagnosis demonstrating 
changes in water content between tumour and non-tumour specimen spectra 
Data is mean of spectra from all tumour specimen spectra (n=672) and all non-tumour specimen spectra 
(n=663), fluorescent baseline subtraction with a 3rd order polynomial, and normalised to the CH peak at 
2935cm-1. Shading either side of solid line in same colour is +/- 1 S.D. Red spectra=measurement from 
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Having established there was a difference in water/total area ratio between 
tumour and non-tumour specimen spectra, the aim was to investigate if there was 
a ratio threshold that could predict if a spectrum corresponded to tumour or non-
tumour tissue, i.e. if a spectra had a ratio above a certain value it would be 
classified as coming from tissue containing tumour. This could then be used to 
differentiate between normal and cancerous tissue and be a foundation of intra-
operative margin analysis. Binomial logistic regression was performed with the 
water/total area ratio with the known classifier of whether the ratio was obtained 
from tumour or non-tumour tissue. A Receiver Operator Characteristic (ROC) 
curve (Figure 4-9) was constructed to obtain this ratio threshold value – which 
was the point on the curve that related to the optimal balance between sensitivity 
and specificity for diagnosis. The water/total area ratio from all the spectra as 
individual data points (n=1335) was used to construct ROC curves, and a 
classification trees prediction model with a two way split, which were then cross-
validated with a number of techniques, the results are shown in (Table 4-1). All 













































Figure 4-8 Bar charts illustrating the difference in water/total area ratio between tumour (n=96) and 
non-tumour specimens (n=96) 
A Bar graph demonstrating the mean water/total area ratio per specimen of tumour and non-tumour 
specimens, error bars represent +/- 1 S.D. Statistically significant difference between the mean water/total 
area ratio of tumour (0.7709; SD +/- 0.1240) versus non-tumour (0.2169; SD +/- 0.2027) calculated by 
student T-Test (P=1.6X10-42) 
B Bar graph demonstrating the median water/total area ratio per specimen of tumour and non-tumour 
specimens, error bars represent +/- interquartile range. Statistically significant difference between the 
median water/total area ratio of tumour (0.827; IQR – 0.0284) versus non-tumour (0.1065; IQR – 0.1536) 




of between 92-94%, specificity of 86-87% with an overall accuracy of 89%, with 















0.75 0.95 n/a 92.7 86.4 89.6 
0.56 0.95 Hold out 91.5 87.4 89.5 
0.77 0.95 K folds 5 93.1 86.6 89.9 
0.76 0.95 K fold 10 92.7 86.4 89.6 
0.76 0.95 LOOCV 92.7 86.6 89.7 
Classification 
Trees 
0.68 0.95 LOOCV 87.5 91.7 89.6 




















Figure 4-9 ROC curve for classification by binomial logistic regression of water/total area ratio 
prediction of tumour versus non-tumour of all spectra (n=1335)  
Red circle denotes the optimal water/total area ratio threshold for classification = 0.75  
Table 4-2 Summary table of results following Model predictions of categorising spectra as tumour 





A possible limitation of using every spectrum in the analysis is that multiple 
spectra from each specimen is used in the construction of the prediction model. 
This means that if a specimen had a large number of spectra taken from it, or had 
some outlying ratio values, this may disproportionately influence the model and 
limit the accuracy of the threshold value. Therefore, the same sequence of 
analysis was undertaken with a single value for each specimen. The value was 
the mean of all the water/total area ratio for each specimen. Multiple ROC curves 
were constructed using binomial logistic regression and a classification tree with 
a two way split (a representative ROC curve is shown in Figure 4-10) with a 
number of different cross validation methods (Table 4-3). There was improved 
accuracy using the mean spectral data compared to the individual data, with an 


























Figure 4-10 ROC curve for classification by binomial logistic regression of water/total area ratio 
prediction of tumour versus non-tumour of mean spectra (n=192) 















0.6264 0.98 n/a 95.8 88.5 92.2 
0.83 0.95 Hold out 92.9 86.2 89.5 
0.6587 0.97 K folds 5 94.8 89.6 92.2 
0.6333 0.97 K fold 10 94.8 88.5 91.7 
0.6524 0.97 LOOCV 94.8 88.5 91.7 
Classification 
Trees 




A clinically relevant method of processing spectral data would be to analyse all 
the spectra obtained from the resected edge of a specimen and determine 
whether there was tumour present at the resected edge. This would provide a 
simple dichotomous output to inform the surgeon that the margin was ‘positive’ 
and that the tumour bed of the resected edge required resecting. A way of 
providing this output is to determine that if the majority of the resected edge had 
a ‘tumour’ water/total area ratio (as defined by the threshold ratio set by binomial 
logistic regression e.g. 0.75), then the entire resected edge would be classified 
as tumour. The water/total area ratio data was analysed in an algorithm that 
stipulated that if the majority of the specimen measurements had a ‘tumour’ 
water/total area ratio, the whole specimen was classified as tumour (Voting 
threshold 1). 
 
Table 4-3 Summary table of results following Model predictions of categorising spectra as tumour 




A second algorithm was used on the same data that stipulated if any of the 
specimen demonstrated a single ‘tumour’ water/total area ratio, the whole 
specimen would be determined as tumour (Voting threshold 2). 
 
The results of these two algorithms showed that voting threshold 1 gave a high 
degree of specificity (95.8%), but a lower sensitivity of 87.5% with a good overall 
accuracy of 91.7%. Voting threshold 2 had a higher degree of sensitivity of 
95.98%, but a low specificity (88.0%) of and an overall accuracy was 88.0 % 
(Figure 4-11).  
 
A      B 
    
 
The threshold used to classify as a ‘tumour’ signal in these voting thresholds 
could be manipulated to tend towards being more sensitive or more specific 
based on what is necessary when analysing an entire margin. For example, if a 
water/total area ratio threshold of 0.4 is used in voting threshold 1, the algorithm 
has a 90.1% accuracy, with 97.9% sensitivity and 82.3% specificity, and if a 
water/total area threshold of 0.8 is used in voting threshold 1, the algorithm has 






Figure 4-11 Confusion matrices of specimen diagnosis after voting threshold analysis of water/total 
area ratio using the optimal threshold of water/total area ratio of 0.75 
A. Voting threshold 1 which achieved overall accuracy – 91.7%, sensitivity – 87.5%, specificity – 95.8% B. 




Ratio Threshold Sensitivity Specificity Accuracy 
0.1 99.0 44.8 71.9 
0.2 99.0 70.8 84.9 
0.3 97.9 79.2 88.5 
0.4 97.9 82.3 90.1 
0.5 95.8 86.5 91.1 
0.6 93.8 90.6 92.2 
0.7 93.8 93.8 93.8 
0.8 79.2 99.0 89.1 
0.9 1 99.0 <50 
 
Using the intra-patient difference in water/total area ratio 
The methods illustrated above, to provide differentiation between tumour versus 
non-tumour, have used a water/total area ratio threshold based on a value 
obtained from all spectra from all individuals. The physiological ‘normal’ in terms 
of water content for each patient is known to be different (and is explored in a 
later section of this chapter for these patients). Therefore, having the same cut-
off value for all specimens could lead to some diagnostic inaccuracy.  A measure 
of the change in the water/ total area ratio within a patient between tumour and 
non-tumour could be sufficient to differentiate areas of tumour versus non-
tumour. Logistically this could be achieved by the surgeon ‘calibrating’ the 
instrument on some obviously normal tissue, well away from the tumour site, prior 
to examining the specimen for IMA, and areas of difference compared to the 
‘calibration’ measurement flagged as abnormal and requiring resection.  
 
A simple and effective measure of this change is to calculate the difference in the 
water/total area ratio between the area that is being measured and the 
‘calibration’ measurement from the normal tissue. The diagnostic ability of the 
water/total area ratio difference to diagnose breast cancer was investigated using 
the water/total area ratio from all spectra (n=1335). For each patient, the mean 
Table 4-4 Table demonstrating the change in diagnostic accuracy with a change in water/total area 




water/total area ratio was calculated from the spectra obtained from the non-
tumour specimen – this was the ‘calibration’ measurement. Then each individual 
spectra (from tumour and non-tumour specimens) for each patient had the 
water/total area ratio calculated, and the difference from that reading taken from 
the ‘calibration’ measurement as per Equation 4-2: 
 
𝑊 𝑇𝐴𝑅⁄  𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒
=  𝑊 𝑇𝐴𝑅 𝑜𝑓 𝑐𝑢𝑟𝑟𝑒𝑛𝑡 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑚𝑒𝑛𝑡⁄  −  ′𝐶𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛′ 𝑊 𝑇𝐴𝑅⁄   
 
This provides a unique measure for each reading that represents the difference 
from the mean non-tumour specimen. It could be presumed that non-tumour 
measurements would be approximately 0 (as they produce the ‘calibration’ ratio), 
and tumour measurements would be substantially greater than 0. The cut off 
W/TAR difference of 0.1 was chosen as it is close to 0 and allows for some intra-
specimen variation of non-tumour specimens W/TAR difference, but would likely 
give a model with high sensitivity. Therefore, for all spectra, the W/TAR difference 
was calculated, and if the W/TAR difference was >0.1, it was classified as a 
tumour, and if <0.1, it was classified as non-tumour, and a confusion matrix 
produced (Figure 4-12). It shows that using this method, the overall accuracy is 
89.5%, with a high sensitivity of 93.6% but low specificity of 85.4%. 
 
 
Equation 4-2 – Calculation of the water/total area ratio difference 
W/TAR = Water/Total area ratio 







An improved diagnostic accuracy may be possible, and so binomial logistic 
regression was used using the W/TAR difference calculated for each spectrum, 
and the classifier of whether it came from a tumour or non-tumour specimen used 
to train the model. The resultant ROC curve is shown, which produced an AUC 
of 0.95, and predicted the optimal threshold (cut off for the W/TAR difference) 
was 0.3275 (if the W/TAR difference >0.3275, the measurement was classified 
as a tumour reading, and if <0.3275, it was classified as a non-tumour reading) 
(Figure 4-13). Using a k-folds 5 cross validation method, the model achieved an 
accuracy of 90.1%, a sensitivity of 87.0% and specificity of 93.2%. The results of 
using the ‘optimal threshold’ of 0.3275 (high specificity) compared to the 
previously chosen threshold of 0.1 (high sensitivity) demonstrate that the 
threshold can be manipulated to provide the desired test characteristics, similar 
to using the more simple water/total area ratio calculation. 
 
Figure 4-12 Confusion matrix showing the diagnostic results of the W/TAR difference cut off= 0.1 for 









Another way of performing this analysis to perform IMA would be to take a 
number of readings over the area of the margin and calculate the mean 
water/total area ratio for the entire margin surface prior to subtracting the mean 
‘calibration’ reading and providing a single output for that area. The mean 
water/total area ratio from each patient’s ‘non-tumour’ specimen was subtracted 
from the matched patient’s ‘tumour’ specimen (as representative of values that 
might be obtained along the margin), to give the water/total area ratio difference 
for that patient’s ‘tumour’ specimen (Figure 4-14). This shows that for the mean 
readings, the water/total area ratio difference was greater than 0 in all but 1 




















Figure 4-13 Results of binomial logistic regression model with k folds 5 cross validation for 
predicting tumour versus non-tumour specimen using the W/TAR difference 
A. ROC curve for classification by binomial logistic regression of W/TAR difference prediction of tumour 
versus non-tumour of all spectra (n=1335). Red circle denotes the optimal threshold for classification, which 




patient, suggesting that if a threshold water/total area ratio difference of 0 was 
set, 95 of 96 of patients would be correctly classified. This cannot be assessed 
in more detail for diagnostic accuracy, as the mean non-tumour tissue value is by 






































Figure 4-14 Bar chart of sample number (n=96) and the mean W/TAR Difference for the tumour 
specimen for that sample 
Note – only one sample has a negative value, suggesting that if a cut off of W/TAR Difference of 0 was used, 




4.3.2.3 Spectral analysis to diagnose breast cancer 
HWN region 
PCA analysis of pre-processed HWN spectral data was performed, with the 
results demonstrated in Figure 4-15. Two of the three principal components that 
achieved statistical significance between tumour and non-tumour tissue (PC1 
and PC2) had incredibly small P values (recorded as 0, as they were so low as 
to be rounded to 0). These two PCs were confirmed as accounting for the majority 
of the classification, as PC1 accounted for 66% of the variance, and PC2 33% of 
the variance, with the remaining 10 PC’s accounting for <1% of the variance. 
Plotting the three most significant principal components (as defined by the 
smallest P value) gave excellent visual separation between tumour and non-
tumour spectra.   
 
PC1 and PC2 were correlated with the spectral assignation from previous work 
in this thesis and were shown to correspond to protein and water peaks (PC1), 
and the lipid peak (PC2), which also correlated with the spectral assignation from 
the literature 295, 304 (Figure 4-16). This suggests that it is both of these spectral 
features that allow separation of spectra according to the tumour or non-tumour 
classification, and are in keeping with the findings from the water/total area ratio 
calculations, that tumour (protein and water rich) can be differentiated from non-












PC 1 PC 2 PC 3 PC 4 
0 0 0.97 0.86 
PC 5 PC 6 PC 7 PC 8 
0.91 0.39 0.50 0.0026 
PC 9 PC 10 PC 11 PC 12 
0.24 0.52 0.11 0.99 











































































Figure 4-15 Principal Component Analysis of all HWN spectral data (n=1335) 
A. Principal Components (12 in total) identified in analysis B. Table of principal components and 
corresponding P Values C. Scatter graphs plotting the 3 significant Principal Components (PC1, PC2, PC8), 







The PCA scores were fed into a LDA which achieved good separation between 
spectra and a training performance of 90.5%, and subsequently a LOOCV 
performed, the results of which are in Figure 4-17. After LOOCV the technique 














Figure 4-16 Principal components accounting for the majority of spectral variance between tumour 
versus non-tumour tissue, and spectral assignation 
Graphs on Left are the spectrum of Principal Components 1 and 2, and on the Right are representative 
Raman spectrum of bovine gelatine (protein), soya bean oil (lipid) and distilled water (water). It can be seen 
that PC1 relates to protein and water signal, and PC2 relates to lipid signal, suggesting it is these 









The mean spectrum for each specimen was calculated, providing a single 
spectrum for each specimen (n=192). PCA was performed which revealed similar 
results – PC 1 and PC2, relating to the protein and lipid peak had significant P 
values, with PC1 accounting for 67.4% of variance, and PC2 accounting for 
32.1%, with the remaining scores combined accounting for only 0.3% of the 
variance (Figure 4-18). 
















Figure 4-17 Results of all HWN spectra (n=1335) to compare spectra from tumour versus non- tumour 
specimens with PCA fed LDA analysis 
A. Histogram of LDA scores versus frequency, with tumour scores plotted in red, non-tumour scores in 








PC 1 PC 2 PC 3 PC 4 
5.0X10-64 4.0X10-65 0.97 0.79 
PC 5 PC 6 PC 7 PC 8 
0.81 0.80 0.56 0.53 
PC 9 PC 10 PC 11 PC 12 














































































Figure 4-18 Principal Component Analysis of mean HWN spectral data (n=192) 
A. Principal Components (12 in total) identified in analysis B. Table of principal components and 
corresponding P Values C. Graph plotting the 2 significant Principal Components (PC1 and PC2), with 





LDA analysis gave excellent separation with a training performance of 93.8% 
accuracy, and LOOCV gave a sensitivity of 93.8%, specificity 92.7% and overall 
























Figure 4-19 Results from spectral analysis of the mean HWN spectra for each specimen (n=192)  
A. PCA fed LDA histogram of scores versus frequency using 12 principal components with tumour scores 





Spectra from the FP region underwent pre-processing, the mean spectra from 
tumour and non-tumour specimens is shown in Figure 4-20. There are evident 
spectral differences in the FP region between spectra obtained from tumour 




To understand the spectral differences between tumour and non-tumour 
specimens, the two groups of mean spectra were separated, peaks identified, 
and spectral peak assignation performed based on values from the literature 
(Figure 4-21). This demonstrated that the differences between them primarily 
related to differences in protein and lipid signals. This suggests that the FP region 
may differentiate between tumour and non-tumour based on the differences 
between protein and lipid tissue, which is the same basis for differentiation in the 
HWN region. 
 
Figure 4-20 Mean Fingerprint spectra of all specimens (n=1335) according to diagnosis 
demonstrating differences between tumour and non-tumour specimen spectra 
Data is mean of spectra from all tumour specimen spectra (n=672) and all non-tumour specimen spectra 
(n=663), fluorescent baseline subtraction with a 6th order polynomial and min/max normalisation to avoid 
distortion in peak heights. Shading either side of solid line in same colour is +/- 1 S.D. Red 
















Amide III (proteins) 
1338 
(1335-1345) 
Amide III; CH3CH2 wagging mode of collagen 
1448 CH2 & CH3 deformation; collagen  
1649 Amide I (C=C) 







1060 Skeletal C-C stretch DNA/Lipid 
1296 CH2 deformation 
1441 CH2 scissoring & CH3 bending in Lipids 
1649 Lipid (C=C stretch) 
1740 C=O stretch Lipid, ester group 
 
 



































Figure 4-21 Spectral assignation of Fingerprint spectra in breast tissue  
A. Mean of all spectra taken from tumour tissue, with peaks identified with Raman shift number. B. Spectral 
assignation table for tumour tissue peaks. C. Mean of all spectra taken from non-tumour tissue. D. Spectal 
assignation table for non-tumour tissue peaks. 
The mean Raman spectra have been smoothed with savitzky-golay span of 5, 1st order polynomial and the 
main spectral peaks are identified with corresponding Raman shift value. Biochemical peak assignation is 




PCA analysis was performed and over half of the principal component scores 
reached statistical significance in classifying tumour versus non-tumour scores 
(7 of 12), which is more than that of the HWN region (Figure 4-22). The first 3 
PCs were confirmed as being responsible for the majority of the difference 
between the groups. Variance analysis of the principal components 
demonstrated that PC 1 accounted for 58.5% of the variance, and PC 2 25.4 % 
of the variance, with PC 3 accounting for 10.59% of the variance and the 
remaining 9 PC’s accounting for 5.5% of the variance.  
It can be seen that in plotting the three most significant principal components (as 
defined by the smallest P value), it gave good visual separation between tumour 






























PC 1 PC 2 PC 3 PC 4 
4.08X10-27 4.89X10-115 2.89X10-116 0.99 
PC 5 PC 6 PC 7 PC 8 
1.93X10-6 3.56X10-4 6.30X10-6 0.02 
PC 9 PC 10 PC 11 PC 12 





















































































Figure 4-22 Principal Component Analysis of Fingerprint region spectra of all spectra (n=1335) 
A. Principal Components (12) identified in analysis B. Table of principal components and corresponding P 
Values C. Scatter graphs plotting the 3 most significant Principal Components (PC1,PC2,PC3) accounting 




The spectral peaks, with the Raman shift values, were identified for the spectral 
features of PC1 and PC2 as these accounted for 85% of variance. The peaks of 
PC1 relate to the peaks seen for tumour tissue, and the peaks of PC2 relate to 
the peaks seen for non-tumour tissue (Figure 4-23).  
 
A      B 
 
 
Peak assignments of all of the principal component Raman peak scores that 
reached statistical significance, along with a tentative assignment to the molecule 
type is in Table 4-5. This demonstrates that most of the differentiation between 
tissue types is due to protein and lipid differences, with some minor variance due 
to DNA/RNA. This suggests, along with the mean spectra data analysis above, 
that the differentiation of tumour versus non-tumour tissue in the fingerprint region 
is predominantly based on the difference in tumour (protein rich) and non-tumour 
(lipid rich). This is similar to the HWN region, however, in the fingerprint region 








































Figure 4-23 Spectral assignation in the two most significant principal components in the Fingerprint 
region in differentiating tumour from non-tumour tissue 
A. Principal Component 1; these peaks correspond to those identified as corresponding to tumour tissue 
(protein rich) B. Principal Component 2; these peaks correspond to those identified as corresponding to non-










Biochemical assignation Overall 
tentative 
assignment 
1 1053 C-O stretching, C-N stretching (protein) Protein 
1296 Amide III (proteins) 
1441 CH2 scissoring & CH3 bending in Lipids 
1649 Amide I (C=C) 
2 1068 Skeletal C-C stretch DNA/Lipid Lipid 
 1289 CH2 deformation 
 1441 CH2 scissoring & CH3 bending in Lipids 
 1655 Lipid (C=C stretch) 
3 1296 CH2 deformation Lipid 
 1441 CH2 scissoring & CH3 bending in Lipids 
 1655 Lipid (C=C stretch) 
5 1675 Amide I (Beta sheet) Protein 
6 1154 C-C and C-N stretch protein Protein 
7 1324 CH3 and CH2 wagging of purine bases DNA 
 1441 CH2 scissoring & CH3 bending in Lipids 
 1529 Carotenoids or Cytosine 
11 994 C-O Ribose DNA/RNA 
 1126 C-C stretch protein or carbohydrates 
 1421 CH deformation DNA/RNA/Deoxyribose 
 1516 Cytosine or carotenoids 
 
 
LDA analysis using the scores from the PCA gave a training performance of 
90.6%. LOOCV analysis of the model gave an overall accuracy of 90.3%, 





Table 4-5 Peak assignment of significant Principal component scores in fingerprint spectral analysis  









The mean spectrum for each specimen was calculated and underwent PCA 
analysis. This gave visually similar principal components for the first 12 PC’s to 
the individual spectra data PC 1 accounted for 68.6% of variance,  PC 2- 21.0% 
so PC1 and PC2 accounted for >90% of the variance, with  PC 3 accounting for 
7.26% and PC 4-12 – 3.11% (Figure 4-25).  















Figure 4-24 PCA fed LDA analysis of all Fingerprint region spectral data (n=1335)  to differentiate 
between tumour and non-tumour breast spectra 
A. Histogram of LDA scores versus frequency, with tumour data plotted in red, non-tumour data in green B. 








PC 1 PC 2 PC 3 PC 4 
7.90X10-238 1.97X10-26 0.089 1.32X10-5 
PC 5 PC 6 PC 7 PC 8 
0.049 0.0011 0.0013 4.12X10-6 
PC 9 PC 10 PC 11 PC 12 




















































































Figure 4-25 Principal Component Analysis of Fingerprint region spectra of mean spectra (n=192) 
A. Principal Components (12) identified in analysis B. Table of principal component scores and 
corresponding P Values C. Scatter graphs plotting the first 3 Principal Components (PC1,PC2,PC3) 




Although the principal components were very similar to the individual spectral 
data, not all the significant components were the same ones between individual 
and mean data. Table 4-6 highlights the significant principal components in the 
mean data, with tentative spectral assignment. It shows that, similar to the 
individual data, PC 1 and PC2 (that accounted for the majority of the variance) 





Peaks Biochemical assignation Overall 
tentative 
assignment 
1 1053 C-O stretching, C-N stretching (protein) Protein 
1296 Amide III (proteins) 
1441 CH2 scissoring & CH3 bending in Lipids 
1649 Amide I (C=C) 
2 1068 Skeletal C-C stretch DNA/Lipid Lipid 
1289 CH2 deformation 
1441 CH2 scissoring & CH3 bending in Lipids 
1655 Lipid (C=C stretch) 
4 1038 Collagen Protein 
1197 Amide III 
1649 Amide I (C=C) 
6 1154 C-C and C-N stretch protein Protein 
7 1324 CH3 and CH2 wagging of purine bases DNA 
1441 CH2 scissoring & CH3 bending in Lipids 
1529 Carotenoids or Cytosine 
8 1261 Amide III Protein 
1469 C=N stretch 
1669 C=O stretch; protein band 
9 1075 C-C stretch lipid Lipid or DNA 
1310 CH stretch lipids 
1455 Deoxyribose 
11 994 C-O Ribose DNA/RNA 
1126 C-C stretch protein or carbohydrates 
1421 CH deformation DNA/RNA/Deoxyribose 
1516 Cytosine or carotenoids 
 
 
The scores of the 12 components were fed into LDA analysis which gave a 
training performance of 94.3% (Figure 4-26). LOOCV was performed which gave 
92.7% overall accuracy, sensitivity 91.7% and specificity 93.8%.   
Table 4-6 Peak assignment of significant Principal component scores in fingerprint mean spectral 































Figure 4-26 PCA fed LDA analysis of mean Fingerprint spectra (n=192) to differentiate tumour and 
non- tumour specimens 
A Histogram of PCA fed LDA scores, with tumour data plotted in red, non-tumour data in green. B. confusion 




Concatenated spectral data 
The spectra from the HWN region and FP region were stitched together and 
analysed simultaneously. Principal component analysis found 3 components 
(PC1, PC2 and PC12 with significant P values <0.01 (Figure 4-27). Two of the 
three principal components (PC 1 and PC2) visually relate to the HWN region, 
with the protein/lipid peak and water peak being the spectral features responsible 
for the highly significant scores, as PC1 accounted for 59.8% of the variance, and 
PC2 33.0% of the variance. PC3 related to the fingerprint region amide III peak 
at 1338 cm-1 associated with protein accounting for 3.8% of the variance with the 























B PC 1 PC 2 PC 3 PC 4 
1.27X10-318 0 0.01 0.16 
PC 5 PC 6 PC 7 PC 8 
0.15 0.75 0.20 0.45 
PC 9 PC 10 PC 11 PC 12 

































































































Figure 4-27 Principal component analysis of all concatenated spectral data (n=1335) 
A 12 Principal components that were identified and underwent analysis. B. Table of principal components 
and P Values C. Scatter graphs plotting the first 3 Principal Components (PC1,PC2,PC3) accounting for 




PCA fed LDA analysis was performed using all 12 principal components which 
gave a training performance of 90.5%. LDA LOOCV gave a sensitivity of 90.2%, 






The mean concatenated spectrum for each specimen was calculated and 
underwent PCA analysis. The 2 significant PC’s corresponded to protein (PC1) 
and lipid (PC2) signals, which had significant scores (P<0.01). These two 
principal components accounted for 63.86% (PC1) and 32.7% (PC2) of variance, 
with the remaining 10PC’s accounting for the remaining <4% of variance. Plotting 
the scores from the PC1 and PC2 that accounted for > 95% variance 
demonstrated they achieved good separation (Figure 4-29). 


















Figure 4-28 PCA fed LDA analysis of all concatenated spectral data (n=1335) 
A PCA fed LDA analysis histogram of scores versus frequency,  with tumour data plotted in red, non- tumour 






B PC 1 PC 2 PC 3 PC 4 
1.67X10-62 4.70X10-65 0.556 0.397 
PC 5 PC 6 PC 7 PC 8 
0.858 0.908 0.774 0.915 
PC 9 PC 10 PC 11 PC 12 



















































































Figure 4-29 Principal Component Analysis of concatenated spectra of mean spectra (n=192) 
A. Principal Components (12) identified in analysis B. Table of principal component scores and 
corresponding P Values C. Graph plotting the first 2 significant Principal Components (PC1 and PC2) that 




PCA fed LDA analysis was performed, which gave a training performance of 
94.3%, with LOOCV the prediction gave an overall accuracy of 92.7%, sensitivity   


























Figure 4-30 Analysis results of mean concatenated spectra for each specimen (n=192) 
A. Histogram of PCA fed LDA scores versus frequency, with tumour data plotted in red, non- tumour data in 




4.3.2.4 Summary statistics for NP3 ability to differentiate between tumour and 





Sens. Spec. Overall 
Accuracy 
HWN All spectra PCA/LDA 
 
90.2 90.5 90.3 
Mean spectra 93.8 92.7 93.2 
FP All spectra 90.2 90.5 90.3 
Mean spectra 91.7 93.8 92.7 
Concatenate All spectra 90.2 90.5 90.3 
Mean spectra 93.8 91.7 92.7 
W/TR All spectra Binomial 
Logistic 
regression† 
92.7 86.6 89.7 
Classification 
trees 
87.5 91.7 89.6 
Mean spectra Binomial 
Logistic 
regression† 
94.8 89.6 92.2 
Classification 
trees 





87.5 95.8 91.7 
W/TAR 
Difference 
All spectra cut off 0.1 93.6 85.4 89.5 








Table 4-7 Summary statistics table of best performing spectral analysis and water/total area ratio analysis  
HWN – High Wavenumber region; FP – Fingerprint; Concatenate – HWN +FP spectra stitched together; 
W/TR – Water/ total area ratio; PCA/LDA – PCA fed LDA analysis; Sens. – sensitivity, Spec. - Specificity 




4.3.2.5 Spectral analysis to differentiate between pathology subtypes 
The group of tumour specimens contained a wide range of different pathology 
subtypes. Spectral analysis was performed to investigate if Raman 
measurements had the ability to provide specific pathological diagnosis of the 
tumour. 
Using E(strogen) R(eceptor) status as a representative example, the spectra 
obtained from all tumour samples showed little difference between those tumour 
samples that were ER+ versus those that were ER- by the sequence of analysis 
of looking at the water/total area ratio (Figure 4-31 A), and spectral analysis of 
the concatenated data with PCA (Figure 4-31 B). The findings were similar in 







In the analysis of tumour versus non-tumour differentiation, it was the mean data 
of the specimens that had the highest diagnostic accuracy of the water/total area 
ratio, and the mean data of the concatenated spectral data. Therefore, in the 
analysis of the different pathology types in tumour specimens, these data only 
were analysed, as if there was poor diagnostic accuracy in differentiating 
pathology types using these data, the analysis of all spectra would be presumed 









Figure 4-31 Results of mean tumour specimen (n=96) spectral analysis of ER status (used as a 
representative example) 
A. Mean HWN spectral data of all tumour specimens according to ER status. Data line is mean of spectra 
from each sample of that pathology subtype; Red – ER+ (n=72), Green – ER- (n=24). Shaded area either 
side in the same colour is +/- 1 S.D. Spectra were baselined using 3rd order polynomial and normalised to 
2985cm-1 peak. B. Scatter graph of first 2 principal components (PC1 and PC2) scores derived from PCA 





to be worse. The tumour specimens were analysed to investigate if there were 
any spectral differences according to pathology groups using the water/total area 
ratio and a PCA fed LDA analysis. 
 
Spectral analysis with PCA was performed according to each pathological 
subtype. It was performed using the HWN spectral region (Figure 4-32) and the 
fingerprint spectral region (Figure 4-33).  
 
The PCA scores did not reach statistical significance in either the HWN or FP 
data for any of the pathological subtypes apart from carcinoma type. The principal 
components obviously relating to the protein, lipid and water peak in both the 
HWN and FP region (PC1 and PC 2) did not reach statistical significance 
(P>0.01) in the majority of pathological subtypes, suggesting that these peaks 
were not different between pathological subtypes (unlike in tumour versus non-
tumour differentiation). Although, in the HWN region PC2 (that accounted 4% of 
variance) and PC4 (accounted for 0.2% variance) were significant (P<0.01) for 
carcinoma type. These both relate to lipid signal, suggesting there may be a 
difference in lipid signal between some carcinoma type. Also, in the FP region 
PC 5 (accounted for 0.5% variance) and PC6 (accounted for 0.2% variance) were 
significant (P<0.01) for carcinoma type. These both relate to the amide III region 
of protein, suggesting that difference in protein signal can differentiate between 
carcinoma type. However, conclusions of biochemical differences between 
carcinoma types are limited based on these results, as the significant principal 





















1 2 3 4 5 6 7 8 9 10 11 12 
ER 0.09 0.30 0.02 0.07 0.43 0.40 0.68 0.30 0.17 0.64 0.23 0.62 
HER2 0.62 0.41 0.71 0.54 0.84 0.17 0.49 0.42 0.43 0.18 0.16 0.76 
Carcinoma 
Type 
0.03 <0.01 0.57 <0.01 0.89 0.98 0.36 0.99 0.31 0.17 0.14 0.26 
Carcinoma 
Grade 
0.95 0.92 0.72 0.14 0.84 0.22 0.62 0.75 0.03 0.61 0.76 0.87 
Assoc. 
w/DCIS 
0.08 0.26 0.07 0.57 0.54 0.21 0.15 0.04 0.81 0.38 0.25 0.42 
Lymph Node 
status 




























































































Figure 4-32 Principal component analysis of mean HWN tumour spectra according to pathological 
subtype classification (n=96) 
A Principal components of mean HWN spectra of all tumour specimens. B Summary table of Principal 
component score P values according to pathological subtype classification. P values of principal component 










1 2 3 4 5 6 7 8 9 10 11 12 
ER 0.15 0.16 0.69 0.79 0.44 0.58 0.64 0.31 0.03 0.07 0.52 0.28 
HER2 0.36 0.70 0.40 0.19 0.06 0.37 0.88 0.99 0.32 0.89 0.80 0.87 
Carcinoma 
Type 
0.60 0.05 0.02 0.73 <0.01 <0.01 0.18 0.93 0.96 0.81 0.49 0.92 
Carcinoma 
Grade 
0.69 0.80 0.48 0.11 0.09 0.71 0.80 0.91 0.10 0.24 0.09 0.47 
Assoc 
w/DCIS 
0.03 0.05 0.56 0.46 0.73 0.37 0.47 0.65 0.55 0.49 0.43 0.67 
Lymph 
Node status 


























































































Figure 4-33 Principal component analysis of mean FP  tumour spectra specimens according to 
pathological subtype classification (n=96) 
A Principal components of mean FP spectra of all tumour specimens. B Summary table of Principal 
component score P values according to pathological subtype classification. P values of principal component 




Given the results from spectral analysis of the HWN and FP region suggest that 
these individual regions cannot differentiate between tumour pathological 
subtypes, the concatenated spectral data was analysed to investigate if this 
improved accuracy (Figure 4-34). The only significant result was in the different 
carcinoma types, where the ‘carcinoma type’ classification did reveal a single 
significantly different score in PC 2 and PC5 (P<0.01). Both PC2 (accounting for 
4.5% of variance) and PC5 (accounting for 0.36% of variance) relate to the lipid 
peak in both the FP and HWN region (by separate spectral peak analysis not 
displayed). This suggests that spectral features of lipid differentiate between 
different carcinoma types. Again, these significant components only account for 
a small degree of variance between spectra. 
 
The PCA scores were used in a PCA fed LDA analysis for all pathological 
subtypes using the three different spectral regions (HWN, FP and Concatenated), 
to investigate if spectral differences could predict pathological subgroups- the 
results are in Table 4-8. The results show that for the HWN region and FP region 
results were similar between spectral regions – out of 6 subgroups tested, three 
had better prediction results from the HWN region spectra than the FP region, 
and vice versa. The concatenated data compared to the individual regions was 
very similar in the prediction ability. All prediction accuracies were between 40% 
(for lymph node status prediction using FP region) up to 78% (for ER prediction 
using FP region. 
 
Overall the results are poor and suggest that with the NP3 system, neither HWN, 
FP or concatenated spectral analysis can accurately differentiate between 



















1 2 3 4 5 6 7 8 9 10 11 12 
ER 0.08 0.17 0.47 0.77 0.88 0.01 0.62 0.54 0.12 0.60 0.29 0.76 
HER2 0.55 0.38 0.88 0.72 0.18 0.76 0.16 0.25 0.65 0.36 0.33 0.45 
Carcinoma 
Type 
0.04 <0.01 0.60 0.24 <0.01 0.08 0.73 0.70 0.60 0.36 0.91 0.54 
Carcinoma 
Grade 
0.93 0.92 0.86 0.15 0.47 0.51 0.07 0.07 0.31 0.98 0.88 0.65 
Assoc 
w/DCIS 
0.06 0.09 0.23 0.74 0.23 0.37 0.77 0.85 0.17 0.76 0.42 0.48 
Lymph Node 
status 




























































































Figure 4-34 Principal component analysis of mean concatenated tumour spectra according to 
pathological subtype classification (n=96) 
A Principal components of mean concatenated spectra of all tumour specimens. B Summary table of 
Principal component score P values according to pathological subtype classification. P values of principal 




Pathological Subtype PCA fed LDA accuracy (%) 
HWN region FP 
region 
Concatenated 
ER 76.0 78.1 77.1 
HER2 63.5 61.4 66.7 
Carcinoma Type 58.3 61.5 61.5 
Carcinoma Grade 59.4 64.5 61.5 
Assoc w/DCIS 73.9 65.6 66.7 
Lymph Node status 51.0 40.6 41.7 
 
 
The analysis of the concatenated spectral data was compared to the analysis of 
the ability of water/total area ratio to differentiate between different pathological 
subtypes (Table 4-9). The mean water/total area ratio was calculated for each 
pathological subtype and compared between the other subtypes with a student t-
test (for dichotomous groups) or one-way ANOVA (for more than 2 groups). The 
outcomes are displayed in Table 4-9, which shows that there were no water/total 
area ratios that were significantly different to another. The mean water/total area 
ratio was close to reaching significance between carcinoma types (P=0.0185, 
one-way ANOVA), and on comparison of multiple means the only difference was 
the ratio between ductal carcinoma (mean ratio 0.78; S.D. 0.11 (n=64)) versus 
lobular carcinoma (0.70; S.D.0.16 (n=21)) which did not reach statistical 
significance (P=0.03). This suggests that areas of ductal carcinoma tissue may 
have a higher water/total area ratio than lobular carcinoma tissue. Using a 
multiclass error-correcting output codes (ECOC) model based on the water/total 
area ratio to predict carcinoma type had an AUC of 0.64, which suggests that 
using the water/total area ratio to predict different carcinoma types performed 
poorly.  
 
The consistent significant finding in both the spectral analysis of all three regions, 
and the water/total area ratio analysis, was the difference in carcinoma type. The 
water/total area ratio suggested there was a difference between ductal and 
lobular carcinoma. Spectral analysis also suggested differences in protein and 
lipid peaks between carcinoma types which is concordant with the known 
Table 4-8 Results of ability of the three different spectral regions to predict pathological subtype by 




histopathological differences between ductal and lobular tumours (lobular having 
more fatty tissue, which is explored later in this chapter in our histological study). 
To investigate this a PCA fed LDA sub-analysis was performed, grouping all 
carcinoma types that were not lobular together, and compared all carcinoma 
types versus lobular carcinoma (not displayed). The PCA showed a significant 
difference in scores of PC1 and PC2, that accounted for changes in protein, lipid 
and water changes. The PCA fed LDA analysis had a prediction accuracy of 
81.2%, which is higher than when the carcinoma types were not grouped (61%). 
This suggests that there are biochemical differences between ductal and lobular 
carcinoma (these are investigated and discussed in the histological study), which 
can be detected with our Raman system. However, both models (water/total area 
ratio and PCA/LDA) performed poorly when using the spectral data to predict 
between carcinoma types suggesting the spectral data could not accurately 
differentiate between carcinoma type. It may be that this study was under 
powered to detect differences in carcinoma type (the number of lobular 
carcinoma was 21). It may be that with a larger data set, these differences may 
reach greater significance, and allow prediction models to differentiate between 
different carcinoma types. 
 
Analysis of the other tumour characteristics of ER and HER2 status, carcinoma 
grade, whether the tumour was associated with DCIS and axillary lymph node 
status revealed no significant difference in comparison of the mean ratios 
(P>0.01), and demonstrated the AUC of the binomial logistic regression model 
with cross validation was generally poor ranging between 0.47 – 0.54, which is 
similar to random chance of classification. Analysing the concatenated spectra 
data with PCA fed LDA analysis according to the pathological subtypes revealed 
a poor ability to accurately predict pathological subtype with the accuracy ranging 
from 45 – 77%.  
 
These results suggest that the spectra obtained in these experiments cannot 

















ER +  0.76 0.19 0.54 77% 
-  0.81 
























Table 4-9 Table demonstrating analysis of mean spectra of tumour specimens (n=96) of pathology 
subtypes 
AUC was calculated from binomial logistic regression in dichotomous classifiers, and a multiclass ECOC 
model for multiple classifiers  using mean ratio values and k-folds 10 cross validation  
Spectral accuracy data was from the mean spectral data, with a 12 component PCA fed LDA model, and 
the resultant accuracy of the LDA model is quoted 
+ - denotes values derived from spectral data that had been baselined with 3rd order polynomial and the 
mean water/total area ratio calculated 
 † - denotes values derived from mean concatenated spectral data  




4.3.2.6 Ability of Raman to differentiate DCIS only from non-tumour tissue 
The majority of the tumour samples were also associated with DCIS (77%), 
therefore, when measuring a ‘tumour’ sample, the measurement could be of the 
invasive element of the tumour, or the associated DCIS. Therefore, in the analysis 
of tumour versus non – tumour above, the samples that contained DCIS only, 
and no invasive tumour (n=3) were included as ‘tumour’ samples. DCIS is 
responsible for the majority of positive margins 187, therefore the ability to 
differentiate DCIS only from non-tumour tissue is important in furthering the goal 
of being able to provide IMA. 
 
To understand if the NP3 system, and the data processing techniques, can 
differentiate DCIS from non-tumour tissue, the samples from the patients with 
DCIS only tissue (n=3) underwent a separate analysis.  
 
The HWN spectra of DCIS only tissue compared to the matched non-tumour 
tissue demonstrated obvious differences, with DCIS only tissue having strong 
protein and water peaks, and non-tumour tissue showing lipid peaks with little 
water signal (Figure 4-35). The water/total area ratio was calculated which 
showed a difference between DCIS only tissue (mean water/total area ratio- 0.83; 
SD- 0.019 ) and non-tumour tissue (mean water/total area ratio – 0.22; SD 0.19) 
which did not reach statistical significance (P= 0.035), it is possible the small 







The water/total area ratio was used in a binomial logistic regression to construct 
a ROC curve and obtain the optimal threshold with k-folds 5 cross validation for 
classifying the specimen as DCIS or non- tumour tissue. All spectral 
measurements (n=42) were used. The model showed that with a water/total area 
ratio threshold of 0.76, it achieved an AUC of 0.96, sensitivity of 100% and 
specificity of 90.5%. With such a small number of readings, and all spectra 
obtained from just 3 patients, this should be interpreted with caution, but it does 
suggest that the water/total area ratio can differentiate between DCIS only and 
non-tumour tissue and may be used for diagnostic prediction. 
 
Spectral analysis was performed on the concatenated spectra of all 
measurements (n=42) (Figure 4-36). 97% of the variance was accounted for by 
PC1 (61.8% of variance), PC 2 (31.16% of variance) and PC 3 (4.7% of variance) 
of which PC 1 and PC 2 scores achieved statistical significance (P<0.01), these 
PC’s related to protein and water (PC1) and lipid (PC2 and PC3) spectra and 
plotting these two PC’s gave excellent separation, suggesting that the 
Figure 4-35 Mean HWN spectra of all specimens (spectra n=42, patients n=3) according to diagnosis 
demonstrating changes in water content between DCIS only and non-tumour specimen spectra 
Data is mean of spectra from all DCIS only specimen spectra (n=21) and the matched non- tumour specimen 
spectra (n=21), fluorescent baseline subtraction with a 3rd order polynomial, and normalised to the CH peak 
at 2935cm-1. Shading either side of solid line in same colour is +/- 1 S.D. Red spectra=measurement from 




differentiation between DCIS only and non-tumour tissue is based on the same 





PC 1 PC 2 PC 3 PC 4 
3.3 X10-19 3.3 X10-17 0.19 0.294 
PC 5 PC 6 PC 7 PC 8 
0.56 0.54 0.97 0.94 
PC 9 PC 10 PC 11 PC 12 















































































Figure 4-36 Principal Component Analysis of concatenated spectral data for patients with DCIS only 
(n=42) 
A. Principal Components (12 in total) identified in analysis B. Table of principal components and 
corresponding P Values C. Graph plotting the 2 significant Principal Components (PC1 and PC2), with 




PCA fed LDA analysis with LOOCV gave a 95.2% accuracy, with 95.2% 
sensitivity and 95.2% specificity. As the numbers of spectra are so small it does 
not give a statistically robust outcome, but it does suggest that the spectral 
features of DCIS only tissue from Raman measurements and our data analysis 
protocol can differentiate between DCIS only and non-tumour breast tissue.   
 
4.3.2.7 Spectral analysis of non- tumour specimens to differentiate between 
physiological variation 
Spectra from non-tumour specimens were analysed according to patient 
characteristic information that were collected from patients which may be 
hypothesised to lead to variation in normal breast tissue composition between 
patients based on the literature – these were age and menopausal status 280, 306. 
Patients were classed according to two age brackets – with an age cut off of <60 
and <50, and menopausal status (pre and post), the summary results table is 
seen in Table 4-10. 
 
Classifying spectra obtained from non-tumour specimens according to 
menopausal status found that the water/total area ratio was higher in the pre-
menopausal (water/total area ratio 0.3374; SD 0.21)(n=73)  patients compared 
to the post – menopausal (0.1858; SD 0.19)(n=16) patients, which reached 
statistical significance (P=0.006; two tailed t-test). In Figure 4-37 B, the principal 
components of the PCA analysis of all the non-tumour specimen spectra can be 
seen. PC 1 which accounted for 89.8% of variance did not reach statistical 
significance (P>0.01), however PC 2 (accounting for 8.2% of variance) reached 
statistical significance (P<0.01) and relates to the protein and water peak in the 
HWN region, suggesting that there are differences in these areas between the 
groups of patients. 
 
Using the same classification of menopausal status to classify the specimen 
concatenated spectral data, PCA fed LDA achieved an accuracy of 84%, 
suggesting there were differences in the spectral data between patients that were 
pre- compared to post- menopausal that could allow prediction. Due to the 
significance of the LDA analysis, a LOOCV analysis was performed to assess the 
accuracy of prediction on spectral data using LDA, and a sensitivity of 80.2%, 




that using the PCA fed LDA analysis data that did not form the training set is not 
particularly accurate at predicting whether non-tumour specimens were from pre 
or post-menopausal patients. Regardless of this, the results suggest there are 
differences in the non-tumour breast tissue between pre and post-menopausal 
patients, and due to the difference in the water/total area ratio, and the P values 
of the principal components relating to the HWN region, it suggests that normal 





PC 1 PC 2 PC 3 PC 4 
0.04 0.008 0.60 0.82 
PC 5 PC 6 PC 7 PC 8 
0.88 0.41 0.74 0.13 
PC 9 PC 10 PC 11 PC 12 

















































































Figure 4-37 Results of mean spectral analysis of non-tumour breast specimens classified according 
to menopausal status (n=89) 
A. Mean data of all tumour specimens according to menopausal status. Data line is mean of spectra from 
each sample of that pathology subtype; Red – post- menopausal (n=73), Green – pre-menopausal (n=16). 
Shaded area either side in the same colour is +/- 1 S.D. Spectra were baselined using 3rd order polynomial 
and normalised to 2935cm-1 peak. B. Principal components of mean concatenated spectra of all tumour 
specimen (n=89). PCA analysis performed on mean concatenated spectra. C. P values of principal 
component scores according to menopausal status. D. Scatter graph of PC1 and PC2 scores that accounted 
for >97% of variance, PC2 also had statistical significance. Each circle represents a specimen mean data, 




Spectral data was then classified according to age. Using the age cut off of 60 to 
classify the water/total area ratio, the non-tumour specimens of those <60 had a 
higher water/total area ratio (mean water/total area ratio 0.31; SD 0.21)(n=27) 
compared to those patients >60 (mean water/total area ratio 0.18; SD 0.19) 
(n=68), this reached statistical significance (P= 0.0063; two tailed t-test). Analysis 
of concatenated spectral data using a PCA fed LDA analysis showed a model 
accuracy of 78.9%, and with cross validation with LOOCV it achieved an accuracy 
of 75.8%, with a sensitivity of 80.9%, and specificity of 63% showing poor ability 
for prediction.  
 
Using the age cut off of 50 to classify the water/total area ratio results showed a 
greater difference between the groups. Figure 4-38 shows the results of the 
analysis, and in figure A the difference in the water peak between the two groups 
can be seen, with the younger group having a higher water peak. The non-tumour 
specimens of those <50 had a higher water/total area ratio (mean water/total area 
ratio 0.37; SD 0.21) (n=16) compared to those patients > 50 (mean water/total 
area ratio 0.19; SD 0.19) (n=79), this reached statistical significance (P=0.00063; 
two tailed t-test). Despite this highly significant P value, using binomial logistic 
regression of water/total area ratio and age of 50 as a classifier, the model 
achieved poor diagnostic ability with an accuracy of 69%. Analysis of the 
concatenated spectral data using a PCA fed LDA analysis showed a model 
accuracy of 85.3%. The principal components PC 1 (accounting for 89.5% of 
variance) and PC2 accounting for 8.51% of variance) gained statistical 
significance in their scores with age as the classifier (P<0.01), related to the lipid 
(PC 1) and protein and water peak (PC 2) (Figure 4-38). The PCA scores 
underwent LOOCV LDA analysis to validate the findings, and found a sensitivity 
of 82.3%, specificity of 56.2% and accuracy 77.9%.  
 
These results demonstrate that there is a difference in the normal breast tissue 
composition according to the age of the patient. Younger patients have a higher 
water/total area ratio, suggesting the breast tissue has a higher water content. 
The difference is more obvious in using the younger age cut off of 50, with a 
highly significant different water/total area ratio, however the accuracy of being 









PC 1 PC 2 PC 3 PC 4 
0.003 0.0013 0.082 0.1236 
PC 5 PC 6 PC 7 PC 8 
0.9453 0.2955 0.6142 0.0173 
PC 9 PC 10 PC 11 PC 12 


























































































Figure 4-38 Results of spectral analysis of non-tumour breast specimens classified according to Age 
(cut off 50) (n=95) 
A. Mean data of all tumour specimens according to Age (cut off 50). Data line is mean of spectra from each 
sample of that pathology subtype; Red – Age >50 (n=79), Green – Age <50 (n=16). Shaded area either side 
in the same colour is +/- 1 S.D. Spectra were baselined using 3rd order polynomial and normalised to 
2985cm-1 peak. B. Principal components of mean Concatenated spectra of all tumour specimen (n=95). C. 
P values of principal component scores according to age (cut off 50). D. scatter graph of the significant 
principal components (PC1 and, PC2) scores that also accounted for >95% of variance. Each circle 




The importance of these findings summarised in Table 4-10  is not in the 
prediction ability of the models, but in the difference in water/total area ratios. 
This demonstrates that there are significant physiological variations between the 
normal, non-tumour tissue of patients according to menopausal status and age. 
In the use of the HWN spectrum, or the water/total area ratio, to diagnose breast 
cancer it must be considered that the baseline ‘normal’ to which the tumour 
spectra are being compared is a fluctuating baseline that changes according to 













Pre  0.3374 0.006 0.65 84% 
Post 0.1858 
Age - 60 <60 0.31 0.0063 0.65 78.9% 
>60 0.18 












Table 4-10 Summary results table of analysis of non-tumour specimens mean spectra classified by 
physiological characteristics  
AUC was calculated from binomial logistic regression using mean ratio values and k-folds 10 cross validation  
Spectral accuracy data was from the mean spectral data, with a 12 component PCA fed LDA model, and 
the resultant accuracy of the LDA model is quoted 
+ - denotes values derived from spectral data that had been baselined with 3rd order polynomial and the 
mean water/total area ratio calculated 
 † - denotes values derived from mean concatenated spectral data  




4.3.3 Estimation of water content by dehydration  
Tumour Specimens 
Five tumour specimens underwent serial dehydration, of these five, two samples 
and the corresponding Raman data were discarded due to the samples becoming 
so small through dehydration that accurate Raman measurement or weighing 
was not possible. Therefore, the weights and corresponding Raman data of three 
specimens were included for analysis. 
 
The starting weight of the three specimens were 0.167 g, 0.083 g and 0.089 g, 
the dry weight was 0.041, 0.019 and 0.022 g, giving a total weight loss of 75%, 
77% and 75% of the starting weight respectively. Corresponding HWN Raman 
spectra over the period of dehydration showed visual changes in the spectra with 
a decrease in the water peak (in spectra normalised to the protein peak), as 
shown in Figure 4-39 A. This suggests that the weight loss was secondary to 
dehydration, and that the HWN Raman measurements could measure these 
changes. 
 
The water/total area ratio was calculated for all acquired Raman spectra. These 
were plotted against the known water fraction of the specimen at the time the 
Raman spectra was acquired, the results are shown in Figure 4-39 B-E. In graph 
E the dehydration curve of the Raman spectra is comparable between all 3 
spectra, suggesting that the changes in water/total area ratio with water fraction 
of tumour breast tissue is repeatable, and equivalent between different patients. 
 
These results demonstrate that changes in water concentration in tumour 
containing breast tissue can be measured, and to a certain extent, quantified by 
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Figure 4-39 Results of serial dehydration of tumour specimens (n=3) and corresponding water/total 
area ratio 
A. Spectral data of a single tumour specimen that underwent serial dehydration, with spectra for each 
corresponding water fraction plotted. Data line is mean of all spectra from the specimen at that water fraction 
(n=5 areas measured). Shaded area either side in the same colour is +/- 1 S.D. Spectra were baselined 
using 3rd order polynomial and normalised to 2935cm-1 peak. Graphs B (Specimen 1) C (Specimen 2) D 
(Specimen 3) and E (combined data of Specimen 1, 2 and 3) plots the mean water/total area ratio 
(represented by plotted points, error bars +/- S.D.) calculated from the spectra (n=5 measurements for each 
water fraction point, for each specimen) obtained at each water fraction plotted against the water fraction 






Two non-tumour specimens underwent serial dehydration, however only one 
specimen was suitable for analysis due to an inability to accurately weigh one 
sample. The non-tumour specimen that underwent serial dehydration had a 
starting weight of 0.240 g and dry weight of 0.215 g, which was a 10% weight 
loss. This suggests that the, generally fatty, normal breast tissue had a low initial 
water content. The Raman spectra normalised to the protein/lipid peak 
demonstrated very little change in the water peak with serial dehydration, and 
analysis of the water/total area ratio suggested there was no trend in ratio with 
the water fraction (Figure 4-40).  
 
 



















































Figure 4-40 Results of serial dehydration of a non-tumour specimen with corresponding Raman 
spectra (n=1) 
A. Spectral data of a single non-tumour specimen that underwent serial dehydration, with spectra for each 
corresponding water fraction plotted. Data line is mean of all spectra from the specimen at that water fraction 
(n=5 areas measured). Shaded area either side in the same colour is +/- 1 S.D. Spectra were baselined 
using 3rd order polynomial and normalised to 2935cm-1 peak. B. Scatter graph of the mean water/total area 
ratio (represented by plotted points, error bars +/- S.D.) calculated from the spectra (n=5 measurements for 





Interpretation and implementation of results 
The results from the tumour specimen dehydration curve demonstrates that HWN 
Raman, and using the water/total area ratio, can detect changes in water content, 
and it may be possible with the dehydration curve to quantify changes in water 
concentration in tumour specimens. The results from the non-tumour specimens 
suggests that HWN Raman cannot detect changes in water content in low water 
environments or highly lipid environments.  
 
The dehydration curve from the tumour specimens could be used for 
interpretation of differences in water content between tumour specimens. As an 
example, there were differences in the mean water/total area ratio between 
lobular carcinoma (0.70) and mucinous carcinoma (0.87), looking at these values 
on the dehydration curve they equate to approximately a water fraction of 1.0 (for 
a water/total area ratio for mucinous carcinoma) and 0.25 (for a water/total area 
ratio for lobular carcinoma), suggesting there is a 75% difference in water content 
between mucinous and lobular carcinoma. This is in concordance with the 
understanding of the histopathological differences between the two types of 
tumour – mucinous tumours are mucin ( a glycoprotein) producing and may be 
associated with a higher water content, and lobular carcinoma which infiltrate 
adjacent fat and so could be associated with a more fatty environment 357 which 
are associated with a lower water content. 
 
4.3.4 Raman micro spectrometry experiments 
Non- tumour specimens  
Review of H+E slides from non-tumour specimens demonstrated that a large 
number had areas of fat cells only, with very little histopathological features. 
Some non-tumour specimens however, while still predominantly fat cells, had 
areas of stromal tissue (Figure 4-41). It should be noted that the patients 
demonstrating these areas of heterogeneity were younger (age range 43-51) 
than the mean age of the sample population (67). 
 
A non-tumour specimen had histopathological analysis followed by HWN Raman 
using Raman micro spectroscopy. The specimen was chosen for analysis 
because it was histologically heterogenous, and had good enough H+E staining 












Figure 4-41 H+E slides of non-tumour specimens 
A. Patient 14 (age – 51)) Specimen composed of mostly fatty tissue. Note that little of the H+E stain is taken 
up by the fat cells, and there are few histopathological features B. Patient 105 (age-43) and C. Patient 59 
(age-44) demonstrate non-tumour specimens with a mixture of tissue types. Black circle denotes area of fat 












Figure 4-42 HWN Micro-Raman analysis of non-tumour specimen from patient 105 
A. H+E slide of non-tumour specimen, black dotted line demonstrates the area of the corresponding Raman 
map. B. Area of fatty normal tissue highlighted in black at X5 magnification, and at X50 magnification with 
representative HWN Raman spectra showing the lipid peak. C. Area of stromal normal tissue highlighted in 






Histopathological assessment of the tumour specimen indicated that the majority 







However, there were some specimens that had areas of normal tissue within the 
specimens. Raman analysis of one of these specimens shows that the areas of 
the section that were identified as being tumour had a protein signal (matching 
the Raman signal seen from the tumour specimen fresh frozen sample 
measurements), and areas of the section that were identified as normal and non-
cancerous had a lipid signal (matching the majority of the non-tumour specimen 
fresh frozen sample measurements) (Figure 4-44). 
One of the specimens analysed (notably a lobular carcinoma), had 
histopathological evidence of tumour throughout the specimen, as is common in 
lobular carcinoma, there was cancer cell infiltration into surrounding fatty 
tissue357. Raman analysis of the specimen demonstrated areas of tumour that 
had Raman spectra with a protein signal, which would be expected in tumour 
according to our results from the fresh frozen specimens, but it also demonstrated 
areas of tumour with a strong lipid signal, which would likely be classified as being 
non-tumour based on the measurements gained from the fresh frozen specimens 
(Figure 4-45). This highlights that lobular carcinoma may be a potential source of 
diagnostic inaccuracy. 
Figure 4-43 H+E slides of tumour specimens 
A. (patient 17) Grade 3, Invasive ductal carcinoma, ER/HER2 -ve with no DCIS present. B. (patient 31) 
Grade 2, invasive ductal carcinoma, ER +ve/HER2-ve, associated with DCIS. Both slides demonstrate 











Figure 4-44 HWN Micro-Raman analysis of tumour specimen from patient 105 
A. H+E slide of tumour specimen, a Grade 2 invasive ductal carcinoma, ER +ve, HER2+ve associated with 
DCIS, and corresponding Raman map. B. Area of tissue containing tumour highlighted in red at X5 
magnification, and at X50 magnification with representative HWN Raman spectra showing the protein peak. 
C. Area of normal fatty tissue highlighted in black at X5 magnification, and at X50 magnification with 











Figure 4-45 HWN Micro-Raman analysis of tumour specimen from patient 14 
A. H+E slide of tumour specimen, a Grade 2 invasive lobular carcinoma, ER +ve, HER2-ve associated with 
DCIS, and corresponding Raman map. B. Area of tissue containing tumour highlighted in red at X5 
magnification, and at X50 magnification with representative HWN Raman spectra showing the protein peak. 
C. Area of tumour containing tumour tissue highlighted in black at X5 magnification, and at X50 magnification 





This chapter demonstrates the diagnostic ability of HWN Raman spectroscopy to 
differentiate tumour from non-tumour tissue in human breast tissue, which has 
been demonstrated for the first time. This is a promising technique that may be 
able to provide IMA in breast conserving surgery. The individual aspects of the 
results from the study will be discussed, and the clinical implications considered, 
with a view to what future work can be recommended to successfully translate 
the findings of this proof of concept study to a clinically robust method of IMA. 
 
The results of this study have demonstrated that through analysis of the 
water/total area ratio as a measure of water content, and spectral analysis of both 
the fingerprint and HWN region a number of techniques can be utilised in the 
differentiation of human breast tissue with good diagnostic accuracy. The results 
suggest that the spectral data obtained using the NP3 system, a 785 nm 
excitation laser and InGaAs camera configuration, is unable to give specific 
pathological diagnoses, as there were no differences between pathological 
subtypes, however, tissue that had DCIS only was able to be differentiated from 
non-tumour tissue which is crucial for accurate IMA. The dehydration 
experiments have given an important insight into the role of measuring water 
content in breast tissue in the diagnosis of tumour tissue, and suggest that HWN 
Raman measures a change in the microenvironment of water more accurately 
than quantitatively assessing the change in water content. The biochemical 
changes seen from the Raman spectra to differentiate between tumour and non-
tumour tissue using NP3 have been matched to the histopathological diagnosis 
using Raman micro spectrometry, which validates the conclusions regarding 
differences between tissue types. 
 
4.4.1 Interpretation of results 
4.4.1.1 Chemometric analysis  
The results from this study highlight the biochemical differences between tissue 
types. Analysis of the differences in water/total area ratio between tumour (high 
water/total area ratio) compared to non-tumour tissue (low water/total area ratio) 
suggest that tumour contains a higher water content compared to non-tumour 
tissue. This difference in water content between tumour and non-tumour tissue 




techniques, but it has not been used as the primary diagnostic marker  276, 297. In 
this study we have quantified those changes in water content between the two 
tissue types and demonstrated that this simple marker is powerful enough to 
accurately differentiate between tumour and non-tumour tissue with an overall 
accuracy of >90% (depending on the exact data analysis protocol). 
 
Peak assignation with values from the literature of the significant principal 
components identified that in both the fingerprint region and HWN region of the 
Raman spectrum non-tumour tissue had a high lipid profile and tumour tissue 
was predominately protein, and that there are the spectral components that 
differentiate between tumour and non-tumour tissue. Haka et al. used spectral 
data from the fingerprint region to differentiate between tumour and benign breast 
tissue, and noted that lipid and protein changes were central to the diagnostic 
algorithm that achieved good specificity of 93%, but a poor sensitivity of 83% due 
to misclassification of certain benign breast tissue types 186. Previous data from 
the HWN region from breast tissue in rats 271 and human tissue 336 suggested 
these biochemical changes were also observed in the HWN region, but no 
studies have previously been performed on human breast tissue with a view to 
using the biochemical changes for diagnostic classification. Neither has a study 
concatenated data from both of the regions to produce a single spectrum from a 
single area that includes this data from both regions. The study outlined in this 
thesis confirms that both regions are evaluating similar biochemical changes, and 
the main spectral features in differentiating tumour from non-tumour tissue are 
protein and lipid changes (fingerprint region) and protein, lipid and water changes 
(HWN region). 
 
The Raman mapping experiments validate the main chemometric findings from 
the NP3 system. The Raman mapping showed that areas of tumour, confirmed 
by histopathology diagnosis, were characterised by protein signal, and areas of 
non-tumour were characterised by lipid signal. This demonstrates that there is 
agreement in the chemometric data gained from HWN Raman spectra gained 
with the NP3 system with peak assignation from the literature and spectra from 
micro spectrometry that were matched to a formal histopathological diagnosis. 
This gives confidence to the assumption that ‘tumour’ signals were indeed from 





A limitation of the Raman mapping method is that it used dried slices of tissue, 
and therefore no information on water content could be ascertained, and changes 
in water content could not be matched with the histopathology diagnosis. 
However, it was a consistent feature in the fresh frozen samples that protein rich 




4.4.1.2 The role of water content in differentiating tumour from non-tumour tissue 
An original aim of this study was to investigate whether water content was a 
marker of differentiating tumour from non-tumour, and whether this could be 
quantified to assess if changes in tissue water content could be used in the 
assessment of pathological margins. 
 
The results from this study suggest that differences in water content are able to 
differentiate tumour from non-tumour. The spectral data from the HWN region, 
particularly when normalised to the protein peak demonstrate that tumour 
specimens have a much higher water peak than non-tumour specimens, and 
when using the water/total area ratio as a measure of water content, tumour 
specimens have a significantly higher water content than non-tumour specimens. 
Using the water/total area ratio alone could accurately differentiate between 
tumour and non – tumour specimens, with an accuracy of 89-91%, confirming 
that the difference in water content between tumour and non-tumour tissue is 
substantial, measurable, and diagnostic. 
 
The dehydration experiments had some success in quantifying changes in water 
content. Using tumour tissue, which had a high initial water content, the water 
content of the tissues was sequentially measured, and the associated Raman 
signals obtained, from which a measure of water content at that time (the 
water/total area ratio) could be calculated. This produced a calibration curve 
allowing HWN Raman spectra to be taken of a breast tumour specimen, the 
water/total area ratio to be calculated, and the calibration curve used to assess 
the water content of that breast tumour specimen, the example of a lobular 




quantification of changes in water content can be performed in tumour tissue. It 
should also be noted that it is only relative changes in water content that can be 
measured, as the absolute starting water concentration of the tumour specimen 
was not calculated, and, as stated in chapter 3, other absolute measures of water 
concentration may not be relevant to the microenvironment of breast tissue.  
Measuring the relative differences in water can be used to improve HWN Raman 
in providing IMA, as it has been utilised in skin cancer 295, and oral SCC 174. It 
also allows correlation with HWN Raman findings with other modes of 
investigation and diagnosis that use changes in water content, such as DOS 276, 
Terahertz imaging 288 and MRI 358, and so allow the findings with these modalities 
be translatable to Raman research, and vice versa.  
 
The dehydration experiment results also demonstrated what was predicted in 
chapter 3, that the water/total area ratio relationship with water content is different 
according to the tissue microenvironment. This means that if the same water/total 
area ratio is measured in an area of tumour tissue and non- tumour tissue the 
two areas will not have the same water concentration. An obvious illustration of 
this in the dehydration experiment results is that when the specimen is in a state 
of complete dehydration (where the water fraction =0), for non-tumour tissue, the 
water/total area ratio is 0.12, and for tumour tissue it was between 0.5 and 0.6. 
This is the only point at which the two types of tissue can be directly comparable 
as having no water content, whereas at the other points of measurement they will 
have varied according to the initial water concentration. One of the reasons for 
this particular finding is that protein has a peak at 3280 cm-1 due to NH stretch 
345, which is present in dehydrated protein tissue, but not in lipid tissue, which will 
contribute to the ‘water’ part of the water/total area ratio giving protein a higher 
reading at this complete dehydration compared to lipid tissue. However, this is 
not the only reason for the findings, as lipid is more Raman active than protein, 
and lipid gives a broader Raman peak, both of which would also alter the 
relationship with the water/total area ratio, even if the water peak was identical in 
both tissue types. This confirms what has been discussed in Chapter 3, that the 
water/total area ratio, and the change in HWN spectrum according to changes in 
water content, is dependent on the microenvironment of the water, and so 




(non-tumour) environment, meaning the same dehydration curve cannot be used 
for calibration for both environments.   
 
There are limitations to the methods of the dehydration experiments, which need 
to be considered. The experiments were done in fresh frozen samples, which 
may have a different initial water content to fresh breast tissue, and the thawing 
process could alter the water content rapidly. The distribution of water and type 
of water (bound versus unbound) could also be different between fresh frozen 
tissue and fresh tissue – chapter 3 demonstrated that this has an effect on the 
HWN Raman spectrum, and subsequently the water/total area ratio. The 
dehydration curves also demonstrate that the majority of the dehydration (as 
measured by loss of mass) occurred between the initial and second 
measurement (over the course of the first hour), with some specimens losing 
almost 50% of their mass during this period. The specimens were so small the 
rate of dehydration was rapid. However, despite these limitations, the findings are 
consistent and repeatable (in the tumour specimens, 3 different specimens gave 
remarkably similar results). The findings would ideally be validated by repeating 
these experiments in larger pieces of fresh breast tissue that could be measured 
more frequently. This would be logistically very difficult.  
 
Comparing the dehydration curve of the breast tumour tissue and the dehydration 
curve of the pork meat tissue, and the breast non-tumour tissue and the pork fat 
tissue in chapter 3, the curves are very similar in shape, rate of dehydration, and 
findings. The pork tissue did not have any of these limitations and gave similar 
results, suggesting that the findings in the fresh frozen breast tissue are valid and 
may not be altered if performed in more ideal tissue.  
 
These findings demonstrate that HWN RS differentiates between the tumour/ 
non-tumour specimens as an analysis of the microenvironment (whether it is a 
protein or lipid environment) and the effect of that microenvironment on the water 
peak, rather than by quantifying the changes in water content.  Therefore, when 
measuring different tissue types containing protein and/or lipid, the protein and 
lipid peak should be considered along with the water peak for diagnosis, rather 




Within the tumour (protein) environment, there can be differentiation and 
quantification in changes in water content as the water/total area ratio changes 
in response to changes in the water content. These more subtle changes in the 
tumour environment may assist in the diagnosis of pathological margins. 
Previous work has suggested that in breast tissue, and breast cancer, rather than 
there being an abrupt change in the water content, there is a steady change in 
the water content when measuring from a higher water environment ( tumour) 
across the border of the tumour to low water environment (non-tumour) 293. This 
theory has been examined with HWN Raman spectroscopy in the diagnosis of 
oral SCC margins 228, but has not been investigated for the diagnosis of breast 
pathological margins. In these previous studies, the effect that the change in 
protein and lipid microenvironment going from tumour to a non-tumour 
environment would have on the ability to interpret the difference in water peak 
was not explored – and our results suggest this is crucial to understanding the 
differences in water content in different microenvironments. The results from our 
study suggest that HWN Raman spectroscopy is able to detect and quantify 
changes in water content, allowing the theory of water changes at the margins of 
breast tumour tissue to be investigated in the future. 
 
4.4.1.3 DCIS only tissue 
The ability to differentiate between DCIS only tissue and non-tumour tissue is 
paramount for IMA. Despite this, in a number of studies intending to provide IMA, 
DCIS only tissue is often excluded from analysis, which results in a major 
limitation of the clinical relevance of the study 156, 180, 185. The majority of positive 
margins are due to DCIS only 187, and not invasive tumour, and so the NP3 
system must have the ability to identify DCIS only tissue as requiring resection if 
it is to be clinically useful. 
 
The initial analysis on all tumour tissue (which was composed of mainly invasive 
tumour tissue, but 3 DCIS only specimens) suggested that this was possible. The 
majority of tumour tissue (77%) was associated with DCIS, and it is highly 
probable that when measuring the tumour specimens, the associated DCIS was 
being measured as well, and contributing to the tumour signals. When the 
detailed histopathological analysis was performed for the Raman micro 




tumour. There was also no difference identified between water/tumour area ratio, 
nor on principal component spectral analysis when pathological subgroup 
analysis was performed between those associated with DCIS, and those that 
were not.  
 
In addition to this a subgroup analysis was performed on the specimens from 3 
patients that had DCIS only (and no invasive element) in their tumour specimen. 
This analysis demonstrated that there were obvious visual differences between 
the DCIS only tissue and non-tumour tissue. The biochemical differences were 
the same as the analysis between the all tumour data (of invasive tumours and 
DCIS only) and non-tumour specimens, DCIS only tissue was predominately 
protein with a high water content, compared to the non-tumour tissue of lipid with 
a low water content. Analysis of these spectra using the water/total area ratio and 
concatenated spectral data suggested the potential for satisfactory diagnostic 
ability to differentiate between DCIS only tissue and non- tumour tissue. A 
limitation of this subgroup analysis is the small number of patients and therefore 
the statistically significant findings should be interpreted with caution. However, 
these results do suggest that the basic chemometric principles that are used to 
differentiate tumour from non-tumour specimens hold true for differentiating DCIS 
only and non-tumour specimens. Although it would require a larger number of 
DCIS only tissue to be conclusive, these results suggest that NP3 has the ability 
to differentiate between DCIS only and non-tumour tissue, a crucial attribute for 
IMA. 
 
4.4.1.4 Comparing data analysis techniques 
Based on the chemometric findings, a number of data analysis techniques were 
used to assess the ability to differentiate between tumour and non-tumour tissue 
based on the Raman spectra. Each technique had broadly similar results, with 
generally good overall accuracies between 89-93%, and a broader range of 
sensitivities 87-96% and specificities 86-96%. An important feature of the 
analysis is that all methods underwent cross validation, with testing of the 
prediction accuracy with a ‘prediction’ set of data that was separate to the data 
used for ‘training’ the diagnostic model. This suggests that if the diagnostic model 





A benefit of having performed a number of methods of spectral analysis is that 
the protocol that would be suitable for clinical use can be assessed. The 
technique for use in a clinical environment for IMA would take into account what 
is needed from the test in order to get the desired clinical outcome. For example, 
a test that has very high sensitivity would reduce the re-excision rate 
considerably, but if there was a low specificity of the test it may result in an 
unnecessary removal of breast tissue, which is associated with poor cosmesis. 
Equally a highly specific test would guard against the unnecessary removal of 
breast tissue but may not be sensitive enough to reduce the number of re-
excision operations significantly. Therefore, each analysis technique should be 
considered in turn and assessed as to how it could be used for IMA. 
 
Water/total area ratio 
The water/total area ratio is a simple technique for assessing differences between 
spectra. It requires minimal pre-processing (fluorescence baseline subtraction 
only), and a simple calculation of the AUC of two peaks (water and the total HWN 
spectral region) in order to calculate the ratio. This ratio is also a single figure that 
can be used to characterise a spectrum. Using simple data analysis such as this 
may have real strengths in the clinical environment for IMA, as it would require 
less processing power, be quicker than more complex techniques and be easier 
to devise diagnostic algorithms.  
 
A use of the water/total area ratio is by using different voting thresholds to provide 
a single dichotomous answer for each specimen. In a clinical setting this method 
could be used to take a number of measurements for the entire resected edge of 
a specimen and using the data to provide an outcome of whether that resected 
edge had a positive margin and further resection was required or not. The results 
demonstrated that it was possible to use a defined cut off of water/total area ratio 
to classify a spectrum as tumour or non-tumour, the proportion of the number of 
‘tumour’ readings could then be taken into account to ‘vote’ if the specimen (or 
resected edge) was positive. The cut-off could be varied according to the clinical 
outcome required – and whether greater or lesser sensitivity or specificity was 
required needs more research. The two voting methods give very different clinical 
outcomes (Voting threshold 1 sensitivity - 87.5%, overall accuracy 91.7%, Voting 




evident, voting threshold 1 (where the majority spectrum classifies the entire 
specimen) could lead to small areas of tumour being ‘missed’, and voting 
threshold 2 (where a single tumour spectrum classifies the entire specimen as 
tumour) could lead to an unnecessary amount of tissue being excised. However, 
these methods represent a clinically relevant method for data analysis and giving 
a clear outcome for a resected edge, which is essential for IMA. 
 
Using the W/TAR difference is a different way of utilising the ratios to take into 
account variations between patients physiological ‘normal’. The analysis of the 
normal breast tissue demonstrated significant variations in the Raman spectra 
between patient specimens, particularly with age. Using a ‘calibration’ reading 
from obviously normal tissue, and comparing the possible tumour readings to this 
‘calibration’, there is the possibility of increasing the accuracy of the device. The 
results in this study are very dependent on the ‘cut off’ used to define a tumour 
or non-tumour, though this could be adjusted for the desired objective of analysis. 
Though, interestingly, whatever the cut off used, the overall accuracy of this 
technique was equivalent to the other methods that did not take into account the 
individual patients baseline normal tissue, perhaps suggesting that this does not 
affect the diagnostic accuracy significantly. This method of ‘calibration’ of the 
machine prior to taking margin readings is already performed in another device 
that is used for IMA – the ClearEdge 266, suggesting others have thought it 
important to take into account the individual baseline of the patient. However, 
ultimately the results from the ClearEdge were disappointing, and in a number of 
cases there was surgeon error in using the device to achieve the ‘calibration’ 
reading. It may be that a calibration reading step could over-complicate the 
measurement protocol, without giving sufficient additional diagnostic accuracy. 
 
There are limitations to using the water/total area ratio. One, explored above, is 
that the physiological normal, non-tumour, readings can overlap with the ratio of 
tumour tissue. Particularly younger, pre-menopausal women may have higher 
water/total area ratios in normal tissue and have a greater incidence of false 
positive readings using this technique. Another consideration is that although in 
this analysis the water/total area ratio diagnostic accuracy was similar to the more 
complex spectral analysis, it may be that there are subtle changes in the spectral 




diagnosis. Spectral analysis gives greater tissue biochemical information and it 
may be that minor variations did not reach statistical significance in this setting 
due to the relatively small number of spectra, but with a greater sample number 




Spectral analysis was performed on the fingerprint region, HWN region and the 
two regions concatenated. The diagnostic performance using the mean spectra 
from the fingerprint (accuracy 92.7%) was slightly reduced compared to the HWN 
(accuracy 93.2%) region. Interestingly the accuracy from the concatenated 
spectra was the same as that of the FP only region (92.7%), suggesting that the 
addition of the fingerprint region reduces accuracy compared to the diagnostic 
information of the HWN region alone.  
 
The chemometric analysis suggest that similar biochemical differences in the 
tissue are used to differentiate between tissue types, but that the HWN region 
provides information on water content in addition to the protein/lipid changes 
seen in the fingerprint region, suggesting that the change in water content 
information may be responsible for the increased diagnostic accuracy when using 
the HWN region. 
 
When using the spectral data for differentiating tissue types, the concatenated 
spectra could be used. There are no negative aspects of using the entire 
spectrum that is available when measuring using the NP3 system, and both 
fingerprint and HWN regions are captured using the NP3 system without having 
to change any hardware such as laser excitation wavelength or filters – unlike 
other systems that have used both regions for tissue diagnosis 299, 304. This means 
to capture both regions does not take any more time or expense compared to 
capturing just a single region. Although, from this study, there appears to be no 
diagnostic benefit to using both regions, it may be that further work with a greater 
number of samples exposes subtle spectral changes that allow an increased 





A limitation of using the entire spectrum and performing spectral analysis is that, 
although in this study the acquisition time allowed for obtaining both regions of 
the spectrum with good spectral resolution, if acquisition time was decreased 
significantly (to allow more rapid IMA) it may mean the entire spectral region was 
not adequate for analysis. In the spectral analysis a sequence of principal 
component analysis (PCA) was used to calculate scores which were fed into a 
linear discriminate analysis (LDA). This is a complex method of analysis that 
would take longer than for calculation of the water/total area ratio and may require 
greater computing hardware. A way to decrease this burden of spectral analysis 
would be to reduce the number of principal components used. In all cases it was 
the first 2 principal components (with a minor contribution from PC3) that 
accounted for >95% of variance in spectra contributing to tissue diagnosis. The 
spectral analysis could be reduced to the first 2 or 3 principal components to 
reduce the data processing time, however, it may come with a decrease in 
diagnostic accuracy. 
 
Another limitation of spectral analysis is that it is reliant purely on mathematical 
modelling to decide the best way to analyse the tissue specimens, without the 
ability to change it according to clinical need. Using the water/tumour area ratio, 
the threshold for diagnosing a spectrum as ‘tumour’ is easily manipulated to 
achieve the desired clinical aim, whereas using a PCA fed LDA model it is not so 
easy to ‘fine-tune’ the model to the desired clinical outcome. 
 
The use of mean data  
A consistent finding in all the spectral analysis, regardless of method, was that 
the mean data (that is obtaining a mean spectrum or ratio for each specimen, so 
each specimen had a single output) gave an improved diagnostic accuracy 
compared to analysing each individual spectrum as a discrete reading. The most 
apparent example is for spectral analysis of the HWN region, where using 
individual spectra gave an overall accuracy of 90.3%, and using the mean spectra 
gave an accuracy of 93.2%. The reason for this is likely to be when analysing the 
data as single spectra, if a large number of specimens each had a small number 
of ‘discordant’ spectra (i.e. non-tumour measurements in a tumour sample), this 
would give a large number of ‘discordant’ spectra overall that would be classified 




‘discordant’ spectra would be averaged out, compared to the large number of e.g. 
tumour spectra in tumour specimens. The Raman mapping experiments 
demonstrated that within ‘tumour’ specimens, there were areas of non-tumour, 
so this may explain why there were a small number of ‘discordant’ spectra which 
negatively affected the diagnostic accuracy when assessing the spectra 
individually. 
 
Analysing the data from these experiments using the mean data has greater 
statistical validity, as for each patient specimen there is a single outcome. When 
analysing each spectrum individually, in the diagnostic models a number of 
measurements are originating from the same tissue, and if, theoretically one 
patient contributed 100 measurements, and another only 10 (which did not occur, 
the variation in the number of contributed measurements was +/-2) that would 
unbalance the model in favour of the type of measurements from the patient 
contributing 100. However, from a practical point of view of providing IMA, it is 
not necessarily clinically relevant to use a ‘mean’ spectrum. The mean could be 
the mean of a number of readings from a small area, or the mean of all readings 
from an entire resected surface. The area over which to average the readings 
needs to be determined, and would be reliant on the sampling area and properties 
of the device that would be performing IMA. The findings from chapter 3, and 
observing the raw ‘counts’ from spectra gained from this study, is that the protein 
signal is weak and lipid has a relatively strong Raman cross section, and so small 
areas of tumour (protein rich) could easily go undetected with this method of data 
analysis. The main danger of using a mean spectrum over a large area, such as 
the entire resected surface, would be a reduced sensitivity that small areas of 
abnormal tissue would be averaged out and not be detected. It may be that 
providing a mean spectrum over a small area would improve accuracy, account 
for minor physiological variations, and improve the diagnostic accuracy of the 
analysis. 
 
Suggested protocol for data analysis 
It is important that the data analysis of Raman spectra can be processed and 
utilised to provide a clinical outcome, which is easily interpreted by a surgeon, 




further resection is required, or a resected edge is ‘negative’ (i.e. no tumour 
identified) and no further resection is required. 
Based on the results and subsequent discussion of the various data analysis 
techniques of the spectral data obtained with NP3, the following sequence is 
suggested as the most accurate, and clinically relevant, method of data analysis 
(Figure 4-46): 
1. The resected edge of the specimen has all Raman measurements taken. 
• The measurements are obtained in a systematic order, with the 
resected edge divided into ‘sections’ that allow grouping of close by 
measurements together. The ability to do this would depend on the 
final design/ measurement protocol of the probe to be used. 
2. Pre-process data 
• Fluorescence background subtraction using 3rd order polynomial for 
HWN region, and 6th order polynomial for FP region 
3. Calculate the water/total area ratio from the HWN region of each spectrum  
4. Primary classification -  the mean water/total area ratio for each section 
is used to classify the section as tumour or non-tumour with a low threshold 
of water/total area ratio (e.g. 0.4 - to provide high sensitivity). 
5. Secondary classification- for all sections classified as tumour, analyse 
the spectral data to provide high specificity. 
• All the spectra from a section identified as ‘tumour’ by the first 
classification would be used in the reclassification of that section 
• The concatenated spectral data has min/max normalisation 
followed by PCA fed LDA analysis to re-classify if the section is 
tumour/ non – tumour. 
6. Final classification-  All section outcomes of resected edge are 
processed with a voting threshold analysis, if there is one or more area 
classified as ‘tumour’, the entire resected edge is classified as ‘positive’ 









Figure 4-46 A schematic representation of how the suggested data processing algorithm could be 




4.4.2 Limitations of methods 
4.4.2.1 Demographics of study patient and tumour characteristics 
The demographics of the patients were broadly representative of patients 
undergoing breast cancer surgery in normal clinical practice. The age of patients 
(mean age 67) is representative of the age of patients diagnosed with breast 
cancer seen in clinical practice, the majority being post- menopausal 359.  
 
A vital inclusion criteria in the study – that is tumours had to be greater than 2 cm 
to allow core biopsy and tissue sampling- leads to selection bias in the tumour 
characteristics of the specimens measured. 2 cm tumours are usually 
symptomatic- 89% of patients in the study group were diagnosed via a 
symptomatic route of referral; whereas only 75% of all breast cancers present 
with symptoms 41. 2 cm tumours are also more likely to be removed by 
mastectomy rather than breast conserving surgery – 48% of the study group 
underwent mastectomy as opposed to breast conserving surgery. Mastectomy 
rates vary, but account for around 30-40% of breast cancer operations 6. This 
means that larger tumours that would undergo a procedure not requiring IMA are 
slightly over-represented in this population study, when compared to the 
population that are likely to require IMA, that is, more screen-detected, smaller 
tumours undergoing breast conserving surgery. The result of this is that the 
tumour characteristics of the study population are possibly not representative of 
the population likely to require IMA. Screen detected tumours are more likely to 
be smaller, and diagnosed and treated at an earlier stage 359. The screen 
detected population also present the majority of DCIS only disease which is often 
treated with breast conserving surgery, and represent a large number of patients 
that require re-excision of margins 187. Therefore, early-stage disease and DCIS 
only disease is under-represented in the population study. The under-
representation of DCIS only disease needs to be considered in future work. The 
initial assessment suggests that the NP3 system is capable of differentiating 
between DCIS only tissue and non – tumour tissue, but the number of such 
patients was small (n=3) and so further work does need to be performed to 
confirm this. 
 
Despite these limitations the number treated by breast conserving surgery are 




breast cancer disease, and the carcinoma type (with the majority being Ductal), 
carcinoma grade (majority Grade 2) the receptor status (with the majority being 
ER+ and minority HER2+ve) is broadly in keeping with the tumour characteristics 
of a typical patient undergoing breast conserving surgery. Therefore, the study 
population is similar enough that it is probably representative, and so the data 
drawn from these studies is likely to be translatable to a general breast cancer 
population undergoing breast conserving surgery. 
 
4.4.2.2 Specimen type  
The specimens that underwent measurement had been taken from areas that 
were macroscopically tumour or non- tumour in the view of an experience 
healthcare professional (pathologist or associated practitioner). The review of the 
histopathology H+E slides suggest that the tissue samples were mostly 
composed of homogenous tissue types that had been correctly categorised as 
tumour or non- tumour. The benefit of using these samples is that the study 
specimens are similar to the type of tissue that is measured in IMA. They are 
larger pieces of tissue, over which a number of measurements were obtained, 
and a diagnosis made based on the Raman spectrum – similar to IMA. 
 
The limitations of the tissue type are that they were fresh frozen, then thawed 
prior to measurement. This is unlikely to have affected the composition of the 
specimen with regards to protein or lipid but is likely to have affected the water 
content. Indeed, during the dehydration experiments the specimens lost almost 
50% of their mass (in presumed water dehydration) in only an hour. However, the 
measurements took less than 5 minutes to complete, so significant amounts of 
dehydration may not have occurred. This is evidenced by the fact that the 
differences in water content between tumour and non-tumour tissue could still be 
measured, were significant and used for diagnostic purposes as demonstrated 
by the diagnostic accuracy of using the water/total area ratio. It is also true that 
in fresh breast tissue, when performing IMA, there would be dehydration from the 
resected specimen edge in the clinical environment. Therefore, if the water 
content remains a major spectral feature to differentiate tumour from non-tumour 
even in tissue that has been freeze/thawed, is small, and has a rapid dehydration 
time, may suggest that these are robust findings that would be valid in fresh 




specimens is unknown, and measurements in fresh tissue are necessary to 
understand if the findings regarding water content are valid in fresh breast tissue, 
which is the tissue type IMA would take place in.  
 
A further limitation of the sample types is that they were all homogenous tissue 
and the tumour sample was taken from the centre of the tumour. This means the 
periphery of the tumour – which is where a positive margin would most likely be 
– was not necessarily included in the sample. Previous studies have investigated 
the ‘borderline’ regions of tumours, describing a gradual decrease in water 
content the further from the tumour is measured 228, 293. It may be this gradual 
decrease in water content that could be measured to provide IMA. This study has 
demonstrated the basic science underpinning this technique – that tumours have 
higher water content, this can be measured using HWN Raman, and changes in 
tumour water content quantified using the water/total area ratio. Further work with 
access to take Raman measurements from the tumour and the borderline region 
into non-tumour tissue is necessary to see if this can provide IMA. 
 
The non-tumour specimens did not undergo histopathological analysis and were 
all considered to be a homogenous group of ‘normal’ tissue. On review of a select 
few H+E slides of the non-tumour tissue, they were confirmed to be normal with 
no particular histopathological features. ‘Normal’ breast tissue is a broad variety 
of tissue encompassing a number of pathological features, from fatty tissue which 
has few histological features, to the myriad of benign breast tissue changes 
named under the umbrella term ‘Aberrations in the normal Development and 
Involution of the Breast’ (ANDI) 360. These all have their own specific 
histopathological features which may have particular Raman signals associated 
with them. A previous study using fingerprint Raman demonstrated that these 
benign abnormalities could affect the diagnostic accuracy of the technique, as 
there was overlap in the Raman spectrum of these benign findings and tumour, 
particularly in fibrocystic change and fibroadenomas 262. However, it is not known 
if any of the non-tumour tissue in this study contained these histopathological 





4.4.2.3 Methods of Analysis 
Using the NP3 system for this study demonstrated the potential for performing 
IMA. Each measurement was simple to perform and would not require a specialist 
operator to perform, requiring only light contact between the needle probe and 
the sample. If necessary, the needle could have a single use covering over it to 
allow the actual needle to remain clean between patients.  
 
There are limitations to the method of analysis. The NP3 probe had sufficient 
sampling volume (5.19 x 104 µm2) to measure small biopsies of tissue, but to 
sample an entire resected edge of a breast tissue specimen would not be 
possible. The time taken for each measurement was 25 seconds (5 second 
acquisition with 5 accumulations), to measure such a small area this is not a 
clinically relevant period of measurement. The reason for this was to gain 
accurate diagnostic information, as this was a proof of principle study. The results 
suggest that the HWN region alone gives sufficient diagnostic information, and 
the water/total area ratio is as accurate as full spectral analysis. The water/total 
area ratio could still be calculated with a reduced spectral resolution, and so the 
acquisition times could be reduced significantly, while maintaining diagnostic 
accuracy to make the method more clinically relevant.  
 
Although the NP3 system gave more clinically relevant readings than the micro 
spectrometry analysis, the readings obtained with the NP3 system could not be 
directly correlated with the histopathological features. The micro spectrometry 
analysis of the tissue sections demonstrated that there are some ‘normal’ areas 
of breast tissue within the breast tumour specimens. When measuring with the 
NP3 it was not possible to know if a ‘tumour’ area or ‘normal’ area was being 
measured from the tumour specimen, so ‘normal’ readings may have been 
obtained from a tumour specimen, which would have been classified as ‘false 
negative’ in the prediction models (when the readings were actually true 






4.4.3 Tissue types presenting a diagnostic challenge  
4.4.3.1 Pathological subtypes 
The analysis of tumour specimens investigating spectral differences between 
pathological subtypes demonstrated that there were no significant differences 
between subtypes. This means the NP3 system cannot differentiate between 
different tumour characteristics. This is not a limitation for IMA, as the 
differentiation only needs to be tumour versus non-tumour, but if the probe were 
to be developed for other clinical needs such as needle biopsy, it may be relevant 
that it is unlikely the NP3 system could provide a specific diagnosis.  
 
4.4.3.2 ‘Normal’ tissue 
Breast tissue composition varies between patients according to a number of 
physiological factors including age 283, menopausal status 282 and hormonal 
factors such as menstrual cycle and exogenous hormones 283, 285. The 
demographic data that had been collected on these samples allowed analysis of 
the differences in non-tumour tissue according to age and menopausal status. 
These are independently associated with changes in breast tissue 
composition284, however there is obviously a link between these two 
characteristics, as post-menopausal patients are generally older.  
 
The analysis found significant spectral differences between the non-tumour 
specimens of younger and older patients and pre-and post -menopausal patients. 
Younger patients, and pre-menopausal patients had significantly higher 
water/total area ratios than those that were older or post-menopausal. This 
suggests young and pre-menopausal patients have a higher water content in the 
non-tumour breast tissue. This is in keeping with previous findings seen with other 
techniques such as Diffuse Optical Spectroscopy 284 and Magnetic Resonance 
imaging 285, however, in these studies the optical technique findings were not 
correlated with the histopathological findings but on radiological imaging. The 
micro spectroscopy analysis of non-tumour tissue demonstrated that younger 
patients had areas of stromal tissue (protein rich tissue) which gave a protein 
peak in the HWN region. However, the HWN spectra obtained from non-tumour 
tissue was dominated by a lipid peak, rather than a protein peak. The areas of 
protein tissue are still embedded within surrounding lipid tissue and the sampling 




greater than protein and only a small amount of lipid is needed within that 
sampling area to give a lipid peak, which dominates the protein peak in the CH 
stretch region (similar to the findings with the mixed gelatine/soya bean phantoms 
in Chapter 3). This results in no observable protein peak and the higher amount 
of water still measurable in an increased water peak. This would result in a higher 
water/total area ratio, and perhaps explains the differences observed between 
non-tumour specimens. 
 
These differences in the physiological ‘normal’ could account for any diagnostic 
inaccuracy seen in the method, as at the extremes of variation, the physiological 
‘normal’ spectra overlap with the tumour spectra. In a number of studies 
investigating the changes in water content to differentiate between tumour and 
non-tumour breast tissue using optical techniques other than Raman, the range 
of the physiological ‘normal’ breast water measurements have overlapped with 
the range of the ‘tumour’ water measurements, thus affecting the diagnostic 
accuracy of using water to differentiate between tissue types 276, 289, 291. A 
limitation of these studies was that in the calculation of the ‘tumour’ water 
measurements they used information from scans of large areas of breast tissue 
that contained both tumour and non-tumour tissue, which may have 
underestimated the degree of difference in water content between tissue types. 
If the variation in physiological ‘normal’ was significant and the cause of 
diagnostic inaccuracy it may mean that using water content as a main diagnostic 
marker is less accurate in the young/pre-menopausal in particular. It would 
therefore be expected that accounting for this variation would improve diagnostic 
accuracy of the technique. Calculation of the W/TAR difference allowed for 
interpretation of the tumour Raman spectra to be performed as a measure against 
the patient’s own baseline, provided in a ‘calibration’ measurement. Therefore, if 
a patient had a high water/total area ratio baseline in their non-tumour tissue, this 
would be accounted for as the tumour tissue readings would be measured as any 
change from that baseline. The results from this analysis did not show an 
increased diagnostic accuracy compared to other methods of analysis. This 
suggests that the physiological variation of non-tumour tissue water/total area 
ratio between patients does not adversely affect the diagnostic accuracy of 





4.4.3.3 Lobular Carcinoma 
Lobular carcinoma can be a diagnostic challenge; mammography has poor 
sensitivity in detection of the disease 361, and is poorly circumscribed 
histologically with a single line infiltration of malignant cells 25. It may also present 
a diagnostic challenge in Raman spectroscopy; previous studies using Raman 
spectroscopy for IMA do not investigate lobular carcinoma as a possible 
pathological sub-group that may cause diagnostic inaccuracy 189, 262. 
 
The micro spectroscopy analysis of the tumour specimen of patient 14 (which 
was a lobular carcinoma) demonstrated lipid signals (which are generally 
associated with non – tumour tissue) even within tumour. It was also noted by the 
histopathologist on review of the H+E slide, that it was a difficult case to examine 
and the scattered cancer cells made it a diagnostic challenge. 
 
The histopathological features are different between lobular and ductal 
carcinoma, and the water/total area ratio was lower for lobular carcinoma, 
suggesting there are some spectral differences between the two carcinoma 
types. However, despite this possible diagnostic challenge in the subgroup 
analysis of all the tumour specimens, although the water/total area ratio was 
different between ductal (mean ratio - 0.77) and lobular carcinoma (mean ratio. 
0.70), it did not reach statistical significance. Comparing these ratios with the 
mean water/total area ratio for the non-tumour specimens which was 0.2 
demonstrates that the variation between carcinoma types was relatively small, 
compared to the differences between tumour and non-tumour tissue. This 
suggests that although lobular carcinoma may present a diagnostic challenge for 
Raman spectroscopy, it is the nature of the pathology, and NP3 is capable of 




This study has demonstrated the ability of NP3 to differentiate between tumour 
and non-tumour breast tissue with an excellent diagnostic accuracy of up to 93%. 
A wide range of data processing techniques using the fingerprint region, HWN 
region and the water/total area ratio are capable of differentiating tissue types. 




time whilst providing accuracy equal to more complex spectral analysis, 
suggesting this may be the most clinically relevant method of data analysis to 
provide IMA. 
 
The biochemical differences between tumour (protein and water rich) tissue and 
non-tumour (lipid rich, water poor) have been demonstrated with spectral 
assignation, and validated with micro spectroscopy Raman measurements, that 
matched histopathological features with Raman spectral features. The impact of 
pathological subtypes that have previously been difficult to diagnose, such as 
DCIS only tissue, the broad range of variation in physiological ‘normal’ non-
tumour breast tissue and lobular carcinoma on the diagnostic ability of the 
technique has been discussed. Although more work is required, it suggests that 
the NP3 system is capable of good diagnostic accuracy even in these traditionally 
more difficult pathological subgroups. 
 
There are some limitations to the study, such as the study was conducted on 
fresh frozen tissue and the time taken for each spectral measurement was 25 
seconds. Further work is required to validate these study findings on fresh breast 
tissue and a probe and study protocol that could provide IMA within clinically 
relevant times needs to be developed. However, the findings and analysis of the 
data from this study suggests how this may be accomplished, and highlights 
which areas need particular attention. 
 
This study has been successful in providing the proof of principle that NP3, and 
in particular HWN Raman spectroscopy, can differentiate between tumour and 
non-tumour tissue with excellent diagnostic accuracy. This gives a basis for 
further work to translate these findings to providing IMA. 
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CHAPTER 5:  
An optimised Raman system for 
Intraoperative Margin Analysis 
 
5.1 Introduction 
Chapter 4 demonstrated the proof of principle that tumour can be differentiated 
from non- tumour breast tissue using the NP3 system. However, a number of 
limitations of the NP3 system were recognised in the acquisition of the data.  
Particular problems encountered with the NP3 system were: 
- The probe was physically fragile and susceptible to breaking if incorrectly 
handled or dropped 
- Some of the collection fibres did not work, and these were 
inaccessible/difficult to replace 
- Transporting it between the laboratory and the hospital site was difficult 
(due to fragility) 
- A small sampling volume 
-  
The NP3 system was unlikely to be successfully utilised without further probe 
manufacturing to become a system capable of providing IMA due to these 
limitations. To effectively translate the promising findings in chapter 4 towards 
providing Intraoperative Margin Analysis (IMA), the limitations of the probe need 
to be addressed. Therefore, using the knowledge gained through the thesis with 
the NP3 system, and using the same basic set up of a 785 nm laser excitation 
wavelength and InGaAs camera, a new handheld probe Raman system was 
developed for future clinical use. 
 
This chapter explores this new handheld Raman system (HH Raman system), 
ensuring the basic characteristics (i.e. ability to obtain HWN Raman 
measurements) are similar to the NP3 system, and going on to investigate the 
limitations and clinically relevant capabilities of the system to assess its suitability 






5.2.1 HH Raman system configuration 
The HH Raman system is similar in principle to the NP3 system, however the 
probe delivery system is different (Figure 5-1). Laser excitation was delivered at 
785 nm IPS spectrum stabilised laser module (Innovative Photonic 
Solutions,USA) with a 105µm core fibre through a collimating lens and then a 
785nm laser bandpass filter (Thorlabs,NJ,USA), and collimated light passed 
through a 785 nm dichroic mirror (Thorlabs,NJ,USA). A plano-convex 20mm lens 
with anti-reflective coating (Thorlabs,NJ,USA) and a 20mm spacer ensure light is 
focused at the tip of the probe, providing a maximum power of 250mW to the 
sample with a 0.19mm spot size. The light was then collected through an SMA 
7X 105 µm collection bundle with a collection spot size of 0.64 mm through a 
785nm notch filter to the entry port on the spectrometer - Kaiser Holospec 
Imaging Spectrograph (Kaiser optical systems inc, Ann Arbour,USA) with a broad 
HVG 800 grating which is coupled to a camera InGaAs camera (iDus InGaAs 



























5.2.2 Breast Phantom construction 
To assess the HH Raman system, and to compare the results with all previous 
work in the thesis, the same phantoms were used for testing purposes. Gelatine 
phantoms were made to produce a range of water concentrations 85-95% using 
the same methods described in full in Chapter 2. 
Pork tissue was used to mimic biological tissue, analogous to fat rich, normal 
breast tissue (pork fat, and pork lard in later lumpectomy phantom construction) 
and protein and water rich tumour tissue (pork meat). Pork tissue and lard were 
purchased from a local supermarket (Tesco, UK). 
Figure 5-1 HH Raman system configuration 
A. Schematic diagram showing the system components, configuration and light path. Red line is excitation 
light (785 nm), Green line is Raman scattered light. B. Picture of handheld component taking a measurement 




The composition of each phantom was specific to each experiment, and is 
described in the corresponding section below. 
 
5.2.3 Measurement protocol 
Spectra were recorded using SOLIS software (Andor, UK) and processed in 
Matlab (Mathworks, USA). Daily calibrations were performed with Neon Argon 
lamp, Ethanol, water, PTFE, paracetamol and aspirin. The Raman peaks of 
paracetamol in the HWN region were used to calibrate the Raman shift using the 
inbuilt calibration tool in the SOLIS software. A dark signal measurement (with 
laser and background lights off) that corresponded to the signal acquisition time 
was taken daily for subsequently detailed spectral pre-processing. 
 
Specimens were wrapped in clingfilm to reduce probe contamination, and 
because in clinical studies the probe will need a disposable protective sheath of 
clingfilm for each measurement. Measurements taken of pork tissue with and 
without clingfilm on the surface revealed no discernible difference to the resulting 
Raman spectra – data not shown. As a main aim of these experiments was to 
reduce signal acquisition time - signal acquisition for these experiments was a 
single acquisition of 5 seconds per measurement (apart from in the experiments 
evaluating decreasing signal acquisition time).  
 
Measurements were taken with the HH Raman system, with the probe in light 
contact with the specimen (apart from in the experiments evaluating increasing 
this distance). 5 measurements were taken, at random, over the surface of each 
phantom. 
 
5.2.4 Data processing and analysis 
Spectra were pre-processed initially by dark noise subtraction. A smoothed dark 
noise baseline was obtained by a Savitzky-Golay filter with a 7th order polynomial 
of the dark noise reading of the corresponding spectral acquisition time (5 
seconds unless otherwise stated in the individual sections) and this was 
subtracted from each spectrum. Baseline subtraction was undertaken with a 2nd 
order polynomial fit. Spectra presented are the mean spectra of the 5 repeats 
(n=5) +/- 1 Standard Deviation (SD), and have been normalised to the CH stretch 




water/total area ratio method, (area under the curve of 3035-3680 cm-1 region 
divided by area under the curve of 2850-3680 cm-1 region) as previously 
described in Chapter 3 and 4. The mean water/total area ratio +/- 1 SD is used 
to describe each specimen. Scatter graphs were constructed for the gelatine 
phantoms using this data plotted versus the known water fraction of the gelatine 
phantom, and a linear fit calculated based on all points with quality of fit described 
by the Root Mean Square Error (RMSE). 
 
Statistical analysis to compare water/total area ratio was performed with one -
way ANOVA, statistical significance P<0.05. 
 
5.3 Experimental protocol and results 
5.3.1 Assessment of probe detecting changes in water content 
The initial test of the HH system was to ensure it could obtain Raman spectra 
with a good signal to noise ratio using the phantoms that had previously been 
used to mimic breast tissue (pork meat and fat), as these were to be used in 
subsequent experiments. Figure 5-2 shows that high quality, high signal to noise, 




The ability of the HH Raman system to detect changes in water content were then 
tested. The results from the fresh frozen breast tissue suggest that normal, fatty, 
Figure 5-2 Showing Raman spectrum of pork meat and pork fat obtained with HH Raman system. 





breast tissue has a very low water content and that changes in the water content 
cannot be measured using HWN Raman – therefore changes in water content in 
a lipid environment were not tested as it is of limited clinical relevance. However, 
the protein rich tumour areas had a range of water contents that could be 
measured using the water/total area ratio calculation. Therefore, gelatine 
phantoms at a range of water concentrations (95-85% water) were measured to 
test if the HH Raman system could measure changes in water concentration 
using the water/total area ratio method of spectral analysis. Figure 5-3 shows that 
there was a linear relationship between known water fraction and the water/total 
area ratio, with a gradient of 0.533 and RMSE of 0.002. This demonstrates that 
the HH Raman system can obtain HWN spectra of sufficient quality to detect 
small changes of 2.5% (in a protein rich environment) in water concentration. 
These results are similar to the results from the NP3 system (where similar plots 
of water fraction vs water/total area ratio had a gradient of 0.57), suggesting that 
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Figure 5-3 showing Raman spectra in the HWN region of different water concentrations of gelatine 
phantoms and the relationship with the water/total area ratio 
A. Graph showing Raman spectra of gelatine phantoms at 5 different water concentrations, normalised to 
CH stretch region between 2850 – 2950 cm-1. Plotted lines are mean (n=5) for each concentration after pre-
processing, shading in the same colour either side is +/- 1 SD. B. Scatter graph of known water fraction 
versus water/total area ratio. Points plotted are mean water/total area ratio (n=5), error bars +/- 1 SD. Red 




5.3.2 The effect of changing measurement parameters on signal acquisition 
5.3.2.1 Decreasing laser power 
The standard power of the 785 nm laser for these experiments was 250 mW. 
Higher laser powers could be obtained and attempted with this system (up to 350 
mW), but this led to sample degradation through burning. With the power at 250 
mW no burning of any samples was observed, this was also the power that was 
used for the NP3 system measurements of fresh frozen breast tissue (where the 
power density is much higher due to the laser being focused on a smaller area 
362) where there was no burning of small, dry, biopsy samples. The method of 
IMA that is envisaged with the HH probe is for ex vivo analysis of excised breast 
tissue samples. Therefore, although burning of samples is to be avoided as it 
may confound subsequent histopathological analysis, it would not cause 
immediate harm to a patient. It may be that future uses for the HH Raman system 
could be in vivo assessment of the tumour bed, similar to work done in 
neurosurgery 223. It is possible that the laser power would have to be reduced 
below 250 mW to avoid deleterious tissue temperature increases and burning for 
future in vivo studies. Most studies using Raman spectroscopy in vivo on skin 363 
and within the abdominal cavity 248 use a delivered power of 100 -150 mW, and 
in vivo analysis of the tumour bed it was as low as 37-64 mW 223 (though no 
studies actually measured specimen temperatures/degradation).  
 
As the intensity of Raman scattering is related to the laser power, reducing laser 
power could negatively affect signal acquisition 362. To investigate the potential 
for the system to be used in vivo on biological tissue at reduced power, a series 
of measurements were performed on pork meat at different laser powers. The 
Raman cross section of protein and water is much lower than lipid 364, and so any 
anticipated reduction in signal to noise ratio would affect the ability to detect 
protein and water more than the ability to detect lipid. Therefore, pork meat was 
measured as the detection of protein and water rich areas (mimicking a tumour 
environment) is the most clinically relevant. 
 
Figure 5-4 shows the results of measuring pork meat at different laser powers. At 
all laser powers there is good signal to noise and Raman signal could be 
recovered. Analysis of the water/total area ratio between the laser powers 




– 0.794 (SD 0.006), 150 mW – 0.787 (SD 0.006), 80 mW – 0.776 (SD 0.012)) 
and this reached statistical significance (P= 0.016) and multi-group comparison 
of the ratios was significant between 250 mW and 80 mW (P= 0.013), but not 




   
  
These results demonstrate that the HH Raman system can be used with a 
decreased laser power, and Raman signal is obtained at the low power of 80 
mW. Although the water/total area ratio is statistically different between the laser 
powers, in real terms it only varies maximally by a ratio value of 0.04 between the 
highest and lowest power, and this would be unlikely to adversely affect the 
diagnostic ability in differentiating tumour and non- tumour tissue (in the fresh 
frozen samples the differences in water/total area ratio between tissue types were 
in the order of 0.5). This may be useful if future work requires the probe to be 
used at lower laser powers for in vivo use. 
 
5.3.2.2 Measurement acquisition time 
A limitation in previous experiments in this thesis has been the acquisition time 
to obtain measurements. In the fresh frozen breast specimens, a total acquisition 






















Figure 5-4 Results of measurement of pork meat with HH Raman system with different laser 
excitation powers 
A Graph showing Raman spectra of pork meat at 3 different laser powers, normalised to CH stretch region 
between 2850 – 2950 cm-1. Plotted lines are mean (n=5) for each concentration after pre-processing, 
shading in the same colour either side is +/- 1 SD. B. Bar graph comparing the mean water/total area ratio 
between the signal acquisition times, error bars +/- 1 SD. One-way ANOVA to compare between samples, 





proof of principle phase. Future work with the HH Raman system will be in the 
clinical environment and reducing the signal acquisition time would allow a 
reduction in time for specimen analysis.  
 
A limitation of InGaAs cameras is the increased dark noise, requiring additional 
pre-processing steps, and readout detector noise, requiring longer acquisition 
times to overcome this, compared to CCD cameras 340, 365. Santos et al. used an 
InGaAs camera in biological tissue (skin) and used acquisition times of 10 
seconds, and when reduced acquisition times were attempted the results were 
poor (though they were measuring pigmented skin lesions) 365. This is in 
comparison to a recent study by Liao et al. a CCD camera and excitation 
wavelength of 671 nm with a 2-axis scanning galvo- mirror system was used to 
obtain signals with a signal acquisition time of 10 ms, however, this did not 
provide signals in the entire HWN region (omitting the water peak), there was 
significant background fluorescence and the HWN signals were not diagnostic 
signals 299. This work by other groups suggests that advancing the HH Raman 
system and the use of InGaAs cameras requires the ability to reduce signal 
acquisition time to compete with the timescales achieved with CCD cameras for 
signal acquisition. 
 
In the previous sections in this chapter, an acquisition time of 5 seconds has been 
used, and the results have so far demonstrated that this provides excellent 
Raman signals with good signal to noise, and that this reduced acquisition could 
be used in the future. Reducing the signal acquisition times even further could 
have great clinical benefits in progressing the HH Raman system closer towards 
providing IMA in clinically relevant timeframes. Therefore, a series of 
measurements were obtained on pork meat over a range of signal acquisition 
times (from 5 seconds to 0.1 seconds), and the resultant spectra water/total area 
ratio compared to determine the effect of signal acquisition times on obtaining 














































Figure 5-5 shows that discernible Raman signal was recovered at all signal 
acquisition times, even to the very short time of 0.1 second. The spectra for 
acquisition times of 0.5 seconds and greater were remarkably similar in 
appearance. However, spectra obtained at 0.1 seconds are visually poor quality, 
with a low signal to noise, and the background noise impacting significantly on 
the spectra particularly in the region of the OH stretch (3035 – 3680 cm-1). 
Analysis of the water/total area ratio for the spectra showed the mean water/total 
area ratio did decrease with signal acquisition time (from 5 seconds – 0.77 to 0.1 
second - 0.71) but this did not reach statistical significance on multiple 
comparison between all groups (P >0.05).  
 
These signal acquisition times are considerably shorter than other Raman 
systems utilising an InGaAs camera, while still maintaining Raman spectra with 
reasonable signal to noise 345, 365. One reason could be the pre-processing that 
we perform with dark noise subtraction, which is not performed in the other 
studies. The quality of Raman spectra obtained at 0.1 second (100 ms) is 
comparable, if not better (considering they are with less scattering protein rich 
tissue), than those obtained in fatty tissue with a CCD at 10 ms 299. Some 
biochemical information (the water peak) may be lost at these lower acquisition 
times, however, depending on the spectral features required for analysis, 
acquisition times could be reduced further.   
 
These results demonstrate that it is possible to reduce signal acquisition times to 
as low as 0.5 seconds with the HH Raman system and our pre-processing 
methods and obtain sufficient quality Raman spectra for full biochemical analysis 
and interpretation. 
 
Figure 5-5 Raman spectra of pork meat obtained with HH Raman system with a range of signal 
acquisition times (5 second – 0.1 second) 
A – G –Raman spectra of pork meat at  different signal acquisition times (titled), normalised to CH stretch 
region between 2850 – 2950 cm-1. Plotted lines are mean (n=5) for each acquisition time after pre-
processing, shading in the same colour either side is +/- 1 SD. H. Bar graph comparing the mean water/total 
area ratio between the signal acquisition times, error bars +/- 1 SD. One-way ANOVA to compare between 




5.3.2.3 Reduced probe contact 
An element of signal acquisition that is particularly important with a handheld 
probe is the variability in contact between the probe and the surface being 
measured. These variations may occur either due to human factors (i.e. not 
consistently putting the probe directly in contact with the specimen) or specimen 
factors (i.e. unequal surface of specimen). This occurred in the use of the 
ClearEdge probe which caused an error in the device and the margin could not 
be assessed in a number of specimens 266. This is a potential major limitation 
with a handheld probe.  
 
The HH Raman system is designed for the probe objective to be in light contact 
with the surface of the specimen throughout the acquisition time, as the 20 mm 
lens focuses the excitation light at that point. However, it is important to assess 
the effect that variation would have if the specimen was measured not in the ‘ideal 
conditions’ of having the probe in light contact with the specimen, as this is likely 
to happen with some measurements in a clinical setting. A series of 
measurements were taken with the probe at a range of distances from the surface 
of the specimen (pork meat) to investigate the effect that reduced probe contact 










































Figure 5-6 shows the spectra obtained of pork meat at a range of probe to 
specimen distances. It can be seen that the spectra obtained when the probe is 
in contact with the specimen (0 mm probe to specimen distance) has a smaller 
standard deviation by a factor of 10 compared to other measurements (mean 
water/total area ratio (SD)- 0 mm 0.789 (0.005); 1 mm 0.731 (0.053); 3 mm 0.767 
(0.031); 5 mm 0.714 (0.121); 10 mm 0.764 (0.053)). This suggests the least 
variability in measurements when the probe is in contact with the specimen. 
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Figure 5-6 Raman spectra of pork meat obtained with HH Raman system with a range of probe to 
specimen distances  (0 mm – 10 mm) 
A – E –In the left column is a photo demonstrating the distance from probe to specimen (pork meat in 
clingfilm), in the right column is Raman spectra of pork meat at  different probe to specimen distances (titled), 
normalised to CH stretch region between 2850 – 2950 cm-1. Plotted lines are mean (n=5) for each acquisition 
time after pre-processing, shading in the same colour either side is +/- 1 SD. H. Bar graph comparing the 
mean water/total area ratio between the probe to specimen distances, error bars +/- 1 SD. One-way ANOVA 




However, when the water/total area ratios were compared between all groups 
they were not significantly different (P>0.05).  
There are a number of reasons why introducing a gap between the probe and 
specimen would introduce greater spectral variability, such as stray light 263 and 
reduced efficiency of collection of Raman scattering 160. These results suggest 
the optimal method of measurement is with the probe in light contact with the 
specimen, but that adequate Raman spectra can be obtained when the probe is 
up to 10 mm away from the surface of the specimen. Therefore, if there was 
deviation from measurement protocol, and the probe takes measurements not in 
contact with the specimen, it should not critically affect results. 
 
5.3.2.4 Sub-surface Sampling depth 
A characteristic of the probe that has particular clinical relevance is the sampling 
depth. The sub-surface sampling depth of a Raman system is defined by the 
lateral distance from the illumination source to the collection system 160. In 
traditional Raman microspectroscopy, where the illumination and collection light 
are in the same place, the sampling depth is in the order of a few hundred microns 
and is predominantly a surface technique 366. If there is a spatial offset the 
photons that have travelled some depth into the tissue are collected, thus likely 
to collect scattered photons from beyond the surface of the sample 160. There is 
a clinical significance to this, as if there is disease within 2 mm of the resected 
edge re-excision should be considered, and if disease is at the resected edge, 
re-excision should be undertaken 56. In the HH Raman system the illumination 
source and collection bundle are not separated and there is negligible spatial 
offset. Therefore, there should be minimal contribution from spatial scattered 
photons beyond the sample surface. Understanding the sampling depth of the 
probe is important to interpret the Raman signals, and what the clinical 
significance may be, when it is applied to IMA. 
 
Most studies examining sampling depth measure a highly scattering substance 
at increasing depths 367 to ascertain if the Raman signal from the buried medium 
can be detected. However, for a clinical probe this is of limited value and 
significance, as the ability to measure a buried medium is dependent on the 
Raman cross section of the buried medium i.e. if it is highly scattering the Raman 




Therefore, as the biological tissue will have a different Raman cross section to 
the experimental buried medium, the sampling depth will not necessarily be valid 
in the clinical application 368. 
 
To further understand the sampling depth of the probe with clinical relevance, 
substances that have analogous scattering properties to human breast tissue 
were used. Pork fat was used to mimic normal, fatty breast tissue as it is highly 
scattering 162, 314. For the first experiment measuring fatty tissue underneath a 
protein rich tissue, a 90% water gelatine phantom was used to mimic protein rich 
tumour tissue, rather than pork meat. This is because gelatine phantoms have 
lower scattering properties than pork meat, and it was noted in chapter 4 that 
tumour tissue had a low degree of scattering (with low intensity signals), and have 
been used to mimic tumour tissue previously 304. Gelatine phantoms will have 
lower scattering than breast tumour tissue, and therefore these models represent 
a ‘worst case scenario’ of a low scattering, thin layer of tumour overlying a thick 
layer of highly scattering normal fatty tissue.  
 
The first experiment measured pork fat with an increasing depth of gelatine 
phantom on top. The 90% water gelatine phantom was sliced into 1 mm deep 
strips and placed on top of the pork fat (range from no gelatine– 7 mm of gelatine). 
This is analogous to measuring a tumour overlying normal fatty tissue. 
Figure 5-7 shows that with 1 and 3 mm of gelatine phantom overlying the pork 
fat, the lipid signal is predominant, though the water content of the gelatine 
phantom is apparent. With 5 and 7 mm of gelatine phantom the protein and water 
of the gelatine phantom predominate, though there is still some residual lipid 
signal contribution to the spectra. Analysis of the water/total area ratio shows that 
the mean ratio increases with the depth of gelatine over the fat, highlighting the 
increasing contribution from the water peak to the spectra and these were 
statistically significant (No Gelatine water/total area ratio – 0.12 (SD 0.015) 
versus 1 mm Gelatine – 0.41 (SD 0.16); 3 mm Gelatine 0.46 (SD 0.035); 5 mm 













The second experiment aimed to assess the sampling depth with lipid overlying 
a protein rich sample. Due to the results from experiment one suggesting that the 
gelatine phantom has a low Raman cross section, it seemed unlikely that gelatine 
phantom under a layer of lipid would be detected. Therefore, pork meat (which 
had been observed to have a more intense Raman signal) was used as the 
protein rich sample. To get as thin a layer of lipid over the top of the meat, pork 
lard was used as fat could not be cut thin enough. This model replicates an area 
of tumour, with a very thin layer of normal fatty tissue overlying it – this could 
represent a positive margin that requires consideration for re-excision. 
Figure 5-8 demonstrates that even with as thin a layer of lard as possible, no 
meat signal could be recovered, as the lard is so highly scattering the lipid signal 
dominates. 
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Figure 5-7  Raman spectra of pork meat obtained with HH Raman system with a range of depths of 
90% water gelatine phantom overlying the fat (0 mm – 7 mm) 
A Graph showing Raman spectra of pork meat with different depths of overlying gelatine phantom, 
normalised to CH stretch region between 2850 – 2950 cm-1. Plotted lines are mean (n=5) for each 
concentration after pre-processing, shading in the same colour either side is +/- 1 SD. B. Bar graph 
comparing the mean water/total area ratio between the signal acquisition times, error bars +/- 1 SD. One-
way ANOVA to compare between samples, comparison between 0 mm (no gelatine) and all other depths of 







These results demonstrate that when a protein rich layer with low scattering and 
a low Raman cross section (gelatine phantom) is overlying a highly scattering 
agent (pork fat), significant contribution from the highly scattering agent persists 
at substantial depths of up to 5 mm using the HH Raman system. However, the 
water/total area ratio analysis suggests that despite this, the Raman spectra are 
significantly different between just fat, and fat with gelatine overlying it. In the 
second experiment protein rich tissue (mimicking tumour) could not be detected 
beneath a thin (<1 mm) layer of lipid rich tissue (mimicking normal fatty tissue). 
 
There are some limitations to these experiments. The thickness of the gelatine 
slices in experiment 1, and the thickness of the lard in experiment 2 could not be 
precisely established. It may also be that the scattering properties and Raman 
cross section of the phantoms may not exactly mimic breast tissue, which would 
alter the subsurface sampling depth. The first experiment of gelatine overlying 
pork fat represents a ‘worst case scenario’ of small amounts of low scattering 
breast tumour overlying normal fatty tissue. As breast tumour tissue is more 
scattering than gelatine phantoms, this issue may not be so pronounced with 
clinical tissue measurements. Despite these limitations, this work highlights the 
difficulty in detecting protein rich tissue (tumour) below even a thin layer of lipid 
rich tissue (normal breast tissue). Further work is required when there is access 
to human breast tissue to ascertain the depths below normal fatty tissue at which 
tumour tissue can be detected. If this is found to be necessary in clinical 
Figure 5-8 Raman spectra of pork meat and lard covering pork meat obtained with HH Raman system  
Graph showing Raman spectra normalised to CH stretch region between 2850 – 2950 cm-1. Plotted lines 





specimens, the probe could be modified to introduce a spatial offset to maximise 
signal from below the surface. 
 
5.3.3 Assessment of probe in ‘tumour’ detection  
Assessing the sampling area of the probe is an essential step in understanding 
the capability of the probe and the clinical significance of the results generated 
from the HH Raman system. The important clinical question is – what is the 
smallest area of tumour that can be detected by the probe? 
 
Raman based techniques have been reported to detect residual tumours on the 
surface of specimens as small as 1 mm2, though the diagnostic threshold 
sensitive enough to detect these smaller tumours had a specificity of 83% 
indicating a significant number of false positives using this diagnostic 
threshold189. The MarginProbe (currently the most advanced and ‘at market’ tool 
for IMA) reported a sensitivity of only 56% for detecting tumours of 0.7mm 369. 
These literature reports suggest that detection of tumours around 1 mm2 is 
necessary for the HH Raman system to be clinically useful, and competitive with 
other devices and technologies. 
 
Similar to the previous work on investigating sampling depth, experimental 
methods with other materials could ascertain, perhaps with greater theoretical 
precision, the sampling area of the probe. However, as the diameter of the 
sampling volume is affected by the optical properties (such as refraction, 
scattering, absorption) of the measured specimen, using biological tissue gives a 
closer understanding of what may be seen with human breast tissue in the clinical 
setting 362.  
 
For these experiments a series of lumpectomy phantoms were created from pork 
lard (to mimic normal, fatty breast tissue) and pork meat (to mimic protein and 
water rich tumour breast tissue). Pork meat was dissected into pieces ranging 













5.3.3.1 Point scans 
To assess the sampling area, measurements were taken directly over the area 
of pork meat of each lumpectomy phantom. If the sampling area is greater than 
the piece of meat, it would also sample the surrounding lard. As lipid is much 
more scattering than protein, the lipid signal may dominate the resultant spectra 
and the protein and water signal may not be detected. This would result in that 
‘tumour’ size not being detectable. Therefore, the size of the pork meat in lard 
ranged from as small as possible that was able to be dissected and measured 
accurately (0.5 mm2) and was predicted to be smaller than the sampling area, to 
Figure 5-9 Figure showing the lumpectomy phantoms 
A. pork meat (tumour mimic) cut into a range of sizes (0.5-5mm2). B. Lumpectomy phantoms with the pork 
meat (tumour mimic) of a range of sizes (written next to the corresponding phantom) in a square of lard 




large pieces (5 mm2) that, if remained undetectable with the probe, would render 
the probe clinically inappropriate. 
 
The results displayed in Figure 5-10 A demonstrate the change in the Raman 
spectra as the pork meat (‘tumour’) increases in size. As there is an increase in 
size of the pork meat, the protein signal and the water peak become more 
dominant in the spectrum. The water peak is small in the 0.5 mm lumpectomy 
specimen which could be due either to a small amount of water in the pork meat 
(with rapid dehydration from the surface due to relatively large surface area), poor 
targeting of the probe on the lesion, or, more likely, because of dominant lipid 
signals giving a relative decrease in the water peak. As there is some lipid 
contribution to this spectrum, this suggests that the sampling area of the HH 
Raman system is at least 0.5 mm2. This would likely adversely affect the 
diagnostic ability of the system in tumours of this size. 
 
The water/total area analysis in Figure 5-10 B shows that there is a difference in 
the mean water/total area ratio between pure lard (0.013 (SD 0.011)) compared 
to the lumpectomy phantoms (0.5 mm phantom 0.31 (0.021);  1 mm phantom 
0.59 (0.0055); 2 mm phantom 0.51 (0.068); 3 mm phantom 0.49 (0.056); 4 mm 
phantom 0.60 (0.036); 5 mm phantom 0.67 (0.030)), and this reached statistical 
significance (P<0.001; one-way ANOVA). All lumpectomy phantoms had 
significantly different water/total area ratios to each other (1 mm phantom versus 
2 mm phantom (P=0.03) and 3 mm phantom (P=0.0026), all other comparisons 
P<0.001), apart from 1 mm phantom and 4 mm phantom (P=0.99) and 2 mm 
phantom and 3 mm phantom (P=0.99). 
 
The limitations to these experiments are that the pork meat may have a different 
Raman cross section to real human breast tumour tissue, which may alter the 
detection rate. The lumpectomy phantoms with >1 mm2 pieces of pork meat had 
different water/total area ratios on comparison, which suggests there may have 
been other influences on the Raman signal than just the pork meat (i.e. the 
sampling area may have been greater than 1 mm2). However, the water/total area 
ratios for these phantoms were of a similar magnitude (0.49 - 0.67), compared to 
that of lard (0.013). Therefore, it is more likely that this variation represents 




used for each lumpectomy phantom, which will have had slightly different 
biochemical/water properties, and a different rate of dehydration, all of which will 
affect the water/total area ratio. 
 
These results demonstrate that all lumpectomy phantom ‘tumours’ (ranging from 
0.5 – 5 mm2) had significantly different water/total area ratios compared to lard 
(mimicking normal breast tissue). This suggests that tumours as small as 0.5 
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5.3.3.2 Line scanning 
The final component of assessment of the HH Raman system was to 
conceptualise how the system may be used in the future to provide IMA for Breast 
Conserving Surgery. One method would be using the probe as a hand-held 
device and taking measurements of an area of concern – similar to the method 
described above. However, this would rely on the surgeon identifying an area of 
concern for analysis, and would not be capable of scanning an entire resected 
edge / specimen in a methodical manner. A way of measuring an entire resected 
edge systematically would be to have the probe stationary, and the specimen on 
a mechanical stage that would automatically move the specimen in the 
appropriate step sizes for each measurement to ensure the entire area of the 
resected edge was measured. This could then give a real time read out of the 
specimen as it is scanned, or a binary outcome at the end of scanning of whether 
the resected edge is clear or not of tumour. 
 
To test the feasibility of this potential use, the HH Raman system was kept 
stationary, and a lumpectomy phantom was moved manually with a roughly 1 mm 
step size in a line through the tumour. The lumpectomy phantom with a 1 mm2 
piece of pork meat in the centre was measured, to mimic a small 1 mm2 tumour 
at the resected edge of a lumpectomy specimen. The signal acquisition time was 
1 second, to further reduce the time taken for specimen analysis. The acquired 
spectra were pre-processed and the water/total area ratio calculated. In clinical 
practise for IMA the surgeon would want a binary, and easily interpretable, output 
Figure 5-10 Raman spectra of lumpectomy phantoms obtained with HH Raman system with a range 
of pork meat (to mimic ‘tumour’) sizes  (0 mm2 – 5 mm2) 
A. On the left column is a graphic illustrating the measurements were taken from the centre of the ‘tumour’ 
in the lumpectomy phantom. The lumpectomy phantoms had a range of pork meat areas to mimic different 
tumour sizes. On the right column is the resultant Raman spectra from the centre of the ‘tumour’ for the 
corresponding lumpectomy phantom, normalised to CH stretch region between 2850 – 2950 cm-1. Plotted 
lines are mean (n=5) for each acquisition time after pre-processing, shading in the same colour either side 
is +/- 1 SD. B. Bar graph comparing the mean water/total area ratio between the lumpectomy phantoms, 
error bars +/- 1 SD. One-way ANOVA to compare between samples, found all water/tumour area ratios were 
significantly different between the phantom with no pork meat (0mm) and all other lumpectomy phantoms 
(denoted by * P<0.001) and all lumpectomy phantoms were significantly different from each other (P<0.05), 
apart from between lumpectomy phantoms with ‘tumours’ of 2mm and 3mm (denoted by †= P>0.05), and 




of the Raman spectra findings to determine whether the margin was positive or 
not and aid their clinical decision to resect further tissue or not. Therefore, based 
on the results and methods in chapter 4 (using binomial logistic regression to 
obtain the optimal water/total area ratio cut off to detect tumour) a water/total area 
ratio of 0.5 was used to classify the resulting spectrum as tumour (water/total 




There are limitations to this illustrative experiment. Although the point 
measurements had suggested that ‘tumours’ of 0.5 mm2 could be detected, the 
1 mm phantom was used because the pork meat in the 0.5 mm phantom could 
Figure 5-11 demonstrating the concept of a rapid line scan of a lumpectomy phantom 
Left-illustration of HH Raman system taking measurements from the lumpectomy phantom, and the line of 
measurements to be taken (dotted line). Measurements taken at 1 mm step size in a line on the phantom, 
the corresponding spectrum is displayed, and water/total area ratio (W/TAR) calculated. A visual output is 
provided based on a W/TAR cut off of 0.5 to differentiate tumour (≥ 0.5; green) from non-tumour (<0.5; red). 
Raman spectra are single spectrum with 1 second acquisition, pre-processed and normalised to CH stretch 




not be accurately seen to confirm it was being measured in the dark laser safe 
room. A manual single line scan directly through an area of known ‘tumour’ will 
obviously have an improved detection rate compared to an automated scan 
through tissue of unknown composition. The spectral differences between pork 
meat and lard will undoubtedly be easier to identify than the more subtle changes 
that can be seen between breast tumour and non-tumour tissue. 
 
Despite these limitations, this experiment illustrates the potential in the HH 
Raman system for providing IMA. These results demonstrate that a small area of 
‘tumour’ (1mm2) could be easily detected with the HH Raman system in a 
lumpectomy phantom measured in a line scan, with acquisition times of 1 second. 
The calculation of the water/total area ratio allows for rapid assessment of the 
Raman spectra and could give outputs that are easy to interpret by the surgeon 




The series of experiments in this chapter demonstrates the technical capabilities 
and limitations of the HH Raman system, focused on its clinical application to 
providing IMA in human breast tissue.  
 
5.4.1 Clinical context of findings 
The results from the gelatine phantoms of varying water concentrations 
demonstrate that the HH Raman system can quantify changes in water content 
in a protein rich environment, and the results are very similar to those obtained 
with the NP3 system. This suggests that the previous work performed with the 
NP3 system concerning water content, and the influences on the HWN spectral 
region, remain valid with the new HH Raman system. 
 
The experiments concerning laser power, acquisition time and probe to specimen 
distance were designed to assess the influence of changing these parameters on 
the resultant Raman spectra. The experiments found that Raman spectra with an 
adequate signal to noise can still be obtained with the laser power as low as 80 
mW, which is a laser power utilised in other studies using Raman in vivo 223, 363. 




with 250 mW power, it would be unlikely to have a detrimental impact on 
diagnostic ability. 
 
Adequate Raman spectra could be obtained with signal acquisition times as low 
as 1 second. Even measurement with an acquisition time of 0.5 seconds did not 
have a significantly different water/total area ratio compared to the longer 
acquisition times, however visually the signal to noise was suboptimal and would 
likely cause diagnostic difficulties. These are significantly shorter acquisition 
times than previous work with InGaAs cameras in biological tissue, and may be 
due to our pre-processing methods of dark noise subtraction 345, 365. 
 
The probe is best used with the tip in light contact with the specimen. 
Measurements performed in this way had the least variability in the water/total 
area ratio. However, the results were not significantly different from when 
measurements were taken with the probe not in contact with the specimen and 
spectra could still be obtained when the probe was at a distance of up to 10 mm 
away from the specimen. This is reassuring that if there is variability in using the 
probe between users, or between specimens, the results would not be adversely 
affected, which is a potential pitfall for handheld probes providing IMA 266. 
 
These effects of the change of measurement parameters are important to note, 
as during clinical measurements they may alter erroneously, or if these 
parameters needed to be altered for experimental need, the effect this may have 
on the Raman spectra can be anticipated, and this information can inform the 
decisions on experimental protocol. 
 
Experiments were performed to understand the subsurface sampling depth of the 
HH Raman probe. Many other Raman systems developed for IMA have focused 
primarily on surface techniques, with no ability to sample below the surface 186, 
189, 299, though SORS probes have had a subsurface sampling capability of up to 
2 mm 185, and 3 mm 265 . The experiments investigating the subsurface sampling 
depth of the probe demonstrated that with up to 3 mm of gelatine phantom 
overlying fat, lipid signal still contributed to the Raman spectra. There was still a 
spectral difference, and significant difference in the water/total area ratio, 




suggests that in a ‘worse case scenario’ if there was a small area of protein rich 
tumour tissue overlying a lot of lipid tissue the signal may be overwhelmed by the 
lipid contribution and cause diagnostic inaccuracy. More clinically relevant was 
the finding that even a small amount of lipid (lard) overlying protein rich tissue 
(pork meat) resulted in no signal from the protein rich tissue being obtained. 
Translating this to the provision of IMA, if a tumour has a small amount of normal, 
fatty tissue overlying it, it may go undetected. Currently the guidance is that 
further excision should only be performed if there is tumour at the resected edge 
(tumour ‘on ink’) i.e. an exposed tumour with no normal tissue overlying it 56. 
Margins of 0-2mm are subject to discussion about re-excision only, and therefore 
it is probable they would not take place necessarily at the time of the operation 
anyway. With these current guidelines therefore, the subsurface sampling depth 
of the HH Raman probe (of <1 mm in areas of lipid) are ideal for the provision of 
IMA. 
 
Experiments on lumpectomy phantoms (with pork meat mimicking ‘tumour’, and 
lard ‘non-tumour’ tissue) gave insight into the sampling area of the HH Raman 
system. Raman spectra obtained from point measurements of the 0.5 mm 
lumpectomy phantom had some lipid contribution from the surrounding lard, 
whereas the spectra from the 1 mm phantom did not, suggesting that the 
sampling area of the probe is between 0.5 – 1 mm2. The lipid contribution was 
visually apparent in the spectra from the 0.5 mm phantom which did reduce the 
water/total area ratio in this phantom compared to the larger ‘tumour’ phantoms 
(1-5 mm) but the water/total area ratio was still significantly different between lard 
and all the lumpectomy phantoms (0.5 – 5 mm). This suggests that ‘tumours’ as 
small as 0.5 mm2 could be detected using the HH Raman system, and certainly 
‘tumours’ of 1mm2 or greater could be readily detected. This size of tumour 
detection would compare very favourably with not only other Raman systems 189 
but also other technologies 370 aiming to provide IMA. 
 
The line scan of a lumpectomy phantom with a 1 mm2 ‘tumour’ (pork meat within 
lard) demonstrates the potential of the HH Raman system and possible future 
application. The scan demonstrated the potential to detect a small tumour of 1 
mm2 with 1 second acquisition times, with the water/total area ratio calculated 




decision making. The line scan shows that the entire resected edge of a small 
lumpectomy specimen (30 X 30 mm) could be analysed in 15 minutes with this 
system (assuming 1 mm step size). This is potentially a highly favourable 
specimen analysis time when compared to other Raman systems 156, 189, and 
other methods of IMA such as frozen section or cytology 136 and is a clinically 
relevant time.  
 
5.4.2 Limitations 
Many of these experiments compared pork meat to pork fat/lard through the 
water/total area ratio. Although fat/lard had consistent water/total area ratio, pork 
meat had more heterogenous findings. This is due to the natural variation in pork 
meat, but also its water content, as the pork meat may have had different initial 
water content and it may dehydrate at different rates according to the size it was 
dissected into (i.e. the difference in surface area between 0.5 mm2 and 5 mm2). 
This led to some variation between water/total area ratios between 
measurements of pork meat that may not have been expected (e.g. in the 
lumpectomy specimens the 2 mm and 3 mm phantoms had lower water/total area 
ratios than the 1 mm and 4 mm phantom). However, this heterogenous tissue, 
with a variation of water content and water/total area ratio makes it more 
comparable to human breast tissue than a more experimentally produced 
phantom with a fixed water content. It should also be noted that these (relatively) 
minor variations between pork meat tissue did not diminish the large spectral 
differences between pork meat and pork fat and the general findings and 
conclusions. 
 
A specific limitation of the subsurface sampling depth experiments was the 
inability to accurately measure the depth of the material (gelatine phantom or 
lard) overlying the base tissue (pork fat or meat). This means that the results are 
estimations of sampling depths only. The lard overlying meat was particularly 
limiting as no meat signals could be obtained, it would be interesting to see if that 
would still be true with only microns of lard overlying. Due to these limitations the 
subsurface sampling depth of the probe could not be accurately quantified, 
however, clinically relevant deductions regarding the ability to detect tumour 





A general limitation of the experiments is that pork meat and fat and lard may not 
have the same Raman cross section as breast tissue and the results found with 
pork tissue may not be precisely validated in human breast tissue. Similarly, 
spectral differences between pork meat and fat are well defined and precise, 
compared to more heterogenous breast tissue. The ability to differentiate meat 
and fat in these experiments may not equal the diagnostic ability of the system in 
breast tissue. However, the aim of these experiments was to provide a close 
representation of what could be expected with breast tissue and pork tissue is 
the most suitable phantom for breast tissue, as has previously been 
demonstrated in this thesis, and in other studies 371. 
 
The line scan measurements performed at 1 second acquisition time show great 
promise in reducing specimen analysis time, however, it is not just signal 
acquisition time that dictates this. The entire specimen analysis time would need 
to include the movement between step measurements of an electronic stage, or 
the turning of a specimen on a platform to allow measurement of another resected 
edge. Working to reduce the specimen analysis time will be necessary in the 
future. 
 
5.4.3 Further work 
Further work with the HH Raman probe will be with human breast tissue. With 
the understanding of the probe capabilities demonstrated in this chapter, 
measurements on fresh breast tissue can be performed. If it is found e.g. that the 
laser power needs to be reduced, or an uneven specimen surface results in poor 
probe contact with the specimen, the results can now be interpreted accordingly. 
The main emphasis is on using fresh breast tissue to determine the ability of HH 
Raman system to differentiate between tumour and non-tumour tissue. Once this 
has been ascertained, more refined diagnostic capabilities such as the minimal 
detectable tumour size and reducing specimen analysis time can be the focus. 
 
Optimisation of the HH Raman system towards IMA provision can continue 
alongside clinical studies in human breast tissue. Acquisition times of 1 second 
are plausible with the HH Raman system immediately, however, with some 
further work shorter acquisition times look likely to be obtainable. Further work 




fluorescent subtracting baselining, further InGaAs camera cooling 339 and a 
higher quality InGaAs camera with less inherent dark noise 365 are all possible 
and could lead to reduced signal acquisition times. Introducing a mechanical 
electronic stage scan, and a sampling procedure to minimise the overall 
specimen analysis time would all be steps towards translating this technology into 
the clinical sphere. 
 
5.5 Conclusion 
This chapter has presented a new HH Raman system that was constructed to 
address the recognised limitations of the NP3 system that has been used 
previously throughout the thesis. A variety of the probe’s characteristics have 
been explored, demonstrating that laser power, signal acquisition time and probe 
to specimen contact can be changed according to the needs of future 
experimental design, and the impact on these changes on Raman spectra are 
demonstrated. The limitations of the probes subsurface sampling depth are now 
recognised, but this is unlikely to have a negative clinical effect in providing IMA. 
Ultimately the future potential of the probe is demonstrated, in a pork meat/lard 
lumpectomy phantom a line scan could be performed with 1 second signal 
acquisition identifying a ‘tumour’ of 1 mm2. Future work identified will be in human 
breast tissue validating these findings and assessing the diagnostic ability of the 
probe. This is a robust Raman system that has the potential to measure small 
tumours in a clinically relevant time and is the next stage in project development 
towards successfully providing IMA. 
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CHAPTER 6: Discussion 
 
6.1 Summary of Thesis findings 
In the background to this thesis (chapter 1), the primary clinical problem was 
outlined – a large proportion (17%) of women undergoing BCS in the UK have a 
second operation for re-excision of margins 91. This represents a substantial cost 
to health services and is a source of anxiety for patients 372. If it was possible to 
provide accurate Intraoperative Margin Analysis (IMA), this would improve patient 
outcomes and reduce the cost of treating breast cancer in a resource-stretched 
NHS. Raman spectroscopy is capable of rapid, non-invasive tissue analysis 
providing excellent diagnostic accuracy and shows promise for IMA in a number 
of pathologies, and a detailed review of the current literature is presented in 
chapter 1. A common limitation for Raman spectroscopy to provide IMA is that 
the time taken to analyse a specimen can be impractical, due to spectral 
acquisition time and small sampling volumes. The increased spectral intensity in 
the HWN region can reduce measurement times compared to the fingerprint 
region, thus making it an ideal emerging technology that warrants investigation 
to provide IMA. This aim of the thesis was to investigate the potential of HWN RS 
to provide IMA using its high sensitivity to detect protein, lipid and particularly 
water changes, and explore the ability of HWN RS to differentiate tumour from 
non-tumour in breast tissue.  
 
The first step was to develop a Raman system configuration that was capable of 
accurately detecting changes in protein, lipid and water content. Chapter 2 
demonstrates the evolution of the Raman system. All three Raman systems that 
were trialled could measure changes in water content. However, I found that 
surgical pigments (particularly blue dye) that are commonly used in BCS 
produced overwhelming fluorescence with a 680 nm laser excitation wavelength. 
Many previous Raman studies either avoid samples with blue dye 299, wash 
samples or avoid areas with surgical pigments on 174, 189, however, this is 
impractical for clinical ex vivo assessments. A Raman system to provide IMA 
must be accurate in the presence of surgical pigments. I found that capturing the 




785 nm laser with an InGaAs camera – the NP3 system. We are the first group 
to directly address the issue of blue dye fluorescence when capturing the HWN 
region and NP3 is the first Raman system that has been shown to capture the 
HWN region in the presence of blue dye. 
 
In chapter 3 I investigated how the HWN spectra change in response to water 
content, particularly in biological samples. I demonstrated that the Raman water 
peak, and changes with water content of a sample, are affected by the 
microenvironment (whether it was in a protein or lipid rich area) of the water. This 
means that in a biological sample, such as breast tissue, when measurements 
are taken from different microenvironments it is difficult to quantify differences in 
water content with HWN RS. Previous studies have not acknowledged the 
importance that the microenvionment of water has on the ability of HWN RS to 
measure changes in water content 174. These new insights into the influences of 
the microenvironment on the ability of HWN RS to quantify water content in 
complex biological systems help to deepen the understanding of the technique 
within the field. However, the experiments did confirm that changes in water 
content within a homogenous environment can be quantified accurately, and that 
HWN spectral analysis using the water/total area ratio can be used to measure 
differences in water content, and differences in protein or lipid rich areas. 
 
Human breast samples were measured in chapter 4 to investigate if HWN 
Raman, and NP3 could diagnose breast cancer with a view to IMA. It showed 
that breast tumour tissue is a protein rich, high water, low fat environment and 
that non-tumour is a low protein, fat rich environment with a low water content, 
and, for the first time, it was shown that these HWN features can be used to 
differentiate tumour from non-tumour breast tissue using HWN RS with excellent 
accuracy. A number of different spectral analyses were undertaken, with similar 
diagnostic accuracies – of note – the simplest analysis using the water/total area 
ratio had a comparable diagnostic accuracy to complex concatenated spectral 
analysis using PCA fed LDA analysis. No studies have previously compared the 
diagnostic ability of Raman spectra from the HWN region compared to the FP 
region taken from the same measurement spot in breast tissue, and we found 
that the HWN region had a similar diagnostic accuracy, if not marginally better, 




capable of differentiating DCIS only tissue from non-tumour tissue, which is 
important in the provision of IMA, and has not been assessed in other studies 
investigating the HWN region.  
 
Having performed the proof of principle studies, the NP3 system configuration 
was optimised for clinical use by the development of the HH probe in chapter 5. 
The technical capabilities of the probe were assessed, and studies in lumpectomy 
phantoms demonstrated the potential of the system to identify small (<1 mm) 
tumours in measurement times that would allow analysis of a resected specimen 
edge in a clinically relevant timeframe (15 minutes). 
 
Ultimately this thesis has shown, for the first time, the excellent diagnostic 
capability of a Raman system to differentiate tumour from non-tumour using HWN 
RS and this can be performed in the presence of blue dye. The HH probe and 
measurement protocol suitable for clinical use has been developed for the next 
experimental stage to translate these findings towards the provision of IMA.  
These results need to be considered compared to other methods of IMA, and 
how to further these thesis findings and Raman systems into a working clinical 
device for IMA, which is now discussed. 
 
6.2 Clinical applications of thesis findings  
The primary aim was to develop a Raman system to provide IMA. However, some 
of the findings from this thesis have wider implications. In 2018 The Association 
of Breast Surgery Surgical Gap Analysis Working Group published a report of 
suggested areas of focus for future research relating to breast surgery. Raman 
spectroscopy is well suited to a number of these research areas and exploration 
for the potential applications of the technique is warranted 98. A brief summary of 
how some of the findings from this thesis could be exploited for clinical use, or 
areas worthy of further research identified by the ABS Gap analysis (identified by  
*) are highlighted. 
 
- Biochemical understanding of breast cancer. We demonstrate the 
differences between tumour and non-tumour tissue, in the differences in 
protein/lipid, and the substantial differences in water content. These have 




laboratory environment. The results in chapter 4 robustly corroborate 
these findings in human breast tissue, suggesting these biochemical 
differences are easily detectable with HWN RS. 
- Biochemical differences in non-tumour tissue. We found that there is a 
significant physiological variation in water content in normal, non-tumour 
specimens related to age and menopausal status. This may be important 
in understanding the role of Raman spectroscopy in the diagnosis of 
disease states. For example, breast density (which is closely related to 
water content) is an independent breast cancer risk factor 280. This 
detection of physiological differences with HWN RS could be utilised in 
screening or risk assessment etc. for personalised medicine to identify 
patients at an increased risk of breast cancer e.g. those in need of earlier 
or more intensive screening for breast cancer as a way to reduce 
screening overdiagnosis (*). 
- Diagnosis / tumour guidance with needle biopsy. We have shown that a 
Raman system using a needle biopsy (22G) is clinically effective and can 
take measurements to diagnose cancer. This demonstrates that HWN RS 
could be used percutaneously for instant biopsy diagnosis to improve cost-
effectiveness of symptomatic assessment (*), tumour localisation 
guidance (i.e. in replacement of wire guided tumour localisation for 
impalpable tumours) or local brachytherapy. 
- Translating findings to Deep Raman. Using the understanding of changes 
in water content from this thesis has already been translated into furthering 
understanding of HWN RS in Deep Raman, with a view to providing 
transcutaneous Raman measurements for the screening program or to 
complement Mammography 371. 
- Neoadjuvant therapy monitoring(*). An exciting prospect for this specific 
Raman system, would be for monitoring patient tumour response to 
neoadjuvant chemotherapy. Indications for neoadjuvant therapy are 
increasing, and yet there is no accurate way of assessing tumour 
response. Tumour water content changes in response to chemotherapy 






6.3 Comparing findings to other methods of IMA 
It is important to consider the clinical implications of the diagnostic accuracy of a 
system that aims to provide IMA. The aim, as with any diagnostic test, is to have 
as high a sensitivity and specificity as possible, but in reality, there is a balance 
between the two. A system that gives a high degree of sensitivity and low 
specificity would reduce the need for delayed re-excision of margins, but would 
lead to a high number of false positives, unnecessary breast tissue excision and 
an undesirable cosmetic impact 373. A system that has a low sensitivity and high 
specificity may not identify positive margins and not reduce the delayed re-
excision rate sufficiently enough to be of practical use. The sensitivity and 
specificity of our system presented in this thesis needs to be considered in the 
context of other methods of IMA for breast conserving surgery. 
 
A number of established techniques have been previously used to provide IMA  
in breast conserving surgery, however, none have gained widespread adoption 
– invariably due to logistical difficulties or ultimately poor clinical outcomes. A 
review of the commonly used techniques is in Chapter one of this thesis, a 
summary of the sensitivity and specificity of established techniques along with 
their clinical advantages and disadvantages is displayed in Table 6-1. These 
results show that radiological techniques of ultrasound and X-ray give very poor 
sensitivity, and thus do not adequately reduce the need for re-excision of 
margins. Frozen section and cytology are both pathological techniques that 
require real-time histopathology/cytology expertise availability. Although this 
gives them the best diagnostic accuracy, it is also their disadvantage as these 
are expensive services to run – providing the service is only cost effective when 
there are unusually high rates of delayed re-excision of over 36% 132. It may also 
be that the diagnostic accuracy found in funded research studies from specialist 
centres may not translate to equitable clinical benefit in a more ‘normal’ setting of 
a time-pressured, non-academic, routine service. This is the likely reason for 
these methods not being routinely used, but despite these disadvantages, frozen 
section and cytology have the best sensitivity and specificity, and this accuracy 









SENS. SPEC. ADVANTAGES DISADVANTAGES 
FROZEN 
SECTION 
86% 96% Established technology 
and used in other 
surgical oncology 
Expensive as requires 
histopathologist on 
stand-by 
CYTOLOGY 91% 95% Proven efficacy Expensive. Surface 
technique only - Cannot 
provide information on 
margin width. Decline in 




59% 81% Cheap and available 
technology 
Operator dependent. 
Requires surgeon to be 





53% 84% Cheap and available 
technology 




There are a number of new, emerging technologies that aim to provide IMA. 
Some have been available for a number of years, have undergone assessment 
in the clinical environment, and are approved by regulatory bodies.  
 
The MarginProbe ® (DUNE Medical Devices, Alpharetta, Georgia, USA) is a 
handheld probe that provides IMA on resected specimens using radiofrequency. 
In a study that assessed the diagnostic accuracy of the probe compared to 
histopathology diagnosis, the sensitivity was dependent on the size of the tumour 
– with an overall sensitivity and specificity of 70% 369. The diagnostic accuracy 
was dependent on the size of the tumour (large tumours had very good accuracy, 
however, it is unlikely there are large tumours at the resected edge that would 
require IMA), and heterogenous tumours affected the specificity. Despite these 
limitations the device has had a number of clinical trials, stating promising initial 
results, in one study there was a 57% reduction in re-operation rates, however 
the ‘control’ arm (that did not undergo IMA with the device) had a re-excision rate 
Table 6-1 Table demonstrating the sensitivity (Sens.) and specificity (spec.) of commonly used 
Intraoperative Margin Analysis (IMA) techniques 
The figures for sensitivity and specificity obtained from the pooled meta-analysis of techniques from 
reference 136. Studies were clinical studies where the IMA technique outcome (positive/negative margin) was 




of 30%, which is substantially higher than the UK average of 17% 91, and the re-
excision rate was reduced to 14% 374. Another, subsequent study had similar 
results – a high re-excision rate in the control arm of 39% with the re-excision 
rate being reduced to 17% (the current UK average) 370. Neither of the studies 
reduced the re-excision rate substantially below the current UK average. 
However, these results have attracted enough attention for the MarginProbe to 
be the subject of randomised control trial in the UK, the results of which are 
awaited 375. 
 
The ClearEdge (LS BioPath, Saratoga, CA, USA) is a handheld probe that uses 
bioimpedance spectroscopy to analyse tissue and has had more limited clinical 
evaluation. Preliminary results of the diagnostic accuracy of the probe of breast 
tissue matching to the histopathology could not be found on a literature search, 
nor referenced in relevant papers, or on the company website. A single clinical 
study composed of two phases using the device was performed, where the 
outcome recorded from the probe analysis of a margin was compared to the final 
histopathology of the specimen margin, and it gave a sensitivity of 84-87% and 
specificity of 82-75% 266. A result of note is that in the patients where the device 
was used appropriately (which did not always occur), the re-excision rate was 
reduced from 37% (unusually high) to 17% (the current UK average). This 
diagnostic accuracy is reasonable, however, with no preliminary data it is difficult 
to compare against this technology, and the clinical results were acceptable but 
only from a single study, and so further evidence is required before being able to 
make judgements on the diagnostic accuracy of the device. 
 
In these two ‘at market’ products that have undergone clinical evaluation it is 
interesting that when using either devices, the re-excision rate was only ‘reduced’ 
to the current UK average for re-excision (17%), which is the re-excision rate 
without the use of these devices. It does suggest that, although useful in those 
units with an initial high re-excision rate, there is significant room for 
improvement, and the problem of re-excision in breast conserving surgery is 
unlikely to be solved by currently available products.  
 
Novel techniques that are currently at the development stage have therefore 




iKnife, a monopolar hand piece that analyses the diathermy plume of smoke, was 
used for analysis of 260 breast tissue specimens that gave a sensitivity of 90.9% 
and specificity of 98.8% in differentiating between tumour and non-tumour 
samples 376. However, validation of results was by whole specimen final 
pathological diagnosis rather than specific matching of measurement points to a 
corresponding histological analysis. Another obvious limitation of this technique 
for IMA is that it requires the diathermy to go into tumour before giving a result, 
which is not what a surgeon would be aiming for, and it would also not give 
feedback on ‘close’ margins.  
 
Optical techniques have been studied to provide the diagnostic accuracy of 
differentiating tumour from non-tumour tissues, the limitations of which are 
discussed in chapter 1. Some techniques have relatively poor diagnostic 
accuracy such as  Terahertz imaging (Accuracy of 75%, sensitivity 86% and 
specificity 66%) 288 and Diffuse Optical Spectroscopy (sensitivity 81-88% and 
specificity 79-84%) 283. Optical Coherence Tomography (OCT) had initially 
promising results, with work in human breast tissue showing an accuracy of 
91.9% with a sensitivity of 98.1% and specificity 82.4% 377 at differentiating 
tumour from fibroglandular tissue, however, when used to provide IMA in cavity 
shaves from lumpectomy specimens the technique only identified 5 out of 8 
specimens with positive margins, giving it a sensitivity of 62.5% 146. Image 
interpretation was performed by clinicians, and may have contributed to the poor 
accuracy, exemplifying the need for clear outcomes from a clinical device.   
 
A number of groups have investigated Raman spectroscopy to examine the 
accuracy of differentiating tumour from non-tumour specimens, the results of 












ARTICLE RAMAN SYSTEM SPECIMENS SENS SPEC LIMITATIONS TO 
CLINICAL USE 






83% 93% Poor positive 
predictive value of 
36% 
Long acquisition times 






95.6% 96.2% Microscopic diagnosis 
only – not applicable 
to large tissue 










95% 82% Raman measurements 
from specimens were 
not always matched 
with histopathology 
Only one resected 
edge could be 
analysed in clinically 
relevant time 
  






89% 92% Specimen processing 
steps for 
Nanoparticles result in 
overall long 
measurement times 
Small number of 
samples (n=5) 
 
The aim of reviewing these other techniques and previous Raman work is to 
establish what diagnostic accuracy is required from our own Raman system for it 
to be clinical useful, and ‘competitive’ to other more established techniques. It 
would seem the general accuracy for the established techniques is low, hence 
why there is a continued need for methods of IMA. A technique with a sensitivity 
over 85%, and a specificity of over 90% would be comparable to the techniques 
of frozen section and cytology. Compared to the emerging techniques, including 
other work from Raman spectroscopy, a system that could achieve both 
sensitivity of around 90%-92% and specificity of 86-89% would be highly 
favourable. The results from chapter 4 suggest that with NP3 probe and using 
the mean concatenated spectrum from homogenous areas in a PCA fed LDA 
analysis, the system can achieve a sensitivity of 93.8% and a specificity of 92.7% 
Table 6-2 Summary table of diagnostic accuracy of different techniques based on Raman 
spectroscopy for differentiating normal breast tissue from breast tumour. 




at differentiating tumour from non-tumour tissue. This ability to differentiate 
between tumour and non-tumour tissue exceeds the diagnostic accuracy of the 
‘at market’ probes of Marginprobe and ClearEdge, the optical techniques that are 
currently under development and previous Raman studies. If this translates into 
clinical practice this is comparable diagnostic accuracy to the pathological 
methods of frozen section and cytology, and exceeds the commonly used 
methods of US and specimen X ray. However, there does have to be caution in 
the interpretation of how our study data may translate into clinical results due to 
the study limitations.  
 
6.4 Limitations  
There are some limitations to the presented work that require consideration and 
identify areas for future work for translating HWN RS into a clinical effective 
technology to provide IMA. 
 
We were unable to quantify the changes in water content between tumour and 
non-tumour breast tissue. Although this would have been useful to achieve in the 
study, experimental results demonstrated that this is not possible using HWN RS 
in different breast tissue types. In chapter 3 it was shown that changes in the 
water peak in the HWN region was influenced as much by changes in the 
microenvironment of the water, as they were by changes in water content. This 
was confirmed in the dehydration experiments in chapter 4, where different 
water/total area ratio values were obtained for entirely desiccated specimens of 
tumour and non-tumour samples, showing that the ratio values cannot be 
comparable between tissue types. This means that we cannot assign a water 
concentration to the spectral findings in human breast tissue. Although this does 
not impact on the ability to provide IMA, the inability to quantify changes in water 
content between different breast tissue limits our assessment of the role of water 
in diagnosis with HWN RS and ability to compare with water values obtained with 
other techniques. However, the dehydration experiments in chapter 4, and 
spectral analysis demonstrates that there are substantial differences in water 
content between tumour (water rich) and non-tumour (water poor) breast tissue, 





One limitation is that the human breast tissue measured was tissue that had been 
frozen. A previous study suggested that there were no significant differences in 
the Fingerprint Raman spectrum between fresh or frozen breast tissue189, 
however, this may not be true in the HWN region, as frozen samples may have a 
different water content compared to the ‘true’ water content of fresh tissue. Water 
content of the specimen is likely to be affected by the freeze/thaw cycle. However, 
the samples were immediately snap frozen on collection and measured rapidly 
on thawing, reducing the time for dehydration.  
 
Small biopsy samples were measured in this study, where the water in the tissue 
may behave differently to the larger samples of breast tissue that would be 
measured for IMA. Small biopsy samples are often used in preliminary work, 
which may have substantial biochemical or logistical differences in their sampling 
methods compared to in the clinical study of an entire lumpectomy specimen.  
Although it should be noted that one would expect more rapid dehydration from 
smaller samples (due to the increased surface area), and so the differences in 
water content between tissue types may actually be underestimated in smaller 
samples, so it is unlikely these changes in water content would not be seen in 
larger specimens of fresh tissue.  
 
The measured samples are relatively homogenous samples of tumour tissue 
(taken from the centre of the tumour) and non-tumour tissue (taken far from the 
tumour). It may be that the stark difference in water content between the two 
tissue types, in reality, is more of a gradual change in water content from high 
(tumour) to low (normal), as was found between 0 – 4 mm from the tumour margin 
in oral cavity squamous cell carcinoma with HWN RS 228. A study using DRS 
suggested that the water content at the border of the tumour may differ from the 
centre of the tumour and normal breast tissue (>1 cm from the tumour edge) 293. 
This gradual change in water content may assist in the identification of tumour 
margins and ‘close’ margins, and would benefit from further studies to investigate 
if there is a gradual change in water content from the tumour edge. The thesis 
has demonstrated that the difference in water content (as measured by 
water/total area ratio) between pure tumour and pure normal tissue is substantial, 
and if there is a gradual change this would very likely be measurable with our 





The sample size of 96 in the study is a reasonable number, however, it is too 
small to draw definitive conclusions regarding potential differences between 
pathological sub-types. There are a number of differences between breast 
cancers such as receptor status or grade. Our analysis suggested that neither 
the fingerprint nor HWN region identified significant differences between 
pathological sub-types, but this may be due to the small sample size, and the 
study was under-powered to detect subtle differences. 
 
There is some suggestion from our data that lobular carcinoma may prove to be 
a diagnostic challenge, as it has a lower water/total area ratio than ductal 
carcinoma, and the Raman micro-spectroscopy studies showed that Raman 
spectra of lobular carcinoma has similarities to normal breast tissue. Further work 
is needed, with larger numbers of lobular carcinoma to investigate this. It may be 
that additional information from the fingerprint spectrum may aid in refining the 
diagnosis. 
 
There was an insufficient number of DCIS only tumour samples to be confident 
that the Raman system can differentiate between DCIS only and normal tissue. 
The ability to detect DCIS only is essential for IMA, as DCIS accounts for a large 
number of positive margins that require re-excision. The results suggest that the 
Raman system is capable of diagnosis, and are encouraging, but further work 
with a greater number of DCIS only samples is required. 
 
This study has provided the proof of principle that was necessary to demonstrate 
that HWN RS can differentiate between tumour and non-tumour tissue, however 
the NP3 system is a needle probe, which is not a suitable delivery system for 
providing IMA as it has a small sampling volume. The time taken for each 
individual spectral measurement (25 seconds) is also not suitable for clinical use. 
Ultimately it would take too long to analyse an entire BCS specimen using the 
delivery system and the acquisition times used in the study in chapter 4. 
 
Many of the limitations of the NP3 system have been addressed in the 
development of the HH Raman system that is presented in chapter 5. There are 




further work developing the delivery system capable of providing IMA in a 
clinically relevant time. The measurement acquisition times will need to reduce to 
the minimal amount of time necessary to achieve adequate signal to noise for 
diagnosis. This study has demonstrated that the spectral differences between 
tissue types, particularly in the HWN region, are stark and so it is likely this will 
be achievable as even with a substantial reduction in signal to noise the 
differences would still be detectable and measurable, particularly if the water/total 
area ratio was used for diagnosis. In Chapter 5, adequate spectra could be 
obtained with acquisition times as little as 0.5 seconds, and with some 
optimisation (such as improved hardware and optimised spectra processing) this 
could be reduced even further.  
 
Although this study has demonstrated our Raman system has a good diagnostic 
accuracy differentiating between tumour and not tumour when matched to 
histopathology, this is different to reducing the rate of re-excision which is the 
ultimate aim. The number of steps between tissue differentiation and providing 
IMA are multiple, and the ‘diagnostic accuracy’ can get reduced at every stage. 
Initially promising results in laboratory conditions can be disappointing in a clinical 
setting, as was the case with Diffuse Optical Spectroscopy 148. Logistical 
difficulties can also intercede, such as in the ClearEdge study were surgeons 
misinterpreted the probe results 266. However, the opposite can also be true such 
as with the MarginProbe, where initial assessment of tissue differentiation 
seemed poor, but the clinical results at reducing re-excision rate is more 
impressive 370. 
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CHAPTER 7: Further Work and Conclusion 
 
7.1 Further Work 
7.1.1 Validation of diagnostic findings in fresh breast tissue 
The immediate next phase for the project is to validate the thesis findings in 
freshly excised breast tissue. A limitation of the breast tissue study is that the 
specimens were frozen and thawed, which may affect the water content of the 
specimens, or there may be other biochemical differences between frozen and 
fresh specimens. Previous studies suggest that there are minimal differences in 
the Raman spectra between fresh and frozen breast tissue 189, but our findings 
still require validation in fresh tissue.  
 
The aims would be to confirm and validate the diagnostic ability of HWN RS to 
differentiate between tumour and non-tumour breast tissue in fresh specimens 
using the HH Raman system. It would also give us insight into the differences in 
water content between tissue types, and allow exploration of the concept that 
there may be a gradual change in water content from the centre of the tumour to 
the tumour edge and towards normal tissue. We have already gained ethical and 
local approval for this study (REC ref: 18/NW/0366, IRAS ID: 210732), using 
freshly excised breast tissue of mastectomy and lumpectomy specimens that will 
be sliced in half to expose the tumour surface, allowing Raman measurements to 
be taken from tumour and non-tumour tissue. A diagram will indicate to the 
pathologist where measurements have been obtained, and this will allow for a 
block to be taken for histopathological diagnosis to allow pathology matching with 
the Raman measurements. Initial ethical approval is for 50 patients to be recruited 
for the study. 
 
Once the initial phase is completed, and if the thesis diagnostic findings are 
confirmed in fresh tissue, we may need to extend the study. This may be 
necessary to increase sample size to ensure all pathology subtypes are 
encountered during analysis, especially adequate numbers of DCIS and lobular 
carcinoma, as these are potential diagnostic challenges. There should also be 
some histological matching for normal tissue, to investigate the Raman spectra 





7.1.2 Probe optimisation 
Alongside validation of diagnostic accuracy of the HH Raman system in 
differentiating tumour from non-tumour tissue, probe optimisation is required. 
This is to develop a probe that is capable of analysing a lumpectomy in a clinically 
relevant time frame (<30 minutes). 
 
Two components of this optimisation are to reduce the signal acquisition times 
for each measurement, or to reduce the number of measurements required to 
accurately analyse a specimen. The signal acquisition time needs further 
investigation to discover what is the shortest signal acquisition time possible that 
still gives a diagnostic Raman spectrum, this can be done by testing a number of 
signal acquisition times as part of the fresh breast tissue experiments. The main 
limitation to reducing the signal acquisition time currently is the high degree of 
detector noise from the InGaAs camera, which is a known limitation of this type 
of camera. However, technology is improving, and there are recent reports of 
novel deep cooled InGaAs cameras that have a lower noise characteristics, 
comparable to those of CCD cameras 365. Assessment of the detector noise 
characteristics of different InGaAs cameras may be necessary to identify the 
optimal hardware for reducing signal acquisition times. 
 
Another method to reduce signal acquisition times is to reduce the number of 
spectra required for specimen assessment. If the beam area of the probe was 
increased to increase the probe’s ‘field of view’, this would reduce the number of 
measurements required to measure the entire specimen. Further work to assess 
how much the probe area can be increased without a reduction in diagnostic 
accuracy is required. 
 
We have developed a handheld probe for the initial phases of the project, and it 
may be that this is the most suitable device for the clinical environment. The 
margin of concern to the surgeon can be easily analysed using a clinical probe, 
and the fact that the other ‘at market’ devices for IMA are also handheld probes 
(ClearEdge and MarginProbe) suggests that this might be the most effective way 
of IMA. However, other devices should be considered, whether that is an 




probe (such as an automated stage with rapid raster scanning for analysis of a 
single margin), or a more complex device allowing all margins to be analysed 
such as the Marginbot 265. A recently reported Raman system using a 2 axis 
galvo-mirror system and a microscope with a large field of view may provide rapid 
analysis, and our configuration could be incorporated into a similar system 299. 
These possibilities should be explored to determine the optimal device for 
delivering IMA in clinically relevant times. 
 
7.1.3 Data analysis optimisation 
The results in this thesis from the analysis of frozen breast tissue suggests that 
the diagnostic ability from the water/total area ratio and PCA fed LDA analysis of 
the HWN or FP region and the concatenated spectra were similar. The planned 
fresh tissue studies will help to clarify this further, and assist in deciding the exact 
diagnostic route that should be used for IMA; a suggested algorithm based on 
the thesis results is presented in Chapter 4, but this may alter depending on the 
results of this further work. 
 
Data analysis needs to be as rapid as possible, to reduce the time taken for 
specimen analysis. It also needs a simple output for each of the analysed 
specimen resected edges that is easily interpretable to the surgeon, to allow them 
to make a clinical decision to excise further tissue or not. A suggested simplified 
algorithm based just on the water/total area ratio is presented in chapter 5. 
 
7.1.4 Clinical trial  
Once these phases of optimisation have been successfully completed, we could 
be confident that we have a Raman system that can differentiate between tumour 
and non-tumour tissue accurately, can analyse a lumpectomy specimen in 
clinically relevant times and the data can be presented in a clinically meaningful 
way to a surgeon. At this stage a clinical study assessing the ability of the final 
Raman system to provide IMA is necessary, along with commercialisation of the 
probe. This will involve recruiting patients undergoing lumpectomy and analysing 
the margins of specimens and determining the sensitivity and specificity of the 
system of detecting positive margins compared to the final histopathology report. 
The next phase is a randomised controlled trial with one arm using the IMA 




arm being surgeons continuing their usual methods of IMA. The measurable 
outcome will be if the Raman IMA system reduces the re-excision rate with 
minimal unnecessary breast volume loss. 
 
7.2 Conclusion 
This thesis presents a Raman system, and method of spectral analysis, capable 
of quantifying changes in water content in a number of different environments 
using HWN RS. This is unaffected by the presence of commonly used surgical 
pigments. I explored the optical influences on Raman spectra in the HWN region, 
and concluded the interpretation of the water peak is dependent on its 
microenvironment. This formed the basis for a study using human breast tissue 
which demonstrated, for the first time, that HWN RS has an excellent diagnostic 
accuracy in differentiating tumour from non- tumour specimens. These findings 
could be useful in a number of novel ways in future clinical applications, but 
providing IMA is the immediate focus for further work and development. Our study 
results compare favourably, if not better, than current and emerging methods for 
IMA.  
 
Further work must focus on assessing the diagnostic ability of HWN RS in larger 
volumes of freshly excised breast tissue in a large number of patients, and in the 
future, translating this proof of principle into the operating theatre to improve 
patient outcomes in BCS and reduce the need for surgical re-excision.  
 
This thesis has demonstrated that high wavenumber Raman Spectroscopy has 
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